false 0001498148 0001498148 2026-03-01 2026-05-31 0001498148 dei:BusinessContactMember 2026-03-01 2026-05-31 0001498148 2026-02-28 0001498148 2025-02-28 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2025-02-28 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember 2025-02-28 0001498148 2026-05-31 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2026-05-31 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesGPreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember 2026-05-31 0001498148 us-gaap:SubsequentEventMember 2026-07-15 0001498148 2025-03-01 2026-02-28 0001498148 2024-03-01 2025-02-28 0001498148 AITX:CostOfGoodsSoldMember 2025-03-01 2026-02-28 0001498148 AITX:CostOfGoodsSoldMember 2024-03-01 2025-02-28 0001498148 AITX:DepreciationAndAmortizationMember 2025-03-01 2026-02-28 0001498148 AITX:DepreciationAndAmortizationMember 2024-03-01 2025-02-28 0001498148 AITX:LossOnDisposalOfRevenueEarningDevicesMember 2025-03-01 2026-02-28 0001498148 AITX:LossOnDisposalOfRevenueEarningDevicesMember 2024-03-01 2025-02-28 0001498148 2025-03-01 2025-05-31 0001498148 AITX:CostOfGoodsSoldMember 2026-03-01 2026-05-31 0001498148 AITX:CostOfGoodsSoldMember 2025-03-01 2025-05-31 0001498148 AITX:DepreciationAndAmortizationMember 2026-03-01 2026-05-31 0001498148 AITX:DepreciationAndAmortizationMember 2025-03-01 2025-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-02-29 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-02-29 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-02-29 0001498148 us-gaap:CommonStockMember 2024-02-29 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-02-29 0001498148 us-gaap:RetainedEarningsMember 2024-02-29 0001498148 2024-02-29 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:CommonStockMember 2025-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0001498148 us-gaap:RetainedEarningsMember 2025-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:CommonStockMember 2026-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-02-28 0001498148 us-gaap:RetainedEarningsMember 2026-02-28 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-03-01 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:CommonStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-03-01 2025-02-28 0001498148 us-gaap:RetainedEarningsMember 2024-03-01 2025-02-28 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:CommonStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-03-01 2026-02-28 0001498148 us-gaap:RetainedEarningsMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-03-01 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:CommonStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-03-01 2026-05-31 0001498148 us-gaap:RetainedEarningsMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2026-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-05-31 0001498148 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-05-31 0001498148 us-gaap:CommonStockMember 2026-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-05-31 0001498148 us-gaap:RetainedEarningsMember 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2017-07-25 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesEPreferredStockMember 2017-08-27 2017-08-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesFPreferredStockMember 2017-08-27 2017-08-28 0001498148 us-gaap:CommonStockMember AITX:EquityFinancingAgreementMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-31 0001498148 srt:ControllerMember 2025-03-01 2026-02-28 0001498148 srt:ControllerMember 2026-02-28 0001498148 srt:ControllerMember 2025-02-28 2025-02-28 0001498148 srt:ControllerMember 2025-02-28 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:TwoCustomerMember 2025-03-01 2026-02-28 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:OneCustomerMember 2024-03-01 2025-02-28 0001498148 AITX:TwoCustomerMember 2026-02-28 0001498148 AITX:OneCustomerMember 2025-02-28 0001498148 AITX:IncentiveCompensationPlanMember 2025-03-01 2026-02-28 0001498148 AITX:IncentiveCompensationPlanMember 2024-03-01 2025-02-28 0001498148 srt:ControllerMember 2026-03-01 2026-05-31 0001498148 srt:ControllerMember 2026-05-31 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:TwoCustomerMember 2026-03-01 2026-05-31 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:ThreeCustomerMember 2024-03-01 2025-02-28 0001498148 AITX:TwoCustomerMember 2026-05-31 0001498148 AITX:OneCustomerMember 2025-05-31 0001498148 AITX:IncentiveCompensationPlanMember 2026-03-01 2026-05-31 0001498148 AITX:IncentiveCompensationPlanMember 2025-03-01 2025-05-31 0001498148 us-gaap:ComputerEquipmentMember 2026-02-28 0001498148 us-gaap:FurnitureAndFixturesMember 2026-02-28 0001498148 us-gaap:OfficeEquipmentMember 2026-02-28 0001498148 AITX:WarehouseEquipmentMember 2026-02-28 0001498148 AITX:DemoDevicesMember 2026-02-28 0001498148 us-gaap:VehiclesMember 2026-02-28 0001498148 us-gaap:LeaseholdImprovementsMember 2026-02-28 0001498148 us-gaap:ComputerEquipmentMember srt:MinimumMember 2026-05-31 0001498148 us-gaap:ComputerEquipmentMember srt:MaximumMember 2026-05-31 0001498148 us-gaap:OfficeEquipmentMember 2026-05-31 0001498148 AITX:ManufacturingEquipmentMember 2026-05-31 0001498148 AITX:WarehouseEquipmentMember 2026-05-31 0001498148 us-gaap:ToolsDiesAndMoldsMember 2026-05-31 0001498148 AITX:DemoDevicesMember 2026-05-31 0001498148 us-gaap:VehiclesMember 2026-05-31 0001498148 us-gaap:LeaseholdImprovementsMember 2026-05-31 0001498148 us-gaap:FairValueInputsLevel1Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel2Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel3Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel1Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel2Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel3Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel1Member 2026-05-31 0001498148 us-gaap:FairValueInputsLevel2Member 2026-05-31 0001498148 us-gaap:FairValueInputsLevel3Member 2026-05-31 0001498148 AITX:SimpleAgreementForFutureEquityMember 2022-12-23 0001498148 2024-06-03 2024-06-03 0001498148 us-gaap:SeriesAPreferredStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:CommonStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:WarrantMember 2025-01-03 2025-01-03 0001498148 us-gaap:SeriesAPreferredStockMember 2025-02-28 0001498148 us-gaap:WarrantMember 2025-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2024-03-01 2025-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-02-28 0001498148 us-gaap:AutomobilesMember 2026-02-28 0001498148 us-gaap:AutomobilesMember 2025-02-28 0001498148 AITX:DemoDevicesMember 2025-02-28 0001498148 us-gaap:ToolsDiesAndMoldsMember 2026-02-28 0001498148 us-gaap:ToolsDiesAndMoldsMember 2025-02-28 0001498148 us-gaap:MachineryAndEquipmentMember 2026-02-28 0001498148 us-gaap:MachineryAndEquipmentMember 2025-02-28 0001498148 us-gaap:ComputerEquipmentMember 2025-02-28 0001498148 us-gaap:OfficeEquipmentMember 2025-02-28 0001498148 us-gaap:FurnitureAndFixturesMember 2025-02-28 0001498148 AITX:WarehouseEquipmentMember 2025-02-28 0001498148 us-gaap:LeaseholdImprovementsMember 2025-02-28 0001498148 us-gaap:AutomobilesMember 2026-05-31 0001498148 us-gaap:MachineryAndEquipmentMember 2026-05-31 0001498148 us-gaap:ComputerEquipmentMember 2026-05-31 0001498148 us-gaap:FurnitureAndFixturesMember 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-03-01 2026-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2026-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2026-03-01 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-03-01 2025-05-31 0001498148 AITX:FixedAssetsMember 2025-03-01 2026-02-28 0001498148 AITX:FixedAssetsMember 2024-03-01 2025-02-28 0001498148 AITX:RevenueEarningDevicesMember 2025-03-01 2026-02-28 0001498148 AITX:RevenueEarningDevicesMember 2024-03-01 2025-02-28 0001498148 AITX:FixedAssetsMember 2026-03-01 2026-05-31 0001498148 AITX:FixedAssetsMember 2025-03-01 2025-05-31 0001498148 AITX:RevenueEarningDevicesMember 2026-03-01 2026-05-31 0001498148 AITX:RevenueEarningDevicesMember 2025-03-01 2025-05-31 0001498148 us-gaap:InvestorMember 2019-02-01 2019-02-01 0001498148 us-gaap:InvestorMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorOneMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorOneMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorTwoMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorTwoMember 2020-02-29 2020-02-29 0001498148 us-gaap:InvestorMember 2025-03-01 2026-02-28 0001498148 AITX:InvestorOneMember 2019-11-18 0001498148 AITX:InvestorOneMember 2019-11-18 2019-11-18 0001498148 us-gaap:InvestorMember 2020-02-29 0001498148 AITX:InvestorOneMember 2020-05-31 0001498148 AITX:InvestorTwoMember 2019-12-30 0001498148 AITX:InvestorTwoMember 2019-12-30 2019-12-30 0001498148 AITX:InvestorTwoMember 2020-02-29 0001498148 us-gaap:InvestorMember 2020-04-22 0001498148 us-gaap:InvestorMember 2020-04-22 2020-04-22 0001498148 us-gaap:InvestorMember 2020-07-01 2020-07-01 0001498148 us-gaap:InvestorMember AITX:SimilarAgreementMember 2020-07-01 2020-07-01 0001498148 us-gaap:InvestorMember AITX:AgreementOneMember 2019-02-01 0001498148 us-gaap:InvestorMember AITX:AgreementTwoMember 2019-11-18 0001498148 us-gaap:InvestorMember AITX:AgreementThreeMember 2020-07-01 0001498148 us-gaap:InvestorMember 2020-08-27 0001498148 us-gaap:InvestorMember 2020-08-31 2020-08-31 0001498148 us-gaap:InvestorMember AITX:AgreementMember 2020-08-27 2020-08-27 0001498148 2021-03-01 0001498148 us-gaap:InvestorMember srt:MaximumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember srt:MinimumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-05-31 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-05-31 0001498148 us-gaap:InvestorMember 2026-02-28 0001498148 us-gaap:InvestorMember 2025-02-28 0001498148 us-gaap:InvestorMember 2026-03-01 2026-05-31 0001498148 us-gaap:InvestorMember 2020-08-27 2020-08-27 0001498148 us-gaap:InvestorMember 2026-05-31 0001498148 us-gaap:RelatedPartyMember 2026-02-28 0001498148 us-gaap:RelatedPartyMember 2025-02-28 0001498148 us-gaap:RelatedPartyMember 2025-03-01 2026-02-28 0001498148 us-gaap:RelatedPartyMember 2024-03-01 2025-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2026-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2025-03-01 2026-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2025-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2024-03-01 2025-02-28 0001498148 2023-12-01 2023-12-31 0001498148 us-gaap:SeriesGPreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:RelatedPartyMember 2026-05-31 0001498148 us-gaap:RelatedPartyMember 2026-03-01 2026-05-31 0001498148 srt:ChiefExecutiveOfficerMember 2026-03-01 2026-05-31 0001498148 srt:ChiefExecutiveOfficerMember 2023-12-01 2023-12-31 0001498148 srt:ChiefExecutiveOfficerMember 2025-03-01 2025-05-31 0001498148 srt:ChiefExecutiveOfficerMember us-gaap:SeriesGPreferredStockMember 2026-05-31 0001498148 AITX:PromissoryNotePayableOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableNineteenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFiveMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySixMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFortyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFiveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableNineMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableElevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableElevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-05-31 0001498148 AITX:PurchaseAgreementMember 2026-03-01 2026-05-31 0001498148 AITX:PurchaseAgreementMember 2026-05-31 0001498148 AITX:PurchaseAgreementOneMember 2026-03-01 2026-05-31 0001498148 AITX:PurchaseAgreementOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2026-03-01 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-05-31 0001498148 AITX:BusinessLoanMember 2026-03-01 2026-05-31 0001498148 AITX:BusinessLoanMember 2026-05-31 0001498148 AITX:ConvertibleNoteMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-05-31 0001498148 AITX:ConvertibleNoteOneMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-03-01 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-05-31 0001498148 AITX:ConvertibleNoteFiveMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteFiveMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2026-05-31 0001498148 AITX:ConvertibleNoteSevenMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSevenMember 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-05-05 2026-05-05 0001498148 AITX:PromissoryNotePayableTwoMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThreeMember 2023-03-01 2024-02-29 0001498148 AITX:PromissoryNotePayableThreeMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableThreeMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThreeMember 2026-02-08 0001498148 AITX:PromissoryNotePayableThreeMember 2026-02-08 2026-02-08 0001498148 AITX:PromissoryNotePayableSixMember 2024-03-01 0001498148 AITX:PromissoryNotePayableSevenMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineMember 2024-03-01 0001498148 AITX:PromissoryNotePayableNineMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableNineMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineMember 2025-02-11 2025-02-11 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-05 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-05 2025-03-05 0001498148 AITX:PromissoryNotePayableTenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableElevenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableElevenMember 2025-03-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2022-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-11-24 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-11-24 2025-11-24 0001498148 AITX:PromissoryNotePayableThirteenMember us-gaap:SeriesFPreferredStockMember 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember srt:DirectorMember us-gaap:SeriesFPreferredStockMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-03-01 2025-08-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-04-25 2025-04-25 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-04-25 0001498148 AITX:PromissoryNotePayableFourteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableFifteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableSeventeenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEighteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableNineteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:LenderMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:LenderMember us-gaap:SeriesFPreferredStockMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-10-26 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2023-10-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2025-11-24 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-02-29 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember AITX:SeriesFPreferredshareWarrantsMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyTwoMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyThreeMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyFourMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyFiveMember AITX:SeriesFPreferredshareWarrantsMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySixMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentySixMember AITX:SeriesFPreferredshareWarrantsMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentySixMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentySevenMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyNineMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentyNineMember AITX:SeriesFPreferredshareWarrantsMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2024-03-01 0001498148 AITX:PromissoryNotePayableThirtyMember 2023-10-27 0001498148 AITX:PromissoryNotePayableThirtyMember AITX:SeriesFPreferredshareWarrantsMember 2023-10-27 0001498148 AITX:PromissoryNotePayableThirtyMember 2024-03-01 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2023-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2023-11-30 2023-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2024-07-01 2024-07-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2024-07-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThirtyTwoMember AITX:LenderMember 2024-03-08 0001498148 AITX:PromissoryNotePayableThirtyTwoMember AITX:LenderMember 2024-03-08 2024-03-08 0001498148 AITX:PromissoryNotePayableThirtySixMember 2025-08-25 2025-08-25 0001498148 AITX:PromissoryNotePayableFourtyMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyOneMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyOneMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyTwoMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableFourtyTwoMember srt:MinimumMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableFourtyTwoMember srt:MaximumMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableFourtyTwoMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyTwoMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyThreeMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyThreeMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFourMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFourMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFiveMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyFiveMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySixMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySixMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySevenMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtySevenMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyEightMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyEightMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyNineMember 2026-02-28 0001498148 AITX:PromissoryNotePayableFourtyNineMember 2025-06-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-12-10 0001498148 AITX:PromissoryNotePayableThreeMember 2025-11-24 0001498148 AITX:PromissoryNotePayableFiveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableFiveMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableFiveMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSixMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEightMember 2024-03-01 0001498148 AITX:PromissoryNotePayableEightMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEightMember 2025-02-11 2025-02-11 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-05 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-05 2025-03-05 0001498148 AITX:PromissoryNotePayableTenMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableTenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEighteenMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:SeriesFPreferredshareWarrantsMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-03-01 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-09 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteOneMember 2022-11-10 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteOneMember 2024-03-01 0001498148 AITX:PromissoryNoteOneMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteOneMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2022-11-15 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2024-03-01 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteTwoMember 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteThreeMember 2023-01-11 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteThreeMember 2024-03-01 0001498148 AITX:PromissoryNoteThreeMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteThreeMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNoteFourMember AITX:SeriesFPreferredshareWarrantsMember 2023-02-06 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteFourMember 2024-03-01 0001498148 AITX:PromissoryNoteFourMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteFourMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNoteFiveMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-05 0001498148 AITX:PromissoryNoteFiveMember AITX:SeriesFPreferredshareWarrantsMember 2024-03-01 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteFiveMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteFiveMember 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2023-04-20 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2024-03-01 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSixMember 2026-05-31 0001498148 AITX:PromissoryNoteSevenMember AITX:SeriesFPreferredshareWarrantsMember 2023-05-11 0001498148 AITX:SeriesFPreferredshareWarrantsMember AITX:PromissoryNoteSevenMember 2024-03-01 0001498148 AITX:PromissoryNoteSevenMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteSevenMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2023-10-27 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2024-03-01 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNoteEightMember AITX:SeriesFPreferredshareWarrantsMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2023-11-30 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2023-11-30 2023-11-30 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-07-01 2024-07-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-07-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-08 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-08 2024-03-08 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2023-11-30 2023-11-30 0001498148 AITX:PromissoryNotePayableTwentySixMember 2025-08-25 2025-08-25 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-12-17 0001498148 AITX:ConvertibleNoteTwoMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember srt:MaximumMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-04-13 2026-04-13 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2025-12-17 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2025-12-17 2025-12-17 0001498148 AITX:ConvertibleNoteFiveMember 2025-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2025-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember srt:MaximumMember 2026-05-31 0001498148 us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesBConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesBConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesBConvertibleRedeemablePreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2024-03-01 2025-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesFConvertiblePreferredStockMember 2026-02-28 0001498148 us-gaap:PreferredStockMember us-gaap:SeriesGPreferredStockMember 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 2025-02-10 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-03-01 2026-02-28 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-09 2025-08-09 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-01 2025-08-31 0001498148 2025-08-01 2025-08-31 0001498148 2025-09-01 2025-09-30 0001498148 2025-12-01 2025-12-31 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-12-01 2025-12-31 0001498148 2026-01-01 2026-01-30 0001498148 AITX:AmendedEquityFinancingAgreementMember 2026-03-19 2026-03-19 0001498148 AITX:SeriesFConvertiblePreferredStockMember 2024-04-30 0001498148 AITX:SeriesFConvertiblePreferredStockMember 2026-02-28 0001498148 AITX:SeriesFConvertiblePreferredStockMember 2025-02-28 0001498148 AITX:UnissuedSeriesFPreferredStockMember 2025-03-01 2026-02-28 0001498148 AITX:UnissuedSeriesFPreferredStockMember 2024-03-01 2025-02-28 0001498148 us-gaap:CommonStockMember 2022-07-07 0001498148 us-gaap:CommonStockMember 2022-07-08 0001498148 us-gaap:CommonStockMember 2023-03-18 0001498148 us-gaap:CommonStockMember 2023-03-19 0001498148 us-gaap:CommonStockMember 2023-08-29 0001498148 us-gaap:CommonStockMember 2023-08-30 0001498148 us-gaap:CommonStockMember 2024-03-21 0001498148 us-gaap:CommonStockMember 2024-03-22 0001498148 us-gaap:CommonStockMember 2024-10-03 0001498148 us-gaap:CommonStockMember 2024-10-04 0001498148 us-gaap:CommonStockMember 2025-02-20 0001498148 us-gaap:CommonStockMember 2025-02-21 0001498148 us-gaap:CommonStockMember 2025-07-24 0001498148 us-gaap:CommonStockMember 2025-07-25 0001498148 us-gaap:CommonStockMember 2025-10-14 0001498148 us-gaap:CommonStockMember 2025-10-15 0001498148 2026-03-18 0001498148 2026-03-19 0001498148 AITX:CommonStockActivityMember 2025-03-01 2026-02-28 0001498148 AITX:CommonStockActivityMember 2026-02-28 0001498148 AITX:CommonStockActivityMember us-gaap:SeriesCPreferredStockMember 2025-03-01 2026-02-28 0001498148 us-gaap:WarrantMember 2025-03-01 2026-02-28 0001498148 us-gaap:WarrantMember 2024-03-01 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2026-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2024-03-01 2025-02-28 0001498148 AITX:TwentyTwentyOnePlanMember 2022-08-10 2022-08-11 0001498148 AITX:TwentyTwentyOnePlanMember 2021-04-14 0001498148 AITX:TwentyTwentyOnePlanMember us-gaap:OptionMember 2025-03-01 2026-02-28 0001498148 us-gaap:OptionMember AITX:TwentyTwentyThreePlanMember 2025-03-01 2026-02-28 0001498148 AITX:TwentyTwentyOnePlanMember us-gaap:OptionMember 2024-03-01 2025-02-28 0001498148 us-gaap:OptionMember AITX:TwentyTwentyThreePlanMember 2024-03-01 2025-02-28 0001498148 2025-02-10 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-10 2025-05-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-08-09 0001498148 AITX:SeriesCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-25 2025-08-25 0001498148 2025-08-25 2025-08-25 0001498148 2025-09-30 2025-09-30 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 2025-12-31 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001498148 2026-01-01 2026-01-31 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-01-01 2026-01-31 0001498148 AITX:SeriesCRedeemablePreferredStockMember srt:MaximumMember 2025-09-01 2025-09-30 0001498148 AITX:SeriesCRedeemablePreferredStockMember srt:MinimumMember 2025-09-01 2025-09-30 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-01 2026-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-03-19 2026-03-19 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-05-06 2026-05-06 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-05-12 2026-05-12 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-12 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-05-31 0001498148 2026-02-05 2026-02-05 0001498148 AITX:CommonStockActivityMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockActivityOneMember 2026-03-01 2026-05-31 0001498148 2026-03-25 0001498148 2026-03-25 2026-03-25 0001498148 2026-04-20 0001498148 2026-04-20 2026-04-20 0001498148 2026-05-04 0001498148 2026-05-04 2026-05-04 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2025-03-01 2025-05-31 0001498148 AITX:SeriesFPreferredWarrantsMember 2025-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2024-03-01 2025-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2025-03-01 2026-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-05-31 0001498148 2023-02-28 0001498148 2023-03-01 2024-02-28 0001498148 2023-03-01 2024-02-29 0001498148 us-gaap:EmployeeStockOptionMember 2024-02-29 0001498148 us-gaap:EmployeeStockOptionMember 2023-03-01 2024-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2026-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2026-03-01 2026-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2026-05-31 0001498148 2025-06-01 2025-06-30 0001498148 2025-08-01 2025-08-01 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-09 2021-03-10 0001498148 AITX:FerndaleMichiganMember AITX:TenYearsLeaseAgreementMember 2021-03-09 2021-03-10 0001498148 AITX:FerndaleMichiganMember AITX:TenYearsLeaseAgreementMember 2021-03-10 0001498148 AITX:ThreeYearsLeaseAgreementMember 2024-02-05 2024-02-05 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-10 2025-03-11 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-11 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-10 2021-03-10 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-10 0001498148 AITX:ThreeYearsLeaseAgreementMember 2024-02-04 2024-02-05 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-11 2025-03-11 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2025-03-01 2026-02-28 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2024-03-01 2025-02-28 0001498148 AITX:ConvertibleSeriesCPreferredSharesMember 2025-03-01 2026-02-28 0001498148 AITX:ConvertibleSeriesCPreferredSharesMember 2024-03-01 2025-02-28 0001498148 AITX:ConvertibleAndExchangeableDebtMember 2025-03-01 2026-02-28 0001498148 AITX:ConvertibleAndExchangeableDebtMember 2024-03-01 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2026-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2024-03-01 2025-02-28 0001498148 AITX:ConvertibleExchangeableDebtMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleExchangeableDebtMember 2025-03-01 2025-05-31 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesCPreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2026-03-01 2026-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2025-05-31 0001498148 us-gaap:SubsequentEventMember AITX:SharePurchaseAgreementMember 2026-03-01 2026-03-01 0001498148 us-gaap:SubsequentEventMember AITX:ExchangeAgreementsMember 2026-03-01 2026-03-01 0001498148 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-03-01 2026-03-01 0001498148 us-gaap:CommonStockMember us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-03-01 2026-03-01 0001498148 us-gaap:SubsequentEventMember AITX:AmendedEquityFinancingAgreementMember 2026-05-04 2026-05-04 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-12 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-12 2026-03-12 0001498148 us-gaap:SubsequentEventMember us-gaap:SeriesCPreferredStockMember 2026-03-19 2026-03-19 0001498148 us-gaap:SubsequentEventMember us-gaap:SeriesCPreferredStockMember 2026-03-19 0001498148 us-gaap:SubsequentEventMember us-gaap:SeriesCPreferredStockMember us-gaap:CommonStockMember 2026-03-19 2026-03-19 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 2026-03-25 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-03-25 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-03-25 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-05 2026-05-05 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-04-20 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-04-20 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-04-20 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-05-01 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-04 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-04 2026-05-04 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-29 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-05-29 2026-05-29 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-03 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-03 0001498148 us-gaap:SubsequentEventMember us-gaap:CommonStockMember AITX:SharePurchaseAgreementMember 2026-06-01 2026-07-14 0001498148 us-gaap:SubsequentEventMember AITX:SharePurchaseAgreementMember 2026-06-01 2026-07-14 0001498148 us-gaap:SubsequentEventMember AITX:ExchangeAgreementsMember 2026-06-01 2026-07-14 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 2026-06-09 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 2026-06-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-15 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember 2026-06-15 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2027-06-15 2027-06-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-12-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-12-15 2026-12-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2027-07-15 2027-07-15 0001498148 us-gaap:SubsequentEventMember AITX:AmendedEquityFinancingAgreementMember 2026-06-23 2026-06-23 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-26 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-26 2026-06-26 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-26 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-26 0001498148 AITX:LenderMember AITX:PromissoryNotePayableMember us-gaap:SubsequentEventMember 2026-07-09 0001498148 AITX:LenderMember AITX:PromissoryNotePayableMember us-gaap:SubsequentEventMember 2026-07-09 2026-07-09 0001498148 us-gaap:CommonStockMember AITX:EquityFinancingAgreementMember us-gaap:SubsequentEventMember 2026-06-23 2026-06-23 0001498148 AITX:CommonStockWarrantMember 2026-02-28 0001498148 AITX:CommonStockWarrantMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2026-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure AITX:Integer

 

As filed with the Securities and Exchange Commission on July 16, 2026

 

Registration No. 333-[_________]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM S-1

 

REGISTRATION STATEMENT

 

UNDER

 

THE SECURITIES ACT OF 1933

 

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

 

Nevada   3714  

27-2343603

(State or other jurisdiction of incorporation or organization)   (Primary Standard Industrial Classification Code Number)   (I.R.S. Employer Identification Number)

 

10800 Galaxie Avenue, Ferndale, Michigan 48220

(877) 787-6268

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Steve Reinharz, Chief Executive Officer 

Artificial Intelligence Technology Solutions Inc.

10800 Galaxie Avenue, Ferndale, Michigan 48220

(877) 787-6268

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

Frederick M. Lehrer, P. A.

2108 Emil Jahna Road

Clermont, Florida 34117

(561) 706-7646

flehrer@securitiesattorney1.com

 

Approximate date of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐

 

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.

 

 

 

 

 

 

The information in this prospectus is not complete and may be changed. The Selling Stockholder may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

SUBJECT TO COMPLETION, DATED JULY 16, 2026

 

PROSPECTUS

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

1,555,000,000 Shares of Common Stock

5,000,000 Commitment Shares

1,550,000,000 Maximum of Put Shares

 

This prospectus relates to the resale, from time to time, by Trillium Partners LP (the “Selling Stockholder” or “Trillium”) of up to 1,555,000,000 shares of our common stock, par value $0.0001 per share, consisting of (i) 5,000,000 shares issuable to Trillium as commitment shares (the “Commitment Shares”) under the Equity Purchase Agreement described in this prospectus, issuable in two equal tranches of 2,500,000 shares, and (ii) up to 1,550,000,000 shares (the “Put Shares”) that we may elect to issue and sell to Trillium from time to time under the Equity Purchase Agreement dated June 23, 2026 (the “Purchase Agreement”) between us and Trillium.

 

The Purchase Agreement establishes an “equity line of credit” or “ELOC.” Under the Purchase Agreement, we have the right, but not the obligation, to require Trillium to purchase up to $10,000,000 of our common stock over a 36-month commitment period, subject to the conditions and limitations described in this prospectus. We may direct purchases through either of two mechanisms that we elect in each put notice:

 

●a “Regular Put,” for which the purchase price equals 85% of the average of the three (3) lowest daily closing bid prices of our common stock during the ten (10) consecutive trading days immediately preceding the put date (a “lookback” price with next-trading-day settlement, no floor price and no post-closing adjustment); and
   
●an “Accelerated Put,” for which the purchase price equals 85% of the average of the three (3) lowest daily closing bid prices during a forward ten (10) trading day valuation period beginning the trading day after the put date, subject to a Floor Price and the knock-out mechanics described in this prospectus, and for which we deliver estimated shares equal to 125% of the applicable investment amount at the time of the put, followed by a true-up at the end of the valuation period.

 

We will not receive any proceeds from the resale of shares by the Selling Stockholder. We will, however, receive proceeds from our sale of Put Shares to Trillium under the Purchase Agreement. See “Use of Proceeds.”

 

Trillium is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”), in connection with the resale of our common stock under the Purchase Agreement. No other underwriter or person has been engaged to facilitate the sale of shares of our common stock in this offering.

 

Our common stock is quoted on the OTC Markets under the symbol “AITX.” On July 15, 2026, the last reported sale price of our common stock was $0.0086 per share.

 

INVESTING IN OUR COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD CAREFULLY REVIEW THE RISKS AND UNCERTAINTIES DESCRIBED UNDER THE HEADING “RISK FACTORS” BEGINNING ON PAGE 5 OF THIS PROSPECTUS.

 

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

The date of this prospectus is July 16, 2026.

 

 

 

 

TABLE OF CONTENTS

 

Prospectus Summary 1
The Offering 2
About This Offering 3
Risk Factors 5
Cautionary Note Regarding Forward-Looking Statements 8
Use of Proceeds 8
Dilution 13
Selling Stockholder 14
Plan of Distribution 14
Description of the Equity Purchase Agreement and Registration Rights Agreement 15
Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Business 22
Directors, Executive Officers, and Corporate Governance 30
Executive Compensation 31
Security Ownership of Certain Beneficial Owners and Management 32
Certain Relationships and Related Transactions 33
Description of Securities 34
Legal Matters 36
Experts 36
Where You Can Find More Information 36
Index to Financial Statements F-1

 

i

 

 

PROSPECTUS SUMMARY

 

This summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information you should consider before investing in our common stock. You should read this entire prospectus carefully, including the “Risk Factors” section and our consolidated financial statements and the related notes included elsewhere in this prospectus, before making an investment decision. Unless the context otherwise requires, references to “AITX,” the “Company,” “we,” “us,” and “our” refer to Artificial Intelligence Technology Solutions Inc. and its subsidiaries. All dollar amounts are in U.S. dollars unless otherwise indicated.

 

Our Company

 

Artificial Intelligence Technology Solutions Inc. is a developer and operator of artificial intelligence-driven security and productivity solutions for enterprise clients. Through its family of companies—including Robotic Assistance Devices, Inc. (“RAD-I”), Robotic Assistance Devices Mobile (“RAD-M”), Robotic Assistance Devices Group (“RAD-G”), Robotic Assistance Devices Residential (“RAD-R”), and Robotic Assistance Devices Lanka (Private) Limited (“RAD Lanka”), the Company develops and delivers a range of AI-driven technologies and services designed to transform security, automation, and operational workflows across multiple industries.

 

Through its primary subsidiary, RAD-I, the Company markets an AI-driven “Solutions-as-a-Service” model to the security and guarding services industry, which the Company estimates to be an approximately $50 billion market in the United States. The Company’s solutions are designed to deliver cost savings of between 35% and 80% compared with traditional manned security and monitoring, using a suite of stationary and mobile devices together with the Company’s software and monitoring platforms.

 

The Company describes its operations across three principal pillars: (i) stationary security devices (RAD-I); (ii) mobile autonomous platforms (RAD-M), including the ROAMEO mobile security unit, early commercial deployment of which began in May 2026; and (iii) the Company’s SARA agentic artificial intelligence platform (RAD-G). RAD Lanka, a wholly owned subsidiary located in Sri Lanka and operating under Port City Colombo status, supports software development, artificial intelligence initiatives, and technical operations across the Company’s subsidiaries. Internally, the Company refers to the long-term outcome of this strategy as “RAD Town,” an integrated autonomous-security deployment across a campus, community, or jurisdiction.

 

Recent Financial Results

 

For the fiscal year ended February 28, 2026, we reported revenue of $7,745,336, an increase of $1,614,450, or 26%, over the prior fiscal year. Gross profit increased 48% to $5,533,700 and gross margin expanded to approximately 71% from approximately 61%. Operating expenses were essentially flat at approximately $17,477,097, and our loss from operations improved by approximately $2.0 million to $(11,943,397). We reported a net loss of approximately $14.5 million for the fiscal year ended February 28, 2026 and had an accumulated deficit of approximately $171 million as of that date.

 

Our independent registered public accounting firm has included an explanatory paragraph in its report on our consolidated financial statements expressing substantial doubt about our ability to continue as a going concern. For the year ended February 28, 2026, the Company had negative cash flow from operating activities of $9,344,534. As of February 28, 2026 the Company has an accumulated deficit of $171,121,742 and negative working capital of $17,017,745. Management does not anticipate having positive cash flow from operations in the near future. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

We have funded our operations principally through the issuance of equity and debt securities, including variable-priced instruments, and we expect to continue to rely on external financing, including the equity line established by the Purchase Agreement described in this prospectus. See “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

Corporate Information

 

We are a Nevada corporation. Our principal executive offices are located at 10800 Galaxie Avenue, Ferndale, Michigan 48220, and our telephone number is. Our common stock is quoted on the OTC Markets under the symbol “AITX.” Our website address is www.aitx.ai. Information contained on, or accessible through, our website is not incorporated by reference into, and does not constitute a part of, this prospectus.

 

1

 

 

THE OFFERING

 

Common stock offered by the Selling Stockholder   Up to 1,555,000,000 common stock shares, consisting of 5,000,000 Commitment Shares and up to 1,550,000,000 Put Shares issuable under the Purchase Agreement.
     
Common stock outstanding before this offering   419,371,776 shares as of July 15, 2026.
     
Common stock to be outstanding after this offering   Up to 1,974,371,776 shares, assuming issuance of all Commitment Shares and all Put Shares registered hereby. This number will change as Put Shares are issued at then-current prices.
     
Commitment period   36 months, commencing on the Effective Date of the registration statement of which this prospectus forms a part.
     
Use of proceeds   We will not receive any proceeds from the resale of shares by the Selling Stockholder. We may receive up to $10,000,000 in aggregate gross proceeds from sales of Put Shares to Trillium under the Purchase Agreement, which we intend to use for working capital and general corporate purposes. See “Use of Proceeds.”
     
Beneficial ownership limitation   We may not issue shares to the extent that, after giving effect to the issuance, Trillium together with its affiliates would beneficially own more than 4.99% of our outstanding common stock. See “Description of the Equity Purchase Agreement and Registration Rights Agreement.”
     
Risk factors   An investment in our common stock involves a high degree of risk. See “Risk Factors” beginning on page 5.
     
OTC Markets symbol   AITX

 

2

 

 

ABOUT THIS OFFERING

 

On June 23, 2026, we entered into an Equity Purchase Agreement (the “Purchase Agreement”) and a related Registration Rights Agreement (the “Registration Rights Agreement”) with Trillium Partners LP. This offering relates to the resale by Trillium of the Commitment Shares and the Put Shares. The following is a summary of the material terms of the equity line established by the Purchase Agreement and is qualified in its entirety by reference to the full text of the Purchase Agreement and the Registration Rights Agreement, which are filed as exhibits to the registration statement of which this prospectus forms a part. For a description of our registration obligations to Trillium and the liquidated damages that may become payable if we fail to satisfy specified registration deadlines, see “Risk Factors” and “Description of the Equity Purchase Agreement and Registration Rights Agreement.” In addition, because our common stock is quoted on the OTC Markets and Trillium is an underwriter with respect to the resale of the shares, Trillium must resell the Commitment Shares and the Put Shares registered in this offering at a fixed price for the duration of the offering rather than at prevailing market prices; see “Plan of Distribution.”

 

The Equity Line; Put Right

 

Under the Purchase Agreement, we have the right, but not the obligation, to require Trillium to purchase up to $10,000,000 of our common stock during the 36-month commitment period, subject to the satisfaction of the conditions described below and in the Purchase Agreement. To exercise a put, we deliver a written put notice to Trillium specifying the dollar amount we elect to draw (the “Investment Amount”) and electing the applicable put type. If no put type is specified, the put is deemed a Regular Put. At least five (5) trading days must elapse between put notices.

 

Regular Puts

 

For a Regular Put, the purchase price per share equals 85% of the average of the three (3) lowest daily closing bid prices of our common stock during the ten (10) consecutive trading days immediately preceding (but not including) the put date. The number of Put Shares equals the Investment Amount divided by that purchase price. A Regular Put is not subject to a valuation period, a floor price, or any post-closing adjustment, and no estimated shares are delivered. The closing of a Regular Put occurs no later than one (1) trading day following the put date.

 

Accelerated Puts

 

For an Accelerated Put, the purchase price per share equals 85% of the average of the three (3) lowest daily closing bid prices of our common stock during a forward valuation period of ten (10) consecutive trading days beginning on the first trading day after the put date, subject to the Floor Price described below. Concurrently with an Accelerated Put notice, we deliver to Trillium’s brokerage account, via DWAC, “Estimated Shares” equal to 125% of the Investment Amount divided by the closing bid price on the trading day immediately prior to the put notice date. At the end of the valuation period, the parties “true up”: if the Estimated Shares exceed the number of Put Shares actually issuable, Trillium returns the excess to us via DWAC; if the Estimated Shares are fewer than the number issuable, we issue the shortfall to Trillium.

 

Floor Price and Knock-Out Mechanic (Accelerated Puts Only)

 

Each Accelerated Put is subject to a minimum price (the “Floor Price”) equal to the greater of (i) 75% of the closing bid price of our common stock on the put date or (ii) any higher minimum price we specify in the applicable Accelerated Put notice. If, on any trading day during the valuation period, the closing bid price is less than the Floor Price (a “Low Price Day”), then for each such Low Price Day neither party has the right or obligation to sell or purchase one-tenth (1/10th) of the Investment Amount, and the Investment Amount is reduced accordingly. If three (3) Low Price Days occur during a valuation period, the balance of the parties’ rights and obligations under that put terminate on the third Low Price Day, and the Investment Amount is adjusted to include only one-tenth (1/10th) of the initial Investment Amount for each trading day during the valuation period prior to termination on which the closing bid price equaled or exceeded the Floor Price.

 

3

 

 

Limitations on Puts

 

Our ability to require Trillium to purchase shares is subject to limitations, including that: (i) the aggregate of all Investment Amounts may not exceed $10,000,000; (ii) the Investment Amount for any single put may not exceed 250% of the average daily trading volume of our common stock for the ten (10) trading days preceding the put notice date, multiplied by the applicable purchase price; (iii) we may not deliver a put notice during an active valuation period for a prior put; (iv) at least five (5) trading days must have elapsed since the immediately preceding put notice; and (v) we may not deliver an Accelerated Put notice if, after giving effect to the issuance of the Estimated Shares, Trillium together with its affiliates would beneficially own more than 4.99% of our outstanding common stock (the “Beneficial Ownership Cap”). The 4.99% Beneficial Ownership Cap applies to all puts, whether Regular Puts or Accelerated Puts; on each closing date we may not issue, and Trillium is not required to purchase, Put Shares to the extent Trillium and its affiliates would beneficially own more than 4.99% of our outstanding common stock following the issuance.

 

Commitment Shares

 

As partial consideration for Trillium’s purchase commitment, we agreed to issue Trillium an aggregate of 5,000,000 Commitment Shares in two equal tranches: 2,500,000 shares upon the date the registration statement is declared effective by the SEC, and 2,500,000 shares on the date that is ninety (90) days following such effectiveness. The Commitment Shares are deemed fully earned upon execution of the Purchase Agreement. Both tranches are being registered for resale under this prospectus.

 

Conditions to Puts

 

Our right to deliver a put notice and Trillium’s obligation to purchase are subject to specified conditions, including that the registration statement of which this prospectus forms a part remains effective and available for the resale of the shares subject to the put, the accuracy of our representations and warranties, the absence of a material adverse effect, the continued quotation of our common stock without suspension or delisting, our continued DTC and DWAC eligibility, satisfaction of the Beneficial Ownership Cap, and delivery of a closing certificate. In addition, we may not issue Put Shares to the extent the issuance would exceed any applicable exchange cap or require stockholder approval under the rules of our principal market; because our common stock is quoted on the OTC Markets and is not listed on a national securities exchange, we do not currently expect these limitations to apply. There is no assurance that we will satisfy these conditions or be able to access the full amount available under the Purchase Agreement.

 

No Short Selling

 

Trillium has agreed that neither it nor its affiliates will engage in short sales of our common stock during the term of the Purchase Agreement, subject to customary exceptions, including sales after delivery of a put notice of a number of shares not exceeding the number reasonably expected to be issued under that put notice, sales of shares already held in Trillium’s brokerage account (including Estimated Shares previously delivered), and certain hedging transactions that do not involve the direct sale or transfer of our common stock.

 

4

 

 

RISK FACTORS

 

An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information contained in this prospectus, before deciding to invest in our common stock. If any of the following risks actually occurs, our business, financial condition, results of operations, and prospects could be materially and adversely affected, the trading price of our common stock could decline, and you could lose all or part of your investment. The risks described below are not the only risks we face.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Form S-1 contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact contained in this report — including statements regarding our future results of operations and financial condition, revenue and gross margin expectations, business strategy, product development and commercialization plans, planned international expansion, characterizations of our markets and industry, and the plans and objectives of management for future operations — are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “could,” or “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these identifying words.

 

Forward-looking statements are based on our current expectations, estimates, and assumptions regarding our business, the economy, and other future conditions, and reflect management’s beliefs only as of the date of this report. Because forward-looking statements relate to matters that have not yet occurred, they are inherently subject to risks, uncertainties, and changes in circumstances that are difficult to predict and many of which are outside our control. Our actual results, performance, and financial condition may differ materially from those expressed or implied by these statements. Factors that could cause actual results to differ materially include, among others, those described under “Risk Factors” in this Item 1A and elsewhere in this report. Accordingly, you should not place undue reliance on any forward-looking statement.

 

The forward-looking statements include, but are not limited to, statements concerning the matters described in the categories set forth below. These categories and the examples within them are illustrative only and do not constitute an exhaustive list of the forward-looking statements contained in this report, and the cautionary statements and risk factors set forth herein qualify all forward-looking statements wherever they appear. Except as required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

 

FORWARD LOOKING STATEMENTS

 

1. Revenue and Financial Projections.

 

Statements that RAD-I’s recurring revenue and gross margin could, on a standalone basis, support positive cash flow operations and management’s characterization that RAD-I has “achieved a point” at which it could support positive cash flow operations today; that RAD-M will surpass RAD-I’s monthly recurring revenue contribution at some future point; that subscription gross margin will exceed 75% and outright-sale gross margin will exceed 50% based on average bill of materials costs and pricing that the market “has appeared to accept,” each of which is a forward-looking characterization dependent on assumptions about continued pricing acceptance, stable input costs, and manufacturing scale that may not be realized; that RAD-G will generate substantial revenue from SARA platform licensing; that RAD-M represents a higher revenue ceiling than stationary solutions; and that penetration of any covered industry would produce sufficient revenue to support profitability.

 

2. Product Development and Commercialization.

 

Statements regarding the planned introduction of additional stationary solutions during fiscal year 2027; the establishment of RAD Europe during fiscal 2027 and the anticipated benefits thereof; all statements regarding ROAMEO’s commercial viability, autonomous operation without on-site human pilots, production ramp, and revenue trajectory following commencement of commercial billing in May 2026; statements regarding planned RAD-I product introductions, including their timing, features, and market acceptance; and statements regarding expansion of the authorized dealer network and anticipated contributions from the dealer channel.

 

3. Market and Industry Characterizations.

 

All characterizations of the physical security industry as undergoing a structural transition analogous to Industry 4.0; assertions that the human-guard labor model is experiencing unsustainable cost pressures; characterizations of the total addressable market for AI-driven and autonomous security solutions; any implication that competitive dynamics will favor the Company; and the “RAD Town” concept in its entirety, which is a conceptual design target and strategic roadmap, not a contracted project, existing deployment, or assured business outcome.

 

4. SARA Platform and Agentic AI.

 

All characterizations of SARA as an agentic AI platform enabling autonomous real-time action without continuous human intervention, including the Item 1 description that SARA enables devices to “perceive, decide, communicate, and act autonomously in real time, without continuous human intervention,” which states this as a present operational characteristic rather than design intent and should be read in light of the actual performance qualifications in this Item 1A; statements regarding SARA licensing and commercialization with third-party hardware manufacturers and monitoring platforms (including the Immix integration); anticipated expansion of the dealer network and platform ecosystem; statements regarding SARA’s performance in detection, escalation, and response workflows; the characterization in Item 1 that the firearm detection analytic “identifies visible handguns and long guns in real time,” which omits the design-intent and environmental-conditions qualifications that investors should consider when evaluating this statement; and all characterizations of RAD-G’s sales funnel as “substantial” or of management’s expectations for RAD-G revenue as “high.” Industry award recognitions do not constitute validation of product safety, efficacy, or commercial viability.

 

5

 

 

5. Management Estimates and Unaudited Financial Characterizations.

 

The approximate $20 million cumulative ROAMEO development figure is a management estimate not audited or reviewed by the Company’s independent registered public accounting firm. Segment-level profitability and cash flow characterizations for RAD-I—including management’s characterization in Item 1 that RAD-I “has achieved a point” at which its recurring revenue and gross margin could support positive cash flow operations today—are based on internal analysis for which no separately audited financial statements are published. This characterization excludes all expenses not directly attributable to the stationary solutions business, including shared corporate overhead, interest expense, and investment in RAD-M and RAD-G, and does not indicate that the Company as a whole operates at or near positive cash flow. No financial characterization of any individual subsidiary should be treated as audited data. Characterizations of gross margin expectations are based on average bill of materials costs and market pricing over limited historical periods, as well as pricing that the market “has appeared to accept,” and may not be representative of future results.

 

6. International Expansion.

 

Statements regarding the anticipated establishment of RAD Europe during fiscal 2027; expected benefits of RAD Lanka’s Port City Colombo status, including cost efficiency and tax benefits; and anticipated GDPR-compliant service capabilities to be provided through RAD Europe. All such forward-looking statements are subject to regulatory, legal, and operational risks inherent in international expansion.

 

RISK FACTORS

 

In addition to the forward-looking statement categories described above, investors should carefully consider the following material risk factors. Each could cause actual results, financial condition, or business performance to differ materially from those described in this Form S-1. This list is not exhaustive, and additional risks not currently anticipated by management may emerge.

 

I. FINANCIAL AND GOING CONCERN RISKS

 

Substantial Doubt About the Company’s Ability to Continue as a Going Concern.

 

The Company’s independent registered public accounting firm has included an explanatory paragraph in its audit reports expressing substantial doubt about the Company’s ability to continue as a going concern. The Company has incurred recurring net losses, has a history of negative operating cash flows, and carries an accumulated deficit that, as of recent reporting periods, has exceeded $176 million. The Company’s total liabilities substantially exceed its total assets, and it maintains negative stockholders’ equity. These conditions raise material uncertainty as to whether the Company will be able to meet its obligations as they come due. The Company’s financial statements do not include any adjustments to reflect the possible effects on the classification or carrying value of assets and liabilities that might result from the outcome of this uncertainty. There can be no assurance that the Company will be able to generate sufficient revenue, raise adequate capital, or otherwise secure the resources necessary to continue operations beyond the near term.

 

The Company Requires Continued External Financing and May Be Unable to Obtain It on Acceptable Terms or at All.

 

The Company’s operations are not yet self-funding. The Company has relied, and expects to continue to rely, on external debt and equity financing to fund operations, capital expenditures, product development, and the planned production ramp of ROAMEO and other new products. A significant portion of the Company’s debt has historically been owed to entities controlled by a single individual, creating concentrated lender risk and potential conflicts of interest. The Company has also utilized equity financing arrangements, including agreements providing for the issuance of common shares at variable prices, to access capital. If the Company is unable to obtain financing on acceptable terms—or if existing financing arrangements are not renewed or are terminated—the Company may be required to curtail or cease operations, defer planned capital expenditures (including the ROAMEO production ramp and RAD Europe establishment), reduce headcount, or otherwise alter its operating plans in ways that could materially harm its business and prospects.

 

The Company’s Common Stock Is Subject to Substantial Dilution Risk.

 

The Company has issued, and may continue to issue, substantial numbers of shares of common stock in connection with financing transactions, employee and director compensation, debt conversions, and other purposes. As of February 28, 2026, total common shares outstanding exceeded 267 million (post-reverse-split). In March 2026, FINRA processed a 100-for-1 reverse stock split; however, the authorized share count remains at approximately 12 billion shares, preserving the structural capacity for future dilutive issuances. Variable-price equity financing arrangements and debt conversion rights may result in issuances at prices below the then-current market price of the Company’s common stock, causing material dilution to existing shareholders. The reverse stock split does not alter the underlying financial condition of the Company or reduce the potential for future dilutive issuances. The Company does not provide assurance that future equity issuances will not substantially reduce the proportionate ownership or economic interest of existing stockholders.

 

The Company Has a History of Net Losses and Cannot Assure Future Profitability.

 

The Company has not achieved profitability in any fiscal year. Net losses for the three months ended May 31, 2026 and the fiscal year ended February 28, 2026 were approximately $5.7 million and $14.5 million, respectively. Operating expenses—including research and development, sales and marketing, and general and administrative costs—have consistently exceeded gross profit, and interest expense on the Company’s debt obligations represents an additional recurring charge. While gross margin on deployed subscription units has improved and the Company’s Solutions-as-a-Service model is designed to produce improving margins at scale, the Company’s operating cost structure, investment in ROAMEO commercialization, RAD-G platform development, and debt service obligations may prevent it from achieving profitability even as revenues increase. No assurance can be given as to whether or when the Company will achieve or sustain profitability.

 

Gross Margin Expectations May Not Be Achieved.

 

Item 1 of this Report states that subscription gross margin “will exceed” 75% and outright-sale gross margin “will exceed” 50% over deployment lifecycles, based on average bill of materials costs and pricing that the market “has appeared to accept”—language that reflects observed pricing acceptance rather than contracted or assured revenue, and that is itself a forward-looking characterization. These expectations assume continued pricing acceptance, no material input cost increases, manufacturing cost improvements associated with scale, and the absence of significant warranty, maintenance, or retrieval costs on churned units. To date, hardware gross margins have been achieved under small-batch production conditions. None of these assumptions are guaranteed, and actual gross margins may differ materially, particularly during the ROAMEO production ramp period when per-unit manufacturing costs may be higher than at scale.

 

6

 

 

II. OPERATIONAL AND PRODUCT RISKS

 

ROAMEO Commercial Deployment and Production Ramp Involve Significant Execution Risk.

 

The Company commenced commercial billing on ROAMEO units in May 2026 following what management estimates to be approximately $20 million in cumulative development investment. ROAMEO is a fully autonomous, outdoor mobile security vehicle operating without on-site human pilots, and its commercial viability depends on the continued reliable performance of its autonomous navigation stack, on-board sensor systems, cellular and 5G connectivity, and full integration with the SARA agentic AI platform in real-world field conditions. Initial commercial deployments are at a limited number of enterprise customer sites. Scaling ROAMEO to meet broader commercial demand will require significant expansion of the Company’s production capacity and manufacturing operations, neither of which has been demonstrated at commercial scale. Mechanical failures, software defects, connectivity disruptions, navigation errors, environmental limitations, or other operational issues experienced by deployed ROAMEO units could damage the Company’s reputation, result in contract terminations, expose the Company to liability, and materially impair the Company’s ability to achieve the revenue projections attributed to the RAD-M business. Management’s statements that RAD-M will surpass RAD-I’s revenue contribution are forward-looking and dependent on successful execution of each of these steps.

 

The Company’s Revenue Is Highly Concentrated and Dependent on Subscription Renewals.

 

Substantially all of the Company’s revenue is derived from recurring monthly subscription contracts, typically with initial terms of twelve months. Customer retention and subscription renewal are critical to the Company’s revenue stability and growth. A single customer has at times represented a disproportionate share of the Company’s revenue—one customer has previously accounted for approximately 47% of six-month revenue. The loss of one or more significant customers, a material reduction in subscription renewal rates, a failure to maintain service quality levels that support renewals, or disruption to services provided to the Fortune Top 10 enterprise customer or any large enterprise account could materially and adversely affect the Company’s revenue, cash flow, and operating results. The Company retains ownership of hardware deployed under subscription contracts; accordingly, subscriber churn results not only in revenue loss but also in costs associated with device retrieval, redeployment, or write-down.

 

The Company’s Hardware Manufacturing Operations Are Subject to Supply Chain, Capacity, and Quality Risks.

 

The Company performs final assembly, system integration, software loading, and quality assurance at its facility in Ferndale, Michigan, and sources sub-components—including machined metal and plastic components, printed circuit boards, and selected sub-assemblies—from domestic and international suppliers. The Company’s hardware gross margins to date have been produced under small-batch production conditions, and the ability to achieve projected margin improvements depends on production volume increases that have not yet been demonstrated. A disruption affecting one or more key suppliers, an inability to secure critical components at acceptable prices, quality defects, or a failure to scale manufacturing capacity to meet demand could delay product deployments, increase costs, reduce gross margins, and impair the Company’s ability to fulfill customer commitments. International supply chain disruptions, tariff changes, or export control regulations affecting components sourced from outside the United States could have a material adverse effect on component availability and cost. These risks are heightened during the ROAMEO production ramp, when any manufacturing bottleneck would directly constrain the Company’s ability to generate revenue from its highest-anticipated growth segment.

 

The RAD-R Residential Business Has Underperformed and Presents Ongoing Uncertainty.

 

The Company’s RAD-R subsidiary, which operates the RADCam residential security product, generated an immaterial amount of consolidated revenue during fiscal 2026, substantially below the Company’s expectations. The Company attributes this underperformance primarily to the structural differences between its B2B-oriented sales model and the consumer marketing investment required to compete in the B2C residential channel. The Company has no immediate plans to discontinue the RADCam product but has not committed to the additional consumer marketing spend management believes would be required to compete effectively. Although the Company has modified the residential software for deployment into small-and-medium business and enterprise markets through RAD-I, there can be no assurance that this repositioning will generate material revenue. The RAD-R segment may continue to generate losses, and the Company’s assessment of the segment’s strategic value may change in ways that result in impairment charges, operational restructuring, or reallocation of capital.

 

New Product Introductions and RAD Europe Establishment Are Subject to Execution Risk.

 

The Company has stated its intention to introduce additional stationary solutions during fiscal year 2027 and to establish RAD Europe during the same period. Both initiatives involve engineering, regulatory, operational, and commercial risks that could delay or prevent their realization. New product introductions may be delayed by supply chain constraints, manufacturing challenges, software development setbacks, or unfavorable customer reception. The establishment of RAD Europe will require legal entity formation, regulatory compliance infrastructure, staffing, and local market development in a new geography. There can be no assurance that either initiative will proceed on the stated timeline or will produce the anticipated revenue contribution.

 

III. TECHNOLOGY AND INTELLECTUAL PROPERTY RISKS

 

The Company’s AI and Autonomous Technology May Not Perform as Described or Expected.

 

The SARA platform and the Company’s suite of AI-driven security products rely on large language model architecture, machine learning models, computer vision analytics, autonomous decision-making systems, and voice interaction capabilities. AI systems of this nature are subject to known limitations, including errors in detection or classification, failure to perform reliably across varied environmental conditions, susceptibility to adversarial inputs, and performance degradation as the threat landscape or deployment environment changes. Item 1 of this Report states that SARA enables devices to “perceive, decide, communicate, and act autonomously in real time, without continuous human intervention” — describing this as a present operational characteristic. Investors should understand that this characterization reflects design intent under supported field conditions; deployed systems may require more human oversight than described in certain situations and may not consistently deliver the autonomous escalation, voice intervention, and first-responder coordination described in this Report. Item 1 also states that the Company’s firearm detection analytic “identifies visible handguns and long guns in real time”—an unqualified performance claim. Actual detection accuracy and response performance are subject to environmental conditions, image quality, and system configuration; the Company does not represent that the analytic will detect all firearms in all conditions, and the ASTORS award recognition does not constitute independent validation of detection accuracy rates or performance specifications. Failures of the Company’s AI systems to detect threats, correctly identify individuals or vehicles, or appropriately escalate or de-escalate situations could result in harm to persons or property, exposure to liability, and damage to the Company’s reputation and customer relationships. Industry award recognitions referenced in this Report do not constitute validation of the safety, accuracy, or commercial efficacy of any product.

 

7

 

 

The Company Relies on Trade Secrets and Confidentiality Protections Rather Than Patents and May Be Unable to Adequately Protect Its Intellectual Property.

 

The Company does not currently rely materially on patent protection for its hardware designs, software, firmware, AI models, the SARA platform, autonomous navigation stack, or related technology. Instead, the Company relies on trade secret protection, confidentiality and invention-assignment agreements with employees and contractors, copyrights, and trademark registrations. These protections may be insufficient to prevent misappropriation, reverse engineering, or independent development of competing technologies by third parties. Confidentiality agreements may be breached; trade secret protections may prove difficult to enforce, particularly across international jurisdictions; and employees or contractors with access to the Company’s proprietary systems, code, or AI models may depart and join competitors or establish competing businesses. The Company’s Sri Lanka operations at RAD Lanka introduce additional jurisdictional complexity with respect to IP enforcement. If the Company’s intellectual property is misappropriated or independently replicated, the Company may lose the technological differentiation that underpins its competitive positioning.

 

Cybersecurity Incidents Could Compromise the Company’s Products, Customer Data, and Operations.

 

The Company’s products are connected to the internet and to customer networks, and the SARA platform and related cloud services process and transmit data from deployed devices—including video, audio, and access-control information—across an expanding footprint of connected devices. Although the Company has achieved and maintained SOC 2 Type 2 status since February 2025, cybersecurity certifications do not guarantee the absence of vulnerabilities or the prevention of successful attacks. A breach of the Company’s systems, a compromise of deployed customer devices, or a successful attack on the SARA platform could result in unauthorized access to sensitive data, disruption of device functionality at customer sites, customer contract terminations, regulatory scrutiny, litigation, and significant reputational damage. The Company’s cybersecurity posture will require ongoing investment as threats evolve, as ROAMEO deployments expand the number of connected autonomous vehicles in the field, and as RAD Europe operations increase the Company’s exposure to GDPR and other international data protection regimes.

 

The SARA Platform May Not Achieve the Commercial Adoption Anticipated by RAD-G.

 

RAD-G’s business model depends substantially on expanding the SARA ecosystem through licensing and integration arrangements with third-party hardware manufacturers, monitoring platforms (including central station platforms such as Immix), dealers, and enterprise end users. The commercial success of RAD-G depends on third parties choosing to integrate SARA into their products, platforms, and workflows—decisions that are outside the Company’s control and that may not materialize on the timeline or at the scale management anticipates. The RAD-G sales funnel, characterized by management as substantial for an early-stage AI platform business, has not yet produced revenue commensurate with management’s expectations. Competition from large, well-funded AI technology companies with greater distribution and integration resources could impair RAD-G’s ability to establish SARA as a platform-of-choice in the physical security ecosystem.

 

IV. MARKET, COMPETITIVE, AND REGULATORY RISKS

 

The Company Operates in a Competitive Market and Faces Competition from Larger, Better-Capitalized Companies.

 

The Company competes across three distinct but related markets: traditional guard services and manned monitoring; legacy passive security hardware (cameras, access control devices, alarm systems); and an emerging set of AI-driven and autonomous security technology companies. Many of the Company’s actual and potential competitors have substantially greater financial resources, brand recognition, established distribution networks, and installed customer bases than the Company. Large security integrators and major technology companies may develop, license, or acquire AI and autonomous security capabilities that compete directly with the Company’s products and platform. The market characterizations, including statements that incumbent competitors are “structurally disadvantaged” or that legacy vendors “typically lack” agentic AI capability, reflect management’s view and are not statements of established fact. Competitive dynamics may develop in ways unfavorable to the Company, including through technological advances by competitors, price compression across the autonomous security category, or the market entry of well-capitalized technology companies.

 

Deployment of Autonomous Security Devices Is Subject to Evolving Legal, Regulatory, and Privacy Constraints.

 

The Company’s products deploy autonomous devices—including outdoor mobile robotic vehicles (ROAMEO), vehicle access management systems (AVA), visitor management systems (TOM), and AI-enabled cameras (ROSA, RIO, RAM, RADCam)—that collect audio, video, biometric, and identification data in commercial, residential, industrial, and potentially public-access environments. The legal framework governing the collection and processing of such data is complex, rapidly evolving, and varies significantly across jurisdictions. Applicable regulations include state biometric privacy statutes (such as the Illinois Biometric Information Privacy Act), the California Consumer Privacy Act, GDPR as applicable to the Company’s anticipated European operations through RAD Europe, and various other federal, state, and local privacy and data protection laws. Autonomous vehicles and robotic platforms operating in public or semi-public spaces may be subject to licensing, permitting, insurance, or operational requirements that vary by municipality, state, or country. The Company’s anticipated establishment of RAD Europe during fiscal 2027 will directly increase its exposure to GDPR compliance obligations. Failure to comply with applicable laws and regulations could result in regulatory enforcement actions, fines, litigation, mandatory product modifications, or constraints on the Company’s ability to operate or deploy products in affected markets.

 

Market Adoption of AI-Driven and Autonomous Security Solutions May Be Slower Than Management Anticipates.

 

The Company’s business plan assumes that customers in the physical security market will adopt AI-driven and autonomous solutions at a pace and scale consistent with management’s view of the industry’s structural transition. This assumption may not prove correct. Customers may be slower than expected to replace human guard labor or legacy surveillance systems with automated alternatives, whether due to risk aversion, labor union obligations, insurance requirements, regulatory constraints, concerns about AI reliability, or other factors. The “RAD Town” concept—in which the Company’s portfolio of stationary and mobile products operates as an integrated autonomous-security fabric across a campus or jurisdiction—is a long-term design target, not an existing deployment or contracted commercial arrangement. The analogies drawn in this Report to Industry 4.0 transitions in other sectors are management’s narrative framework and may not accurately predict the pace or trajectory of adoption in the physical security industry. Slower-than-anticipated adoption would adversely affect the Company’s ability to achieve its revenue projections and extend the period during which the Company requires external financing.

 

8

 

 

Government and Municipal Markets Present Additional Regulatory and Procurement Risks.

 

The Company’s end-user base includes government entities, and the Company has identified government as a target vertical market. Government procurement cycles are typically longer and more complex than commercial sales cycles, are subject to appropriations risk and political change, and may require certifications, clearances, or compliance with specific regulatory frameworks (including federal cybersecurity standards) that the Company may not currently hold or may be unable to obtain. Autonomous security devices deployed in public or government-managed spaces may attract heightened public and regulatory scrutiny regarding civil liberties, facial recognition, and autonomous decision-making in law enforcement-adjacent contexts. There can be no assurance that the Company will be able to successfully compete for or retain government contracts.

 

V. MANAGEMENT, PERSONNEL, AND KEY PERSON RISKS

 

The Company Is Dependent on Key Personnel, Particularly Its Chief Executive Officer and Chief Technology Officer.

 

The Company’s success is substantially dependent on the continued services of Steven Reinharz, who serves as both Chief Executive Officer and Chief Technology Officer and is the founder of RAD and its principal architect. Steven Reinharz is also the Company’s single largest equity holder and plays a central role in product strategy, customer relationships, investor relations, and industry positioning, including through his service on the Board of the Security Industry Association and chairmanship of its Autonomous Working Group. Item 1 of this Report states that Steven Reinharz has “written and spoken extensively” about the physical security industry’s structural transformation since the Company’s inception and is a “regular speaker” at events hosted by SIA and ASIS, the two leading industry organizations. This public profile, while reflecting genuine industry standing, further concentrates the Company’s market credibility and industry positioning in a single individual; any reputational, health, or availability issue affecting Steven Reinharz could have an outsized adverse effect on the Company’s relationships with customers, partners, dealers, and investors beyond the direct operational impact of his absence. The combined CEO and CTO role concentrates both business leadership and technical architecture in a single individual. The loss of Steven Reinharz, or any material reduction in his involvement in the Company’s business, could have a severe and potentially irreversible adverse effect on the Company. The Company does not currently represent that it has key-person insurance sufficient to compensate for this risk, and the ability to recruit a suitable replacement would be highly uncertain given the specialized combination of technical, operational, and strategic capabilities involved.

 

The Company’s Ability to Attract and Retain Qualified Technical, Sales, and Operational Personnel Is Critical.

 

The Company has approximately 135 employees across the United States, Canada, the United Kingdom, and Asia, including Sri Lanka, and its operations depend on specialized technical expertise in robotics engineering, AI development, autonomous systems, software architecture, and security operations. Competition for qualified engineers and AI talent is intense. The loss of other senior technical, sales, or operational personnel could disrupt operations and product development. The Company’s culture—centered on emotional intelligence, accountability, and multidisciplinary ownership—is described by management as a meaningful operational asset, but there can be no assurance that the Company can maintain this culture or retain key team members as it scales, particularly during periods of capital constraint, extended development timelines, or operational setbacks.

 

The Company’s International Operations Introduce Additional Risks.

 

The Company currently operates internationally through RAD Lanka, a Sri Lanka subsidiary operating within the Port City Colombo special economic zone, and has team members in the United Kingdom and Asia. The Company anticipates establishing RAD Europe during fiscal 2027 to support European market entry and GDPR-compliant service delivery. International operations expose the Company to risks including currency fluctuation, geopolitical instability, changes in local tax and regulatory regimes, difficulty enforcing contracts or intellectual property rights in foreign jurisdictions, and the operational complexity of managing distributed teams across multiple time zones and legal systems. The special economic zone status under which RAD Lanka operates may be subject to changes in Sri Lankan law or policy. The anticipated benefits of RAD Lanka’s Port City Colombo status, including cost efficiency and tax advantages, are not guaranteed to continue. There can be no assurance that the Company’s international expansion will proceed as planned or that the anticipated benefits of international operations will be realized.

 

VI. SECURITIES AND INVESTOR RISKS

 

The Company’s Common Stock Trades on the OTC Pink Market and Is Subject to Significant Volatility and Liquidity Constraints.

 

The Company’s common stock is quoted on the OTC Pink marketplace under the symbol “AITX,” which is not a registered national securities exchange. OTC Pink securities are generally subject to less rigorous disclosure and listing standards than exchange-listed securities, and the market for such securities may be less liquid, more volatile, and more susceptible to manipulation than exchange-listed markets. Shareholders may find it difficult to buy or sell shares at prices that reflect the Company’s intrinsic value, and bid-ask spreads may be wide. The Company’s stock price has been, and may continue to be, highly volatile in response to operating results, financing transactions, product announcements, press releases regarding ROAMEO deployments or RAD-G partnerships, and general market conditions. The March 2026 reverse stock split (100-for-1) does not guarantee any improvement in trading liquidity, price stability, or long-term shareholder value. Investors in OTC Pink securities should be aware that such investments carry a high degree of risk, and the Company’s shares should be considered highly speculative.

 

9

 

 

Insider and Related-Party Transactions Represent Potential Conflicts of Interest.

 

Approximately 96% of the Company’s total loans payable has, at recent reporting dates, been owed to entities controlled by a single individual. Related-party lending of this concentration creates potential conflicts of interest between the interests of that lender and the broader shareholder base, including with respect to the terms of any refinancing, conversion, restructuring, or settlement of such indebtedness. Transactions between the Company and related parties may not be negotiated at arm’s length, and the Company’s ability to obtain independent third-party financing to refinance related-party debt on terms favorable to all shareholders is uncertain. Steven Reinharz, as CEO, CTO, and the Company’s single largest equity holder, may have interests that diverge from those of other stockholders in certain circumstances. The Company’s governance framework may not fully mitigate these potential conflicts, and investors should be aware that the interests of related-party lenders and controlling stockholders may not always be aligned with those of the broader shareholder base.

 

The Company’s Prior and Ongoing Use of Variable-Price Equity Financing Creates Structural Dilution Risk.

 

The Company has historically utilized equity financing arrangements that provide for the issuance of common shares at variable prices, including at prices below the then-prevailing market price. These arrangements have contributed to the Company’s substantial share count (in excess of 267 million shares post-reverse-split) and have resulted in material dilution to existing shareholders. Although the Company completed a 100-for-1 reverse stock split in March 2026, the authorized share count of approximately 12 billion shares remains unchanged, preserving the structural capacity to issue additional shares. Continued reliance on these financing mechanisms, which may be required to fund ongoing operations, the ROAMEO production ramp, RAD-G platform development, or RAD Europe establishment, could result in further dilution and downward pressure on the trading price of the Company’s common stock.

 

VII RISKS RELATING TO OUR FINANCIAL CONDITION AND NEED FOR CAPITAL

 

Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.

 

Our consolidated financial statements for the fiscal year ended February 28, 2026 were prepared assuming we will continue as a going concern. We have incurred recurring net losses, including a net loss of approximately $14.5 million for the fiscal year ended February 28, 2026, and had an accumulated deficit of approximately $171 million and a stockholders’ deficit as of that date. Our total liabilities substantially exceed our total assets. These conditions raise substantial doubt about our ability to continue as a going concern. If we are unable to obtain sufficient additional financing, we may be required to curtail, delay, or discontinue our operations.

 

We will require substantial additional capital, and our reliance on variable-priced equity financing, including the equity line with Trillium, may result in substantial dilution.

 

We have historically funded our operations through the issuance of equity and debt securities, including variable-priced instruments and convertible securities, and we expect to continue to require substantial additional capital. The equity line established by the Purchase Agreement is a variable-priced financing arrangement under which the number of shares we must issue increases as our stock price declines. Sales of Put Shares to Trillium, and Trillium’s resale of those shares, may cause substantial dilution to existing stockholders and may depress the market price of our common stock.

 

A substantial portion of our outstanding indebtedness is owed to related parties, which creates refinancing risk and potential conflicts of interest.

 

A significant portion of our loans payable is owed to entities controlled by a single individual affiliated with the Company. This concentration creates refinancing risk and potential conflicts of interest between that individual and our minority stockholders. Approximately 96% of the loans payable are owed to entities controlled by our CEO.

 

VIII RISKS RELATING TO THIS OFFERING AND OUR COMMON STOCK

 

Trillium will pay less than the prevailing market price for our common stock, which may cause our stock price to decline.

 

The Put Shares will be sold to Trillium at a discount of 15% to the applicable measure of market price (that is, at 85% of the average of the three lowest closing bid prices over the applicable pricing window). Trillium has a financial incentive to sell the shares it acquires promptly to realize the difference between the discounted purchase price and the market price. These sales, and the perception that these sales may occur, could cause the market price of our common stock to decline. As the price declines, we would be required to issue an increasing number of shares to raise the same amount of proceeds, resulting in further dilution and potential additional downward pressure on our stock price.

 

10

 

 

It is likely that the number of shares registered in this offering will be insufficient to allow us to draw the full commitment amount.

 

The number of Put Shares registered in this offering is based on assumptions about our stock price and trading volume. Because the number of shares issuable under the Purchase Agreement increases as our stock price declines, and because per-put and beneficial-ownership limitations restrict the size and timing of puts, it is likely that the number of shares registered will be insufficient to enable us to draw the full $10,000,000, and we may be required to register additional shares in one or more subsequent registration statements in order to do so.

 

The 4.99% beneficial ownership limitation and per-put volume limitation restrict our ability to access the equity line when we may most need capital.

 

We may not require Trillium to purchase shares to the extent Trillium and its affiliates would beneficially own more than 4.99% of our outstanding common stock following the purchase, and the size of each put is limited to 250% of the average daily trading volume over the preceding ten trading days multiplied by the purchase price. As a result, our ability to access the equity line depends in part on Trillium’s resale of previously purchased shares and on our trading volume, and the equity line may not be available in the amounts or at the times we need capital.

 

If an “Event” occurs under the Registration Rights Agreement, we will be required to pay liquidated damages.

 

Under the Registration Rights Agreement, if specified “Events” occur, including a failure to file or obtain effectiveness of the registration statement by the applicable deadlines, or a failure to maintain effectiveness beyond permitted blackout periods, we are required to pay Trillium liquidated damages equal to 1.5% of the aggregate Investment Amount paid as of the Event date, and an additional 1.5% for each subsequent 30-day period during which the Event continues, subject to an aggregate cap of 4% of the aggregate Investment Amount. These payments would increase our cash needs at a time when we may be unable to access the equity line.

 

Resales under this prospectus could be characterized as an indirect primary offering, which could limit the number of shares we may register or require a fixed offering price.

 

Rule 415 under the Securities Act permits the registration of securities for resale as a secondary offering that is not an offering “by or on behalf of” the issuer. If the SEC were to take the position that the resale of the shares by Trillium constitutes an indirect primary offering by us, the number of shares we are able to register in a single registration statement could be limited, the shares could be required to be sold at a fixed price, and the timing and cost of accessing the equity line could be adversely affected.

 

11

 

 

Our common stock is subject to the “penny stock” rules, which may make it more difficult for investors to resell their shares.

 

Our common stock is a “penny stock” as defined under the Exchange Act. The penny stock rules impose additional sales-practice requirements on broker-dealers that sell penny stocks to persons other than established customers and accredited investors. These requirements may reduce the level of trading activity in the secondary market for our common stock and may make it more difficult for investors to sell their shares.

 

The market price of our common stock has been and may continue to be volatile, and a large number of shares are or may become available for sale.

 

The market price of our common stock has been volatile and could fluctuate widely in response to various factors, many of which are beyond our control. In addition, we have a history of significant dilution and have effected reverse stock splits in the past. Sales of a substantial number of shares of our common stock in the public market, including under this prospectus, or the perception that such sales could occur, could adversely affect the market price of our common stock.

 

IX RISKS RELATING TO OUR BUSINESS AND INDUSTRY

 

●We operate in a competitive and rapidly evolving market for AI-driven security and automation solutions, and we may be unable to compete effectively.
   
●We depend on continued market adoption of our Solutions-as-a-Service model and on the successful commercial deployment of newer products, including ROAMEO mobile units and the SARA agentic AI platform.
   
●We depend on key personnel, including our Chief Executive Officer, and on our ability to attract and retain qualified technical and operational personnel.
   
●We identified that our disclosure controls and procedures were not effective as of February 28, 2026, and we may be unable to remediate material weaknesses in our internal control over financial reporting.
   
●Our business depends on proprietary technology, and we may be unable to adequately protect our intellectual property.

 

12

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include statements regarding our plans, objectives, expectations, and intentions and other statements that are not historical facts, and may be identified by words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” and similar expressions. These statements are based on our current expectations and assumptions and are subject to risks and uncertainties, including those described under “Risk Factors,” that could cause actual results to differ materially from those expressed or implied. We undertake no obligation to update any forward-looking statement, except as required by law. The safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995 does not apply to the offering made by this prospectus.

 

USE OF PROCEEDS

 

This prospectus relates to the resale of shares of our common stock by the Selling Stockholder for its own account. We will not receive any proceeds from the resale of shares by the Selling Stockholder.

 

We may receive up to $10,000,000 in aggregate gross proceeds from sales of Put Shares to Trillium under the Purchase Agreement over the 36-month commitment period, assuming we exercise our put right in full and satisfy the conditions to each put. We cannot predict the actual amount of proceeds we will receive, which will depend on the number of shares we elect to sell, the market price of our common stock during the applicable pricing periods, and our ability to satisfy the conditions to each put. Based on historical trading volumes and the limitations in the Purchase Agreement, we do not expect to be able to draw the full commitment amount.

 

We intend to use the net proceeds we receive from sales of Put Shares for working capital and general corporate purposes, which may include research and development, sales and marketing, capital expenditures related to the deployment of our devices, repayment of indebtedness, and other general corporate purposes. We will pay Trillium’s counsel a fee of $15,000, payable upon the initial closing, and will bear the expenses of this registration. See “Plan of Distribution.”

 

DILUTION

 

Sales of Put Shares under the Purchase Agreement will have a dilutive effect on our existing stockholders. Because the purchase price of the Put Shares is determined by reference to the market price of our common stock during the applicable pricing period and reflects a 15% discount, the number of shares we must issue to raise a given amount of proceeds will increase as the market price of our common stock declines. In addition, the issuance of the 5,000,000 Commitment Shares will dilute existing stockholders. The following illustrates the potential dilutive effect of the equity line at assumed prices.

 

Sales of Put Shares under the Purchase Agreement will have a dilutive effect on our existing stockholders. Because the purchase price of the Put Shares is determined by reference to the market price of our common stock during the applicable pricing period and reflects a 15% discount, the number of shares we must issue to raise a given amount of proceeds will increase as the market price of our common stock declines. In addition, the issuance of the 5,000,000 Commitment Shares will dilute existing stockholders. The following table illustrates the potential dilutive effect of the equity line, assuming we sell $10,000,000 of Put Shares (the assumed aggregate proceeds), based on 387,232,589 shares of common stock outstanding as of July 1, 2026.

 

Assumed Market Price per Share  Purchase Price per Put Share (85% of Market Price)¹   Put Shares Issuable²   Commitment Shares   Total Shares Issued   Total Shares Outstanding After Issuance³   Shares Issued as % of Outstanding After Issuance⁴ 
$0.1000 (assumed recent price)  $0.0850    117,647,059    5,000,000    122,647,059    509,879,648    24.1%
$0.0750 (25% below recent price)  $0.0638    156,862,745    5,000,000    161,862,745    549,095,334    29.5%
$0.0500 (50% below recent price)  $0.0425    235,294,118    5,000,000    240,294,118    627,526,707    38.3%

 

  1. Reflects the 15% discount to the applicable market price provided under the Purchase Agreement.
  2. Represents the number of Put Shares required to generate $10,000,000 in gross proceeds at the applicable purchase price, rounded to the nearest whole share.
  3. Based on 387,232,589 shares of common stock outstanding as of June 1, 2026, plus the Put Shares and Commitment Shares set forth in the table.
  4. Represents the total shares issued under the equity line (Put Shares plus Commitment Shares) as a percentage of the total shares of common stock outstanding after giving effect to such issuance.

 

The foregoing is illustrative only. The actual number of shares issuable, and the resulting dilution, will depend on the market price of our common stock during the applicable pricing periods and the aggregate amount of Put Shares we elect to sell, and may differ materially from the amounts shown. The table does not give effect to any beneficial ownership limitation, exchange cap, or other issuance limitation that may apply under the Purchase Agreement or applicable listing rules.

 

13

 

 

SELLING STOCKHOLDER

 

The shares of common stock being offered by the Selling Stockholder are those issuable to the Selling Stockholder as Commitment Shares and those issuable upon our exercise of put rights under the Purchase Agreement. We are registering the shares in order to permit the Selling Stockholder to offer the shares for resale from time to time. The table below sets forth certain information regarding the beneficial ownership of our common stock by the Selling Stockholder as of the date of this prospectus and the number of shares being offered.

 

The Selling Stockholder is Trillium Partners LP, a Delaware limited partnership. Stephen Hicks holds voting and dispositive power over the shares held by the Selling Stockholder. Except for the transactions contemplated by the Purchase Agreement and the Registration Rights Agreement, and as otherwise described below, the Selling Stockholder has not held any position or office, or had any other material relationship, with us or any of our affiliates within the past three years. Trillium has represented to us that it is not a registered broker-dealer or an affiliate of a registered broker-dealer.

 

Trillium is an underwriter within the meaning of the Securities Act with respect to the resale of the shares offered by this prospectus.

 


SELLING SECURITY HOLDER

 

The following table details the name of each selling stockholder, the number of shares owned by Trillium Partners, LP (“Trillium”) the sole selling stockholder, and the number of shares that may be offered by Trillium. Trillium is not a broker-dealer. Trillium is deemed an underwriter in this offering. Trillium may sell up to 1,160,000,000 shares, which are issuable upon the exercise of our put right with Trillium. Trillium will not assign its obligations under the equity line of credit.

 

Name  Total
number of
shares owned
prior to offering
   Percentage of
shares owned
prior to
offering
   Number of
shares being
offered
  

Percentage of
shares owned

after the offering
assuming

all of the
shares are
sold in the
offering(1)

Trillium Partners, LP(2)   0    -    1,555,000,000   Less than 1%

 

(1) The number assumes the Selling Security Holder sells all of its shares being offered pursuant to this prospectus.
(2) Represents up to 5,000,000 Commitment Shares and up to 1,550,000,000 Put Shares registered for resale under the Purchase Agreement. Trillium Partners LP holds no shares of our common stock as of the date of this prospectus. Stephen Hicks, as manager of the general partner of Trillium Partners LP, has voting and dispositive power over the shares held by Trillium. Trillium’s beneficial ownership at any time is subject to the 4.99% Beneficial Ownership Cap described in this prospectus.

 

PLAN OF DISTRIBUTION

 

The common stock offered by this prospectus is being offered by the Selling Stockholder, Trillium Partners LP. The shares may be sold or distributed from time to time by the Selling Stockholder.

 

The Selling Stockholder may use any one or more of the following methods when selling shares, in each case at the fixed price described above: ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; privately negotiated transactions; and a combination of these methods. Broker-dealers engaged by the Selling Stockholder may arrange for other broker-dealers to participate in sales. In connection with the sale of the shares, the Selling Stockholder and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act, and any commissions received by such broker-dealers or agents and any profit on the resale of the shares may be deemed to be underwriting commissions or discounts under the Securities Act.

 

We have advised the Selling Stockholder that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the Selling Stockholder and its affiliates. The Selling Stockholder has agreed not to engage in short sales of our common stock during the term of the Purchase Agreement, subject to the exceptions described under “About This Offering—No Short Selling.” We have agreed to pay the expenses of registering the shares. We have agreed to indemnify the Selling Stockholder against certain liabilities, including liabilities under the Securities Act, in accordance with the Registration Rights Agreement and the indemnification provisions of the Purchase Agreement.

 

14

 

 

DESCRIPTION OF THE EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT

 

The following summarizes the material terms of the Purchase Agreement and the Registration Rights Agreement, each dated June 23, 2026, between us and Trillium. This summary is qualified in its entirety by reference to the full text of those agreements, which are filed as exhibits to the registration statement of which this prospectus forms a part.

 

Equity Purchase Agreement

 

Commitment; Puts. We have the right to require Trillium to purchase up to $10,000,000 of our common stock during a 36-month commitment period through Regular Puts and Accelerated Puts, as described under “About This Offering.” The purchase price for both put types is 85% of the applicable measure of the three lowest closing bid prices; Accelerated Puts are subject to a Floor Price (the greater of 75% of the put-date closing bid price or a higher price we specify) and a knock-out mechanic upon three Low Price Days. Accelerated Puts require delivery of Estimated Shares equal to 125% of the Investment Amount, subject to a true-up.

 

Commitment Shares. We agreed to issue 5,000,000 Commitment Shares in two equal tranches (upon effectiveness and 90 days thereafter), deemed fully earned on execution and registered for resale hereunder. Failure to timely issue either tranche constitutes an event of default under the Purchase Agreement.

 

Beneficial Ownership Cap. We may not issue shares to the extent Trillium and its affiliates would beneficially own more than 4.99% of our outstanding common stock following the issuance, calculated in accordance with Section 13(d) of the Exchange Act and Rule 13d-3.

 

Representations, Covenants and Conditions. The Purchase Agreement contains customary representations, warranties, and covenants, including covenants relating to reservation of shares, maintenance of DTC and DWAC eligibility, and a restriction (for the first 180 days of the commitment period) on entering into substantially comparable equity line arrangements with third parties without Trillium’s consent. Our right to deliver put notices is subject to the conditions described under “About This Offering—Conditions to Puts.”

 

Settlement; Defaults; Remedies. Regular Puts settle no later than one trading day after the put date; Accelerated Puts settle following the valuation period true-up. A failure by Trillium to fund, or by us to deliver Put Shares, constitutes an event of default. The Purchase Agreement provides for termination rights and remedies, and excludes specific performance against Trillium with respect to its funding obligations. Fees and expenses include a $15,000 reimbursement of Trillium’s counsel fees payable at the initial closing.

 

Governing Law. The Purchase Agreement is governed by Nevada law, and the parties submit to the exclusive jurisdiction of the federal and state courts located in Nevada and waive trial by jury.

 

Registration Rights Agreement

 

Under the Registration Rights Agreement, we agreed to file, as soon as practicable following the signing date, a registration statement on Form S-1 (or Form S-3, if available) covering the resale of all Registrable Securities (the Put Shares and the Commitment Shares), and to use reasonable best efforts to have it declared effective by the applicable Effectiveness Deadline (generally the 60th calendar day following the filing deadline, subject to acceleration if the SEC does not review the registration statement and subject to day-for-day extension for delays attributable to SEC review). We agreed to keep the registration statement continuously effective until the Registrable Securities cease to be Registrable Securities or have been sold.

 

Liquidated Damages. If an “Event” occurs (including a failure to file or achieve effectiveness by the applicable deadline, subject to specified SEC-review carve-outs, or a failure to maintain effectiveness beyond the permitted blackout period), we must pay Trillium liquidated damages equal to 1.5% of the aggregate Investment Amount paid as of the Event date, plus an additional 1.5% for each subsequent 30-day period during which the Event continues, subject to an aggregate cap of 4% of the aggregate Investment Amount.

 

Blackout Periods; Rule 415 Cutback. We may suspend use of the registration statement for no more than 20 consecutive trading days and no more than 45 trading days in any 12-month period. If the SEC determines that all Registrable Securities cannot be registered for resale on a single registration statement as a result of Rule 415, we agreed to reduce the number of shares registered in the order specified in the Registration Rights Agreement and to use reasonable best efforts to register omitted shares on subsequent registration statements. Indemnification under the Registration Rights Agreement is governed by the indemnification provisions of the Purchase Agreement.

 

15

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion together with our consolidated financial statements and the related notes included elsewhere in this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those described under “Risk Factors.”

 

Results of Operations — Fiscal Year Ended February 28, 2026 Compared to Fiscal Year Ended February 28, 2025

 

Revenue. Revenue increased $1,614,450, or 26%, to $7,745,336 for the fiscal year ended February 28, 2026, from $6,130,886 for the prior fiscal year, reflecting continued customer adoption and expanding recurring revenue programs.

 

Gross Profit. Gross profit increased 48% to $5,533,700, and gross margin expanded to approximately 71% from approximately 61%, primarily due to lower cost of goods sold relative to revenue.

 

Operating Expenses; Loss from Operations. Operating expenses were essentially flat at approximately $17,477,097. As a result, our loss from operations improved by approximately $2.0 million to $(11,943,397).

 

Net Loss. We reported a net loss of approximately $14.5 million for the fiscal year ended February 28, 2026.

 

Liquidity and Capital Resources

 

As of February 28, 2026, our total liabilities substantially exceeded our total assets, and we had a stockholders’ deficit. We have funded our operations principally through the issuance of equity and debt securities, including variable-priced instruments and related-party loans. Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. We expect to continue to rely on external financing, including the equity line established by the Purchase Agreement, to fund our operations. There is no assurance that financing will be available to us on acceptable terms, or at all.

 

Cash Flows

 

As of February 28, 2026, we had cash and cash equivalents of $109,043, compared to $865,975 as of February 28, 2025, a decrease of $756,932. Our cash and cash equivalents consist of cash on deposit with high-quality U.S. financial institutions and money market instruments.

 

Net cash used in operating activities was $9,344,534 for the fiscal year ended February 28, 2026, compared to $12,196,388 for the fiscal year ended February 28, 2025. Cash used in operating activities in fiscal 2026 was primarily attributable to our net loss of $14,510,251, adjusted for non-cash items including depreciation and amortization of $2,122,730, stock-based compensation of $1,815,848, amortization of debt discounts of $536,078 and a gain on settlement of debt of $3,434,685, together with changes in operating assets and liabilities, including an increase in accrued interest payable of $3,847,474 and an investment in device parts inventory of $2,133,437.

 

Net cash used in investing activities was $12,861 for the fiscal year ended February 28, 2026, compared to $79,965 for the prior fiscal year, consisting primarily of purchases of fixed assets and trademarks.

 

Net cash provided by financing activities was $8,600,463 for the fiscal year ended February 28, 2026, compared to $13,036,402 for the prior fiscal year. Financing activities in fiscal 2026 consisted principally of net proceeds from the issuance of common stock of $5,219,853 and proceeds from loans payable of $4,808,171, partially offset by repayments of loans payable of $1,302,561 and redemptions of preferred stock of $125,000. As a result of the foregoing, cash decreased by $756,932 during the fiscal year ended February 28, 2026, compared to a net increase of $760,049 during the prior fiscal year.

 

Indebtedness

 

As of February 28, 2026, our total liabilities were $61,965,374, compared to total assets of $9,302,228. Our indebtedness consisted principally of loans payable with an aggregate face value of $33,672,294, of which $8,848,140 (net of unamortized discount of $635,774) was classified as current and $24,188,380 was classified as non-current. Substantially all of our long-term debt matures in the fiscal year ending February 29, 2028. Our loans payable bear interest at rates generally ranging up to 22% per annum, with the substantial majority bearing interest at 12% per annum, and certain notes were in default as of February 28, 2026. Accrued interest payable on our outstanding indebtedness totaled $11,393,658 as of February 28, 2026, of which $2,271,106 was classified as current and $9,122,552 was classified as non-current.

 

Certain of our outstanding notes are convertible into shares of our common stock, including a $495,000 convertible note and a $165,000 convertible note, each of which may be redeemed at a premium and bears interest at 12% per annum. During the fiscal year ended February 28, 2026, we exchanged $6,484,000 of loans payable and accrued interest for shares of our common stock.

 

A significant portion of our indebtedness is owed to related parties. As of February 28, 2026, $32,178,506, or approximately 96%, of our total loans payable was owed to companies controlled by a single individual, compared to $28,581,506, or approximately 87%, as of February 28, 2025. In addition, as of February 28, 2026, we had a loan payable to a related party of $461,633, which included $285,638 of deferred salary bearing interest at 12% per annum, together with accrued interest of $79,268. As of February 28, 2026, we also had deferred compensation payable to our Chief Executive Officer of $1,811,856 and an incentive compensation plan payable of $5,500,000, in respect of which we had accrued 1,500 shares of Series G Redeemable Preferred Stock, valued at $1,500,000, to be issued.

 

Preferred Stock

 

As of February 28, 2026, we had outstanding 417 shares of Series C Convertible, Redeemable Preferred Stock, with a carrying value of $547,941, which accrue dividends at 12% per annum and are redeemable at 109.5% of their $1,200 stated value; 3,350,000 shares of Series E Preferred Stock; and 2,513 shares of Series F Convertible Preferred Stock. No shares of our Series B Convertible, Redeemable Preferred Stock or Series G Redeemable Preferred Stock were issued and outstanding as of February 28, 2026. Our redeemable preferred stock is classified outside of permanent stockholders’ equity on our consolidated balance sheets.

 

Going Concern

 

We have incurred recurring net losses and negative cash flows from operations. For the fiscal year ended February 28, 2026, we incurred a net loss of $14,510,251 and had negative cash flow from operating activities of $9,344,534, and as of February 28, 2026, we had an accumulated deficit of $171,121,742, negative working capital of $17,017,745 and a total stockholders’ deficit of $53,211,087. These conditions raise substantial doubt about our ability to continue as a going concern for the twelve months following the date the consolidated financial statements were issued. Our consolidated financial statements do not include any adjustments to the recoverability and classification of asset carrying amounts, or to the amounts and classification of liabilities, that might result should we be unable to continue as a going concern. Management intends to address our liquidity requirements by growing revenues and raising additional capital through equity and debt financings, including the equity line described elsewhere in this prospectus, under which approximately $10 million remained available for issuance as of the date of this prospectus. There can be no assurance that such financing will be available on acceptable terms, or at all, or that our plans will be successful.

 

Critical Accounting Policies and Estimates

 

The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates. We consider the accounting policies described below to be those most important to the portrayal of our financial condition and results of operations and that require our most difficult, subjective or complex judgments. These policies should be read together with the summary of significant accounting policies set forth in Note 2 to our consolidated financial statements included elsewhere in this prospectus.

 

Use of Estimates

 

The most significant estimates reflected in our consolidated financial statements relate to the assumptions used to value equity instruments issued in connection with debt settlements, amendments and extensions; the classification and fair value measurement of liability-classified instruments and equity awards; the allowance for credit losses; inventory valuation reserves; the estimated useful lives and recoverability of long-lived assets; and the realizability of deferred tax assets. The ultimate resolution of the matters underlying these estimates could differ significantly from the amounts on which our financial statements are based.

 

16

 

 

Revenue Recognition

 

We recognize revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers, and, for the short-term rental of our devices, in accordance with ASC Topic 842, Leases. Under Topic 606, we recognize revenue when we transfer promised goods or services to a customer in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services, applying a five-step model that requires us to identify the performance obligations in each contract, estimate the amount of variable consideration to include in the transaction price, and allocate the transaction price to each separate performance obligation. The application of this model requires judgment, particularly in identifying distinct performance obligations and in estimating variable consideration. Our revenue is concentrated among a limited number of customers; for the fiscal year ended February 28, 2026, two customers accounted for approximately 55% of total revenue, and for the fiscal year ended February 28, 2025, one customer accounted for approximately 55% of total revenue.

 

Going Concern

 

In connection with the preparation of our consolidated financial statements, we evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. This evaluation requires management to make significant judgments about our projected cash flows, our available sources of financing, and our ability to execute our operating plans. As described in Note 1 to our consolidated financial statements, our recurring losses, negative working capital and negative cash flows from operations raise substantial doubt about our ability to continue as a going concern, and our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Classification and Measurement of Financial Instruments; Derivative and Liability-Classified Instruments

 

We rely on the guidance in ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable or convertible instruments. We first determine whether a financial instrument should be classified as a liability, which is the case if the instrument is mandatorily redeemable or embodies a conditional obligation that we must or may settle by issuing a variable number of our equity shares. If an instrument is not classified as a liability, we then determine whether it should be presented as temporary equity, where redemption is outside our control, or as permanent equity. Instruments classified as liabilities are initially recorded at fair value, or cash received, and are remeasured to fair value at each subsequent reporting date, with changes in fair value recorded in other income (expense). Determining the appropriate classification of these instruments, and measuring their fair value, requires significant judgment and the use of estimates and assumptions that can materially affect our reported results.

 

Fair Value Measurements

 

We measure certain assets and liabilities at fair value on a recurring basis in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, which establishes a three-level hierarchy that prioritizes the inputs used to measure fair value, giving the highest priority to quoted prices in active markets (Level 1) and the lowest priority to unobservable inputs (Level 3). Our recurring fair value measurements are classified within Level 3 of the hierarchy because they rely on significant unobservable inputs. These measurements include our incentive compensation plan payable, which represents the revaluation of equity awards payable in Series G Preferred Shares and was recorded at $5,500,000 and $4,000,000 as of February 28, 2026 and February 28, 2025, respectively, and an investment for which the Level 3 portion of the fair value measurement is based on an independent third-party valuation. Because these measurements depend on unobservable inputs, including the redemption value of the Series G Preferred Shares, they are inherently uncertain, and changes in the underlying assumptions could have a material effect on our financial statements.

 

Share-Based Compensation and Incentive Compensation Plan

 

We recognize compensation expense in connection with an incentive compensation plan under which amounts are payable to our Chief Executive Officer in Series G Preferred Shares. The related liability is measured based on the redemption value of the Series G Preferred Shares, which are redeemable at $1,000 per share, and is remeasured at each reporting date. We recorded stock-based compensation of $1,500,000 for each of the fiscal years ended February 28, 2026 and February 28, 2025, with corresponding adjustments to the incentive compensation plan payable. In addition, we periodically issue warrants and other equity instruments in connection with financing transactions and debt settlements, the fair values of which we estimate using the Black-Scholes option-pricing model. That model requires us to make assumptions regarding the expected term, expected volatility, risk-free interest rate and the fair value of our common stock, and changes in these assumptions can significantly affect the estimated fair value of the instruments and the amounts we recognize.

 

Impairment of Long-Lived Assets

 

Our long-lived assets consist principally of revenue earning devices and fixed assets. Revenue earning devices are stated at cost and depreciated on a straight-line basis over an estimated useful life of 48 months, and our other fixed assets are depreciated over estimated useful lives ranging from three to five years. We continually evaluate whether events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable or that a revision to their estimated useful lives is warranted. In assessing recoverability, we use a combination of undiscounted cash flow and market approaches, and we measure any impairment loss as the amount by which the carrying amount of an asset exceeds its fair value. These assessments require significant judgment regarding future cash flows and asset utilization.

 

Inventory

 

Device parts inventory is stated at the lower of cost, determined using the weighted-average cost method, or net realizable value. We record a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification, and we recognize a charge to income when factors such as excess or obsolete inventory indicate that an increase in the reserve is required. Our inventory valuation reserve was $175,000 and $465,000 as of February 28, 2026 and February 28, 2025, respectively. Estimating net realizable value and the appropriate reserve requires judgment regarding future demand for, and usage of, our device parts.

 

Sales of Future Revenues

 

We have entered into transactions in which we received funding from investors in exchange for the right to receive payments based on a percentage of sales of certain revenue categories. We evaluate the facts and circumstances of each such arrangement to determine whether it should be accounted for as a sale of future revenues or, in substance, as debt, considering factors such as whether the arrangement purports to be a sale, whether we have continuing involvement in generating the underlying cash flows, whether the transaction is cancellable, whether the investor’s rate of return is implicitly limited by the terms of the agreement, and whether the investor has recourse. Where an arrangement is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of our financial statements, we have determined that all such arrangements constitute debt. This determination requires significant judgment and could materially affect the classification and timing of amounts reflected in our financial statements.

 

Income Taxes

 

We account for income taxes under the asset and liability method, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized, which requires significant judgment regarding the timing and amount of future taxable income.

 

17

 

 

 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

  

Forward-Looking Statements

 

The following discussion of our financial condition and results of operations for the three months ended May 31, 2026 and May 31, 2025 should be read in conjunction with our unaudited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended February 28, 2026, as filed on June 9, 2026 with the SEC. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

 

Unless expressly indicated or the context requires otherwise, the terms “AITX”, the “Company”, “we”, “us”, and “our” refer to Artificial Intelligence Technology Solutions Inc.

 

Overview

 

AITX was incorporated in Florida on March 25, 2010. AITX reincorporated into Nevada on February 17, 2015. AITX’s fiscal year end is February 28 (February 29 during leap year). AITX is located at 10800 Galaxie Ave., Ferndale Michigan, 48220, and our telephone number is 877-767-6268.

 

AITX’s mission is to apply Artificial Intelligence (AI) technology to solve enterprise problems categorized as expensive, repetitive, difficult to staff, and outside of the core competencies of the client organization.

 

A short list of basic examples include:

 

  1. Typical security guard-related functions such as monitoring a parking lot during and after hours and responding appropriately. This scenario applies to perimeters, interior yard areas, and related similar environments.
     
  2. Integrated hardware/software with AI-driven responses, simulating and expanding on what legacy or manned solutions could perform.
     
  3. Automation of common access control functions through technology utilizing facial recognition and machine vision, leapfrogging most legacy solutions in use today.

 

RAD solutions are unique because they:

 

  1. Start with an AI-driven autonomous response utilizing cellular-optimized communications, while easily connecting to a human operator for a manned response, as needed.
     
  2. Use unique hardware purpose-built by RAD for delivery of these solutions. Various form factors have been customized to deliver this new functionality.
     
  3. Deliver services through RAD-developed software and cloud services, allowing enterprise IT groups to focus on core competencies instead of maintenance of complex video and security platforms.

 

We encourage everyone to ensure they have the most up to date news by visiting AITX at AITX News - AITX - Artificial Intelligence Technology Solutions.

 

18

 

 

Management Discussion and Analysis

 

Results of Operations for the Three Months Ended May 31, 2026 and 2025

 

The following table shows our results of operations for the three months ended May 31, 2026 and 2025. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

 

   Period     
   Three Months Ended   Three Months Ended   Change 
   May 31, 2026   May 31, 2025   Dollars   Percentage 
Revenues  $1,831,202   $1,854,837   $(23,635)   (1)%
Gross profit   1,183,824    1,233,501    (49,677)   (4)%
Operating expenses   3,893,188    4,412,170    (518,982)   (12)%
Loss from operations   (2,709,364)   (3,178,669)   469,305    15%
Other expense, net   (3,006,474)   (1,415,349)   (1,591,125)   (112)%
Net loss  $(5,715,838)  $(4,594,018)  $(1,121,820)   (24)%

 

Revenue

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

   Three Months Ended   Three Months Ended   Change 
   May 31, 2026   May 31, 2025   Dollars   Percentage 
Device rental activities  $1,613,095   $1,627,286   $(14,191)   (1)%
Direct sales of goods and services   218,107    227,551    (9,444)   (4)%
   $1,831,202   $1,854,837   $(23,635)   (1)%

 

Total revenue for the three-month period ended May 31, 2026 was $1,831,202which represented a decrease of $23,635 or 1% compared to total revenue of 1,854,837 for the three months ended May 31, 2025. The decrease in revenue was attributable to a significant drop in the sales for one major customer due to their internal cost cutting initiatives. This major customer previously represented about 48% of the Company’s revenues for the three months ended May 31, 2025 represented 21% of the Company’s revenues for the three months ended May 31, 2026. The Company managed to mitigate this reduction by gaining new customers and diversifying its customer base. For the three months ended May 31, 2026, two customers accounted for 36% of total revenue and for the three months ended May 31, 2025, two customers accounted for 65% of total revenue. The Company expects to see sales growth through new mobile products and software starting in the second quarter of this fiscal year. The mobile products will see a slow steady rollout over the fiscal year due to the capital intensive nature of these products.

 

Gross profit

 

Total gross profit for the three-month period ended May 31, 2026 was $1,183,824which represented a decrease of $49,677 compared to gross profit of $1,233,501 for the three months ended May 31, 2025. The decrease is consistent with the decrease in revenues as well as changes in product mix. The gross profit % of 65% for the three-month period ended May 31, 2026 compared with the gross profit % of 67% for the three month period ended May 31, 2025.

 

Operating Expenses

 

   Period   Change 
  

Three Months Ended

May 31, 2026

  

Three Months Ended

May 31, 2025

   Dollars   Percentage 
                 
Research and development  $885,593   $1,087,619   $(202,026)   (19)%
General and administrative   2,907,577    3,232,211    (324,634)   (10)%
Depreciation and amortization   32,646    34,121    (1,475)   (4)%
Operating lease cost and rent   67,372    58,219    9,153    16%
Operating expenses  $3,893,188   $4,412,170   $(518,982)   (12)%

 

19

 

 

Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the three-month period ended May 31, 2026 and May 31, 2025, were $3,893,188 and $4,412,170, respectively. The overall decrease of $518,982 was primarily attributable to the following changes in operating expenses of:

 

  ● General and administrative expenses decreased by $324,634. In comparing the three months ended May 31, 2026 and May 31, 2025 this decrease was primarily due to the following decreases: wages and salaries by $227,585, professional fees by $45,167, stock based compensation by $19,847, production supplies by $45,525, RMC costs by $59,948, marketing by $53,486, freight and duty costs by $49,508 and dues and subscriptions by $27,858. These costs were partially offset by increases in subcontractor by $198,837 and with other net G& A account decreases.
     
  ● Research and development decreased by $202,026 due to a decrease in software development as the product is being released.
     
  ● Depreciation and amortization decreased by $1,475.
     
  ● Operating lease cost and rent increased by $9,153 due to one new lease in 2026.

 

Other Expense

 

Other expense during the three months ended May 31, 2026 and May 31, 2025, was $3,006,474 and $1,415,349, respectively. The $1,591,125 increase in other expense was primarily attributable to a $885,525 increase in interest expense due to an approximately $338,000 increase in debt discount amortization expense, an approximately $204,000 increase in interest on DVPO balance with the balance due to the switch to some notes (see Note 11) to compounding interest and interest on approximately $2.7 million increase in loans payable. The $707,600 loss on settlement was on the exchange of loans payable and accrued interest for the three months ended May 31, 2026

 

Net loss

 

We had a net loss of $5,715,838 for the three months ended May 31, 2026, compared to a net loss of $4,594,018 for the three months ended May 31, 2025. The increase in net loss of $1,121,820 is due to a number of factors: higher other expenses is reduced by lower operating expenses for the three months ended May 31, 2026.

 

Liquidity, Capital Resources and Cash Flows

 

Management believes that we will continue to incur losses for the immediate future. Therefore, we will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities, if ever. These conditions raise substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include and adjustments relating to the recovery of assets or the classification of liabilities that may be necessary should we be unable to continue as a going concern.

 

 

As of May 31, 2026, we had a cash balance of $94,643, accounts receivable (net) of $974,897, device parts inventory(net) of $1,378,950 and $44,890,383 in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.

 

The successful outcome of future activities cannot be determined at this time and there is no assurance that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operating results.

 

Capital Resources

 

The following table summarizes total current assets, liabilities and working capital (deficit) for the periods indicated:

 

   May 31, 2026   February 28, 2026 
Current assets  $3,005,227   $2,935,003 
Current liabilities   44,890,383    19,952,748 
Working capital  $(41,885,156)  $(17,017,745)

 

As of May 31, 2026 and February 28, 2026, we had a cash balance of $94,643 and $109,043, respectively.

 

Summary of Cash Flows

 

   Three Months Ended
May 31, 2026
   Three Months Ended
May 31, 2025
 
Net cash used in operating activities  $(2,759,307)  $(3,321,185)
Net cash used in investing activities  $(16,438)  $(9,720)
Net cash provided by financing activities  $2,761,345   $2,789,777 

 

20

 

 

Net cash used in operating activities.

 

Net cash used in operating activities for the three months ended May 31, 2026 was $2,759,307 which included a net loss of $5,715,838, non-cash activity such as bad debts expense of $70,000, reduction of right of use asset of $38,013, accretion of lease liability $23,281, stock based compensation of $60,508, change in operating assets and liabilities of $1,255,482, amortization of debt discount of $385,493, decrease in related party accrued payroll and interest of $129,687 and depreciation and amortization of $545,841 to derive the uses of cash in operations.

 

Net cash used in investing activities.

 

Net cash used in investing activities for the three months ended May 31, 2026 was $16,438 which was the purchase of fixed assets of $15,600 and an acquisition of trademark of $838.

 

Net cash provided by financing activities.

 

Net cash provided by financing activities for the three months ended May 31, 2026 was $2,761,345. This consisted of share proceeds net of issuance costs of $823,480 , proceeds on the issuance of Series C Preferred Shares of $200,000, proceeds from loans payable of $2,714,028 reduced by repayments on loans payable of $976,163.

 

Off-Balance Sheet Arrangements

 

None.

  

Critical Accounting Policies and Estimates

 

Critical accounting policies and estimates are further discussed in our Annual Report on Form 10-K for the year ended February 28, 2026, as filed on June 9, 2026.

 

Related Party Transactions

 

For both the three months ended May 31, 2026, and May 31, 2025, the Company had repayments of net advances of $129,687 and $0, respectively. At May 31, 2026, the loan payable-related party was $331,946 and $461,633 at February 28, 2026. Included in the balance due to the related party at May 31, 2026, is $255,414 of deferred salary and interest, $157,513 of which bears interest at 12%. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. The accrued interest included in the loan at May 31, 2026, and February 28, 2026, was $84,956, and $79,268, respectively.

 

During the three months ended May 31, 2026, the Company paid out gross payments to the CEO of $71,105 offset by a bonus accrual of $250,000, which yields a net change of $178,895 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, 2026, board action which provided an additional $1.5 million in compensation. During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yielded a net change of $1,246,687 relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $1,990,751 and $1,811,856 at May 31, 2026, and February 28, 2026, respectively

 

For the three months ended May 31, 2026, the Company accrued $0 (three months ended May 31, 2025-$0) of incentive compensation plan payable to the CEO. This will be payable in Series G Preferred Shares, which are redeemable at the Company’s option at $1,000 per share. On May 31, 2026, and February 28, 2026, there was $5,500,000 and $5,500,000 incentive compensation payable.

 

During the three months ended May 31, 2026, and 2025, the Company was charged $390,130 and $736,875, respectively for fees for research and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company, and the fees were spent on core development projects. As at May 31, 2026, and February 28, 2026, the balance due to this company was $76,532 and $160,557, respectively.

 

21

 

 

BUSINESS

 

The following is a summary of our business. You should read this summary together with our more detailed disclosure and our consolidated financial statements and the related notes included elsewhere in this prospectus.

 

We are a developer and operator of AI-driven security and productivity solutions for enterprise clients. Through our family of companies—RAD-I, RAD-M, RAD-G, RAD-R, and RAD Lanka—we develop and deliver AI-driven technologies and services designed to transform security, automation, and operational workflows. Through RAD-I, we market a “Solutions-as-a-Service” model to the security and guarding services industry, which we estimate to be an approximately $50 billion market in the United States, and we design our solutions to deliver cost savings of between 35% and 80% compared with traditional manned security and monitoring. We describe our operations across three pillars: stationary security devices (RAD-I); mobile autonomous platforms (RAD-M), including the ROAMEO mobile security unit; and our SARA agentic AI platform (RAD-G). RAD Lanka, located in Sri Lanka under Port City Colombo status, supports software development and technical operations across our subsidiaries.

 

BUSINESS

 

Corporate History and Organization

 

Artificial Intelligence Technology Solutions Inc. (the “Company,” “AITX,” “we,” “our,” or “us”) was incorporated in the State of Florida on March 25, 2010, under the name On the Move Systems Corp., and reincorporated in the State of Nevada on February 17, 2015. On August 24, 2018, the Company changed its name to Artificial Intelligence Technology Solutions Inc.

 

In 2017, the Company acquired all of the ownership and equity interests in Robotic Assistance Devices, Inc. (“RAD”), a Nevada corporation founded by Steven Reinharz, the Company’s current Chief Executive Officer and Chief Technology Officer (the “Acquisition”). Prior to the Acquisition, the Company’s operations consisted of an early-stage transportation services business that was disposed of in connection with the Acquisition. As a result, the Acquisition was accounted for as a reverse recapitalization effected through a share exchange, with RAD treated as the accounting acquirer. No goodwill or other intangible assets were recorded in connection with the Acquisition, and the historical operations reflected in our consolidated financial statements are those of RAD.

 

Since the Acquisition, the Company has been engaged in the development, deployment, and commercialization of artificial intelligence and robotic solutions for security, monitoring, and operational applications. Mr. Reinharz was appointed Chief Executive Officer on March 2, 2021.

 

The Company conducts substantially all of its operations through five (5) wholly owned subsidiaries: Robotic Assistance Devices, Inc. (“RAD-I”); Robotic Assistance Devices Group, Inc. (“RAD-G”); Robotic Assistance Devices Mobile, Inc. (“RAD-M”); Robotic Assistance Devices Residential, Inc. (“RAD-R”); and Robotic Assistance Devices Lanka (PVT) Ltd. (“RAD Lanka”), a Sri Lanka entity holding Port City Colombo status that operates as a wholly owned subsidiary of RAD-G. The Company anticipates establishing an additional subsidiary, Robotic Assistance Devices Europe (“RAD Europe”), during fiscal 2027 to support growing business activity in the European Union and to serve as the Company’s cost center for Genera Data Protection Regulation (GDPR)-compliant services.

 

Business Overview

 

AITX is a vertically integrated developer and operator of artificial intelligence-driven security and operational automation solutions. The Company designs, manufactures, deploys, and supports a portfolio of stationary devices, mobile autonomous platforms, and software products powered by SARA™ (Speaking Autonomous Responsive Agent), our proprietary agentic AI platform. SARA enables our devices to perceive, decide, communicate, and act autonomously in real time, without continuous human intervention.

 

Substantially all of our revenue is generated through recurring monthly subscription contracts, typically with minimum twelve-month initial terms, under a Solutions-as-a-Service model in which the Company retains ownership of the deployed hardware. The Company also sells units outright to a limited number of legacy enterprise customers. We expect that, over the deployment life of a subscribed unit, gross margin will exceed 75%, and that gross margin on outright sales will exceed 50% based on average bill of materials costs over the past two years and related sales and dealer channel pricing that our market has appeared to accept.

 

Our customer base spans logistics, healthcare, commercial real estate, manufacturing, retail, education, government, and residential markets, and includes one Fortune Top 10 enterprise and several additional Fortune 500 enterprises. As of the date of this report, the Company has deployed approximately one thousand devices across the United States and Canada, and is in the early stages of European market entry.

 

22

 

 

Industry Context and Long-Term Vision

 

Management views the physical security industry as being in the early stages of the most significant structural transformation in its history. The founder, Steve Reinharz, has written and spoken extensively and is a regular speaker about this transformation since company inception at industry association events hosted by the two industry leading organizations, SIA (Security Industry Organization) and ASIS (American Society for Industry Security). The industry has historically depended on human guard labor, passive video surveillance, and manually monitored alarm systems—a model substantially unchanged in its fundamentals for more than fifty years. That model is, in our view, is undergoing change driven by a variety of factors including increasing challenges with labor and the advent of AI solutions. Guard labor costs continue to rise faster than commercial security budgets; qualified personnel are increasingly difficult to recruit and retain; manual monitoring workflows cannot scale to the volume of cameras and sensors now deployed; and the response-time performance of human-mediated systems is incompatible with the speed at which modern threats develop.

 

Other industries—logistics, manufacturing, financial services, agriculture—have already passed through the corresponding transition from mechanized labor (the Third Industrial Revolution) to autonomous, AI-orchestrated workflows (commonly described as the Fourth Industrial Revolution, or Industry 4.0). The physical security industry, in management’s view, is now in the first phase of that same transition. AITX is positioned to be a primary participant in this shift, and a substantial portion of the Company’s strategy, capital allocation, and product roadmap is oriented around accelerating it.

 

Internally, the Company refers to the long-term outcome of this transition as “RAD Town”—a vision in which AITX’s portfolio operates as an integrated autonomous-security fabric across a campus, community, or jurisdiction. In a fully realized RAD Town deployment, ROAMEO mobile units conduct outdoor patrol; AVA manages vehicle access at gates and perimeters; TOM handles credentialed pedestrian and visitor access at building entries; stationary ROSA, RIO, and RAM units provide fixed-position coverage of high-value zones; RADCam protects residential and small-business endpoints; and SARA orchestrates all of it as a single agentic layer, escalating to human responders only when necessary. RAD Town is not a single named site or development; it is the design target around which our product roadmap, software architecture, and partnership strategy are organized.

 

We believe that the companies that capture the largest share of the value created by this transition will be those that combine proprietary hardware, proprietary AI, a broad partner ecosystem, and operational discipline. The Company’s strategy is built on each of these elements.

 

Operating Structure and Sales Channels

 

The Company is organized around four operating subsidiaries focused on commercial product sales and one development and licensing subsidiary. For purposes of management reporting and strategic capital allocation, we view our commercial activity as proceeding along three principal sales avenues: (i) the stationary product portfolio operated through RAD-I; (ii) the mobile autonomous platform operated through RAD-M; and (iii) the agentic AI platform and ecosystem partnerships operated through RAD-G. RAD-R operates a residential product line that is currently a smaller component of consolidated revenue and is discussed separately below.

 

Management believes that RAD-I, on a standalone basis (based on direct and expenses for only stationary solutions and therefore stripped of any expense not related to stationary solutions and its development), has achieved a point at which its recurring revenue and gross margin could support positive cash flow operations     today. The Company has elected to continue investing materially in RAD-M and RAD-G because we believe those investments will produce substantially larger long-term revenue and enterprise value than would be achievable from RAD-I alone. The Company’s consolidated results therefore continue to reflect the costs of those investments, specifically in mobile, residential and agentic solutions. This positioning reflects management’s view based on internal segment-level analysis; the Company does not separately publish audited standalone financial statements for individual subsidiaries.

 

RAD-I: Stationary Solutions

 

Robotic Assistance Devices, Inc. (“RAD-I”) operates the Company’s stationary product portfolio. RAD-I is the largest revenue contributor within the consolidated group, and its product line represents the most mature, most deployed, and most operationally proven elements of our portfolio. RAD-I’s solutions are typically deployed at fixed locations—building entries, gates, perimeters, parking facilities, and interior chokepoints—and are delivered as recurring subscription services.

 

RAD-I’s current product portfolio includes the following solutions, each of which is integrated with the Company’s SARA agentic AI platform:

 

ROSA™ (Responsive Observation Security Agent)

 

ROSA is a compact, self-contained stationary security device combining visual analytics, two-way audio engagement, and AI-driven escalation. ROSA is the Company’s most widely deployed solution and serves as the foundation for several other products in the portfolio. ROSA is used for perimeter and entry-point monitoring, loitering and trespass deterrence, firearm detection, and a range of related applications, and replaces or substantially reduces the need for guard services at protected locations.

 

RIO™ (ROSA Independent Observatory)

 

RIO is a portable, solar-powered security tower comprising one or two ROSA devices mounted atop a solar trailer assembly. RIO is designed for rapid deployment in environments where permanent infrastructure is impractical, including construction sites, retail parking lots, healthcare campuses, distribution yards, public events, and temporary high-risk locations. Hundreds of RIO units are actively deployed across the United States.

 

23

 

 

AVA™ (Autonomous Verified Access)

 

AVA is a vehicle gate access management solution combining license plate recognition, two-way voice interaction, and cloud-based authorization. AVA is deployed at logistics hubs, gated communities, corporate and industrial campuses, and multi-tenant commercial properties. AVA is sold both as a standalone subscription and as a component of a broader access platform that includes the Homeowners Association Platform (“HOAP”), a digital pass and visitor management application used by residential communities.

 

TOM™ (The Office Manager)

 

TOM automates visitor management and front-desk functions at credentialed pedestrian access points. TOM is deployed across corporate campuses, multi-tenant commercial facilities, government buildings, and educational institutions. One of the world’s largest third-party logistics providers uses TOM to manage visitor intake across its North American distribution network.

 

ROSS™ and RAM™ (Camera Augmentation Software and Hardware)

 

ROSS is a software platform that adds AI-driven analytics, escalation workflows, and SARA-enabled response to existing third-party IP security cameras. RAM is a complementary hardware module that adds two-way audio, voice interaction, and ROSA-equivalent SARA functionality to third-party cameras. ROSS and RAM enable customers to modernize their existing camera infrastructure without full hardware replacement and provide a low-friction path to broader RAD ecosystem adoption.

 

Firearm Detection Analytic

 

The Company’s firearm detection analytic identifies visible handguns and long guns in real time and is available across RAD-I devices and through the ROSS platform. When integrated with SARA, the analytic produces autonomous escalation, voice intervention, administrator notification, and first-responder outreach within seconds of detection. The analytic received the American Security Today ASTORS award for Best Metal/Weapons Detection Solution.

 

Forthcoming Stationary Solutions

 

The Company expects to introduce additional stationary solutions during fiscal year 2027. These products are in active development and are intended to expand RAD-I’s coverage of indoor environments, specialized vertical markets, and high-volume credentialed-access workflows. The Company will provide additional disclosure regarding specific forthcoming products through press releases and subsequent periodic filings as they progress to commercial release.

 

RAD-M: Mobile Autonomous Solutions

 

Robotic Assistance Devices Mobile, Inc. (“RAD-M”) operates the Company’s mobile autonomous platform business. RAD-M is the second of the Company’s three primary sales avenues and is the principal area in which the Company has invested development capital over the past several fiscal years.

 

24

 

 

ROAMEO™ (Rugged Observation Assistance Mobile Electronic Officer)

 

ROAMEO is a fully autonomous, outdoor mobile security vehicle designed to conduct routine patrol operations across corporate campuses, distribution yards, parking facilities, educational and healthcare campuses, municipal parks, and similar large outdoor environments. ROAMEO operates without on-site human pilots, relying on the Company’s autonomous navigation stack, on-board sensor suite, cellular and 5G connectivity, and full integration with the SARA agentic AI platform. ROAMEO is designed to detect, assess, communicate, escalate, and report autonomously, and to replace or substantially reduce the cost of mobile guard patrols conducted in vehicles or on foot.

 

Development Investment and Deployment Status

 

Management estimates that the Company has spent approximately $20 million in the cumulative development of the ROAMEO platform across fiscal years preceding the fiscal year covered by this report. This estimate includes cash research and development expenditures, engineering costs, allocated executive and indirect labor, and other indirect costs reasonably attributable to the ROAMEO program. The Company does not separately report segment-level research and development on this basis in its audited consolidated financial statements; the $20 million figure reflects management’s internal allocation and view and is provided here to give investors a directionally accurate sense of the scale of investment that has been made.

 

Following the additional engineering, manufacturing, and integration work conducted during the fiscal year ended February 28, 2026, the Company commenced commercial deployment and recurring billing on two ROAMEO units in May 2026. Initial deployments are at two enterprise customer sites: a major logistics operator (previously disclosed by press release) and a healthcare group. The Company has additional pre-sold units in its order pipeline and is actively expanding its ROAMEO production capacity to meet demand.

 

RAD-M Financial Expectations

 

Management has significant expectations for the RAD-M business. Each ROAMEO deployment is structured as a recurring monthly subscription at a substantially higher monthly price point than the Company’s stationary products, and the addressable market for outdoor autonomous patrol is large relative to the Company’s current revenue base . Management expects that, based on the current sales pipeline and assuming successful execution of the ROAMEO production ramp, RAD-M will surpass RAD-I’s monthly recurring revenue contribution at some point as management believes the mobile business has a higher revenue ceiling than stationary solutions. This is a forward-looking statement; actual results may differ materially, and the timing and magnitude of RAD-M’s revenue contribution will depend on a range of factors including production capacity, customer adoption, and the operational performance of deployed units. See “Cautionary Statement Regarding Forward-Looking Information” at the front of this report.

 

RAD-G: Agentic AI and Platform Partnerships

 

Robotic Assistance Devices Group, Inc. (“RAD-G”) operates the Company’s agentic AI development and platform business. RAD-G holds, develops, and commercializes the SARA platform and related AI assets, and is the operating home of the Company’s partnership and ecosystem strategy. RAD Lanka, the Company’s Sri Lanka subsidiary, operates as a wholly owned subsidiary of RAD-G.

 

25

 

 

SARA™ (Speaking Autonomous Responsive Agent)

 

SARA is the Company’s proprietary agentic AI platform. SARA combines large language model architecture, situational logic, voice interaction, and autonomous action to enable RAD devices—and, increasingly, third-party devices and platforms—to engage with and respond to security situations in real time. SARA is embedded in substantially all of the Company’s deployed devices and is the foundational asset around which RAD-G’s commercial activity is organized.

 

SARA received Judges’ Choice and Best in Threat Detection and Response Solutions honors in the Security Industry Association New Product Showcase at ISC West 2025. In 2026, SARA was again recognized at ISC West in connection with the Company’s integration partnership with Immix, the leading central station monitoring software platform.

 

Platform Partnership Strategy

 

The Company’s long-term view is that the value of an agentic AI platform in physical security is determined principally by the breadth of devices, monitoring platforms, dealers, and end users with which it integrates. RAD-G is therefore organized around expanding the SARA ecosystem along five categories of relationship:

 

●Monitoring platforms and central stations. The Company’s integration with Immix, announced and recognized during fiscal 2026, is intended as a model for embedding SARA into the platforms that already sit at the center of the remote video monitoring industry. Management views this category as the highest-leverage opportunity for SARA adoption.

 

●Third-party hardware manufacturers. SARA’s commercial value increases with every additional camera, sensor, and access control device it can operate. The Company is actively pursuing licensing and integration arrangements with hardware vendors across the security industry.

 

●Dealers and integrators. As of the date of this report, the Company’s authorized dealer network has grown to over one hundred dealers across the United States, Canada, and the European Union. The dealer channel is one of the Company’s primary growth engines, and RAD-G supports the channel with SARA-enabled product positioning and joint sales materials.

 

●Enterprise and Fortune 500 end users. The Company’s existing enterprise customer base serves as both a revenue base and a credibility base for SARA adoption. Deepening relationships within existing accounts and converting reference deployments into category-defining case studies is a continuing priority.

 

●Insurance, regulatory, and policy stakeholders. As AI-orchestrated security response becomes a more substantial component of the physical security industry, insurance carriers, municipal regulators, and standards bodies will increasingly shape the operating environment. The Company participates in industry policy efforts, including through Mr. Reinharz’s role on the Board of the Security Industry Association and his chairmanship of its Autonomous Working Group.

 

RAD-G Sales Funnel and Expectations

 

RAD-G, based on it’s developing ‘SARA’ solution, has generated substantial industry interest and a relatively substantial sales funnel. The solution has won two Security Industry Association (SIA) awards and Steve Reinharz has been asked several times to speak to various groups and industries about it. This, combined with various partner relationships, incoming interest, outbound prospect generation and other sales activities have created a substantial RAD G sales funnel in management’s view for an early-stage AI platform business. Management has high expectations for substantial revenue generation in this subsidiary. This is a forward-looking statement and actual results may differ materially.

 

26

 

 

RAD-R: Residential Solutions

 

Robotic Assistance Devices Residential, Inc. (“RAD-R”) operates the Company’s residential security product business, principally through the RADCam™ product line. RADCam is an AI-powered, voice-enabled security camera designed for homeowners, property managers, and small businesses, and is differentiated from typical residential security cameras by its real-time conversational engagement capability, supported by SARA in an “SOS” configuration.

 

RAD-R’s financial performance during fiscal 2026 was substantially below Company’s expectations. The principal cause was the structural difference between business-to-business (“B2B”) and business-to-consumer (“B2C”) go-to-market economics. The Company’s core operating expertise, sales channel, and customer acquisition model are built around B2B sale cycles. The B2C residential market requires a substantially higher level of consumer marketing spend than the Company was prepared to commit during fiscal 2026, given competing capital priorities. The business generated an immaterial amount to consolidated revenue.

 

Notwithstanding the financial result, management continues to view RADCam as a superior product to comparable solutions available in the residential security camera market. The Company has no immediate plans to discontinue service to existing RADCam subscribers or to remove the product from sale. RADCam continues to be available for purchase through radcam.ai, Amazon, and other retail outlets.

 

The Company has modified the Residential software so that it can be deployed through RAD-I into the small-and-medium business and enterprise markets and be compatible with RAD’s primary solution RADSoC™.

 

Sales, Channels, and Customers

 

The Company sells through three principal channels: direct enterprise sales, an authorized dealer network, and online retail (in the case of RADCam). The direct enterprise sales team is led by a Senior Vice President of Sales with multiple direct reports and is supplemented by the President of RAD and the Company’s Chief Executive Officer in larger and more strategic accounts. The dealer network, which has grown to over one hundred authorized dealers across the United States, Canada, and the European Union, addresses small and middle-market accounts and provides geographic reach that direct enterprise sales cannot economically cover.

 

The Company’s end-user base spans a broad cross-section of industries. Sales pipeline and deployment activity during fiscal 2026 was concentrated in logistics and distribution, healthcare, commercial real estate, manufacturing, retail, education, government, and residential community markets.

 

Management has identified that the conversion rate of qualified sales opportunities to deployed clients—which historically lagged behind expectations—improved during fiscal 2026, principally as a result of (i) the maturity of the Gen 4 hardware platform, (ii) the broader integration of SARA across the portfolio, (iii) a growing set of reference deployments and case studies, and (iv) targeted investment in dealer enablement. The Company continues to focus on this conversion rate as a primary operational metric.

 

27

 

 

Manufacturing and Supply Chain

 

The Company performs final assembly, system integration, software loading, and quality assurance for its hardware products at its facility in Ferndale, Michigan. Sub-component manufacturing, including machined metal and plastic components, printed circuit boards, and selected sub-assemblies, is sourced from a network of domestic and international suppliers. The Company works to, when reasonable, maintain redundant suppliers for substantially all critical components and has structured its supply chain to mitigate concentration risk.

 

Hardware gross margins to date have been produced under small-batch production conditions. Management expects margin expansion over time as production volumes increase and as the Company captures economies of scale, particularly in connection with the ROAMEO production ramp and additional stationary product introductions.

 

Intellectual Property

 

All hardware designs, software, firmware, AI models, and supporting platforms used in the Company’s products are designed, developed, and owned by the Company and its subsidiaries. RAD-I owns the principal intellectual property associated with the Company’s stationary product platform, including the RAD Service Organization Control (SoC) command and control software, the RAD Mobile SoC , the RADGuard application, and the related operating architecture. RAD-G owns the SARA platform and the underlying agentic AI assets. RAD-M owns the autonomous navigation, fleet management, and ROAMEO-specific platform technology.

 

The Company relies on a combination of trade secret protection, confidentiality and invention-assignment agreements with employees and contractors, copyright, and trademark protection to protect its intellectual property. The Company holds registered trademarks on its principal product names. The Company does not currently rely materially on patent protection.

 

Competition

 

The Company competes across three distinct but related markets: traditional guard services and manned monitoring; legacy passive security hardware (cameras, access control devices, alarm systems); and an emerging set of AI-driven security technology companies. Traditional guard and monitoring service providers compete on price and incumbency but are structurally disadvantaged by labor cost inflation and labor availability constraints. Legacy hardware vendors compete on installed base and channel breadth but typically lack agentic AI capability and recurring software economics. AI-native security technology companies, including a small number of autonomous robotics competitors, compete on technology positioning, but most lack the integrated hardware-plus-software-plus-AI delivery model that the Company has developed.

 

Management believes the Company’s principal competitive advantages are: (i) the integration of proprietary hardware, software, and the SARA agentic AI platform under common ownership and development; (ii) a broad deployed installed base and the operational learning derived from it; (iii) a recurring-revenue business model that aligns the Company with customer success; (iv) a growing dealer and integration partner ecosystem; and (v) the demonstrated ability to bring complex hardware products from concept to commercial deployment, as evidenced by the ROAMEO program.

 

28

 

 

Human Capital and Culture

 

As of the date of this report, the Company has approximately 135 team members across the United States, Canada, the United Kingdom, and Asia, including Sri Lanka. The Company’s Sri Lanka operations are conducted through RAD Lanka, which holds Port City Colombo special economic zone status, providing tax efficiency and access to a cost-effective, educated technical workforce. None of the Company’s employees are represented by a union, and management considers employee relations to be excellent.

 

The Company has built its culture around the principles of emotional intelligence, accountability, and ownership. Self-awareness, composure, internal motivation, empathy, and social skill are deliberately weighted in the hiring process. Team members are expected to operate with multidisciplinary capability and to adjust scope and focus as the business requires. This culture is, in management’s view, a meaningful operational asset: it allows the Company to move faster than competitors of comparable size, to absorb the inevitable setbacks of a hardware-and-AI development business, and to retain experienced team members through periods of capital constraint.

 

The Company’s leadership team includes deep experience in security operations, robotics engineering, software development, artificial intelligence, sales, and capital markets. Mr. Reinharz serves on the Board of the Security Industry Association and chairs its Autonomous Working Group, and is a frequent speaker and panelist at industry conferences including ISC West and GSX.

 

Cybersecurity and Compliance

 

The Company achieved SOC 2 Type 2 status in February 2025 and has maintained SOC 2 Type 2 through annual audits. The Company has also achieved additional cybersecurity certifications appropriate to its enterprise and government customer base. SOC 2 Type 2 status is a benchmark standard, and in many cases a procurement requirement, for enterprise and government software and security purchases, and the Company’s achievement and maintenance of this status reflects management’s ongoing commitment to data protection and operational integrity. Additional disclosure regarding the Company’s cybersecurity program is provided under Item 1C of this report.

 

Available Information

 

The Company’s principal corporate website is www.aitx.ai. Information regarding the Company’s subsidiaries and products is also available at www.radsecurity.com (RAD-I), www.radm.ai (RAD-M), www.radgroup.ai (RAD-G), www.radresidential.ai (RAD-R), and www.radcam.ai (RADCam consumer information). The Company makes available, free of charge through its website and through the SEC’s EDGAR system at www.sec.gov, its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports, as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission.

 

References to the Company’s websites in this report are provided for convenience and information only; the content of those websites is not incorporated by reference into this report.

 

Press Announcements

 

During the fiscal year, the Company issued over 100 press releases, the vast majority of them being sales announcements and new authorized dealers being signed. Public events, conferences, awards and new product announcements were also publicized via press releases. All Company press releases can be found here: AITX News - AITX - Artificial Intelligence Technology Solutions

 

Legal Proceedings

 

See Item 3 - Legal Proceedings.

 

29

 

 

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth the names, positions and ages of our directors and executive officers as of the date of this report. Our directors serve for one year and until their successors are elected and qualified. Our officers are elected by the board of directors to a term of one year and serve until their successor is duly elected and qualified, or until they are removed from office. The board of directors has no nominating, auditing or compensation committees.

 

Name   Age   Position
Steven Reinharz (1)   50   Chief Executive Officer, Secretary and Director (2)
Anthony Brenz   64   Chief Financial Officer

 

(1) Director as of March 2, 2021
(2) All directors hold office until the next annual meeting of stockholders and until their successors have been duly elected and qualified.

 

Biographical information concerning our director and executive officers listed above is set forth below.

 

Steven Reinharz. RAD was founded by Mr. Reinharz in July of 2016, and he has been continuously employed by RAD and its affiliated companies since that time. He is the holder of a majority of our capital stock. Mr. Reinharz has served as a member of the Board of Directors since March 2, 2021 and as our Chief Executive Officer, Chief Financial Officer, and Secretary of the Company since March 2, 2021 and resigned as our Chief Financial Officer as of April 26, 2021 upon Anthony Brenz’s appointment as our Chief Financial Officer. As our Chief Executive Officer and President of RAD, Mr. Reinharz leverages his extensive knowledge and interest in robotics and artificial intelligence to design and develop robotic solutions that increase business efficiency and deliver immediate and impressive cost savings. Mr. Reinharz is an active voice in both the security and artificial intelligence industries. He started and ran his own security integration company from the age of 24 to 31, becoming one of California’s leading system integrators. Mr. Reinharz later was part of a team that successfully sold an integrator to a global security firm for $42 million and has held various other security industry roles. Mr. Reinharz speaks and contributes to panels at ISC East and West, and ASIS. Mr. Reinharz is a leading member of several industry association committees, mostly through the Security Industry Association. Mr. Reinharz has called Orange County, California home since 1995, having grown up in Montreal and Toronto. He earned a dual Bachelor of Science degree in Political Science and Commercial Studies.

 

Anthony Brenz was appointed as our Chief Financial Officer on April 26, 2021. He is an accomplished senior financial and operational executive for over 20 years of experience in finance and operations, including corporate strategy, procurement and supply chain, human resources, and customer service. From April 2018 to December 2020, Anthony Brenz was the Vice President/Director Finance of AirBoss Flexible Products Company. From September 2014 to April 2018, he was the Chief Financial Officer/Vice President of Finance of Thomson Aerospace and Defense (a Parker Meggitt Company). From August 2012 to September 2014, he was the Vice President/Director of Finance of M B Aeospace US Holdings, Inc. Anthony Brenz received a Bachelor of Accountancy from Walsh College in Troy Michigan in 1989 and has been licensed as a Certified Public Accountant in Michigan since 1989.

 

There are no family relationships between any of the executive officers and directors.

 

Board Committees and Director Independence

 

Mr. Reinharz serves as director, and we do not have a separately designated audit committee, compensation committee or nominating and corporate governance committee. The functions of those committees are being undertaken by our directors. Since we do not have any independent directors and have only two directors, our directors believes that the establishment of committees of the Board would not provide any benefits to our company and could be considered more form than substance.

 

We currently have an employee director, Mr. Reinharz, but no independent directors, as such term is defined in the listing standards of The NASDAQ Stock Market, and we do not anticipate appointing additional directors in the near future.

 

Our directors are not “audit committee financial experts” within the meaning of Item 401(e) of Regulation S-K. As with most small, early stage companies, until such time that the Company further develops its business, achieves a stronger revenue base and has sufficient working capital to purchase directors and officer’s insurance, the Company does not have any immediate prospects to attract independent directors. When the Company is able to expand our Board of Directors to include one or more independent directors, the Company intends to establish an Audit Committee of our Board of Directors. It is our intention that one or more of these independent directors will also qualify as an audit committee financial expert. Our securities are not quoted on an exchange that has requirements that a majority of our Board members be independent, and the Company is not currently otherwise subject to any law, rule or regulation requiring that all or any portion of our Board of Directors include “independent” directors, nor are we required to establish or maintain an Audit Committee or other committee of our Board of Directors.

 

Procedures for Nominating Directors

 

There have been no material changes to the procedures by which security holders may recommend nominees to the Board since the most recently completed fiscal quarter. We do not have a policy regarding the consideration of any director candidates that may be recommended by our stockholders, including the minimum qualifications for director candidates, nor has our sole director established a process for identifying and evaluating director nominees. We have not adopted a policy regarding the handling of any potential recommendation of director candidates by our stockholders, including the procedures to be followed. Our sole director has not considered or adopted any of these policies, as we have never received a recommendation from any stockholder for any candidate to serve on our Board of Directors. Given our relative size and lack of directors and officers insurance coverage, we do not anticipate that any of our stockholders will make such a recommendation in the near future.

 

30

 

 

While there have been no nominations of additional directors proposed, in the event such a proposal is made, all current members of our Board will participate in the consideration of director nominees.

 

Director Qualifications

 

Mr. Steve Reinharz is our sole director and was appointed on March 2, 2021. He is the founder of our operating company, Robotoc Assistance Devices, Inc. (see bio on page 33).

 

Code of Ethics and Business Conduct

 

We have adopted a code of ethics meeting the requirements of Section 406 of the Sarbanes-Oxley Act of 2002. We believe our code of ethics is reasonably designed to deter wrongdoing and promote honest and ethical conduct; provide full, fair, accurate, timely, and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of violations; and provide accountability for adherence to the provisions of the code of ethics.

 

Director Compensation

 

We reimburse our directors for all reasonable ordinary and necessary business-related expenses, but we did not pay any other director’s fees or any other cash compensation for services rendered as a director during the years ended February 28, 2026 and February 28, 2025 to any of the individuals serving on our Board during that period.

 

Compliance with Section 16(a) of the Securities Exchange Act of 1934

 

Section 16(a) of the Exchange Act requires our executive officers and directors, and persons who beneficially own more than 10% of a registered class of our equity securities to file with the SEC initial statements of beneficial ownership, reports of changes in ownership and annual reports concerning their ownership of our common shares and other equity securities, on Forms 3, 4 and 5 respectively. Executive officers, directors and greater than 10% stockholders are required by the SEC regulations to furnish us with copies of all Section 16(a) reports they file. Based on our review of the copies of such forms received by us, or written representations that no other reports were required, and to the best of our knowledge, we believe that all of our officers, directors, and owners of 10% or more of our common stock filed all required Forms 3, 4, and 5.

 

EXECUTIVE COMPENSATION

 

The following table summarizes all compensation recorded by us in the past two fiscal years for Mr. Reinharz , our President and Chief Executive Officer , Anthony Brenz, our Chief Financial Officer

 

2026 AND 2025 SUMMARY COMPENSATION TABLE

 

Name and Principal Position 

Fiscal

Year

   Salary
or
Fees
($)
   Bonus
($)
   Stock
Awards(2)
($)
   Option
Awards
($)
   Non-Equity
Incentive Plan
Compensation
($)
   Non-Qualified
Deferred
Compensation
Earnings
($)
   All Other
Compensation
($)
   Total
($)
 
Steven Reinharz   2026    420,000    —    1,500,000    —    —    1,000,000    —    2,920,000 
Chief Executive Officer, Chief Financial Officer, Secretary (1)   2025    320,000    836,167    1,500,000    —    —    1,663,833    —    4,320,000 
                                              
Anthony Brenz   2026    211,865    —    —    —    —    —    1,200    213,055 
Chief Financial Officer (1)   2025    200,408    1,000    —    17,975    —    —    1,200    208,988 

 

(1) Steven Reinharz was appointed Chief Executive Officer, Chief Financial Officer and Secretary on March 2, 2021.Mr.Reinharz ceased being Chief Financial Officer on June 24, 2021 and on that date appointed Anthony Brenz as Chief Financial Officer
(2) Stock awards are payable in Series G and are included in long term liabilities as they will not be paid out in the current year.

 

Employment Agreements

 

On April 9, 2021 Mr. Reinharz entered into an employment agreement with the Company in connection with his service as Chief Executive Officer. The agreement began on April 9, 2021 and has a three-year term, renewable thereafter on an annual basis if neither party files a notice of termination 90 days prior to the term renewal date. The agreement provides for compensation of $240,000 base salary (to be reviewed annually by the Board of Directors) and bonuses to be granted at the discretion of the Board of Directors. The salary for the fiscal year ended February 28, 2026 was $420,000.

 

31

 

 

Outstanding Equity Awards at 2026 Fiscal Year-End

 

The following table provides information concerning unexercised options, stock that has not vested and equity incentive plan awards for Mr. Brenz, our sole executive officers outstanding as of February 28, 2026:

 

OPTION AWARDS  STOCK AWARDS 
Name  Number of Securities Underlying Unexercised Options (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options
(#)
   Option Exercise Price
($)
   Option Expiration Date  Number of Shares or Units of Stock That Have Not Vested (#)   Market Value of Shares or Units of Stock That Have Not Vested ($)   Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)   Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) 
Anthony Brenz   0    0    45,000   $2.00   Sept. 1, 2027   45,000   $12,825    0    0 
Anthony Brenz   0    0    100,000   $2.00   Sept. 1, 2028   100,000   $28,500    0    0 

 

On April 14, 2021, the Shareholders of Series E Preferred Stock and the Board of Directors of our Company (“Board”) approved and adopted the 2021 Incentive Stock Plan (the “2021 Plan”). On August 11, 2022 the Company amended the 2021 Plan increasing the maximum number of shares applicable to the 2021 Plan from 50,000 to 1,000,000. On August 14,2023 the Company further amended the plan increasing the maximum shares to 2,000,000.

 

The purpose of the 2021 Plan is to promote the success of the Company by authorizing incentive awards to retain Directors, executives, selected Employees and Consultants, and reward participants for making major contributions to the success of the Company. The 2021 Plan authorizes the granting of stock options, restricted stock, restricted stock units, stock appreciation rights and stock awards. A total of two d million (2,000,000) shares of common stock may be issued under the 2021 Plan. All awards under the 2021 Plan, whether vested or unvested, are subject to the terms of any recoupment, clawback or similar policy of the Company in effect from time to time, as well as any similar provisions of applicable law, which could in certain circumstances require repayment or forfeiture of awards or any shares of stock or other cash or property received with respect to the awards, including any value received from a disposition of the shares acquired upon payment of the awards. The 2021 Plan will be administered by the Board or any Committee authorized by the Board, if applicable, which will have the sole authority to, among other things: construe and interpret the 2021 Plan; make rules and regulations relating to the administration of the 2021 Plan; select participants; and establish the terms and conditions of awards, all in accordance with the terms of the 2021 Plan. The 2021 Plan will remain in effect until April 14, 2031, unless sooner terminated by the Board. Termination will not affect awards then outstanding.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

At July 15, 2026, we had 419,371,776 shares of Common Stock issued and outstanding. The following table sets forth information regarding the beneficial ownership of our Common Stock as of July 14, 2026, and reflects:

 

  ● each of our executive officers;
     
  ● each of our directors;
     
  ● all of our directors and executive officers as a group; and
     
  ● each stockholder known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock.

 

32

 

 

Information on beneficial ownership of securities is based upon a record list of our stockholders and we have determined beneficial ownership in accordance with the rules of the SEC. We believe, based on the information furnished to us, that the persons and entities named in the table below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable community property laws, except as otherwise provided below.

 

   Amount and
Nature of
     
Name  Beneficial
Ownership (1)
   Percent of
Common Stock (2)
 
         
Named Executive Officers and Directors:          
Steven Reinharz (3)   1,410,561,057    77.08%
Anthony Brenz   0    0 
           
All executive officers and directors as a group (2 persons)   1,410,561,057    77.08%
           
5% Shareholders:          
Steven Reinharz   1,410,561,057    77.08%

 

(1) Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Beneficial ownership also includes shares of stock subject to options and warrants currently exercisable or exercisable within 60 days of the date of this table. In determining the percent of common stock owned by a person or entity as of the date of this Report, (a) the numerator is the number of shares of the class beneficially owned by such person or entity, including shares which may be acquired within 60 days on exercise of warrants or options and conversion of convertible securities, and (b) the denominator is the sum of (i) the total shares of common stock outstanding on as of July 15, 2026 was 419,371,776 shares, and (ii) the total number of shares that the beneficial owner may acquire upon exercise of the derivative securities. Unless otherwise stated, each beneficial owner has sole power to vote and dispose of its shares.
   
(2) Based on 1,453,137,790 shares of the Company’s common stock issued and outstanding as of July 15, 2026.
   
(3) Steve Reinharz is a director and the Company’s Chief Executive Officer, Chief Financial Officer and Secretary as well as the CEO of RAD and is the holder of (i) 3,350,000 shares of our Series E Preferred Stock and, (ii) 2,450 shares of our Series F Convertible Preferred Stock. If Mr. Reinharz converted the 2,450 shares of the Company’s Series F Convertible Preferred Stock, he would receive 1,410,561,057 shares of the Company’s common stock, which is included in the chart above as if such conversion has occurred. Further, the outstanding shares of Series E preferred stock have the right to take action by written consent or vote based on the number of votes equal to twice the number of votes of all outstanding shares of common stock. As a result, the holders of Series E preferred stock has 2/3rds of the voting power of all shareholders at any time corporate action requires a vote of shareholders.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

 

We do not have a written policy for the review, approval or ratification of transactions with related parties or conflicted transactions. When such transactions arise, they are referred to our board of directors for its consideration.

 

For the years ended February 28, 2026, and February 28, 2025, the Company had net (advances) repayments of ($132,268) and ($71,927), respectively, to its loan payable-related party. At February 28, 2026, the loan payable-related party was $461,633 and $329,365 at February 28, 2025. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. As of February 28, 2025, included in the balance due to the related party is $190,013 of deferred salary all of which bears interest at 12%. The accrued interest included at February 28, 2026, was $79,268 (February 28, 2025- $51,575).

 

During the year ended February 28, 2026, the Company had a net repayment of $390,744 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2026, to $1.0 million. For the fiscal year ended February 28, 2025, the Company paid out $1,390,744 to the CEO. During the year ended February 28, 2025, the Company a net accrual of $1,663,833 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2025, to $2.5 million. For the fiscal year ended February 28, 2025, the Company paid out $836,167 to the CEO. This was all in accordance with a December 2023 board action allowing for $1 million of discretionary compensation.

 

During the years ended February 28, 2026, and February 28, 2025, the Company accrued 1,500 Series G shares to be issued totaling $1,500,000 and 1,500 Series G preferred shares to be issued totaling $1,500,000, respectively, both per Company resolution. The Series G preferred shares are redeemable at $1,000 per share and will be issued by the Company at the appropriate time. The balance of Incentive Compensation Plan Payable at February 28, 2026, was $5,500,000 and the balance February 28, 2025, was $4,000,000.

 

During the years ended February 28, 2026, and February 28, 2025, the Company was charged $2,576,111 and $2,541,180, respectively in consulting fees for research and development to a company partially owned by a principal shareholder included in research and development expenses. The principal shareholder received no compensation from this partially owned research and development company and the fees were spent on core development projects. As at February 28, 2026, and February 28, 2025, the balance due to this company was $160,557 and $76,532, respectively.

 

33

 

 

DESCRIPTION OF SECURITIES

 

Common Stock

 

Our authorized capital stock consists of 27,500,000,000 shares of common stock, par value $0.0001 per share, and 20,000,000 shares of preferred stock, par value $0.001 per share. As of July 15, 2026, we had 419,371,776 shares of common stock issued and outstanding, and 1,250,000 shares of common stock issuable. Holders of our common stock are entitled to one vote per share and, subject to the rights of any outstanding preferred stock, to receive dividends when and if declared by our Board of Directors and to share ratably in our assets legally available for distribution upon liquidation, dissolution or winding up. Holders of our common stock do not have preemptive, subscription, redemption or conversion rights, and no sinking fund provisions apply to our common stock. The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we have designated or that we may designate and issue in the future.

 

The number of authorized shares of our common stock has been amended on several occasions. On October 15, 2025, our Board of Directors increased the authorized common stock from 23,000,000,000 shares to 27,500,000,000 shares. On March 19, 2026, the Board of Directors and the holder of a majority of the Company’s voting power approved, by written consent, a decrease in the Company’s authorized common shares from 27,500,000,000 to 12,000,000,000. The Certificate of Amendment effecting this decrease was not filed with, or accepted by, the Nevada Secretary of State until July 15, 2026, on which date the decrease became effective. As of February 28, 2026 and continuing through the filing date of the Company’s original Annual Report on Form 10-K for the fiscal year ended February 28, 2026, the Company’s authorized common shares remained 27,500,000,000.

 

Preferred Stock

 

Under our Articles of Incorporation, as amended, we are authorized to issue up to 20,000,000 shares of preferred stock, par value $0.001 per share. Our Board of Directors is authorized, without further action by our stockholders, to designate and issue preferred stock in one or more series and to fix the designations, powers, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions thereof, including dividend rights, conversion rights, voting rights, redemption terms and liquidation preferences, of each series. As of the date of this prospectus, our Board of Directors has designated five series of preferred stock, as described below, and 15,534,000 authorized shares of preferred stock remain undesignated. The issuance of preferred stock could adversely affect the voting power, dividend rights and other rights of holders of our common stock and could have the effect of delaying, deferring or preventing a change in control of our Company.

 

Series B Convertible, Redeemable Preferred Stock

 

Our Board of Directors has designated 5,000 shares as Series B Convertible, Redeemable Preferred Stock, par value $0.001 per share, with a stated value of $1,200 per share. As of the date of this prospectus, no shares of Series B Convertible, Redeemable Preferred Stock were issued or outstanding. The Series B preferred stock ranks senior to our common stock and common stock equivalents with respect to distributions upon liquidation, votes together with the common stock on an as-converted basis, and accrues cumulative dividends at 8% per annum, payable quarterly in cash or in additional shares of preferred stock at the Company’s discretion. Each holder may convert its shares into common stock at a conversion price equal to the lower of (i) a fixed price based on the closing bid price of the common stock on the trading day immediately preceding acquisition of the shares and (ii) the lowest traded price of the common stock during the ten calendar days immediately preceding the conversion date, subject to downward adjustment upon an event of default. The Company is obligated to redeem the Series B preferred stock in installments on the 30th, 60th and 90th days following issuance at a redemption price equal to the stated value of each share, plus accrued and unpaid dividends and other amounts due to the holder.

 

Series C Convertible, Redeemable Preferred Stock

 

Our Board of Directors has designated 1,000 shares as Series C Convertible, Redeemable Preferred Stock, par value $0.001 per share, with a stated value of $1,200 per share. As of May 31, 2026, 354 shares of Series C Convertible, Redeemable Preferred Stock were issued and outstanding. The Series C preferred stock ranks senior to our common stock upon liquidation, votes together with the common stock on an as-converted basis, and accrues cumulative dividends at 12% per annum, payable quarterly. Beginning 180 days after issuance, each holder may convert its shares into common stock at a conversion price equal to the lower of (i) a fixed price based on the closing bid price of the common stock on the trading day immediately preceding acquisition of the shares and (ii) the lowest traded price of the common stock during the ten calendar days immediately preceding the conversion date, subject to downward adjustment upon an event of default. The shares are redeemable at 109.5% of stated value, plus accrued and unpaid dividends and other amounts due, on the 180th day following issuance, or earlier at the Company’s election upon three trading days’ written notice.

 

34

 

 

Series E Preferred Stock

 

Our Board of Directors has designated 4,350,000 shares as Series E Preferred Stock, par value $0.001 per share. As of the date of this prospectus, 3,350,000 shares of Series E Preferred Stock were issued and outstanding, all of which are held by Steven Reinharz, our Chief Executive Officer, Chief Financial Officer, Secretary and Chairman. The Series E Preferred Stock is not convertible, is not redeemable, is not entitled to dividends, ranks junior to our common stock with respect to distributions upon liquidation, and has no liquidation preference. The Series E Preferred Stock carries super-voting rights. The outstanding shares of Series E Preferred Stock are entitled to take action by written consent, or to vote together with the common stock, in each case with a number of votes equal to twice the number of votes of all outstanding shares of the Company’s equity securities entitled to vote. As a result, the holder of the Series E Preferred Stock controls two-thirds of the total voting power of the Company on any matter submitted to a vote of stockholders and is able to determine the outcome of substantially all such matters, including the election of directors. In addition, by virtue of this voting power, our Chief Executive Officer and Chairman is able, at any time, to unilaterally approve an increase in the number of authorized shares of our common stock under our Articles of Incorporation and bylaws without the need to call a general meeting of the holders of our common stock. See “Risk Factors” and “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”

 

Series F Convertible Preferred Stock

 

Our Board of Directors has designated 10,000 shares as Series F Convertible Preferred Stock, par value $1.00 per share. As of the date of this prospectus, 2,513 shares of Series F Convertible Preferred Stock were issued and outstanding, of which 2,450 shares are held by Steven Reinharz, our Chief Executive Officer and Chairman. The Series F Convertible Preferred Stock is not redeemable, is not entitled to dividends, has no voting rights and has no liquidation preference. Each holder may, at any time, convert all (but not less than all) of its shares of Series F Convertible Preferred Stock into a number of shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the conversion date by 3.45, allocated pro rata among the holders. So long as any shares of Series F Convertible Preferred Stock are outstanding, the Company may not, without the approval of the holders of a majority of the outstanding shares, alter or change the rights, preferences or privileges of the Series F preferred stock in a manner adverse to the holders or create any senior or pari passu securities. Because of the size of the conversion factor, conversion of the outstanding Series F Convertible Preferred Stock would result in the issuance of a very substantial number of shares of common stock and would be materially dilutive to holders of our common stock.

 

Series G Preferred Stock

 

Our Board of Directors has designated 100,000 shares as Series G Preferred Stock, par value $0.001 per share. As of the date of this prospectus, no shares of Series G Preferred Stock were issued or outstanding. The Series G Preferred Stock is redeemable at $1,000 per share, has no voting rights, has no liquidation preference and is not entitled to dividends.

 

Undesignated Preferred Stock

 

The remaining 15,534,000 authorized shares of preferred stock are undesignated and available for future issuance in one or more series having such designations, powers, preferences, rights, qualifications, limitations and restrictions as our Board of Directors may determine, in each case without further action by the holders of our common stock.

 

Transfer Agent

 

The Company’s transfer agent is Transhare Corporation located at, 17755 US Highway 19 N., Suite 140, Clearwater, Florida 33764 and their telephone number is (303) 662-1112

 

35

 

 

LEGAL MATTERS

 

The validity of the shares of common stock offered by this prospectus will be passed upon for us by Frederick M. Lehrer, P. A.

 

EXPERTS

 

Our consolidated financial statements as of and for the fiscal years ended February 28, 2026 and February 28, 2025 included in this prospectus have been audited by L J Soldinger Associates, LLC, our independent registered public accounting firm, as stated in their report appearing herein (which report expresses an unqualified opinion and includes an explanatory paragraph relating to our ability to continue as a going concern), and are included in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We file annual, quarterly, and current reports and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s website at www.sec.gov. We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of common stock offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement and its exhibits. For further information with respect to us and our common stock, we refer you to the registration statement and its exhibits.

 

36

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Report of Independent Registered Public Accounting Firm F-2
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations F-4
   
Consolidated Statements of Stockholders’ Deficit F-5
   
Consolidated Statements of Cash Flows F-7
   
Notes to the Consolidated Financial Statements F-8

 

Table of Contents

 

  PAGE
PART I FINANCIAL INFORMATION  
     
ITEM 1. Financial Statements F-41
     
  Condensed Consolidated Balance Sheets as of May 31, 2026 and February 28, 2026 (Unaudited) F-41
     
  Condensed Consolidated Statements of Operations for the Three Months Ended May 31, 2026 and 2025 (Unaudited) F-42
     
  Condensed Consolidated Statements of Stockholders’ Deficit for the Three Months Ended May 31, 2026 and 2025 (Unaudited) F-43
     
  Condensed Consolidated Statements of Cash Flows for the Three Months Ended May 31, 2026 and 2025 (Unaudited) F-44
     
  Notes to the Consolidated Financial Statements (Unaudited) F-45

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Artificial Intelligence Technology Solutions, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Artificial Intelligence Technology Solutions, Inc. and its subsidiaries (the “Company”) as of February 28, 2026 and February 28, 2025, and the related consolidated statements of operations, stockholders’ deficit, and cash flows for each of the years in the two-year period ended February 28, 2026, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of February 28, 2026, and February 28, 2025, and the results of its operations and its cash flows for each of the years in the two-year period ended February 28, 2026, in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company had negative cash flow from operating activities of approximately $9.3 million, an accumulated deficit of approximately $171.1 million and negative working capital of approximately $17.0 million as of and for the year ended February 28, 2026, which raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.

 

/s/ L J Soldinger Associates, LLC
   
We have served as the Company’s auditor since 2019.
   
Deer Park, Illinois
PCAOB ID: 318
June 8, 2026  

 

F-2

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

CONSOLIDATED BALANCE SHEETS

 

  

February 28,

2026

  

February 28,

2025

 
ASSETS          
Current assets:          
Cash  $109,043   $865,975 
Accounts receivable, net   1,004,201    1,367,331 
Share proceeds receivable   —    418,669 
Device parts inventory, net   1,318,742    1,583,726 
Prepaid expenses and deposits   503,017    792,842 
Total current assets   2,935,003    5,028,543 
Operating lease asset   931,814    1,010,545 
Revenue earning devices, net of accumulated depreciation of $3,257,668 and $2,292,172, respectively   5,097,627    4,539,180 
Fixed assets, net of accumulated depreciation of $540,426 and $491,186, respectively   183,185    258,328 
Trademarks   35,319    33,321 
Investment at cost   100,000    100,000 
Security deposit   19,280    15,880 
Total assets  $9,302,228   $10,985,797 
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable and accrued expenses  $3,007,270   $2,121,871 
Customer deposits   147,326    91,578 
Current operating lease liability   243,690    197,349 
Current portion of deferred variable payment obligation   3,161,727    1,901,258 
Loan payable - related party   461,633    329,365 
Deferred compensation for CEO   1,811,856    2,202,600 
Current portion of loans payable, net of discount of $635,774 and $0   8,848,140    519,105 
Current portion of accrued interest payable   2,271,106    213,555 
Total current liabilities   19,952,748    7,576,681 
Non-current operating lease liability   676,694    810,513 
Loans payable, net of discount of $0 and $360,163, respectively   24,188,380    31,922,078 
Deferred variable payment obligation   2,525,000    2,525,000 
Incentive compensation plan payable   5,500,000    4,000,000 
Accrued interest payable   9,122,552    13,680,453 
Total liabilities   61,965,374    60,514,725 
           
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly,$1,200 stated value, 5,000 shares authorized, no shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively   —    — 
Series C Convertible, Redeemable Preferred Stock. $0.001 par value; $1,200 stated value, redeemable at 109.5%, 12% dividend, 1,000 shares authorized, 417 and 306 shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively   547,941    402,084 
           
Commitments and Contingencies   -     -  
Stockholders’ deficit:          
Preferred Stock, undesignated; 15,534,000 shares authorized; no shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively   —    — 
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at February 28, 2026 and February 28, 2025, respectively   —    — 
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively   3,350    3,350 
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,513 shares issued and outstanding, respectively   2,513    2,513 
Common Stock, $0.00001 par value; 27,500,000,000 shares authorized as of February 28, 2026 and February 28, 2025 (subsequently decreased to 12,000,000,000 shares authorized effective July 15, 2026 — see Summary of Common Stock Activity below); 267,872,804 and 144,124,538 shares issued, issuable and outstanding, respectively   2,679    1,441 
Additional paid-in capital   117,803,027    106,459,528 
Preferred stock to be issued   99,086    99,086 
Accumulated deficit   (171,121,742)   (156,496,930)
Total stockholders’ deficit   (53,211,087)   (49,931,012)
Total liabilities and stockholders’ deficit  $9,302,228   $10,985,797 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
         
Revenues  $7,745,336   $6,130,886 
           
Cost of goods sold   159,020    1,334,824 
Depreciation and Amortization   1,981,679    1,051,498 
Loss on disposal of revenue earning devices   70,937    - 
Total Cost of Goods Sold   2,211,636    2,386,322 
           
Gross Profit   5,533,700    3,744,564 
           
Operating expenses:          
Research and development (note 9)   4,128,155    3,462,558 
General and administrative   12,933,696    13,559,009 
Depreciation and amortization   141,051    429,139 
Loss on disposal of fixed assets   22,312    — 
Operating lease cost and rent   251,883    240,731 
Total operating expenses   17,477,097    17,691,437 
           
Loss from operations   (11,943,397)   (13,946,873)
           
Other income (expense), net:          
Interest expense   (6,001,539)   (5,456,981)
Gain on settlement of debt   3,434,685    468,262 
Total other income (expense), net   (2,566,854)   (4,988,719)
           
Net Loss  $(14,510,251)  $(18,935,592)
           
Net loss per share - basic  $(0.07)  $(0.16)
           
Net loss per share - diluted  $(0.07)  $(0.16)
           
Weighted average common share outstanding – basic and diluted   202,908,578    116,476,733 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED FEBRUARY 28, 2026 AND FEBRUARY 28, 2025

 

                                             
   Temporary Equity   Shareholder’s Deficit 
   Series B & C   Series E   Series F           Additional       Total 
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 29, 2024   —    —    3,350,000   $3,350    2,533   $101,619    92,387,510   $924   $92,656,977   $(132,962,427)  $       (40,199,557)
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024   —    —    —    —    —    —    —    —    —    (4,175,535)   (4,175,535)
Issuance of shares, net of $701,565 issuance costs   —    —    —    —    —    —    49,796,369    498    13,120,181    —    13,120,679 
Debt exchanged for common stock   —    —    —    —    —    —    1,940,659    19    561,981    —    562,000 
Series F Preferred Shares exchanged for debt   —    —    —    —    (20)   (20)   —    —    (65,793)   (334,187)   (400,000)
Issuance of Series B Preferred Shares   300    360,000    —    —    —    —    —    —    (82,000)   —    (82,000)
Series B Preferred Shares issued as commitment fee   20    24,000    —    —    —    —    —    —    (24,000)   —    (24,000)
Series B Preferred shares issued as dividend   4    5,188    —    —    —    —    —    —    (5,188)   —    (5,188)
Redemption of Series B Preferred shares   (324)   (389,188)   —    —    —    —    —    —    89,189    (89,189)   — 
Issuance of Series C Preferred Shares   306    402,084    —    —    —    —    —    —    (123,504)   —    (123,504)
Stock based compensation   —    —    —    —    —    —    —    —    331,685    —    331,685 
Net loss   —    —    —    —    —    —    —    —    —    (18,935,592)   (18,935,592)
Balance at February 28, 2025   306   $402,084    3,350,000   $3,350    2,513   $101,599    144,124,538   $1,441   $106,459,528   $(156,496,930)  $(49,931,012)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ DEFICIT

 

                                             
   Temporary Equity   Shareholder’s Deficit 
   Series B & C   Series E   Series F           Additional       Total 
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 28, 2025   306    402,084    3,350,000   $3,350    2,513   $101,599    144,124,538   $1,441   $106,459,528   $(156,496,930)  $      (49,931,012)
Issuance of shares, net of $364,161 issuance costs   —    —    —    —    —    —    50,403,802    504    4,800,680    —    4,801,184 
Debt exchanged for common stock   —    —    —    —    —    —    71,350,000    714    6,383,286    —    6,384,000 
Conversion of Series C Preferred shares   (85)   (111,690)   —    —    —    —    1,994,464    20    196,360    (84,690)   111,690 
Cash redemption of Series C shares   (95)   (125,000)   —    —    —    —    —    —    29,871    (29,871)   — 
Series C Preferred shares issued as dividend   44    58,100    —    —    —    —    —    —    (58,100)   —    (58,100)
Penalty on failure to redeem Series C Preferred shares   114    149,307    —    —    —    —    —    —    (149,307)   —    (149,307)
Penalty on failure to convert Series C Preferred shares   133    175,140    —    —    —    —    —    —    (175,140)   —    (175,140)
Stock based compensation   —    —    —    —    —    —    —    —    315,849    —    315,849 
Net loss   —    —    —    —    —    —    —    —    —    (14,510,251)   (14,510,251)
Balance at February 28, 2026   417   $547,941    3,350,000   $3,350    2,513   $101,599    267,872,804   $2,679   $117,803,027   $(171,121,742)  $(53,211,087)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(14,510,251)  $(18,935,592)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   2,122,730    1,480,636 
Inventory provision (recovery)   (290,000)   (494,000)
Bad debts expense   138,405    83,682 
Reduction of right of use asset   141,217    119,151 
Accretion of lease liability   103,956    118,502 
Stock based compensation   1,815,848    1,831,685 
Amortization of debt discounts   536,078    271,234 
Penalty added to face value of the loan   24,510    — 
Gain on settlement of debt   (3,434,685)   (468,262)
Loss on disposal of revenue earning devices and fixed assets   93,249    — 
Increase in related party accrued payroll and interest   132,268    71,927 
Changes in operating assets and liabilities:          
Accounts receivable   224,725    (694,929)
Prepaid expenses   294,264    (160,393)
Deposit on right of use asset   (13,187)   — 
Security deposit on operating lease   (3,400)   — 
Device parts inventory   (2,133,437)   (2,464,468)
Accounts payable and accrued expenses   879,021    505,068 
Deferred compensation for CEO   (390,744)   1,663,833 
Customer deposits   55,748    17,876 
Operating lease liability payments   (238,792)   (225,413)
Current portion of deferred variable payment obligations for Payments   1,260,469    996,881 
Accrued interest payable   3,847,474    4,086,194 
Net cash used in operating activities   (9,344,534)   (12,196,388)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of fixed assets   (10,863)   (23,724)
Purchase of trademarks   (1,998)   (6,241)
Purchase of investment (convertible note receivable)   —    (50,000)
Net cash used in investing activities   (12,861)   (79,965)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Share proceeds net of issuance costs   5,219,853    12,702,010 
Proceeds on issuance of Series B Preferred Shares   —    278,000 
Redemption of Series B or Series C Preferred Shares   (125,000)   (389,188)
Proceeds on issuance of Series C Preferred Shares   —    278,580 
Proceeds from loans payable   4,808,171    350,000 
Repayment of loans payable   (1,302,561)   (183,000)
Net cash provided by financing activities   8,600,463    13,036,402 
           
Net change in cash   (756,932)   760,049 
           
Cash, beginning of period   865,975    105,926 
           
Cash, end of period  $109,043   $865,975 
           
Supplemental disclosure of cash and non-cash transactions:          
Cash paid for interest  $188,993   $94,517 
Cash paid for income taxes  $—   $— 
           
Noncash investing and financing activities:          
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024  $—   $4,175,535 
Right of use asset for lease liability  $53,739   $— 
Transfer from device parts inventory to fixed assets  $2,688,421   $3,506,341 
Series C penalty shares issued  $324,447    — 
           
Discount applied to face value of loans  $811,689   $— 
           
Exchange of Series F Preferred Shares for loans payable  $—   $400,000 
Exchange of loans payable and accrued interest for common shares  $6,484,000   $562,000 
Convertible note receivable exchanged for investment at cost  $—   $50,000 
Dividend on Series B or Series C Preferred Shares paid in Series B or Series C Preferred Shares  $58,100   $5,188 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1. GENERAL INFORMATION AND GOING CONCERN

 

Artificial Intelligence Technology Solutions Inc. (formerly known as On the Move Systems Corp.) (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

 

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a LLC. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc. through the issuance of 10,000 common shares to its sole shareholder.

 

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and AITX was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, in which AITX purchased all of the outstanding shares of capital stock of RAD. As a result, AITX’s business going forward will consist of one segment activity which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

 

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

 

GOING CONCERN

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

For the year ended February 28, 2026, the Company had negative cash flow from operating activities of $9,344,534. As of February 28, 2026 the Company has an accumulated deficit of $171,121,742 and negative working capital of $17,017,745. Management does not anticipate having positive cash flow from operations in the near future. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:

 

Management is committed to raise funds either through convertible debt or equity financing.. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In May 2026, the Company entered into an equity financing agreement whereby an investor will purchase up to $10,000,000 of the Company’s common stock at a discount over a three-year period. There remains approximately $10 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways : growing revenues ,through equity proceeds, and issuing debt.

 

F-8

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2. ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the instructions on Form 10-K of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). The audited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group, Inc, Robotic Assistance Devices Mobile, Inc., Robotic Assistance Devices Residential, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

 

In order to prepare financial statements in conformity with accounting principals generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions.

 

Reclassifications

 

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

 

Concentrations of Loans Payable

 

At February 28, 2026 there were $33,672,294 loans payable, $32,178,506 or 96% of these loans to companies controlled by one individual. At February 28, 2025 there were $32,801,345 loans payable, $28,581,506 or 87% of these loans to companies controlled by one individual..

 

Cash

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions which, at times, may exceed federally insured limits, and, to date has not experienced losses on any of its balances.

 

F-9

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Accounts Receivable

 

Accounts receivable are comprised of balances due from customers, net of estimated allowances for credit losses. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $170,000 and $140,000 provided as of February 28, 2026 and February 28, 2025, respectively. For the year ended February 28, 2026, two customer account for 31% of total accounts receivable . For the year ended February 28, 2025, one customer accounts for 52% of total accounts receivable.

 

Device Parts Inventory

 

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. At February 28, 2026 and at February 28, 2025 there was a valuation reserve of $175,000 and $465,000, respectively.

 

Revenue Earning Devices

 

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

 

Fixed Assets

 

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from three to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

 

Computer equipment   3 years
Furniture and fixtures   3 years
Office equipment   4 years
Warehouse equipment   5 years
Demo Devices   4 years
Vehicles   3 years
Leasehold improvements   5 years, the life of the lease

 

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

 

F-10

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Research and Development

 

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At February 28, 2026 and February 28, 2025, the Company had no deferred development costs.

 

Contingencies

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

Sales of Future Revenues

 

The Company has entered into transactions, as more fully described in footnote 10, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

 

  ● Does the agreement purport, in substance, to be a sale
     
  ● Does the Company have continuing involvement in the generation of cash flows due the investor
     
  ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets
     
  ● Is the investors rate of return implicitly limited by the terms of the agreement
     
  ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return
     
  ● Does the investor have recourse relating to payments due

 

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

 

F-11

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Revenue Recognition

 

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.. For the year ended February 28, 2026, two customers accounted for 55% of total revenue and for the year ended February 28, 2025, one customer accounted for 55% of total revenue (see Note-3).

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2026, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.

 

Leases

 

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

 

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

 

F-12

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our CEO and Chairman holds sufficient shares of the Company’s voting stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company without the need to call a general meeting of common shareholders of the Company.

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

F-13

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

  ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
     
  ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  ● Level 3 – Inputs that are unobservable for the asset or liability.

 

Measured on a Recurring Basis

 

The following table presents information about our assets and liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

 

   Amount at   Fair Value Measurement Using 
   Fair Value   Level 1   Level 2   Level 3 
February 28, 2026                    
Assets                    
Investment at cost  $100,000   $50,000   $—   $50,000 
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $5,500,000   $—   $—   $5,500,000 
                     
February 28, 2025                    
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $4,000,000   $—   $—   $4,000,000 

 

For the incentive compensation plan , the Company recorded stock based compensation of $1,500,000 and $1,500,000 for the years ended February 28, 2026 and February 28, 2025 with corresponding adjustments to incentive compensation plan payable.

 

The method of valuation of the incentive compensation plan payable is based on the redemption value of the Series G Preferred Shares. The method of valuation of the Level 3 investment at cost is an independent third party valuation of the common share value of the investment.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

 

F-14

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

 

Recently Adopted Accounting Pronouncements

 

ASU 2023-07 – Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments require enhanced disclosures about significant segment expenses and other segment items, require disclosure of the title and position of the chief operating decision maker (“CODM”), explain how the CODM uses reported measures of segment profit or loss to assess performance and allocate resources, and expand interim disclosure requirements. The amendments apply to entities with a single reportable segment as well as entities with multiple reportable segments.

 

The Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, during fiscal 2025. The standard requires enhanced disclosures regarding segment expenses and CODM information and applies to entities with a single reportable segment. Adoption of the standard impacted the Company’s segment reporting disclosures only and did not affect its consolidated financial position, results of operations, or cash flows.

 

Recently issued accounting pronouncement not yet effective

 

ASU 2024-04—Debt with Conversion and Other Options (Topic 470-20): Induced Conversions of Convertible Debt Instruments

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments. The amendments clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or as debt extinguishments. Under the amended guidance, an induced conversion requires that the inducement offer provide the holder, at a minimum, the consideration issuable under the existing conversion privileges of the instrument.

 

The amendments are effective for annual reporting periods beginning after December 15, 2025, including interim reporting periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements and related disclosures.

 

ASU 2025-05—Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets

 

In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments refine the guidance in ASC 326 related to the measurement of expected credit losses for accounts receivable and contract assets arising from revenue transactions accounted for under ASC 606. The update clarifies the application of the current expected credit loss (“CECL”) model to such assets, including the use of practical expedients and considerations in estimating expected credit losses over the contractual term of the asset.

 

The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-05 on its consolidated financial statements and related disclosures.

 

3. REVENUE FROM CONTRACTS WITH CUSTOMERS

 

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, , and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

 

As disclosed in the revenue recognition section of Note 2 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 2 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

 

F-15

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

   Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
Device rental activities  $6,920,336   $5,050,255 
Direct sales of goods and services   825,000    1,080,631 
Revenue  $7,745,336   $6,130,886 

 

The Company operates as one reportable segment The Chief Executive Officer (“CEO”) serves as the Chief Operating Decision Maker (“CODM”). The CODM evaluates the Company’s performance based on consolidated net income. This measure aligns with the Company’s consolidated financial statements and serves as the basis for resource allocation and performance assessment. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM monitors profitability and strategic growth initiatives on a consolidated basis, without disaggregating profit or loss into separate operating segments. The Company determined there are no significant segment expenses that require a separate disclosure. The consolidated net income is used to assess overall company performance, benchmark against industry standards, and identify profitability trends, which guides resource allocation and investment in expansion and program upgrades. The CODM also evaluates company performance using operating income. Operating income provides the CODM with a focused view of the Company’s profitability excluding the effects of financing activities, tax strategies, and other non-operating items. This measure enables the CODM to assess operational efficiency, monitor performance trends, and evaluate the effectiveness of strategies aimed at revenue generation and cost management.

 

4. LEASES

 

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

 

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

 

Below is a summary of our lease assets and liabilities at February 28, 2026 and February 28, 2025.

 

Leases  Classification  February 28,
2026
   February 28,
2025
 
Assets             
Operating  Operating Lease Assets  $931,814   $1,010,545 
Liabilities             
Current             
Operating  Current Operating Lease Liability  $243,690   $197,349 
Noncurrent             
Operating  Noncurrent Operating Lease Liabilities   676,694    810,513 
Total lease liabilities     $920,384   $1,007,862 

 

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

 

F-16

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Operating lease cost and rent was $251,883 and $240,731 for both the twelve months ended February 28, 2026 and February 28, 2025, respectively.

 

5. INVESTMENT

 

On December 23, 2022 the Company entered into a Simple Agreement for Future Equity (SAFE) contract to invest $50,000 to acquire shares of a company’s capital stock at a discount. On June 3, 2024 the Company acquired a $50,000 convertible note receivable from Nightingale Intelligent Systems, Inc., a private Delaware corporation that provides unmanned aerial vehicles (UAV) for commercial applications. On January 3, 2025 the Company exchanged it’s convertible note receivable for : 1,770,840 Series A preferred shares, 15,000 common shares and 165,000 common share warrants. On February 28, 2025, there was a 10 :1 split. The Company now holds 177,084 Series A preferred shares, 1,500 common shares and 16,500 common share warrants (at a strike price of $0.80/share). The Company values the Nightingale Intelligent Systems, Inc.’s shares and warrants at $50,000 bringing total investments at cost to $100,000 at February 28, 2026.

 

6. REVENUE EARNING DEVICES

 

Revenue earning devices (RED) consisted of the following:

  

   February 28,
2026
   February 28,
2025
 
Revenue earning devices  $8,355,295   $6,831,352 
Less: Accumulated depreciation   (3,257,668)   (2,292,172)
Total  $5,097,627   $4,539,180 

 

During the year ended February 28, 2026, the Company made total additions to revenue earning devices of $2,632,720 which were transferred from inventory. For the year ended February 28, 2026, the Company disposed of assets with a value $1,108,776 and related accumulated depreciation $1,037,839 with a net book value of $70,937 for zero net proceeds..

 

During the year ended February 28, 2025, the Company made total additions to revenue earning devices of $3,398,505 which were transferred from inventory. There was no permanent impairment on revenue earning services for the year ended February 28, 2025.

 

Depreciation and amortization for the years ended February 28, 2026, and February 28, 2025, are as follows:

 

Depreciation and Amortization RED  Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
         
Cost of Goods Sold  $1,981,679   $1,051,498 
Operating expenses   91,811    287,830 
Total Depreciation and Amortization RED  $2,073,490   $1,339,328 

 

F-17

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

7. FIXED ASSETS

 

Fixed assets consisted of the following:

  

   February 28,
2026
   February 28,
2025
 
Automobile  $74,237   $74,237 
Demo devices   265,421    302,186 
Tooling   107,020    107,020 
Machinery and equipment   17,246    8,825 
Computer equipment   157,448    157,448 
Office equipment   15,312    15,312 
Furniture and fixtures   21,225    21,225 
Warehouse equipment   38,746    36,305 
Leasehold improvements   26,956    26,956 
Fixed assets gross   723,611    749,514 
Less: Accumulated depreciation   (540,426)   (491,186)
Fixed assets, net of accumulated depreciation  $183,185   $258,328 

 

During the year ended February 28, 2026, the Company made additions to fixed assets of $10,863 and also additions through inventory transfers of $55,701. For the year ended February 28, 2026, the Company disposed of assets with a value $92,466 and related accumulated depreciation $70,154 with a net book value of $22,312 for zero net proceeds.

 

During the year ended February 28, 2025, the Company made additions to fixed assets of $23,724 and also additions through inventory transfers of $107,836.

 

Depreciation and amortization for the years ended February 28, 2026, and February 28, 2025, are as follows:

 

Depreciation and Amortization  Year Ended
February 28,
2026
   Year Ended
February 28,
2025
 
         
Fixed assets  $49,240   $141,309 
Revenue earning devices   91,811    287,830 
Total Depreciation and Amortization included in operating expenses  $141,051   $429,139 

 

F-18

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

8. DEFERRED VARIABLE PAYMENT OBLIGATION

 

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

 

On May 9, 2019 the Company entered into two similar arrangements with two investors:

 

  (1) The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
     
  (2) The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

 

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

 

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

 

On November 18, 2019 the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020 the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

 

On December 30, 2019 the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020 the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

 

On April 22, 2020 the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020 the investor has fully funded this commitment.

 

On July 1, 2020 the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment

 

F-19

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

On August 27, 2020 the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020 and the Payments are secured by the assets of the Company. This interest may be secured by UCC filing but is subordinated to equipment financing on the products the Company leases to its customers.

 

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%

 

The Payments will first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and will accrue every quarter thereafter. As of February 28, 2026, the Company has accrued approximately $3,161,727 in Payments, of which $1,901,259 is in arrears. As of February 28, 2025, the Company has accrued approximately $1,901,258 in Payments, of which $904,377 is in arrears No notices have been received by the Company.

 

On March 1, 2021 the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

 

  1) The rate payment was reduced from 14.25 % to 9.65 %
  2) The asset disposition % (see below) was reduced from 31 % to 21%

 

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021 the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

 

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of February 28, 2026, and February 28, 2025, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

 

For both the years ended February 28, 2026 and February 28, 2025, the Company has received $0 related to the deferred payment obligation as the balance remains $2,525,000 at both February 28, 2026 and February 28, 2025.

 

F-20

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

9. RELATED PARTY TRANSACTIONS

 

For the years ended February 28, 2026, and February 28, 2025, the Company had net (advances) repayments of ($132,268) and ($71,927), respectively, to its loan payable-related party. At February 28, 2026, the loan payable-related party was $461,633 and $329,365 at February 28, 2025. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. As of February 28, 2025, included in the balance due to the related party is $190,013 of deferred salary all of which bears interest at 12%. The accrued interest included at February 28, 2026, was $79,268 (February 28, 2025- $51,575).

 

During the year ended February 28, 2026, the Company a net repayment of $390,744 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2026, to $1.0 million. For the fiscal year ended February 28, 2025, the Company paid out $1,390,744 to the CEO. During the year ended February 28, 2025, the Company a net accrual of $1,663,833 in deferred compensation for the CEO. This would bring his annual bonus for the year ended February 28, 2025, to $2.5 million. For the fiscal year ended February 28, 2025, the Company paid out $836,167 to the CEO. This was all in accordance with a December 2023 board action allowing for $1 million of discretionary compensation.

 

During the years ended February 28, 2026, and February 28, 2025, the Company accrued 1,500 Series G shares to be issued totaling $1,500,000 and 1,500 Series G preferred shares to be issued totaling $1,500,000, respectively, both per Company resolution. The Series G preferred shares are redeemable at $1,000 per share and will be issued by the Company at the appropriate time. The balance of Incentive Compensation Plan Payable at February 28, 2026, was $5,500,000 and the balance February 28, 2025, was $4,000,000.

 

During the years ended February 28, 2026, and February 28, 2025, the Company was charged $2,576,111 and $2,541,180, respectively in consulting fees for research and development to a company partially owned by a principal shareholder included in research and development expenses. The principal shareholder received no compensation from this partially owned research and development company and the fees were spent on core development projects. As at February 28, 2026, and February 28, 2025, the balance due to this company was $160,557 and $76,532, respectively.

 

F-21

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

10. LOANS PAYABLE

 

Loans payable at February 28, 2026 consisted of the following:

 

Date  Maturity  Description    Principal   Interest Rate 
July 18, 2016  July 18, 2017  Promissory note (1)*  $3,500    22%
December 10, 2020  March 1, 2027  Promissory note (2)   3,921,168    12%
December 10, 2020  March 1, 2027  Promissory note (3)   2,754,338    12%
December 10, 2020  December 10, 2024  Promissory note (4)   —    12%
December 14, 2020  March 1, 2027  Promissory note (5)   310,375    12%
December 30, 2020  March 1, 2027  Promissory note (6)   350,000    12%
January 1, 2021  March 1, 2027  Promissory note (7)   25,000    12%
January 1, 2021  March 1, 2027  Promissory note (8)   145,000    12%
January 14, 2021  March 1, 2027  Promissory note (9)   237,500    12%
February 22, 2021  March 1, 2027  Promissory note (10)   1,650,000    12%
March 1, 2021  March 1, 2027  Promissory note (11)   6,000,000    12%
June 8, 2021  June 8, 2027  Promissory note (12)   2,750,000    12%
July 12, 2021  July 26, 2026  Promissory note (13)   —    7%
September 14, 2021  September 14, 2027  Promissory note (14)   1,650,000    12%
July 28, 2022  March 1, 2027  Promissory note (15)   170,000    15%
August 30, 2022  August 30,2027  Promissory note (16)   3,000,000    15%
September 7, 2022  March 1, 2027  Promissory note (17)   400,000    15%
September 8, 2022  March 1, 2027  Promissory note (18)   475,000    15%
October 13, 2022  March 1, 2027  Promissory note (19)   350,000    15%
October 28, 2022  October 31, 2026  Promissory note (20)   400,000    15%
November 9, 2022  October 31, 2026  Promissory note (20)   400,000    15%
November 10, 2022  October 31, 2026  Promissory note (20)   400,000    15%
November 15, 2022  October 31, 2026  Promissory note (20)   400,000    15%
January 11, 2023  October 31, 2026  Promissory note (20)   400,000    15%
February 6, 2023  October 31, 2026  Promissory note (20)   400,000    15%
April 5. 2023  October 31, 2026  Promissory note (20)   400,000    15%
April 20, 2023  October 31, 2026  Promissory note (20)   400,000    15%
May 11, 2023  October 31, 2026  Promissory note (20)   400,000    15%
October 27, 2023  October 31, 2026  Promissory note (20)   400,000    15%
November 30, 2023  April 30, 2027  Purchase Agreement (21)   203,000    15%
March 8, 2024  August 8, 2027  Purchase Agreement (22)   350,000    15%
July 26, 2025  July 26, 2026  Promissory note (23)   165,000    15%
August 7,2025  August 7,2026  Promissory note (24)   245,000    15%
August 25, 2025  August 25, 2026  Promissory note (25)   137,500    15%
August 25, 2025  May 6, 2026  Future Receivables Purchase and Sale Agreement (26)   189,951    108%
September 25, 2025  September 25, 2026  Promissory note (27)   550,000    15%
October 30. 2025  October 30. 2026  Promissory note (28)   200,000    15%
November 6, 2025  November 6, 2026  Promissory note (29)   275,000    15%
November 24, 2025  November 24, 2026  Promissory note (30)   450,000    15%
December 9, 2025  December 9, 2026  Promissory note (31)   450,000    15%
December 17, 2025  September 23, 2026  Business loan (32)   329,962    65%
December 22, 2025  December 22, 2026  Convertible note (33)   495,000    12%
December 27, 2025  December 27, 2026  Promissory note (34)   275,000    15%
January 12, 2026  January 12, 2027  Promissory note (35)   330,000    15%
January 27, 2026  January 27, 2027  Promissory note (36)   170,000    15%
February 2, 2026  February 2, 2027  Promissory note (37)   330,000    15%
February 19, 2026  February 19, 2027  Convertible note (38)   165,000    12%
                   
February 24, 2026  February 24, 2027  Promissory note (39)   170,000    15%
           $33,672,294      
                   
Less: current portion of loans payable     (9,483,914)     
Less: discount on non-current loans payable     -      
Non-current loans payable, net of discount    $24,188,380      
                   
Current portion of loans payable    $9,483,914      
Less: discount on current portion of loans payable     (635,774)     
Current portion of loans payable, net of discount    $8,848,140      

 

* In default

 

As of February 28, 2026 , all long term debt matures in the fiscal year ending February 29, 2028.

 

F-22

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
   
(2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. On February 8, 2026, the holder exchanged $192,000 in accrued interest for 8,000,000 common shares at fair value of $320,000 with a loss on settlement of $128,000.
   
(4) This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. The Company was charged a penalty of $24,510 which it added the loan with a corresponding adjustment to interest expense. The Company repaid the loan in full $190,155 with accrued interest of $104,046.
   
(5)

This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. On December 14, 2023, the parties extended the maturity date from December 14. 2023 date to March 1,2027.

   
(6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the year ended February 28, 2026, the Company recorded amortization expense of $138, with an unamortized discount of $0 at February 28, 2026.The loan is fully amortized.
   
(7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

 

F-23

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024, to March 1, 2025, with all other terms and Conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the year ended February 28, 2026, the Company recorded amortization expense of $144, with an unamortized discount of $0 at February 28, 2026.The loan is fully amortized. Through an exchange agreement on February 11, 2025, the Company repaid $162,000 in principal st through the issuance of 600,000 common shares. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. On March 5, 2025 the Company repaid $150,500 in loan principal as well as $275,000 in accrued interest (all totaling $425,500) was repaid on March 5, 2025 through the issuance of 1,850,000 common shares at a fair value of $444,000 with a loss on settlement of $18,500.
   
(10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022, to February 22, 2024, on February 28, 2022, in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the year ended February 28, 2026, the Company recorded amortization expense of $700, with an unamortized discount of $0 at February 28, 2026. The loan is fully amortized. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. For the year ended February 28, 2026, the Company has issued 36,500,000 common shares at fair market value of $4,365,500 to repay $3,840,500 in accrued interest with a loss on settlement of debt of $525,000.
   
(12) The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $964, with an unamortized discount of $0 at February 28, 2026. The loan is fully amortized On April 16, 2025, the parties again extended the maturity date from June 8, 2025, to June 8, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of price the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. During the period the holder exchanged $1,416,000 in accrued interest for 25,000,000 common shares at a fair value of $1,680,000 with a loss on settlement of $264,000.

 

F-24

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(13) This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. During the six months ended August 31, 2025 the Company repaid $420,000 as part of a settlement with the estate of the lender. A settlement agreement was entered into on April 25,2025 between the Company and the Estate of the lender whereby the Company will repay a total of $420,000 to fully discharge the outstanding loan balance and accrued interest which totaled $4,790,185. This settlement agreement was approved by the court on June 5, 2025. Upon settlement in August 2025, the Company recorded a gain on settlement of debt of $4,370,185. At February 28, 2026 the outstanding principal and interest was $0.
   
(14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $8,856, with an unamortized discount of $16,325 at February 28, 2026. On April 16, 2025, the parties again extended the maturity date from September 14, 2025, to September 14, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. On April 16, 2025, the parties again extended the maturity date from August 30, 2025, to August 30, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

 

F-25

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(20) On October 28, 2022, the Company entered into as secured loan agreement with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of this secured loan agreement into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
   
  October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,483, with an unamortized discount of $14,428 at February 28, 2026.
   
  November 9, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,573, with an unamortized discount of $14,502 at February 28, 2026.

 

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,637, with an unamortized discount of $18,647 at February 28, 2026.

 

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,515, with an unamortized discount of $14,456 at February 28, 2026.

 

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,573, with an unamortized discount of $14,502 at February 28, 2026.

 

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,638, with an unamortized discount of $14,557 at February 28, 2026.

 

F-26

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,683, with an unamortized discount of $14,594 at February 28, 2026.

 

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,824, with an unamortized discount of $14,711 at February 28, 2026.

 

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $19,288, with an unamortized discount of $15,096 at February 28, 2026.

 

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with six a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the year ended February 28, 2026, the Company recorded amortization expense of $18,761, with an unamortized discount of $14,657 at February 28, 2026.

 

(21)

On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed April through to August 2024 payments in agreement with the lender. The Company have missed the subsequent monthly payments. On April 16, 2025, the parties extended the maturity date from April 30, 2025, to April 30, 2026, with all other terms and conditions remaining the same. On April 30,2026, the parties extended the maturity to April 30, 2027, with the default rate still applicable after April 30, 2025.

 
(22) On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 8, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The August 2024 through to August 2025 payments have not been made and the note was not repaid at original maturity. On August 8, 2025 the parties extended the maturity to August 8, 2027 , with the default rate still applicable after August 8, 2025.
   
(23) Original $165,000 note may be pre-payable at any time. The note balance includes an original issue discount of $15,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(24) Original $245,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(25) Original $137,500 note may be pre-payable at any time. The note balance includes an original issue discount of $12,500. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(26) On August 25, 2025, the Company entered into Future Receivables Purchase and Sale Agreement secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $555,671 after fees of $29,329 and a financing fee of $222,300 for total fees of $251,629. The Company must repay $807,300, in weekly payments of 7% of estimated receipts from accounts receivables. The estimated monthly payments will be approximately $99,725. For the year ended February 28, 2026, the Company recorded amortization expense of $192,422, with an unamortized discount of $59,207 at February 28, 2026. For the year ended February 28, 2026, the Company has repaid $617,348.
   
(27) Original $550,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $19,988, with an unamortized discount of $30,012 at February 28, 2026.
   
(28) Original $200,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $7,665, with an unamortized discount of $17,335 at February 28, 2026.
   
(29) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $7,229, with an unamortized discount of $17,771 at February 28, 2026.
   
(30) Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $10,704, with an unamortized discount of $39,296 at February 28, 2026.

 

F-27

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

(31)

 

Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $10,410, with an unamortized discount of $39,590 at February 28, 2026.

   
(32)

On December 17, 2025, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $300,000 after fees of $14,000 and a financing fee of $91,060 for total fees of $105,060. The Company must repay $405,060, in 4 weekly payments of $2,276.50 and 36 weekly payments of $10,998.72. The loan is personally guaranteed by the CEO. For the year ended February 28, 2026, the Company recorded amortization expense of $19,478 with an unamortized discount of $85,582 at February 28, 2026. For the year ended February 28, 2026, the Company has repaid $75,098.

   

(33)

$495,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $440,000, with fees of $10,000 and an original issue discount of $45,000. Principal and interest due at maturity. For the year ended February 28, 2026, the Company recorded amortization expense of $9,705, with an unamortized discount of $45,295 at February 28, 2026. After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
   
(34) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $4,122, with an unamortized discount of $20,878 at February 28, 2026.

 

(35)

Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $3,864, with an unamortized discount of $26,136 at February 28, 2026.

 

(36) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $1,769, with an unamortized discount of $18,231 at February 28, 2026.

 

(37)

Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the year ended February 28, 2026, the Company recorded amortization expense of $1,863, with an unamortized discount of $28,137 at February 28, 2026.

 

(38)

$165,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $142,500, with fees of $7,500 and an original issue discount of $15,000. Principal and interest due at maturity. For the year ended February 28, 2026, the Company recorded amortization expense of $484, with an unamortized discount of $22,016 at February 28, 2026. After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.

 

(39)

Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the nine months ended February 28, 2026, the Company recorded amortization expense of $188, with an unamortized discount of $19,812 at February 28, 2026.

 

 

F-28

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

11. STOCKHOLDERS’ DEFICIT

 

Preferred Stock: The Company is authorized to issue up to 20,000,000 shares of $0.001 par value preferred stock. The board of directors is authorized to designate any series of preferred stock up to the total authorized number of shares.

 

Series B Convertible, Redeemable Preferred Stock

 

The board of directors has designated 5,000 shares of Series B Convertible, Redeemable Preferred Stock with a par value of $0.001 per share. As of February 28, 2026 , there are no shares of Series B Preferred Stock outstanding. The Series B Convertible Preferred Stock are redeemable at $1,200 per share, rank in priority to common stock and common stock equivalents upon liquidation of the Company, have voting rights on a converted basis and receives quarterly dividends of 8%. Each holder may, at any time and from time to time convert all, but not less than all, of their shares of Series B Convertible, Redeemable Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by dividing the redemption value by the Conversion Price. The Conversion price is equal to the lower of (1) a fixed price equaling the closing bid price of the Common Stock on the trading day immediately preceding the date of the acquisition of the shares and (2) the lowest traded price of the Common Stock during the ten (10) calendar days immediately preceding, but not including, the Conversion Date. Following an event of default,” as defined in the Purchase Agreement, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price per share equaling eighty five percent (85%) of the lowest traded price for the Company’s common stock during the fifteen (15) Trading Days immediately preceding, but not including, the Conversion Date. Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of eight percent (8%) per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Preferred Share has been converted or redeemed. Dividends may be paid in cash or in shares of Preferred Stock at the discretion of the Company. Any dividends that are not paid a shall continue to accrue and shall entail a late fee, which must be paid in cash, at the rate of 14% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the dividend payment date through and including the date of actual payment in full. On the thirtieth day following the issue date of this Preferred Stock the Company shall have the obligation to redeem one-third of the Preferred Stock outstanding for a redemption price equal to the redemption value of each such share of Preferred Stock, plus any accrued but unpaid dividends, plus all other amounts due to the Holder including, but not limited to Late Fees, liquidated damages and the legal fees and expenses of the Holder’s counsel. On the sixtieth (60th) calendar day following the date Preferred Stock is issued, the Corporation shall have the obligation to redeem one-half of the Preferred Stock then outstanding for the redemption price. On the ninetieth (90th) calendar day following the date Preferred Stock is issued, the Corporation shall have the obligation to redeem all of the Preferred Stock then outstanding for the redemption price. From the date of issuance until the date no shares of Series B Preferred Stock are issued and outstanding, unless Holders of at least 75% in Stated Value of the then outstanding shares of Preferred Stock shall have otherwise given prior written consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly: (a) other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (b) other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (c) amend its charter documents, including, without limitation, its articles of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder; (d) repay, repurchase or offer to repay, repurchase or otherwise acquire of any shares of its Common Stock, Common Stock Equivalents or Junior Securities, other than as to the Conversion Shares as permitted or required under the Transaction Documents: (e) pay cash dividends or distributions on Junior Securities of the Corporation; f) enter into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the Commission, unless such transaction is made on an arm’s-length basis and expressly approved by a majority of the disinterested directors of the Corporation (even if less than a quorum otherwise required for board approval); or(g) enter into any agreement with respect to any of the foregoing.

 

F-29

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Series C Convertible, Redeemable Preferred Stock

 

The board of directors has designated 1,000 shares of Series C Convertible, Redeemable Preferred Stock with a par value of $0.001 per share. As of the February 28, 2026, there are 417 shares of Series C Preferred Stock outstanding. The Series C Convertible Preferred Stock are redeemable at $1,200 per share, rank in priority to common stock and common stock equivalents upon liquidation of the Company, have voting rights on a converted basis and receives quarterly dividends of 12%. Each holder may, after 180 days after issuance, at any time and from time to time convert all, but not less than all, of their shares of Series C Convertible, Redeemable Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by dividing the redemption value by the Conversion Price. The Conversion price is equal to the lower of (1) a fixed price equaling the closing bid price of the Common Stock on the trading day immediately preceding the date of the acquisition of the shares and (2) the lowest traded price of the Common Stock during the ten (10) calendar days immediately preceding, but not including, the Conversion Date. Following an event of default,” as defined in the Purchase Agreement, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price per share equaling ninety percent (90%) of the lowest traded price for the Company’s common stock during the ten (10) Trading Days immediately preceding, but not including, the Conversion Date. Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of twelve percent (12%) per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Preferred Share has been converted or redeemed. Dividends may be paid in cash or in shares of Preferred Stock at the discretion of the Company. Any dividends that are not paid a shall continue to accrue and shall entail a late fee, which must be paid in cash, at the rate of 14% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the dividend payment date through and including the date of actual payment in full. On the one hundred eightieth day following the issue date of this Preferred Stock the Company shall have the obligation to redeem all outstanding Series Preferred Shares for one hundred nine and one half percent (109.5%) of the stated value, plus any accrued but unpaid dividends, plus all other amounts due to the Holder pursuant to the Certificate of Designation and/or any Transaction Documents (“Redemption Date”). Prior to the Redemption Date, the Company at its discretion and on three (3) Trading Days’ written notice, may redeem all outstanding Preferred Shares for one hundred nine and one half percent (109.5%) of the stated value, plus any accrued but unpaid dividends, plus all other amounts due to the Holder pursuant to the Certificate of Designation and/or any Transaction Documents.

 

From the date of issuance until the date no shares of Series C Preferred Stock are issued and outstanding, unless Holders of at least 75% in Stated Value of the then outstanding shares of Preferred Stock shall have otherwise given prior written consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly: (a) other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (b) other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; (c) amend its charter documents, including, without limitation, its articles of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder; (d) repay, repurchase or offer to repay, repurchase or otherwise acquire of any shares of its Common Stock, Common Stock Equivalents or Junior Securities, other than as to the Conversion Shares as permitted or required under the Transaction Documents: (e) pay cash dividends or distributions on Junior Securities of the Corporation; f) enter into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the Commission, unless such transaction is made on an arm’s-length basis and expressly approved by a majority of the disinterested directors of the Corporation (even if less than a quorum otherwise required for board approval); or(g) enter into any agreement with respect to any of the foregoing.

 

F-30

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Series E Preferred Stock

 

The board of directors has designated 4,350,000 shares of Series E Preferred Stock. As of February 28, 2026, there are 3,350,000 shares of Series E Preferred Stock outstanding. The Series E Preferred Stock ranks subordinate to the Company’s common stock as to distributions of assets upon liquidation, dissolution or winding up of the Corporation. The Series E preferred stock is non-redeemable, does not have rights upon liquidation of the Company and does not receive dividends. The outstanding shares of Series E Preferred Stock have the right to take action by written consent or vote based on the number of votes equal to twice the number of votes of all outstanding shares of equity instruments with voting rights. As a result, the holder of Series E Preferred Stock has 2/3rds of the voting power of all shareholders at any time corporate action requires a vote of shareholders.

 

Series F Convertible Preferred Stock

 

The board of directors has designated 10,000 shares of Series F Convertible Preferred Stock with a par value of $1.00 per share. As of February 28, 2026 , there are 2,513 shares of Series F Convertible Preferred Stock outstanding. The Series F Convertible Preferred Stock is non-redeemable, does not have rights upon liquidation of the Company, does not have voting rights and does not receive dividends. Each holder may, at any time and from time to time convert all, but not less than all, of their shares of Series F Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis. So long as any shares of Series F Convertible Preferred Stock are outstanding, the Company shall not, without first obtaining the approval of the majority of the holders: (a) alter or change the rights, preferences or privileges of any capital stock of the Company so as to affect adversely the Series F convertible preferred stock; (b) create any Senior Securities; (c) create any pari passu Securities; (d) do any act or thing not authorized or contemplated by the Certificate of Designation which would result in any taxation with respect to the Series F Convertible Preferred Stock under Section 305 of the Internal Revenue Code of 1986, as amended, or any comparable provision of the Internal Revenue Code as hereafter from time to time amended, (or otherwise suffer to exist any such taxation as a result thereof).

 

Series G Preferred Stock

 

The board of directors has designated 100,000 shares of Series G Preferred Stock. As of the date of this report, there are no shares of Series G Preferred Stock outstanding. The series G shares are redeemable at $1,000 per share The Series G preferred stock does not have voting rights, does not have rights upon liquidation of the Company and does not receive dividends.

 

Summary of Preferred Stock Activity

 

F-31

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Series C Convertible, Redeemable Preferred Stock (Temporary Equity)

 

On February 10, 2025, in connection with a Share Purchase Agreement the Company created a new class of Series C Convertible Redeemable with 1,000 authorized shares.

 

In exchange for 306 Series C Convertible Redeemable Preferred Shares (“Series C”), the Company received gross proceeds of $306,000 with net proceeds of $278,580 after paying $6,000 in legal fees and $21,420 in broker fees both charged against paid in capital. The Company must redeem the shares at stated capital of 1,200 per share and a 1.095 premium at 180 days after issuance. The Company recorded the 306 outstanding shares at its redemption value of $402,084 at February 28, 2025, with the offsetting adjustment to paid in capital. During the year the Company issued 12% quarterly dividends in 44 Series C shares with a value of $58,100. The Company failed to redeem the Series C shares on the August 9, 2025 redemption date and a penalty of 114 Series C shares with a value of $149,307 was recorded. In August 2025 the Company redeemed 95 Series C shares for $125,000 including a deemed dividend of $29,871. In September 2025 the Company failed to convert a conversion notice of 96 shares. This conversion was withdrawn inI December 2025 and a new conversion for 85 Series C shares with a value of $111,690 including a dividend of $84,690 with a corresponding adjustment to paid in capital .In exchange for the converted Series C shares , the Company issued 1,994,464 common shares. In January 2026, the Company failed to convert a conversion notice of 80 shares. On March 19, 2026 the Company entered into an agreement with the investor whereby the parties agreed to reduce the penalty on the September 2025 and January 2026 failed conversion to 133 Series C shares at a value of $175,140 ( The penalty was reduced from 345 Series C shares to 133 Series C shares) . The parties agreed on the Series C share balance at February 28, 2026 to be 417 series C shares. In addition the parties agreed to issue an additional 222 Series C shares for proceeds of $200,000 and fees of $22,000. These shares have a redemption value of $291.708. Also on March 19, 2026 ,the parties agreed to convert 165 Series C shares at a value of $198,000 for 13,550,625 common shares. At February 28, 2026 and February 28, 2025 there are 417 and 306 outstanding Series C shares.

 

Series F Convertible Preferred Stock

 

Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis.

 

On April 30, 2024 the Company increased authorized shares to 10,000 Series F Preferred Shares.

 

Series F Preferred Stock Activity:

 

During the year ended February 28, 2026 Series F shareholders there was no activity.

 

During the year ended February 28, 2025 Series F shareholders had the following activity:

 

  — A Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 11). The Company record an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.

 

At both February 28, 2026 and February 28, 2025 there are 2513 outstanding Series F preferred stock.

 

Unissued Series F Preferred Stock

 

At both February 28, 2026 and February 28, 2025 there remains 46 issuable Series F preferred stock at a value of $99,086.

 

Summary of Preferred Stock Warrant Activity

 

   Number of
Series F
Preferred
Warrants
  

Weighted

Average
Exercise Price

  

Weighted

Average
Remaining
Years

 
Outstanding at March 1, 2025   939   $1.00    8.5 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited and cancelled   —    —    — 
Outstanding at February 28, 2026   939   $1.00    7.5 

 

F-32

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Summary of Common Stock Activity

 

The Company increased authorized common shares from 5,000,000,000 to 6,000,000,000 on July 8, 2022, from 6,000,000,000 to 7,225,000,000 on March 19, 2023 from 7,225,000,000 to 10,000,000,000 on August 30, 2023, from 10,000,000,000 to 12,500,000,000 on March 22, 2024., from 12,500,000,000 to 15,000,000,000 on October 4, 2024 from 15,000,000,000 to 20,000,000,000 on February 21, 2025, from 20,000,000,000 to 23,000,000,000 on July 25, 2025 and from 23,000,000,000 to 27,500,000,000 on October 15, 2025.

 

On March 19, 2026, the Board of Directors and the holder of a majority of the Company’s voting power approved, by written consent, a decrease in the Company’s authorized common shares from 27,500,000,000 to 12,000,000,000. The Certificate of Amendment effecting this decrease was not filed with, or accepted by, the Nevada Secretary of State until July 15, 2026, on which date the decrease became effective. As of February 28, 2026 and continuing through the filing date of the Company’s original Annual Report on Form 10-K for the fiscal year ended February 28, 2026, the Company’s authorized common shares remained 27,500,000,000.

 

On February 5, 2026, the holders of a majority of the voting power of the Company’s outstanding voting securities executed the written consent approving a reverse stock split of the Company’s issued and outstanding Common Stock at a ratio of 1-for-100. The common shares have been adjusted to reflect this reverse stock split.

 

Summary of Common Stock Activity

 

During the year ended, February 28, 2026, common shareholders had the following activity:

 

  — the Company issued 50,403,802 common shares with gross proceeds of $5,185,344 and net proceeds of $4,801,184 after paid issuance costs of $274,161. Included in these common shares was a commitment fee of $90,000 on the issuance of 1,354,167 shares bringing total fees to $364,161.
     
  — the Company issued 71,350,000 common shares in gross proceeds of $6,384,000 to repay $5,411,000 loans payable and $37,500 in accrued interest with loss on settlement of $935,500 .
     
  —

the Company issued 1,994,464 common shares in gross proceeds of $111,690 on the conversion of 85 Series C Preferred Shares. A dividend of $84,690 was recorded with a corresponding adjustment to paid -in capital.

 

During the year ended, February 28, 2025, common shareholders had the following activity:

 

  — the Company issued 49,796,369 common shares with gross proceeds of $13,697,245 and net proceeds of $13,120,679 after paid issuance costs of $576,565. Included in the net proceeds are $418,669 in share proceeds receivable received after year end. Included in these common shares was a commitment fee of $125,000 on the issuance of 43,859,650 shares bringing total fees to $701,565.
     
  — the Company issued 1,940,659 common shares to repay $562,000 loans payable from two different lenders.

 

Summary of Warrant and Stock Option Activity

 

   Number of
Warrants
   Weighted Average
Exercise Price
   Weighted Average
Remaining Years
 
Outstanding at February 29, 2024   3,005,957   $0.30    1.00 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited and cancelled   (2,533,243)   (0.30)   — 
Outstanding at February 28, 2025   472,714   $0.30    2.44 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited and cancelled   (2,714)   (0.04)   — 
Outstanding at February 28, 2026   470,000   $0.04    1.44 

 

During the year ended February 28, 2026 warrant holders had the following activity:

 

  — During the year warrants to acquire 2,714 shares expired.

 

During the year ended February 28, 2025 warrant holders had the following activity:

 

  — During the year warrants to acquire 2,533,243 shares expired.

 

F-33

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

For the years ended February 28, 2026 and February 29, 2025, the Company recorded a total of $0 and $0, respectively on stock-based payments for warrants with a corresponding adjustment to additional paid-in capital.

 

For the years ended February 28, 2026 and February 28, 2025 the Company recorded a total of $315,848 and $331,685 respectively, to stock-based compensation for options and shares with a corresponding adjustment to additional paid-in capital. In addition for both the years ended February 28, 2026 and February 28, 2025 the Company recorded other stock based compensation of $0 payable in Series G Preferred shares which have not yet been issued.

 

Summary of Common Stock Option Activity

 

On April 14, 2021, the Shareholders of Series E Preferred Stock and the Board of Directors of our Company (“Board”) approved and adopted the 2021 Incentive Stock Plan (the “2021 Plan”). On August 11, 2022 the Company amended the 2021 Plan increasing the maximum number of shares applicable to the 2021 Plan from 50,000 to 1,000,0000 On August 14, 2023 the Company further amended the plan increasing the maximum shares to 2,000,000.

 

The purpose of the 2021 Plan is to promote the success of the Company by authorizing incentive awards to retain Directors, executives, selected Employees and Consultants, and reward participants for making major contributions to the success of the Company. The 2021 Plan authorizes the granting of stock options, restricted stock, restricted stock units, stock appreciation rights and stock awards. A total of two million (2,000,000) shares of common stock may be issued under the 2021 Plan. All awards under the 2021 Plan, whether vested or unvested, are subject to the terms of any recoupment, clawback or similar policy of the Company in effect from time to time, as well as any similar provisions of applicable law, which could in certain circumstances require repayment or forfeiture of awards or any shares of stock or other cash or property received with respect to the awards, including any value received from a disposition of the shares acquired upon payment of the awards. The 2021 Plan will be administered by the Board or any Committee authorized by the Board, if applicable, which will have the sole authority to, among other things: construe and interpret the 2021 Plan; make rules and regulations relating to the administration of the 2021 Plan; select participants; and establish the terms and conditions of awards, all in accordance with the terms of the 2021 Plan. The 2021 Plan will remain in effect until April 14, 2031, unless sooner terminated by the Board. Termination will not affect awards then outstanding.

 

During the year ended February 28, 2026 the Company had the following common stock option activity:

 

— On the original 2021 plan, options to purchase 33,000 shares were forfeited due to employee terminations. On the 2023 plan (see below) 57,160 options to purchase shares were forfeited due to employee terminations.

 

During the year ended February 28, 2025 the Company had the following common stock option activity:

 

— On the original 2021 plan, options to purchase 24,750 shares were forfeited due to employee terminations. On the 2023 plan (see below) 39,639 options to purchase shares were forfeited due to employee terminations.

 

F-34

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Summary of Common Stock Option Activity

 

   Number of
Options
  

Weighted

Average
Exercise Price

   Weighted Average
Remaining
Years
 
Outstanding at March 1, 2024   1,886,670   $2.00    4.10 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited, extinguished and cancelled   (64,389)  $2.00    (3.50)
Outstanding at February 28, 2025   1,822,281   $2.00    3.10 

 

   Number of
Options
  

Weighted

Average
Exercise Price

   Weighted Average
Remaining
Years
 
Outstanding at March 1, 2025   1,822,281   $2.00    3.10 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited, extinguished and cancelled   (90,160)  $2.00    (2.60)
Outstanding at February 28, 2026   1,732,121   $2.00    2.10 

 

12. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

The related legal costs are expensed as incurred.

 

On September 24, 2024, a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet made on June 7, 2024. The Company and its counsel believe the claim is without merit however the courts have mandated mediation. After consideration of business factors the parties executed a settlement agreement in June 2025 with the Company agreeing to pay $65,000 with no admission of wrongdoing. The Company paid the $65,000 on August 1, 2025.

 

F-35

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Operating Lease

 

On March 10, 2021, the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

 

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

 

On March 11, 2025, the Company entered into a 3-year lease agreement for a vehicle commencing March 11, 2025 through to March 11, 2028 with a minimum base rent of $1,286 per month. The Company paid a down payment of $13,188. The Company recorded the right of use asset of $53,739 with a corresponding adjustment to operating lease liability.

 

The Company’s leases are accounted for as operating leases. The weighted average discount rate used was 10% and the weighted average remaining lease term at February 28, 2026 was 4.93 years. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $251,883 and $240,731 for the years ended February 28, 2026 and February 28, 2025, respectively.

 

Maturity of Lease Liabilities  Operating
Leases
 
February 28, 2027  $243,690 
February 28, 2028   227,383 
February 29, 2029   207,558 
February 28, 2030   207,558 
February 28, 2031   207,558 
February 28, 2032 and after   34,593 
Total lease payments   1,128,340 
Less: Interest   (207,956)
Present value of lease liabilities  $920,384 

 

F-36

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

13. LOSS PER SHARE

 

The net loss per common share amounts were determined as follows:

 

   2026   2025 
   For the Year Ended 
   February 28,   February 28, 
   2026   2025 
Numerator:          
Net loss available to common shareholders  $(14,510,251)  $(18,935,592)
           
Effect of common stock equivalents          
Less redemption dividend to Series F and Series B preferred shareholders   (114,561)   (423,476)
Net loss adjusted for common stock equivalents   (14,624,812)   (19,358,968)
           
Denominator:          
Weighted average shares - basic   202,908,578    116,476,733 
           
Net loss per share – basic  $(0.07)  $(0.16)
           
Denominator:          
Weighted average shares – diluted   202,908,578    116,476,733 
           
Net loss per share – diluted  $(0.07)  $(0.16)

 

The anti-dilutive shares of common stock equivalents for the years ended February 28, 2026 and February 28, 2025 were as follows:

 

   2026   2025 
   For the Year Ended 
   February 28,   February 28, 
   2026   2025 
Convertible Series F Preferred Shares   924,161,175    497,229,655 
Convertible Series C Preferred Shares   22,830,847    1,718,308 
Convertible and exchangeable debt   1,095,380,027    — 
Stock options and warrants   2,202,121    2,294,996 
Total   2,044,574,170    501,242,959 

 

F-37

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

14. INCOME TAXES

 

The Company has adopted ASC 740-10, “Income Taxes”, which requires the use of the liability method in the computation of income tax expense and the current and deferred income taxes payable (deferred tax liability) or benefit (deferred tax asset). Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

The income tax expense (benefit) consisted of the following for the fiscal years ended February 28, 2026 and ended February 28, 2025:

 

    February 28,
2026
    February 28,
2025
 
Total current  $—   $— 
Total deferred   —    — 
Total  $—   $— 

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

The following is a reconciliation of the expected statutory federal income tax provision to the actual income tax benefit for the fiscal years ended February 28, 2026 and February 28, 2025:

 

   February 28,
2026
 
Federal statutory rate  $(2,900,000)
State income tax benefit, net of federal benefit   (660,000)
Non deductible interest   500,000 
Non deductible stock based compensation   334,000 
Change in valuation allowance   2,726,000 
Total  $— 

 

   February 28,
2025
 
Federal statutory rate  $(4,000,000)
State income tax benefit, net of federal benefit   (900,000)
Non deductible interest   500,000 
Non deductible stock based compensation   322,000 
Change in valuation allowance   4,078,000 
Total  $— 

 

For the years ended February 28, 2026 and February 28, 2025, the expected tax benefit, temporary timing differences and long-term timing differences are calculated at the 21% statutory rate.

 

F-38

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Significant components of the Company’s deferred tax assets and liabilities were as follows for the fiscal years February 28, 2026 and February 28, 2025:

 

   February 28,
2026
   February 28,
2025
 
Deferred tax assets:          
Net operating loss carryforwards  $22,726,000   $20,000,000 
           
Deferred tax liabilities:          
Depreciation   —    — 
Deferred revenue   —    — 
Total deferred tax liabilities   —    — 
           
Net deferred tax assets:          
Less valuation allowance   (22,726,000)   (20,000,000)
Net deferred tax assets (liabilities)  $—   $— 

 

The Company has incurred losses since inception, therefore, the Company has no federal tax liability. Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes which occurred in the Company on August 28, 2017. The net deferred tax asset generated by the loss carryforward has been fully reserved. The cumulative net operating loss carryforward was approximately $90,000,000 at February 28, 2026 and $76,973,800 at February 28, 2025, that is available for carryforward for federal income tax purposes and begin to expire in 2030.

 

Although the Company has tax loss carry-forwards, there is uncertainty as to utilization prior to their expiration. Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance.

 

The Company has maintained a full valuation allowance against its deferred tax assets at February 28, 2026 and February 28, 2025. A valuation allowance is required to be recorded when it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Since the Company cannot be assured of realizing the net deferred tax asset, a full valuation allowance has been provided.

 

The Company does not have any uncertain tax positions at February 28, 2026 and February 28, 2025 that would affect its effective tax rate. The Company does not anticipate a significant change in the amount of unrecognized tax benefits over the next twelve months. Because the Company is in a loss carryforward position, the Company is generally subject to US federal and state income tax examinations by tax authorities for all years for which a loss carryforward is available. If and when applicable, the Company will recognize interest and penalties as part of income tax expense.

 

The Company’s tax returns for the years ended February 28, 2025 and February 29, 2024, and February 28, 2023 are open for examination under Federal statute of limitations.

 

F-39

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15. SUBSEQUENT EVENTS

 

Subsequent to February 28, 2026 through to filing date,

 

— the Company issued 36,786,492 common shares pursuant to a share purchase agreement for gross proceeds of $900,871, issuance costs of $77,391 and cash proceeds of $823,480.

 

—the Company issued 39,000,000 shares to a lender to settle $745,900, pursuant to exchange agreements with the lender.

 

—the Series C Preferred Shareholder converted 298 Series C preferred shares at a value of $391,572 for 24,473,250 common shares

 

—on May 4 2026 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $10,000,000 over the course of thirty-six (36) month at a purchase price of eighty-seven percent (87%) of the average of the three lowest bid trade price in the 10 day preceding period. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement.

 

—on March 12, 2026 the Company issued a promissory note to a lender for $170,000 with cash proceeds of $150,000 and an original issue discount of $20,000. The loan bears interest at 15% compounding annually, matures in 1 year and has a general security charging all of the Company’s present and after-acquired property.

 

—on March 19, 2026 the Company entered into a memorandum of understanding whereby the outstanding Series C Preferred Shares were adjusted to 417 Series C Preferred Shares. The memorandum reduced penalties that were added after the Company refused conversions . The reduction amounted to 212.16 Series C Preferred Shares or a stated value of $254,492. In exchange, the Company agreed to proceed with the present conversion of 165 Series C Preferred shares for 13,550,625 common shares and issue 222 new Series C shares with a redemption value of $291,708 in exchange for net proceeds of $200,000.

 

—on March 25, 2026, the Company issued a convertible, redeemable note to a lender for $110,000 with cash proceeds of $95,000, an original issue discount of $10,000, and $5,000 for fees. The loan bears interest at 12%, the note is redeemable by the Company at any time subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note . The note matures in 1 year and converts after 180 days at 80% of the lowest trading price 15 trading days prior to the conversion date.

 

—on March 25, 2026, the Company issued a convertible, redeemable note to a lender for $630,000 with cash proceeds of $595,000, an original issue discount of $30,000, and $5,000 for fees. The loan bears interest at 12%, the note is redeemable by the Company at any time subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The note matures in 1 year and converts after 180 days at 20% of the lowest trading price 15 trading days prior to the conversion date. A refundable commitment fee of 14.1 million common shares was issued, but is returnable if the loan plus accrued interest is paid back by May 5, 2026. On May 5, 2026, the Company repaid in full, principal and interest of $638,492 and the 14.1 million commitment fee shares were returned.

 

—on April 20, 2026, the Company issued a convertible note to a lender for $277,778 with cash proceeds of $250,000, an original issue discount of $27,778, and $5,000 for fees. The loan bears interest at 12%, and the note matures in 1 year. If the loan is prepaid, one year’s full interest of $ 33,333 is due. The note converts at any time at 75% of the lowest closing trading price 10 trading days prior to the conversion date. Interest is payable in common shares at either the redemption date or maturity. A commitment fee of 5million common shares at a fair value of $164,500 was issued.

 

—on April 20, 2026, the Company issued a convertible, redeemable note to a lender for $257,000 with cash proceeds of $250,000 and $7,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The note matures on January 15, 2027, and converts after 180 days at 65% of the lowest trading price 10 trading days prior to the conversion date.

 

—on May 1, 2026, the Company issued a convertible, redeemable note to a lender for $157,000 with cash proceeds of $150,000 and $7,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The note matures on January 15, 2027, and converts after 180 days at 65% of the lowest trading price 10 trading days prior to the conversion date.

 

—on May 4, 2026, the Company issued a convertible, redeemable note to a lender for $700,000 with cash proceeds of $630,000 and an original issue discount of $70,000. The loan bears interest at 12%, and the note matures in 1 year. The note must be redeemed in monthly instalments of 10% of outstanding principal plus accrued interest commencing 60 days after issuance. The note is convertible after 180 days at 65% of the lowest closing trading price 10 trading days prior to the conversion date. A commitment fee of 1.25 million common shares at a fair value of $28,750 was issued.
   
 —on May 29, 2026 the Company issued a promissory note to a lender for $225,000 with cash proceeds of $200,000 and an original issue discount of $25,000. The loan bears interest at 15% compounding annually, matures in 1 year and has a general security charging all of the Company’s present and after-acquired property.

 

—on June 3, 2026, the Company issued a convertible, redeemable note to a lender for $230,000 with cash proceeds of $200,000 an original issue discount of $23,000 and $7,000 for fees. The loan bears interest at 6%, the note is redeemable by the Company at any time subject to a premium ranging from 105% to 140% if redeemed within the first 180 days of the note. The note matures on June 3, 2027, and converts after 180 days at 65% of the lowest trading price 20 trading days prior to the conversion date, including the conversion date.

 

F-40

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

  

May 31, 2026

  

February 28, 2026*

 
ASSETS          
Current assets:          
Cash  $94,643   $109,043 
Accounts receivable, net   974,897    1,004,201 
Device parts inventory, net   1,378,950    1,318,742 
Prepaid expenses and deposits   556,737    503,017 
Total current assets   3,005,227    2,935,003 
Operating lease asset   891,922    931,814 
Revenue earning devices, net of accumulated depreciation of $3,781,667 and $3,257,668, respectively   4,850,345    5,097,627 
Fixed assets, net of accumulated depreciation of $562,268 and $540,426, respectively   176,943    183,185 
Trademarks   36,157    35,319 
Investment at cost   100,000    100,000 
Security deposit   19,280    19,280 
Total assets  $9,079,874   $9,302,228 
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable and accrued expenses  $2,675,960   $3,007,270 
Customer deposits   127,520    147,326 
Current operating lease liability   239,242    243,690 
Current portion of deferred variable payment obligation   3,459,840    3,161,727 
Loan payable - related party   331,946    461,633 
Deferred compensation for CEO   1,990,751    1,811,856 
Current portion of loans payable, net of discount of $871,697 and $635,774   26,897,629    8,848,140 
Current portion of accrued interest payable   9,167,495    2,271,106 
Total current liabilities   44,890,383    19,952,748 
Non-current operating lease liability   643,129    676,694 
Loans payable, net   7,953,001    24,188,380 
Deferred variable payment obligation   2,525,000    2,525,000 
Incentive compensation plan payable   5,500,000    5,500,000 
Accrued interest payable   3,207,606    9,122,552 
Total liabilities   64,719,119    61,965,374 
           
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly,$1,200 stated value, 5,000 shares authorized, no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively   —    — 
Series C Convertible, Redeemable Preferred Stock. $0.001 par value; $1,200 stated value, redeemable at 109.5%, 12% dividend, 1,000 shares authorized, 354 and 417 shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively   465,465    547,941 
           
Commitments and Contingencies          
Stockholders’ deficit:          
Preferred Stock, undesignated; 15,534,000 shares authorized; no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively   —    — 
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively   —    — 
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively   3,350    3,350 
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,513 shares issued and outstanding, respectively   2,513    2,513 
Common Stock, $0.00001 par value; 27,500,000,000 shares authorized as of May 31, 2026 and February 28, 2026 (subsequently decreased to 12,000,000,000 shares authorized effective July 15, 2026 — see Summary of Common Stock Activity below); 388,482,589 and 267,872,804 shares issued, issuable and outstanding, respectively   3,885    2,679 
Additional paid-in capital   120,717,508    117,803,027 
Preferred stock to be issued   99,086    99,086 
Accumulated deficit   (176,931,052)   (171,121,742)
Total stockholders’ deficit   (56,104,710)   (53,211,087)
Total liabilities and stockholders’ deficit  $9,079,874   $9,302,228 

 

* Derived from audited information

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-41

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   Three Months Ended
May 31, 2026
   Three Months Ended
May 31, 2025
 
         
Revenues  $1,831,202   $1,854,837 
           
Cost of goods sold   134,183    173,381 
Depreciation and amortization   513,195    447,955 
Total Cost of Goods Sold   647,378    621,336 
           
Gross Profit   1,183,824    1,233,501 
           
Operating expenses:          
Research and development (see Note 10)   885,593    1,087,619 
General and administrative   2,907,577    3,232,211 
Depreciation and amortization   32,646    34,121 
Operating lease cost and rent   67,372    58,219 
Total operating expenses   3,893,188    4,412,170 
           
Loss from operations   (2,709,364)   (3,178,669)
           
Other expense, net:          
Interest expense   (2,298,874)   (1,415,349)
Loss on settlement of debt   (707,600)   — 
Total other expense, net   (3,006,474)   (1,415,349)
           
Net loss  $(5,715,838)  $(4,594,018)
           
Net loss per share - basic  $(0.02)  $(0.03)
           
Net loss per share - diluted  $(0.02)  $(0.03)
           
Weighted average common share outstanding - basic   325,956,059    155,176,712 
           
Weighted average common share outstanding - diluted   325,956,059    155,176,712 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-42

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
   Temporary Equity   Shareholder’s Deficit 
  

Series C

Preferred Stock

  

Series E

Preferred Stock

  

Series F

Preferred Stock

   Common Stock  

Additional

Paid-In

   Accumulated  

Total

Shareholders’

 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 28, 2025   306   $402,084    3,350,000   $3,350    2,513   $101,599    144,124,538   $1,441   $106,459,528   $(156,496,930)  $(49,931,012)
                                                        
Issuance of shares, net of $121,746 issuance costs   —    —    —    —    —    —    19,000,000    190    2,691,104    —    2,691,294 
Debt exchanged for common shares   —    —    —    —    —    —    6,850,000    69    1,250,431    —    1,250,500 
Series C Preferred shares issued as dividend   9    12,073    —    —    —    —    —    —    (12,073)   —    (12,073)
Stock based compensation   —    —    —    —    —    —    —    —    80,355    —    80,355 
Net loss   —    —    —    —    —    —    —    —    —    (4,594,018)   (4,594,018)
Balance at May 31, 2025   315   $414,157    3,350,000   $3,350    2,513   $101,599    169,974,538   $1,700   $110,469,345   $(161,090,948)  $(50,514,954)

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
   Temporary Equity   Shareholder’s Deficit 
   Series C
Preferred Stock
   Series E
Preferred Stock
   Series F
Preferred Stock
   Common Stock   Additional
Paid-In
   Accumulated   Total
Shareholders’
 
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                             
Balance at February 28, 2026   417    $547,941    3,350,000   $3,350    2,513   $101,599    267,872,804   $2,679   $117,803,027   $(171,121,742)  $(53,211,087)
                                                        
Issuance of shares, net of $77,391 issuance costs   —    —    —    —    —    —    36,786,492    368    823,112    —    823,480 
Debt exchanged for common shares   —    —    —    —    —    —    39,000,000    390    1,453,110    —    1,453,500 
Commitment fee issuable   —    —    —    —    —    —    1,250,000    13    28,738    —    28,751 
Commitment fee issued   —    —    —    —    —    —    5,000,000    50    173,450    —    173,500 
Commitment fee returnable   —    —    —    —    —    —    14,100,000    141    (141)   —    — 
Redemption of Series C on conversion to common shares   (298)   (391,572)   —    —    —    —    24,473,250    244    484,800    (93,472)   391,572 
Issuance of Series C shares   222    291,708    —    —    —    —    —    —    (91,708)   —    (91,708)
Series C Preferred shares issued as dividend   13    17,388    —    —    —    —    —    —    (17,388)   —    (17,388)
Stock based compensation   —    —    —    —    —    —    —    —    60,508    —    60,508 
Rounding shares   —    —    —    —    —    —    43    —    —    —    — 
Net loss   —    —    —    —    —    —    —    —    —    (5,715,838)   (5,715,838)
Balance at May 31, 2026   354   $465,465    3,350,000   $3,350    2,513   $101,599    388,482,589   $3,885   $120,717,508   $(176,931,052)  $(56,104,710)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-43

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   Three Months
Ended
May 31, 2026
   Three Months
Ended
May 31, 2025
 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(5,715,838)  $(4,594,018)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   545,841    482,076 
Bad debts expense   70,000    48,982 
Inventory provision   —    — 
Reduction of right of use asset   38,013    33,865 
Accretion of lease liability   23,281    27,428 
Stock based compensation   60,508    80,355 
Amortization of debt discounts   385,493    47,089 
Loss on settlement of debt   707,600    — 
Increase (decrease) in related party accrued payroll and interest   (129,687)   5,700 
Changes in operating assets and liabilities:          
Accounts receivable   (40,696)   424,655 
Prepaid expenses and deposits on inventory   (51,841)   104,498 
Deposit on right of use asset   —    (13,187)
Device parts inventory   (336,925)   (480,951)
Accounts payable and accrued expenses   (332,150)   524,109 
Customer deposits   (19,806)   (487)
Operating lease liability payments   (60,449)   (58,962)
Deferred compensation for CFO   178,895    (1,246,687)
Current portion of deferred variable payment obligations for payments   298,112    301,287 
Accrued interest payable   1,620,342    993,063 
Net cash used in operating activities   (2,759,307)   (3,321,185)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of fixed assets   (15,600)   (8,422)
Acquisition of trademarks   (838)   (1,298)
Net cash (used in) investing activities   (16,438)   (9,720)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Share proceeds net of issuance costs   823,480    2,839,777 
Proceeds on issuance of Series C shares   200,000    — 
Proceeds from loans payable   2,714,028    — 
Repayment of loans payable   (976,163)   (50,000)
Net cash provided by financing activities   2,761,345    2,789,777 
           
Net change in cash   (14,400)   (541,128)
           
Cash, beginning of period   109,043    865,975 
           
Cash, end of period  $94,643   $324,847 
           
Supplemental disclosure of cash and non-cash transactions:          
Cash paid for interest  $19,257   $8,910 
Cash paid for income taxes  $—   $— 
           
Noncash investing and financing activities:          
Transfer from device parts inventory to fixed assets and revenue earning devices  $276,717   $917,294 
Exchange of notes payable and accrued interest for common shares  $745,900   $1,250,500 
Discount applied to face value of loan  $419,167   $— 
Conversion of Series C shares to common shares  $391,572   $— 
Series C preferred shares issued as dividend  $17,388   $12,073 
Commitment fee shares as debt discount  $202,050   $— 
Right of use asset for lease liability  $—   $53,739 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-44

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

1. GENERAL INFORMATION

 

Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

 

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

 

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

 

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

 

2. GOING CONCERN

 

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

For the three months ended May 31, 2026, the Company had negative cash flow from operating activities of $2,759,307. As of May 31, 2026, the Company has an accumulated deficit of $176,931,052, and negative working capital of $41,885,156. Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

The Company does not have the resources currently to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:

 

Management is committed to raising funds . There is no assurance that management will be able to raise funds nor can we provide assurance that these possible raises may not have dilutive effects. On June 23, 2026, the Company entered into an equity financing agreement whereby an investor will purchase up to $10,000,000 of the Company’s common stock at a discount over a three-year period. There still remains $10 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

 

F-45

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

3. ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 9, 2026. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., and Robotic Assistance Devices Residential, Inc., and Robotic Assistance Devices Lanka (Private) Limited. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three months ended May 31, 2026, are not necessarily indicative of the results that may be expected for the entire year.

 

Use of Estimates

 

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value equity instruments used in debt settlements, amendments and extensions.

 

Reclassifications

 

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

 

Concentrations

 

Loans payable

 

At May 31, 2026 there were $35,722,326 of loans payable, $32,466,506 or 91% of these loans to companies controlled by one individual. At February 28, 2026 there were $33,672,294 loans payable, $32,178,506 or 96% of these loans to companies controlled by one individual.

Cash

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

 

Accounts Receivable

 

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $240,000 and $170,000 provided as of May 31, 2026, and February 28, 2026, respectively. For the three months ending May 31, 2026, two customers account for 23% of total accounts receivable. For the three months ending May 31, 2025, three customers account for 53% of total accounts receivable

 

Device Parts Inventory

 

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of May 31, 2026, and February 28, 2026, there was a valuation reserve of $175,000 and $175,000, respectively.

 

F-46

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Revenue Earning Devices

 

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

 

Fixed Assets

 

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

 

Computer equipment and software   2 or 3 years
Office equipment   4 years
Manufacturing equipment   7 years
Warehouse equipment   5 years
Tooling   2 years
Demo Devices   4 years
Vehicles   3 years
Leasehold improvements   5 years, the life of the lease

 

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

 

Research and Development

 

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At May 31, 2026 and February 28, 2026, the Company had no deferred development costs.

 

Contingencies

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

Sales of Future Revenues

 

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

 

F-47

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

  ● Does the agreement purport, in substance, to be a sale
  ● Does the Company have continuing involvement in the generation of cash flows due to the investor
  ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets
  ● Is the investors rate of return is implicitly limited by the terms of the agreement
  ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return
  ● Does the investor have recourse relating to payments due

 

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

 

Revenue Recognition

 

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the three months ended May 31, 2026, two customers accounted for 36% of total revenue and for the three months ended May 31, 2025, two customers accounted for 65% of total revenue.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2027, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.

 

Leases

 

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

 

F-48

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

 

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

F-49

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

  ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
     
  ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
     
  ● Level 3 – Inputs that are unobservable for the asset or liability.

 

Measured on a Recurring Basis

 

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

 

   Amount at   Fair Value Measurement Using 
   Fair Value   Level 1   Level 2   Level 3 
May 31, 2026                    
Assets                    
Investment at cost  $100,000   $50,000   $—   $50,000 
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $5,500,000   $—   $—   $5,500,000 
                     
February 28, 2026                    
Assets                    
Investment at cost  $100,000   $50,000   $—   $50,000 
Liabilities                    
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares  $5,500,000   $—   $—   $5,500,000 

 

For the incentive compensation plan referred to above , the Company recorded stock based compensation of $0 and $0 for the three months ended May 31, 2026 and May 31, 2025 with corresponding adjustments to incentive compensation plan payable.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

 

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

 

Recently Adopted Accounting Pronouncements

 

ASU 2023-07 – Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments require enhanced disclosures about significant segment expenses and other segment items, require disclosure of the title and position of the chief operating decision maker (“CODM”), explain how the CODM uses reported measures of segment profit or loss to assess performance and allocate resources, and expand interim disclosure requirements. The amendments apply to entities with a single reportable segment as well as entities with multiple reportable segments.

 

F-50

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

The Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, during fiscal 2025. The standard requires enhanced disclosures regarding segment expenses and CODM information and applies to entities with a single reportable segment. Adoption of the standard impacted the Company’s segment reporting disclosures only and did not affect its consolidated financial position, results of operations, or cash flows.

 

Recently issued accounting pronouncement not yet effective

 

ASU 2024-04—Debt with Conversion and Other Options (Topic 470-20): Induced Conversions of Convertible Debt Instruments

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments. The amendments clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or as debt extinguishments. Under the amended guidance, an induced conversion requires that the inducement offer provide the holder, at a minimum, the consideration issuable under the existing conversion privileges of the instrument.

 

The amendments are effective for annual reporting periods beginning after December 15, 2025, including interim reporting periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements and related disclosures.

 

ASU 2025-05—Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets

 

In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments refine the guidance in ASC 326 related to the measurement of expected credit losses for accounts receivable and contract assets arising from revenue transactions accounted for under ASC 606. The update clarifies the application of the current expected credit loss (“CECL”) model to such assets, including the use of practical expedients and considerations in estimating expected credit losses over the contractual term of the asset.

 

The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-05 on its consolidated financial statements and related disclosures.

 

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

 

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

 

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

 

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

   Three Months Ended
May 31, 2026
   Three Months Ended
May 31, 2025
 
Device rental activities  $1,613,095   $1,627,286 
Direct sales of goods and services   218,107    227,551 
Revenue  $1,831,202   $1,854,837 

 

F-51

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

5. LEASES

 

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

 

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

 

Below is a summary of our lease assets and liabilities at May 31, 2026 and February 28, 2026.

 

Leases  Classification 

May 31, 2026

  

February 28, 2026

 
Assets             
Operating  Operating Lease Assets  $891,922   $931,814 
Liabilities             
Current             
Operating  Current Operating Lease Liability  $239,242   $243,690 
Noncurrent             
Operating  Noncurrent Operating Lease Liabilities   643,129    676,694 
Total lease liabilities     $882,371   $920,384 

 

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

 

Operating lease cost and rent was $67,372 and $58,219 for the three months ended May 31, 2026 and May 31, 2025, respectively.

 

6. INVESTMENT

 

On December 23, 2022 the Company entered into a Simple Agreement for Future Equity (SAFE) contract to invest $50,000 to acquire shares of a company’s capital stock at a discount. On June 3, 2024 the Company acquired a $50,000 convertible note receivable from Nightingale Intelligent Systems, Inc., a private Delaware corporation that provides unmanned aerial vehicles (UAV) for commercial applications. On January 3, 2025 the Company exchanged it’s convertible note receivable for : 1,770,840 Series A preferred shares, 15,000 common shares and 165,000 common share warrants. On February 28, 2025, there was a 10 :1 split. The Company now holds 177,084 Series A preferred shares, 1,500 common shares and 16,500 common share warrants (at a strike price of $0.80/share). The Company values the Nightingale Intelligent Systems, Inc.’s shares and warrants at $50,000 bringing total investments at cost to $100,000 at May 31, 2026 and February 28, 2026.

 

7. REVENUE EARNING DEVICES

 

Revenue earning devices consisted of the following:

 

   May 31, 2026   February 28, 2026 
Revenue earning devices  $8,632,012   $8,355,295 
Less: Accumulated depreciation   (3,781,667)   (3,257,668)
Total  $4,850,345   $5,097,627 

 

During the three months ended May 31, 2026, the Company made total additions to revenue earning devices of $276,717 which were transfers from inventory. During the three months ended May 31, 2025, the Company made total additions to revenue earning devices of $895,547 which were transfers from inventory

 

Depreciation and amortization for the years ended May 31, 2026, and May 31, 2025, are as follows:

 

Depreciation and Amortization RED 

Three Months

Ended

May 31 2026

  

Three Months

Ended

May 31, 2025

 
         
Cost of Goods Sold  $513,195   $447,955 
Operating expenses   10,804    4,104 
Total Depreciation and Amortization RED  $523,999   $452,059 

 

F-52

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

8. FIXED ASSETS

 

Fixed assets consisted of the following:

  

   May 31, 2026   February 28, 2026 
Automobile  $74,237   $74,237 
Demo devices   265,421    265,421 
Tooling   122,620    107,020 
Machinery and equipment   17,246    17,246 
Computer equipment   157,448    157,448 
Office equipment   15,312    15,312 
Furniture and fixtures   21,225    21,225 
Warehouse equipment   38,746    38,746 
Leasehold improvements   26,956    26,956 
Fixed assets gross   739,211    723,611 
Less: Accumulated depreciation   (562,268)   (540,426)
Fixed assets, net of accumulated depreciation  $176,943   $183,185 

 

During the three months ending May 31, 2026, the Company made additions of $15,600. During the three months ending May 31, 2025, the Company made additions of $46,071 of which $22,347 were transfers from inventory with remaining additions of $23,724.

 

Depreciation and amortization for the years ended May 31, 2026, and May 31, 2025, are as follows:

Depreciation and Amortization 

Three Months Ended

May 31 2026

   Three Months Ended
May 31, 2025
 
         
Fixed assets  $21,842   $30,017 
Revenue earning devices   10,804    4,104 
Total Depreciation and Amortization included in operating expenses  $32,646   $34,121 

 

9. DEFERRED VARIABLE PAYMENT OBLIGATION

 

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

 

On May 9, 2019 the Company entered into two similar arrangements with two investors:

 

  (1) The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
     
  (2) The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

 

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

 

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

 

F-53

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

 

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

 

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

 

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

 

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

 

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below, this aggregate asset disposition % was reduced from 43.77 % to 33.77%.

 

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of May 31, 2026, the Company has accrued $3,459,840 in Payments of which $2,202,545 are in arrears. As of February 28, 2026, the Company has accrued approximately $3,161,727 in Payments, of which $1,901,259 is in arrears. No notices have been received by the Company. The Company has recorded cumulative interest of 6% interest totaling $204,427 commencing this quarter, on the balance in arrears, and will continue to adjust quarterly.

 

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

 

  1) The rate payment was reduced from 14.25 % to 9.65 %
  2) The asset disposition % (see below) was reduced from 31 % to 21%

 

F-54

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

 

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of May 31, 2026, and February 28, 2026, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

 

For both the three months ended May 31, 2026, and year ended February 28, 2026, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both May 31, 2026 and February 28, 2026.

 

10. RELATED PARTY TRANSACTIONS

 

For both the three months ended May 31, 2026, and May 31, 2025, the Company had repayments of net advances of $129,687 and $0, respectively. At May 31, 2026, the loan payable-related party was $331,946 and $461,633 at February 28, 2026. Included in the balance due to the related party at May 31, 2026, is $255,414 of deferred salary and interest, $157,513 of which bears interest at 12%. As of February 28, 2026, included in the balance due to the related party is $285,638 of deferred salary all of which bears interest at 12%. The accrued interest included in the loan at May 31, 2026, and February 28, 2026, was $84,956, and $79,268, respectively.

 

During the three months ended May 31, 2026, the Company paid out gross payments to the CEO of $71,105 offset by a bonus accrual of $250,000, which yields a net change of $178,895 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, 2026, board action which provided an additional $1.5 million in compensation. During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yielded a net change of $1,246,687 relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $1,990,751 and $1,811,856 at May 31, 2026, and February 28, 2026, respectively

 

For the three months ended May 31, 2026, the Company accrued $0 (three months ended May 31, 2025-$0) of incentive compensation plan payable to the CEO. This will be payable in Series G Preferred Shares, which are redeemable at the Company’s option at $1,000 per share. On May 31, 2026, and February 28, 2026, there was $5,500,000 and $5,500,000 incentive compensation payable.

 

During the three months ended May 31, 2026, and 2025, the Company was charged $390,130 and $736,875, respectively for fees for research and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company, and the fees were spent on core development projects. As at May 31, 2026, and February 28, 2026, the balance due to this company was $76,532 and $160,557, respectively.

 

F-55

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

11. LOANS PAYABLE

 

Loans payable at May 31, 2026 consisted of the following:

 

Date  Maturity  Description  Principal   Interest Rate 
July 18, 2016  July 18, 2017  Promissory note (1)* $3,500    22%
December 10, 2020  March 1, 2027  Promissory note (2)  3,921,168    A12%
December 10, 2020  March 1, 2027  Promissory note (3)  2,754,338    A12%
December 14, 2020  March 1, 2027  Promissory note (5)  310,375    12%
December 30, 2020  March 1, 2027  Promissory note (6)  350,000    A 12%
January 1, 2021  March 1, 2027  Promissory note (7)  25,000    12%
January 1, 2021  March 1, 2027  Promissory note (8)  145,000    12%
January 14, 2021  March 1, 2027  Promissory note (9)  237,500    A 12%
February 22, 2021  March 1, 2027  Promissory note (10)  1,650,000    12%
March 1, 2021  March 1, 2027  Promissory note (11)  6,000,000    12%
June 8, 2021  June 8, 2027  Promissory note (12)  2,750,000    12%
September 14, 2021  September 14, 2027  Promissory note (14)  1,650,000    A 12%
July 28, 2022  March 1, 2027  Promissory note (15)  170,000    15%
August 30, 2022  August 30,2027  Promissory note (16)  3,000,000    A 15%
September 7, 2022  March 1, 2027  Promissory note (17)  400,000    15%
September 8, 2022  March 1, 2027  Promissory note (18)  475,000    15%
October 13, 2022  March 1, 2027  Promissory note (19)  350,000    15%
October 28, 2022  October 31, 2026  Promissory note (20)  293,000    A 15%
November 9, 2022  October 31, 2026  Promissory note (20)  400,000    A 15%
November 10, 2022  October 31, 2026  Promissory note (20)  400,000    A 15%
November 15, 2022  October 31, 2026  Promissory note (20)  400,000    A 15%
January 11, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
February 6, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
April 5. 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
April 20, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
May 11, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
October 27, 2023  October 31, 2026  Promissory note (20)  400,000    A 15%
November 30, 2023  April 30, 2027  Purchase Agreement (21)  203,000    15%
March 8, 2024  August 8, 2027  Purchase Agreement (22)  350,000    15%
July 26, 2025  July 26, 2026  Promissory note (23)  165,000    C 15%
August 7,2025  August 7,2026  Promissory note (24)  245,000    C 15%
August 25, 2025  August 25, 2026  Promissory note (25)  137,500    C 15%
August 25, 2025  May 6, 2026  Future Receivables Purchase and Sale Agreement (26)  —    108%
September 25, 2025  September 25, 2026  Promissory note (27)  550,000    C 15%
October 30. 2025  October 30. 2026  Promissory note (28)  200,000    C 15%
November 6, 2025  November 6, 2026  Promissory note (29)  275,000    C 15%
November 24, 2025  November 24, 2026  Promissory note (30)  450,000    C 15%
December 9, 2025  December 9, 2026  Promissory note (31)  450,000    C 15%
December 17, 2025  September 23, 2026  Business loan (32)  —    65%
December 22, 2025  December 22, 2026  Convertible note (33)  495,000    12%
December 27, 2025  December 27, 2026  Promissory note (34)  275,000    C 15%
January 12, 2026  January 12, 2027  Promissory note (35)  330,000    C 15%
January 27, 2026  January 27, 2027  Promissory note (36)  170,000    C15%
February 2, 2026  February 2, 2027  Promissory note (37)  330,000    C15%
February 19, 2026  February 19, 2027  Convertible note (38)  165,000    12%
February 24, 2026  February 24, 2027  Promissory note (39)  170,000    C15%
March 16, 2026  March 16, 2027  Promissory note (13)  170,000    C15 %
March 25, 2026  March 25, 2027  Convertible note (40)  110,000    12%
March 25, 2026  March 25, 2026  Convertible note (41)  —    12%
April 9, 2026  January 15, 2027  Convertible note (42)  257,000    10%
April 13, 2026  April 13, 2027  Future Receivables Purchase and Sale Agreement (43)  641,279    NA 
April 20, 2026  April 20, 2027  Convertible note (44)  277,778    12%
May 1, 2026  January 15, 2027  Convertible note (45)  157,000    10%
May 4, 2026  May 4, 2027  Convertible Note (46)  700,000    12%
May 28 2026  May 28 2026  Convertible Note (47)  138,889    12%
May 29, 2026  May 29, 2027  Promissory note (4)  225,000    C15%
         $35,722,327      
                 
Less: current portion of loans payable      (27,769,326)     
Less: discount on non-current loans payable   -      
Non-current loans payable, net of discount     $7,953,001      
                 
Current portion of loans payable     $27,769,326      
Less: discount on current portion of loans payable      (871,697)     
Current portion of loans payable, net of discount     $26,897,629     

 

* In default
AOn June 15, 2026 the Company and lender entered into a Loan Amendment Agreement whereby it was agreed that simple interest was to be calculated from the loan issuance date through to February 28, 2026 and commencing March 1, 2026 compounded on the respective principal and interest balance at February 28, 2026.
CCompounding annually
(1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.

 

F-56

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On December 10, 2025 an exchange agreement was made whereby principal and interest of this note may be exchanged for common shares at 90% of the 5 days’ lowest bid of shares. For the three months ending May 31, 2026 the company exchanged $336,000 accrued interest for 14,000,000 common shares at a fair value of $910,700 with a loss on settlement of $574,700.
   
(3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. On February 8, 2026, the holder exchanged $192,000 in accrued interest for 8,000,000 common shares at fair value of $320,000 with a loss on settlement of $128,000.
   
(4) Original $225,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $115, with an unamortized discount of $24,885 at May 31, 2026.
   
(5) This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. On December 14, 2023, the parties extended the maturity date from December 14, 2023 date to March 1, 2027.
   
(6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized.
   
(7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024, to March 1, 2025, with all other terms and Conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized. Through an exchange agreement on February 11, 2025, the Company repaid $162,000 in principal st through the issuance of 600,000 common shares. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. On March 5, 2025 the Company repaid $150,500 in loan principal as well as $275,000 in accrued interest (all totaling $425,500) was repaid on March 5, 2025 through the issuance of 1,850,000 common shares at a fair value of $444,000 with a loss on settlement of $18,500.

 

F-57

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022, to February 22, 2024, on February 28, 2022, in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. For the three months ending May 31, 2026, the Company exchanged $80,000 of accrued interest for 5,000,000 common at a fair value of $100,000 with a loss on settlement of $20,000.
   
(11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. For the year ended February 28, 2026, the Company has issued 36,500,000 common shares at fair market value of $4,365,500 to repay $3,840,500 in accrued interest with a loss on settlement of debt of $525,000.
   
(12) The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. The loan is fully amortized. On April 16, 2025, the parties again extended the maturity date from June 8, 2025, to June 8, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of price the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. For the year ended February 28, 2026 the holder exchanged $1,416,000 in accrued interest for 25,000,000 common shares at a fair value of $1,680,000 with a loss on settlement of $264,000.
   
(13) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $3,680, with an unamortized discount of $16,320 at May 31, 2026.
   
(14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $2,455, with an unamortized discount of $13,870 at May 31, 2026. On April 16, 2025, the parties again extended the maturity date from September 14, 2025, to September 14, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. On April 16, 2025, the parties again extended the maturity date from August 30, 2025, to August 30, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
   
(17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

 

F-58

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
   
(20) On October 28, 2022, the Company entered into as secured loan agreement with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of this secured loan agreement into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
   
  October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,243, with an unamortized discount of $9,185 at May 31, 2026.For the three months ending May 31, 2026, the Company exchanged $107,000 of principal and $222,900 of accrued interest totaling $329,900 for 20,000,000 common at a fair value of $442,800 with a loss on settlement of $112,900.
   
  November 9, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,269, with an unamortized discount of 9,233 at May 31, 2026.

 

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,288, with an unamortized discount of $8,957at May 31, 2026.

 

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,528, with an unamortized discount of $8,927 at May 31, 2026.

 

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,269, with an unamortized discount of $9,233 at May 31, 2026.

 

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,288, with an unamortized discount of $9,268 at May 31, 2026.

 

F-59

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,302, with an unamortized discount of $9,293 at May 31, 2026.

 

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,343, with an unamortized discount of $9,368 at May 31, 2026.

 

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained For the three months ended May 31, 2026, the Company recorded amortization expense of $5,480, with an unamortized discount of $9,616 at May 31, 2026.

 

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with six a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,325, with an unamortized discount of $9,333 at May 31, 2026.

 

(21) On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed April through to August 2024 payments in agreement with the lender. The Company have missed the subsequent monthly payments. On April 16, 2025, the parties extended the maturity date from April 30, 2025, to April 30, 2026, with all other terms and conditions remaining the same. On April 30,2026, the parties extended the maturity to April 30, 2027, with the default rate still applicable after April 30, 2025.
   
(22) On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 8, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The August 2024 through to August 2025 payments have not been made and the note was not repaid at original maturity. On August 8, 2025 the parties extended the maturity to August 8, 2027 , with the default rate still applicable after August 8, 2025.
   
(23) Original $165,000 note may be pre-payable at any time. The note balance includes an original issue discount of $15,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(24) Original $245,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(25) Original $137,500 note may be pre-payable at any time. The note balance includes an original issue discount of $12,500. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
   
(26) On August 25, 2025, the Company entered into Future Receivables Purchase and Sale Agreement secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $555,671 after fees of $29,329 and a financing fee of $222,300 for total fees of $251,629. The Company must repay $807,300, in weekly payments of 7% of estimated receipts from accounts receivables. The estimated monthly payments will be approximately $99,725. For the year ended May 31, 2026, the Company recorded amortization expense of $59,207, with an unamortized discount of $0 at May 31, 2026. For the year ended February 28, 2026, the Company has repaid $617,348. During the three months ending May 31, 2026 the remaining balance of $ 189,952 was fully repaid.
   
(27) Original $550,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $12,724, with an unamortized discount of $17,288 at May 31, 2026.
   
(28) Original $200,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $6,158, with an unamortized discount of $11,127 at May 31, 2026.
   
(29) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $6,189, with an unamortized discount of $11,582 at May 31, 2026.
   
(30) Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $10,760, with an unamortized discount of $28,536 at May 31, 2026.

 

F-60

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(31)

 

Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $11,888, with an unamortized discount of $27,702 at May 31, 2026.
   
(32) On December 17, 2025, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $300,000 after fees of $14,000 and a financing fee of $91,060 for total fees of $105,060. The Company must repay $405,060, in 4 weekly payments of $2,276.50 and 36 weekly payments of $10,998.72. The loan is personally guaranteed by the CEO. For the year ended February 28, 2026, the Company recorded amortization expense of $19,478 with an unamortized discount of $85,582 at February 28, 2026. For the three months ended May 31, 2026, the Company has repaid $87,990 with the balance of $241,972 transferred to the April 13, 2026 loan described in footnote (43),thereby fully extinguishing this loan.
   
(33) $495,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $440,000, with fees of $10,000 and an original issue discount of $45,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $13,062, with an unamortized discount of $32,233 at May 31, 2026. . After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
   
(34) Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,908, with an unamortized discount of $14,970 at May 31, 2026.
   
(35) Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,019, with an unamortized discount of $19,117 at May 31, 2026.
   
(36) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $4,594, with an unamortized discount of $13,637 at May 31, 2026.
   
(37)

Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,059, with an unamortized discount of $21,078 at May 31, 2026.

   
(38) $165,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $142,500, with fees of $7,500 and an original issue discount of $15,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,167, with an unamortized discount of $16,849 at May 31, 2026. After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
   
(39)

Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $4,555, with an unamortized discount of $15,257 at May 31, 2026.

   
(40) $110,000 convertible note that may be redeemed subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The Company received proceeds of $95,000, with fees of $5,000 and an original issue discount of $10,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $2,429, with an unamortized discount of $12,571 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.

 

F-61

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(41) $630,000 convertible note that may be redeemed subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The Company received proceeds of $595,000, with fees of $5,000 and an original issue discount of $30,000. Principal and interest due at maturity. A refundable commitment fee of 14.1 million common shares was issued, but is returnable if the loan plus accrued interest is paid back by May 5, 2026. The loan was intended as a short term loan with high redemption premiums commencing after 40 days and high conversion discounts after 180 days whereby the note would convert at 20% of the lowest traded price 15 days prior trading to the conversion date. On May 5, 2026, the Company repaid in full, principal and interest of $638,492 and the 14.1 million commitment fee shares will be returned.. For the three months ended May 31, 2026, the Company recorded amortization expense of $35,000, with an unamortized discount of $0 at May 31, 2026.
   
(42) $257,000 convertible note that may be redeemed subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The Company received proceeds of $250,000, with fees of $7,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,000, with an unamortized discount of $0 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest closing traded price in the 10 prior trading days.
   
(43) On April 13, 2026, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $295,028 after fees of $16,500 and a financing fee of $91,060 for total fees of $105,060 and a payback of the $241,972 balance on the December 17, loan described in footnote (32) . The Company must repay $709,500, in 52 weekly payments of $13,644. The loan is personally guaranteed by the CEO. For the three months ended May 31, 2026, the Company recorded amortization expense of $16,587 with an unamortized discount of $155,913 at February 28, 2026. For the three months ended May 31, 2026, the Company has repaid $68,221.
   
(44) $277,778 convertible note that may be redeemed anytime with payment of the first year’s accrued interest of $33,333. The Company received proceeds of $245,000, with fees of $5,000 and an original issue discount of $27,778. In addition a commitment fee of 5,000,000 common shares having a fair value of $173,500 was issued and added as a discount. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $10,072, with an unamortized discount of $196,206 at May 31, 2026. The note and interest is convertible at any time a conversion price of 75% of the lowest closing traded price in the 10 prior trading days.
   
(45) $157,000 convertible note that may be redeemed subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The Company received proceeds of $150,000, with fees of $7,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,000, with an unamortized discount of $0 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest closing traded price in the 10 prior trading days.
   
(46) $700,000 convertible note redeemable 90 days after issuance in monthly installments of 10% of the outstanding principal and interest. The Company received proceeds of $615,000, with fees of $15,000 and an original issue discount of $70,000. In addition a commitment fee of 1,250,000 common shares having a fair value of $28,751 was issued and recorded as a discount. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,185, with an unamortized discount of $105,565 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest traded price in the 10 prior trading days.

 

(47) $138,889 convertible note that may be redeemed subject to a premium ranging from 110% to 135% if redeemed within the first 180 days of the note. The Company received proceeds of $119,000, with fees of $6,000 and an original issue discount of $13,889.. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $762, with an unamortized discount of $19,127 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest traded price in the 10 prior trading days.

 

F-62

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

12. STOCKHOLDERS’ EQUITY (DEFICIT)

 STOCKHOLDERS’ DEFICIT

Summary or Preferred Stock Activity

 

Series C Convertible, Redeemable Preferred Stock (Temporary Equity)

 

On February 10, 2025, in connection with a Share Purchase Agreement the Company created a new class of Series C Convertible Redeemable with 1,000 authorized shares.

 

In exchange for 306 Series C Convertible Redeemable Preferred Shares (“Series C”), the Company received gross proceeds of $306,000 with net proceeds of $278,580 after paying $6,000 in legal fees and $21,420 in broker fees both charged against paid in capital. The Company must redeem the shares at stated capital of 1,200 per share and a 1.095 premium at 180 days after issuance. The Company recorded the 306 outstanding shares at its redemption value of $402,084 at February 28, 2025, with the offsetting adjustment to paid in capital. During the year the Company issued 12% quarterly dividends in 44 Series C shares with a value of $58,100. The Company failed to redeem the Series C shares on the August 9, 2025, redemption date and a penalty of 114 Series C shares with a value of $149,307 was recorded. In August 2025 the Company redeemed 95 Series C shares for $125,000 including a deemed dividend of $29,871. In September 2025 the Company failed to convert a conversion notice of 96 shares. This conversion was withdrawn in December 2025 and a new conversion for 85 Series C shares with a value of $111,690 including a dividend of $84,690 with a corresponding adjustment to paid in capital. In exchange for the converted Series C shares, the Company issued 1,994,464 common shares. In January 2026, the Company failed to convert a conversion notice of 80 shares. On March 19, 2026 the Company entered into an agreement with the investor whereby the parties agreed to reduce the penalty on the September 2025 and January 2026 failed conversion to 133 Series C shares at a value of $175,140 ( The penalty was reduced from 345 Series C shares to 133 Series C shares) . The parties agreed on the Series C share balance at February 28, 2026 to be 417 series C shares. In addition, the parties agreed to issue an additional 222 Series C shares for proceeds of $200,000 and fees of $22,000. These shares have a redemption value of $291,708. Also on March 19, 2026, the parties agreed to convert 165 Series C shares at a value of $216,810 for 13,550,625 common shares. The shareholder also converted 40 shares at a value of $52,560 for 3,285,000 common shares on May 6, 2026, and 93 shares at a value of $122,202 for 7,637,628 common shares on May 12, 2026. During the quarter, a dividend of 13 Series C shares having a value of $ $17,388 were accrued. At May 31, 2026, there were 354 outstanding series C shares with a redemption value of $465,465. Ay February 28, 2026, there were 417 outstanding series C shares with a redemption value of $547,941.

 

Series F Convertible Preferred Stock

 

Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis.

 

Summary of Preferred Stock Warrant Activity

   Number of Series F Preferred Warrants  

Weighted

Average Exercise Price

  

Weighted

Average Remaining Years

 
Outstanding at February 28, 2026   939   $1.00    7.5 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited and cancelled   —    —    — 
Outstanding at May 31, 2026   939   $1.00    7.25 

 

F-63

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Summary of Common Stock Activity

 

For the three months ended May 31, 2026:

 

- On March 19, 2026, the Board of Directors and the holder of a majority of the Company’s voting power approved, by written consent, a decrease in the Company’s authorized common shares from 27,500,000,000 to 12,000,000,000. The Certificate of Amendment effecting this decrease was not filed with, or accepted by, the Nevada Secretary of State until July 15, 2026, on which date the decrease became effective. As of May 31, 2026 and continuing through the filing date of the Company’s original Quarterly Report on Form 10-Q for the quarter ended May 31, 2026, the Company’s authorized common shares remained 27,500,000,000.

 

- On February 5, 2026, the holders of a majority of the voting power of the Company’s outstanding voting securities executed the written consent approving a reverse stock split of the Company’s issued and outstanding Common Stock at a ratio of 1-for-100. This split was deemed effective on March 12, 2026. The common shares have been adjusted to reflect this reverse stock split.

 

- the Company issued 36,784,492 common shares with gross proceeds of $900,871 and net proceeds of $823,480 after issuance costs of $77,391.

 

- the Company issued 39,000,000 common shares having a fair value of $1,453,500 to repay $107,000 in loans payable and $638,900 in accrued interest totaling $745,900 with a loss on settlement of debt of $707,600.

 

-Along with the $630,000 loan of March 25, 2026, a refundable commitment fee of 14,100,000 shares was issued. These shares are refundable if the loan was fully repaid by May 5, 2026, and it was. The shares were recorded at par value of $141 with a corresponding adjustment to paid in capital.

 

-Along with the $277,778 loan of April 20, 2026, a commitment fee of 5,000,000 common shares having a fair value of $173,500 was issued and recorded as a discount.

 

-Along with the $700,000 loan of May 4, 2026, a commitment fee of 1,250,000 common shares having a fair value of $28,751 is issuable and recorded as a discount. These shares will be issued shortly after filing this 10Q.

 

-During the quarter ended March 31, 2026, the Series C Preferred shareholder converted 298 Series C Preferred Shares having a value of $391,572 for 24,473,250 common shares with a deemed dividend of $93,472.

 

The common shares issued , issuable and outstanding at May 31,2026 and February 28, 2026:

Common shares  May 31, 2026   February 28, 2026 
Issued   387,232,589    267,872,804 
Issuable   1,250,000    - 
           
Issued, issuable and outstanding   388,482,589    267,872,804 

 

Summary of Common Stock Warrant Activity

 

For the three months ending May 31, 2026, and May 31, 2025, the Company recorded a total of $60,508 and $80,355 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

   Number of
Warrants
   Weighted Average
Exercise Price
   Weighted Average
Remaining Years
 
Outstanding at February 28, 2026   470,000   $0.04    1.44 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited and cancelled   —    —    — 
Outstanding at May 31, 2026   470,000   $0.02    1.19 

 

F-64

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Summary of Common Stock Option Activity -Employee Stock Options

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Years 
Outstanding at March 1, 2026   1,732,121   $2.00    2.10 
Issued   —    —    — 
Exercised   —    —    — 
Forfeited, extinguished and cancelled   —   $—    — 
Outstanding at May 31, 2026   1,732,121   $2.00    1.85 

 

13. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

The related legal costs are expensed as incurred.

 

Operating Lease

 

On March 10, 2021, the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

 

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

 

On March 11, 2025, the Company entered into a 3-year lease agreement for a vehicle commencing March 11, 2025 through to March 11, 2028 with a minimum base rent of $1,286 per month. The Company paid a down payment of $13,188. The Company recorded the right of use asset of $67,372 with a corresponding adjustment to operating lease liability.

 

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. The weighted average discount rate used was 10% and the weighted average remaining lease term at May 31, 2026 was 4.71 years.

 

Rent expense and operating lease cost was $67,372 and $58,219 for the three months ended May 31, 2026 and May 31, 2025, respectively.

Maturity of Lease Liabilities  Operating
Leases
 
May 31, 2027  $239,243 
May 31, 2028   222,427 
May 31, 2029   207,558 
May 31, 2030   207,558 
May 31, 2031   190,261 
Total lease payments   1,067,047 
Less: Interest   (184,676)
Present value of lease liabilities  $882,371 

 

14. EARNINGS (LOSS) PER SHARE

 

The net income (loss) per common share amounts were determined as follows:

   May 31, 2026   May 31, 2025 
   For the Three Months Ended 
   May 31, 2026   May 31, 2025 
Numerator:          
Net loss available to common shareholders  $(5,715,838)  $(4,594,018)
           
Effect of common stock equivalents          
Less: dividends to C preferred shareholders   (110,860)   (12,073)
Net loss adjusted for common stock equivalents   (5,826,698)   (4,606,091)
           
Denominator:          
Weighted average shares – basic   325,956,059    155,176,712 
           
Net loss per share – basic  $(0.02)  $(0.03)
           
Denominator:          
Weighted average shares – diluted   325,956,059    155,176,712 
           
Net loss per share – diluted  $(0.02)  $(0.03)

 

F-65

 

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

The anti-dilutive shares of common stock equivalents for the three months ended May 31, 2026 and 2025 were as follows:

   May 31, 2026   May 31, 2025 
   For the Three Months Ended 
   May 31, 2026   May 31, 2025 
Convertible or exchangeable debt   3,173,350,733    - 
Convertible Series F Preferred Shares   1,340,264,933    586,412,155 
Convertible Redeemable Series C Preferred Shares   30,948,471    2,958,264 
Stock options and warrants   2,202,121    2,261,775 
Total   4,546,766,258    591,632,194 

 

15. SUBSEQUENT EVENTS

 

Subsequent to May 31, 2026 through to filing date,

 

  — the Company issued 32,797,611 common shares pursuant to a share purchase agreement for gross proceeds of $290,783, issuance costs of $14,397 and net proceeds of $276,386.
     
  — The Company issued 12,000,000 shares to a lender to settle $89,700 in principal pursuant to exchange agreements with the lender.
     
  — on June 3, 2026, the Company issued a convertible, redeemable note to a lender for $230,000 with cash proceeds of $200,000 an original issue discount of $23,000 and $7,000 for fees. The loan bears interest at 6%, the note is redeemable by the Company at any time subject to a premium ranging from 105% to 140% if redeemed within the first 180 days of the note. The note matures on June 3, 2027, and converts after 180 days at 65% of the lowest trading price 20 trading days prior to the conversion date, including the conversion date.
     
  — on June 9, 2026, the Company issued a convertible, redeemable note to a lender for $55,000 with cash proceeds of $47,500, an original issue discount of $5,000, and $2,500 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium of one years interest of $5,500. The note matures on June 9, 2027, and converts any time at 65% of the lowest trading price 10 trading days prior to the conversion date.
     
  —

on June 9, 2026, the Company issued a convertible, redeemable note to a lender for $110,000 with cash proceeds of $95,000, an original issue discount of $10,000, and $5,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium of one years interest of $11,000. The note matures on June 9, 2027, and converts any time at 65% of the lowest trading price 10 trading days prior to the conversion date.

     
  — on June 15, 2026, the Company issued a convertible, redeemable note to a lender for $165,000 with cash proceeds of $142,800, an original issue discount of $15,000, and $7,200 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 115% to 125% if redeemed within the first 180 days of the note. The note matures on June 15, 2027, and converts any time at 65% of the lowest closing bid price 20 trading days prior to the conversion date. The loan is repayable as follows : on December 15, 2026 a payment of $90,750 with 5 monthly payments of $15,125 commencing Jan 15, 2027 through to May 15, 2027 with the remaining $9,625 balance payable June 15, 2027.
     
  — on June 23 , 2026 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $10,000,000 over the course of thirty-six (36) month at a purchase price of eighty-five percent (85%) of the average of the three lowest bid trade price in the 10 day preceding period. The Company may also issue an accelerated put at a purchase price of 85% of the three closing bid prices 10 days following the put date subject to a floor price equal to the greater of: (A) seventy-five percent (75%) of the Closing Bid Price of the Common Stock on the applicable Put Date; or (B) any higher minimum price per share specified by the Company in the applicable Accelerated Put Notice. A commitment fee of five million common shares of the Company’s Common Stock shall be issued in two equal tranches: (i) first tranche of Two Million and Five Hundred Thousand common shares upon S-1 effectiveness; and the remaining (ii) second tranche of Two Million and Five Hundred Thousand common shares, issued ninety days later. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement as well.
     
  — on June 26, 2026, the Company issued a convertible, redeemable note to a lender for $157,000 with cash proceeds of $150,000 and $7,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The note matures on March 30, 2027, and converts after 180 days at 65% of the average of the three lowest trading prices, 10 trading days prior to the conversion date.
     
  — on July 9, 2026, the Company issued a promissory note to a lender for $165,000 with cash proceeds of $150,000 and an original issue discount of $15,000 for fees. The note matures in one year and bears interest at 15%, per annum ,compounding annually. The note is secured by the assets of the Company.

 

F-66

 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13. Other Expenses of Issuance and Distribution

 

The following table sets forth the costs and expenses payable by us in connection with the registration of the securities being registered hereby. All amounts are estimates other than the SEC registration fee.

 

SEC registration fee  $1,503,22 
Accounting fees and expenses  $10,000.00 
Legal fees and expenses  $5,000 
Printing and EDGAR fees  $2,500.00 
Total  $19,003.22 

 

Item 14. Indemnification of Directors and Officers

 

We are a Nevada corporation. Nevada law and our Articles of Incorporation and Bylaws provide for indemnification of our directors and officers to the fullest extent permitted by law.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

Bylaws - Limitation of Liability and Indemnification of Directors and Officers

 

We are incorporated under the laws of the State of Nevada. Our bylaws address the personal liability of our directors and our obligation to indemnify our directors, officers, and employees, in each case to the fullest extent allowed by the Nevada Revised Statutes (the “NRS”).

 

Our bylaws eliminate the personal liability of our directors to us and our stockholders for money damages for breach of their fiduciary duties as directors, to the fullest extent the NRS permits.

 

Our bylaws also require us to indemnify our directors, officers, and employees against expenses, judgments, fines, settlement payments, and other losses (including attorneys’ fees) they reasonably incur in connection with any threatened, pending, or completed legal proceeding — whether civil, criminal, administrative, or investigative — that arises because they serve or served in those roles, or served another entity at our request. This protection continues after a person leaves their position and extends to their heirs and estate.

 

A person is entitled to indemnification only if he or she acted in good faith and in a manner reasonably believed to be in, or not opposed to, our best interests, and, in a criminal matter, had no reasonable cause to believe the conduct was unlawful. We generally will not indemnify a person in a case brought by us, or on our behalf, in which the person is found liable to us, unless a court decides that indemnification is nonetheless fair and reasonable. If a person starts a proceeding themselves, we will indemnify them only if our board authorized or ratified that proceeding.

 

We are also required to advance the expenses a director or officer incurs in defending a proceeding before it is finally resolved. If the NRS requires, we will do so only after the person agrees in writing to repay the advanced amounts if it is ultimately determined that they were not entitled to be indemnified.

 

If we do not pay a valid indemnification claim within 60 days (or an expense-advancement claim within 20 days), the person may sue us to recover the unpaid amount and, if they succeed, to recover the cost of bringing that suit. In such a suit, we bear the burden of proving the person is not entitled to indemnification or advancement.

 

The rights described above are contract rights and are not exclusive of any other rights a person may have under any statute, our articles of incorporation, any agreement, a vote of stockholders, or otherwise. Any future change to these bylaw provisions will apply only going forward and will not reduce the protections tied to events that occurred before the change.

 

We will not indemnify a person for amounts paid to settle a claim without our written consent (which we will not unreasonably withhold), or for a judgment where we were not given a reasonable, timely opportunity to participate in the defense at our own expense. If we make an indemnification payment, we take over the person’s rights to recover from others to the extent of that payment.

 

We are permitted, but not required, to indemnify our other employees and agents on similar terms, as authorized by our board. We may also purchase and maintain directors’ and officers’ liability insurance covering these individuals, whether or not we would have the power to indemnify them under the NRS for the same matters.

 

We believe these provisions and any related insurance are necessary to attract and retain qualified directors and officers.

 

II-1
 

 

Nevada Revised Statutes

 

Section 78.7502 of the NRS permits a Nevada corporation to indemnify any person who is or was a party, or is threatened to be made a party, to any threatened, pending or completed action, suit or proceeding — whether civil, criminal, administrative or investigative, other than an action by or in the right of the corporation — by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the corporation’s request in such a capacity for another corporation, partnership, joint venture, trust or other enterprise. Indemnification may extend to expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with the action, suit or proceeding, if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of a proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent does not, of itself, create a presumption that the person failed to meet the applicable standard of conduct.

 

In the case of an action or suit brought by or in the right of the corporation to procure a judgment in its favor, Section 78.7502 permits indemnification for expenses, including amounts paid in settlement and attorneys’ fees actually and reasonably incurred in connection with the defense or settlement of the action or suit, under the same good-faith standard. Indemnification may not be made, however, for any claim, issue or matter as to which the person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought, or another court of competent jurisdiction, determines that in view of all the circumstances the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

 

Any discretionary indemnification under Section 78.7502, unless ordered by a court or advanced as described below, may be made by the corporation only as authorized in the specific case upon a determination that indemnification is proper under the circumstances because the person has met the applicable standard of conduct. That determination must be made by our stockholders; by our board of directors, by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding; or, if such a quorum so orders or a quorum of such directors cannot be obtained, by independent legal counsel in a written opinion.

 

Section 78.751 of the NRS requires a corporation to indemnify a director, officer, employee or agent, against expenses actually and reasonably incurred (including attorneys’ fees), to the extent that the person has been successful on the merits or otherwise in defense of any action, suit or proceeding described above — including, without limitation, an action by or in the right of the corporation — or in defense of any claim, issue or matter in the proceeding.

 

Section 78.751 further provides that, unless otherwise restricted by the articles of incorporation, the bylaws or an agreement made by the corporation, the corporation may pay the expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding as those expenses are incurred and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that the person is not entitled to be indemnified by the corporation. The articles of incorporation, the bylaws or such an agreement may require the corporation to advance those expenses upon receipt of such an undertaking.

 

Indemnification and advancement of expenses under Section 78.751 and Section 78.7502 do not exclude any other rights to which a person seeking indemnification or advancement of expenses may be entitled under the articles of incorporation, any bylaw, an agreement, a vote of stockholders or disinterested directors, or otherwise. Indemnification — unless ordered by a court or made as an advancement of expenses — may not, however, be made to or on behalf of any director or officer who is finally adjudged by a court of competent jurisdiction, after exhaustion of any appeals, to be liable for intentional misconduct, fraud or a knowing violation of law where that misconduct, fraud or violation was material to the cause of action. In addition, a right to indemnification or to advancement of expenses arising under a provision of the articles of incorporation or the bylaws is not eliminated or impaired by an amendment to that provision after the occurrence of the act or omission that is the subject of the proceeding for which indemnification or advancement is sought, unless the provision in effect at the time of the act or omission expressly authorized such elimination or impairment.

 

Section 78.752 of the NRS permits a corporation to purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the corporation, or who is or was serving at the corporation’s request in such a capacity for another entity, for any liability asserted against the person and any liability and expenses incurred by the person in that capacity or arising out of the person’s status as such, whether or not the corporation would have the authority to indemnify the person against such liability and expenses under the NRS. The other financial arrangements permitted by Section 78.752 include the creation of a trust fund, the establishment of a program of self-insurance, the securing of the corporation’s obligation of indemnification by granting a security interest or other lien on any of its assets, and the establishment of a letter of credit, guaranty or surety. In the absence of fraud, the decision of the board of directors as to the propriety of such an arrangement and the terms and conditions of the insurance or other financial arrangement is conclusive, and the arrangement is not void or voidable and does not subject any approving director to personal liability, even if the director is a beneficiary of the arrangement.

 

Our Articles of Incorporation and Bylaws provide for the indemnification of, and the advancement of expenses to, our directors and officers to the fullest extent permitted by the NRS, consistent with the statutory provisions summarized above.

 

II-2
 

 

Item 15. Recent Sales of Unregistered Securities

 

The Commitment Shares and the Put Shares to be issued to Trillium under the Purchase Agreement are or will be issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D thereunder, based on Trillium’s representations that it is an accredited investor and is acquiring the securities for its own account, and the absence of any general solicitation.

 

The unregistered sales of equity securities during the past three years consist of the following:

 

Date  Transaction  Consideration  Shares Issued 
February 28, 2023(1)  Number of shares outstanding February 28, 2023      58,366,416 
June 2, 2023  Common stock issued for services*  $200,000 in debt exchanged for common shares   21,000 
July 24, 2023  Common stock issued for services*  $200,000 in debt exchanged for common shares   100,000 
July 24, 2023  Common stock issued for services*  $162,000 in debt exchanged for common shares   65,000 
March 1, 2023-February 29, 2024  Other registered sales  Various prices   33,835,094 
   Number of shares outstanding February 29, 2024      92,387,510 

 

Date  Transaction  Consideration  Shares Issued 
April 29,2024  Series B share issuance*  Issuance of 320 Series B Convertible Preferred including 20 Series B share commitment fee for cash proceeds of $278,000   

_

 
August 8, 2024  Debt exchange*  $200,000 in debt exchanged for common shares   571,429 
December 16, 2024  Debt exchange*  $200,000 in debt exchanged for common shares   769,230 
February 11, 2025  Series C share issuance*  Issuance of 306 Series C Convertible Preferred for cash proceeds of $278,580     
February 11, 2025  Debt exchange*  $162,000 in debt exchanged for common shares   600,000 
March 1, 2024-February 28, 2025  Other registered sales  Various prices   49,796,369 
   Number of shares outstanding February 28, 2025      144,124,538 

 

II-1

 

 

Date  Transaction  Consideration  Shares Issued 
March 5, 2025  Debt exchange*  $150,500 in debt and $275,000 in accrued interest for a total Of $425,500 exchanged for common shares at a fair value of $444,000 for a loss on settlement of debt of $18,500   1,850,000 
April 21, 2025  Debt exchange*  $475,000 in accrued interest exchanged for common shares at a fair value of $450,000 for a gain on settlement of debt of $25,000   2,500,000 
May 15, 2025  Debt exchange*  $350,000 in accrued interest exchanged for common shares at a fair value of $350,000   2,500,000 
June 9, 2025  Debt exchange*  $300,000 in accrued interest exchanged for common shares at a fair value of $350,000 for a loss on settlement of debt of $50,000   2,500,000 
June 25, 2025  Debt exchange*  $275,000 in accrued interest exchanged for common shares at a fair value of $300,000 for a loss on settlement of debt of $25,000   2,500,000 
July 24, 2025  Debt exchange*  $315,000 in accrued interest exchanged for common shares at a fair value of $350,000 for a loss on settlement of debt of $35,000   3,500,000 
August 7, 2025  Debt exchange*  $360,000 in accrued interest exchanged for common shares at a fair value of $400,000 for a loss on settlement of debt of $40,000   4,000,000 
August 7, 2025  Series C shares issuance *  114 Penalty shares having a redemption value of $149,307 for failure to redeem Series C shares   — 
September 17, 2025  Debt exchange*  $280,000 in accrued interest exchanged for common shares at a fair value of $480,000 for a loss on settlement of debt of $200,000   4,000,000 
October 1, 2025  Debt exchange*  $280,000 in accrued interest exchanged for common shares at a fair value of $360,000 for a loss on settlement of debt of $80,000   4,000,000 
October 21, 2025  Debt exchange*  $140,000 in accrued interest exchanged for common shares at a fair value of $180,000 for a loss on settlement of debt of $40,000   2,000,000 
November 3, 2025  Debt exchange*  $280,000 in accrued interest exchanged for common shares at a fair value of $320,000 for a loss on settlement of debt of $40,000   4,000,000 
November 14, 2025  Debt exchange*  $350,000 in accrued interest exchanged for common shares at a fair value of $400,000 for a loss on settlement of debt of $50,000   5,000,000 
December 2, 2025  Conversion of Series C Preferred Shares*  Conversion of 85 Series C shares for fair value of $111,690   1,994,464 
December 2, 2025  Debt exchange*  $378,000 in accrued interest exchanged for common shares at a fair value of $480,000 for a loss on settlement of debt of $102,000   6,000,000 
December 4, 2025  Series C shares issuance *  133 Series C s adjusted penalty shares having a redemption value of $175,140 for failure to convert   — 
December 12, 2025  Debt exchange*   $378,000 in accrued interest exchanged for common shares at a fair value of $420,000 for a loss on settlement of debt of $42,000   6,000,000 
December 22, 2025  Convertible debt issuance*  $495,000 Convertible note that converts after 180 days  at 80% of the lowest traded price 15 prior trading days   — 
5-Jan-26  Debt exchange*  $324,000 in accrued interest exchanged for common shares at a fair value of $360,000 for a loss on settlement of debt of $36,000   6,000,000 
18-Jan-26  Debt exchange*  $336,000 in accrued interest exchanged for common shares at a fair value of $420,000 for a loss on settlement of debt of $84,000   7,000,000 
8-Feb-26  Debt exchange*  $192,000 in accrued interest exchanged for common shares at a fair value of $320,000 for a loss on settlement of debt of $128,000   8,000,000 
19-Feb-26  Convertible debt issuance*  $165,000 Convertible note that converts after 180 days at 80% of the lowest traded price 15 prior trading days   — 
March 1, 2025-February 28, 2026  Other registered sales  Various prices   50,403,802 
   Number of shares outstanding February 28, 2026      267,872,804 

 

II-2

 

 

Date  Transaction  Consideration  Shares Issued 
March 9, 2026  Debt exchange*  $224,000 in accrued interest exchanged for common shares at a fair value of $280,000 for a loss on settlement of debt of $56,000   7,000,000 
March 12, 2026  Common share issuance  Rounding shares on reverse split   43 
            
March 19,2026  Series C share issuance*  Issuance of 222 Series C Convertible Preferred including 22 Series C share
Commitment fee for proceeds of $200,000
   — 
March 19,2026  Conversion of Series C Preferred Shares*  Conversion of 165 Series C shares for fair value of $216,810   13,550,625 
March 20,2026  Debt exchange*  $112,000 in accrued interest exchanged for common shares at a fair value of $630,700 for a loss on settlement of debt of $518,700   7,000,000 
March 25,2026  Convertible debt issuance*  $110,000 Convertible note that converts after 180 days at 80% of the lowest traded price 15 prior trading days   — 
March 25, 2026  Convertible debt issuance*  $630,000 Convertible note that converts after 180 days with penalty at 20% of the lowest traded price 15 prior trading days. This loan was repaid May 5, 2026.   — 
March 25, 2026  Common share issuance*  Commitment fee returnable to the Company as $630,00 debt was repaid on May 5, 2025   14,100,000 
April 9, 2026  Convertible debt issuance*  $257,000 Convertible note that converts after 180 days at 65% of the average of the three lowest traded prices 10 prior trading days   — 
April 20, 2026  Convertible debt issuance*  $277,778 Convertible note that converts at 75% of the lowest traded prices 10 prior trading days   — 
April 20, 2026  Common share issuance*  Commitment fee on April 20 ,2026 convertible note   5,000,000 
May 1, 2026  Convertible debt issuance*  $257,000 Convertible note that converts after 180 days at 65% of the average of the three  lowest traded prices 10 prior trading days   — 
February 11, 2025  Series C share issuance*  Issuance of 306 Series C Convertible Preferred for cash proceeds of $278,580     
April 27, 2026  Debt exchange*  $185,600 in accrued interest exchanged for common shares at a fair value of $220,800 for a loss on settlement of debt of $35,200   8,000,000 
May 4, 2026  Convertible debt issuance*  $700,000 Convertible note that converts at 65% of the lowest closing bid prices 10 prior trading days   — 
May 4, 2026  Common share issuance*  Commitment fee issuable on May 4 ,2026 convertible note(2)   1,250,000 
May 5, 2026  Debt exchange*  $80,000 in accrued interest exchanged for common shares at a fair value of $100,000 for a loss on settlement of debt of $20,000   5,000,000 
May 6, 2026  Conversion of Series C Preferred Shares*  Conversion of 40 Series C shares for fair value of $52,560   3,285,000 
May 12, 2026  Conversion of Series C Preferred Shares*  Conversion of 93 Series C shares for fair value of $122,202   7,637,625 
May 27, 2026  Debt exchange*  $144,300 in principal and accrued interest exchanged for common shares at a fair value of $222,000 for a loss on settlement of debt of $77,700   12,000,000 
May 29, 2026  Convertible debt issuance*  $138,889 Convertible note that converts at 65% of the lowest traded prices 10 prior trading days   — 
March 1, 2026-May 31, 2026  Other registered sales  Various prices   36,786,492 
   Number of shares outstanding May 31, 2026 2026(2)      388,482,589 

 

II-3

 

 

Date  Transaction  Consideration  Shares Issued 
June 3, 2026  Convertible debt issuance*  $230,000 Convertible note that converts after 180 days at 65% of the lowest traded prices 20 prior trading days   — 
June 9, 2026  Convertible debt issuance*  $55,000 Convertible note that converts at 65% of the lowest traded prices 10 prior trading days   — 
June 9, 2026     $110,000 Convertible note that converts at 65% of the lowest traded prices 10 prior trading days   — 
June 12, 2026  Debt exchange*  $89,700 in principal exchanged for common shares at a fair value of $138,000 for a loss on settlement of debt of $48,300   12,000,000 
June 15, 2026  Convertible debt issuance*  $165,000 Convertible note that converts at 65% of the lowest traded prices 20 prior trading days   — 
June 26, 2026  Convertible debt issuance*  $230,000 Convertible note that converts after 180 days at 65% of the lowest traded prices 10 prior trading days   — 
July 8, 206  Conversion of convertible note and interest  Conversion of $10,000 in principal and $600 in interest   1,441,576 
July 13,2026  Cancellation  Cancellation of march 25, 2026 issuance due to repayment of loan   (14,100,000)
May 1-July 8, 2026  Other registered sales  Various prices   32,797,611 
   Number of shares outstanding July 15, 2026(2)      420,621,776 

 

* Sold under rule 144

(1) At February 28, 2023 there were 12,100,000 issuable shares

(2) At May 31, 2026 and July 14, 2026 there were 1,250,000 issuable shares.

 

II-4

 

 

Item 16. Exhibits

 

Exhibit No.   Description
3.1   Articles of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on March 12, 2018)
3.2   Bylaws, as amended (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on September 2, 2021)
3.3   Certificate of Designation of Series B Convertible, Redeemable Preferred Stock, filed with the Nevada Secretary of State on or about April 27, 2024 in connection with the Company’s Securities Purchase Agreement with GHS Investments, LLC (filed herewith).*
3.4   Certificate of Designation of Series C Convertible, Redeemable Preferred Stock, filed with the Nevada Secretary of State on or about February 10, 2025 (filed herewith).*
4.1   Form of Common Stock Certificate*
4.3   Amendment to Certificate of Designation of Series E Convertible Preferred Stock (previously filed as Exhibit 3.5 to Registrant’s Transition Report on Form-KT filed on 3/12/18 and incorporated by reference)
4.4   Certificate of Designation of Series F Convertible Preferred Stock (previously filed as Exhibit 3.4 to the Registrant’s Transition Report on Form 10-KT filed on 3/12/2018 and incorporated by reference)
4.5   Amendment Number 2 to Certificate of Series F Convertible Preferred Stock (previously filed as Exhibit 10.1 of Registrant’s Form 8-K filed on 8/24/2021 and incorporated by reference
4.6   Certificate of Designation of Series G Preferred Stock (previously filed as Exhibit 3.4 to the Registrant’s Transition report on Form 10-KT on 3/12/2018 and incorporated by reference
5.1   Opinion of Frederick M. Lehrer, P. A. as to the legality of the securities*
10.1   Equity Purchase Agreement, dated June 23, 2026, between the Company and Trillium Partners LP*
10.2   Registration Rights Agreement, dated June 23, 2026, between the Company and Trillium Partners LP*
10.3  

Lease Agreement, dated March 10, 2021, between the Company and the landlord of 10800 Galaxie Avenue, Ferndale, Michigan (filed herewith).*

21.1   Subsidiaries of the Registrant (incorporated by reference to Exhibit 21 filed on January 20, 2023 with the SEC on Form 10-Q for the period ending November 30, 2025,
23.1   Consent of Independent Registered Public Accounting Firm*
23.2   Consent of Frederick M. Lehrer, P. A. (included in Exhibit 5.1)*
24.1   Power of Attorney (included on the signature page of this Registration Statement)
101   Inline XBRL Instance Document and related taxonomy extension files (Instance, Schema, Calculation, Definition, Label and Presentation Linkbases)*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*
107   Filing Fee Table*

 

* Filed herewith.

† Management contract or compensatory plan or arrangement.

 

Item 17. Undertakings

 

The undersigned registrant hereby undertakes the undertakings required by Item 512 of Regulation S-K applicable to a registration statement on Form S-1, including the Rule 415 undertakings and the undertaking regarding indemnification of directors and officers.

 

Item 17. Undertakings

 

The undersigned registrant hereby undertakes as follows:

 

(a) Rule 415 Offering — include only if securities are registered pursuant to Rule 415.

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

 

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective registration statement;

 

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 

II-5

 

 

Provided, however, That paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the registration statement is on Form S-1 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.

 

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

[Add (a)(4) only if the registrant is a foreign private issuer; add (a)(5) and (a)(6) if relying on Rule 430B or Rule 430C for undertakings regarding the timing/liability of filed prospectuses and primary-offering seller status. These are omitted here as situational — pull the verbatim text of (a)(4)–(a)(7) from 17 CFR 229.512 if your structure triggers them.]

 

(b) Filings incorporating subsequent Exchange Act documents by reference — include if the registration statement forward-incorporates Exchange Act filings by reference (available to certain S-1 filers).

 

The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(h) Request for acceleration of effective date — include if acceleration of effectiveness is requested under Rule 461 (virtually always the case for a Form S-1). This is the indemnification undertaking you referenced.

 

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

II-6

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ferndale, State of Michigan, on July 16, 2026.

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.    
         
By:/s/ Steve Reinharz     
Steve Reinharz      July 16, 2026
Chief Executive Officer (Principal Executive Officer)       
         
 /s/ Anthony Brenz  Chief Financial Officer   July 16, 2026
 Anthony Brenz       

 

II-7

 

 

Exhibit 3.3

 

ARTIFICAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS

OF

SERIES B CONVERTIBLE PREFERRED STOCK

 

The undersigned, Steven Reinharz, does hereby certify that:

 

1. He is the Chief Executive Officer of ARTIFICAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC., a Nevada corporation (the “Corporation” or the “Company”).

 

2. The Corporation is authorized to issue up to 20,000,000 shares of preferred stock, of which 4,450,350 shares have been authorized , as follows: (a) 4.350,000_ Series E Preferred Stock; (b) 4,350 Series F Convertible Preferred Stock; and (c) 100,000 Series G Redeemable Preferred Stock. At April 26. 2024 the Company has issued the following preferred shares: (a) 3,350,000 Series E Preferred Stock and; (b) 2.533 Series F Convertible Preferred Stock.

 

3. The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”):

 

WHEREAS, the Articles of Incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 20,000,000 authorized shares. issuable from time to time in one or more series.

 

WHEREAS, the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series and the designation thereof, of any of them; and

 

WHEREAS, it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and other matters relating to Series B Preferred Stock, a series of the preferred stock, which shall consist of, up to 5,000 shares of the preferred stock which the Corporation has the authority to issue, as follows:

 

NOW, THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of Series B Preferred Stock, a series of preferred stock for cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters relating to such series of preferred stock as follows:

 

TERMS OF PREFERRED STOCK

 

Section 1. Definitions. For the purposes hereof, the following terms shall have the following meanings:

 

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.

 

“Alternate Consideration” shall have the meaning set forth in Section 7(e).

 

“Bankruptcy Event” means any of the following events: (a) the Corporation or any Significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Corporation or any Significant Subsidiary thereof, (b) there is commenced against the Corporation or any Significant Subsidiary thereof any such case or proceeding that is not dismissed within sixty (60) days after commencement, (c) the Corporation or any Significant Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered, (d) the Corporation or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within sixty (60) calendar days after such appointment, (e) the Corporation or any Significant Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Corporation or any Significant Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts, or (g) the Corporation or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

 
 

 

“Beneficial Ownership Limitation” shall have the meaning set forth in Section 6(d).

 

“Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

“Buy-In” shall have the meaning set forth in Section 5(c)(iv).

 

“Change of Control Transaction” means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of 49% of the voting securities of the Corporation (other than by means of conversion or exercise of Preferred Stock and the Securities issued together with the Preferred Stock), (b) the Corporation merges into or consolidates with any other Person, or any Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately prior to such transaction own less than 33% of the aggregate voting power of the Corporation or the successor entity of such transaction, (c) the Corporation sells or transfers all or substantially all of its assets to another Person and the stockholders of the Corporation immediately prior to such transaction own less than 33% of the aggregate voting power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a one year period of more than one-half of the members of the Board of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the Original Issue Date), or (e) the execution by the Corporation of an agreement to which the Corporation is a party or by which it is bound, providing for any of the events set forth in clauses (a) through (d) above.

 

“Closing” means the closing of the purchase and sale of the Securities pursuant to Section 2.1 of the respective Purchase Agreements.

 

“Closing Date” means the applicable Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto and all conditions precedent to (i) each Holder’s obligations to pay the Subscription Amount for a Closing and (ii) the Corporation’s obligations to deliver the Securities have been satisfied or waived.

 

“Commission” or the “SEC” means the United States Securities and Exchange Commission.

 

“Common Stock” means the Corporation’s common stock, par value $0.00001 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed.

 

“Common Stock Equivalents” means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

“Conversion Amount” means the sum of the Stated Value at issue.

 

“Conversion Date” shall have the meaning set forth in Section 5(a).

 

“Conversion Price” shall have the meaning set forth in Section 5(b).

 

“Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms hereof.

 

 
 

 

“Corporation Redemption” has the meaning set forth in Section 8.

 

“Corporation Redemption Price” has the meaning set forth in Section 8.

 

“Corporation Redemption Payment Date” has the meaning set forth in Section 8.

 

“Corporation Redemption Notice” has the meaning set forth in Section 8.

 

“Designation, Amount and Par Value” The series of preferred stock shall be designated as Serie B Convertible Preferred Stock and the number of shares so designated shall be up to 5000 (which shall not be subject to increase without the written consent of all of the Holders of the Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to increase set forth in Section 3 and/or elsewhere in this Certificate of Designation below.

 

“DTC” means the Depository Trust Company.

 

“DTC/FAST Program” means the DTC’s Fast Automated Securities Transfer Program.

 

“Dividend” shall have the meaning set forth in Section 2.

 

“DWAC Eligible” means that (a) the Common Stock is eligible at DTC for full services pursuant to DTC’s Operational Arrangements, including without limitation transfer through DTC’s DWAC system, (b) the Corporation has been approved (without revocation) by the DTC’s underwriting department, (c) the Transfer Agent is approved as an agent in the DTC/FAST Program, (d) the Conversion Shares are otherwise eligible for delivery via DWAC, and (e) the Transfer Agent does not have a policy prohibiting or limiting delivery of the Conversion Shares via DWAC.

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“New York Courts” shall have the meaning set forth in Section 12(d).

 

“Fundamental Transaction” shall have the meaning set forth in Section 7(e).

 

“GAAP” means United States generally accepted accounting principles.

 

“Holders” means Holders of the Preferred Stock.

 

“Indemnified Party” shall have the meaning set forth in Section 11(f).

 

“Indebtedness” means (a) any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Corporation’s balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business, and (c) the present value of any lease payments in excess of $10,000 due under leases required to be capitalized in accordance with GAAP.

 

“Junior Securities” means the Common Stock and all other Common Stock Equivalents of the Corporation other than those securities which are explicitly senior or pari passu to the Preferred Stock in dividend rights or liquidation preference.

 

“Late Fees” shall have the meaning set forth in Section 2(d).

 

“Liens” means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

“Liquidation” shall have the meaning set forth in Section 4. “Losses” shall have the meaning set forth in Section 11(f).

 

“Notice of Conversion” shall have the meaning set forth in Section 5.

 

“Original Issue Date” means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock.

 

 
 

 

“Permitted Governmental Indebtedness” means Indebtedness for the purpose of supporting product sales by the Borrower.

 

“Permitted Indebtedness” means (i)) Indebtedness of the Corporation set forth in Corporation’s most recent SEC report filed with the SEC by the Corporation on Form 10-Q or Form 10-K (the “SEC Reports”) provided none of such Indebtedness, has been increased, extended and/or otherwise changed), (ii) Indebtedness secured by Permitted Liens described in clauses “(iii)” of the definition of Permitted Liens, and (iv) Permitted Governmental Indebtedness.

 

“Permitted Liens” means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as materialmen’s liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (a) upon or in any equipment acquired or held by the Borrower or any of its Subsidiaries to secure the purchase price of such equipment or indebtedness incurred solely for the purpose of financing the acquisition or lease of such equipment, and (b) existing on such equipment at the time of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds of such equipment and (v) any Liens for Permitted Indebtedness set forth in (i) and (ii) of the definition of Permitted Indebtedness provided as to “(ii)” of Permitted Indebtedness such Liens were in existence and not amended, supplemented and/or modified since the original issuance date any such Indebtedness was incurred.

 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Piggy-Back Registration” shall have the meaning set forth in Section 11(a).

 

“Preferred Stock” shall mean Series [  ] Convertible Preferred Stock of the Company.

 

“Premium Rate” shall have the meaning set forth in Section 8(a).

 

“Purchase Agreement” means that certain Securities Purchase Agreement, dated on or about the Original Issue Date, among the Corporation and the original Holders, as amended, modified or supplemented from time to time in accordance with its terms.

 

“Registration Statement” shall have the meaning set forth in Section 11(a).

 

“Securities” means the Preferred Stock and the Underlying Shares.

 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Share Delivery Date” shall have the meaning set forth in Section 5(c)(i).

 

“Stated Value” shall mean $1,200, subject to increase set forth in Section 3 and/or elsewhere in this Certificate of Designation.

 

“Subscription Amount” shall mean, as to each Holder, the aggregate amount to be paid for the Preferred Stock purchased pursuant to the Purchase Agreement as specified below such Holder’s name on the signature page of the Purchase Agreement and next to the heading “Subscription Amount,” in United States dollars and in immediately available funds.

 

“Subsidiary” means any subsidiary of the Corporation as set forth on Schedule 3.1(a) of the Purchase Agreement and shall, where applicable, also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Purchase Agreement.

 

 
 

 

“Successor Entity” shall have the meaning set forth in Section 3.

 

“Trading Day or Date” means a day on which the principal Trading Market is open for business.

 

“Trading Market” means any of the following markets or exchanges on which the Common Stock (or any other common stock of any other Person that references the Trading Market for its common stock) is listed or quoted for trading on the date in question: The NASDAQ Global Market, The NASDAQ Global Select Market, The NASDAQ Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE MKT, CBOE Global Markets or the OTCQX Marketplace, the OTCQB Marketplace, the OTC Pink Marketplace or any other tier operated by OTC Markets Group Inc. (or any successor to any of the foregoing).

 

“Transaction Documents” means this Certificate of Designation, the Purchase Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated pursuant to the Purchase Agreement.

 

“Transfer Agent” means Transhare Corp., with a mailing address of Bayside Center 1, 17755 North US Highway 19, Suite 140, Clearwater, Florida 33764 and any successor transfer agent of the Company.

 

“Triggering Event” shall have the meaning set forth in Section 10(a).

 

“Triggering Redemption Amount” means, for each share of Preferred Stock, the sum of (a) 135% of the Stated Value and (b) all accrued but unpaid dividends thereon and (c) all liquidated damages, Late Fees and other costs, expenses or amounts due in respect of the Preferred Stock including, but not limited to legal fees and expenses of legal counsel to the Holder in connection with, related to and/or arising out of a Triggering Event.

 

“Triggering Redemption Payment Date” shall have the meaning set forth in Section 10(b).

 

“Underlying Shares” means the shares of Common Stock issued and issuable upon conversion of the Preferred Stock.

 

“VWAP” means, for or as of any date for the Common Stock, the dollar volume-weighted average price for the Common Stock on the Trading Market during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (set to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of the Common Stock in the over-the-counter market on the electronic bulletin board for the Common Stock during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for the Common Stock by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for the Common Stock as reported in the “pink sheets” by OTC Markets Group Inc. (formerly Pink Sheets LLC). If the VWAP cannot be calculated for the Common Stock on such date on any of the foregoing bases, the VWAP of the Common Stock on such date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.

 

Section 2. Dividends.

 

(a) Dividends in Cash or in Kind. Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of eight percent (8%) per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Preferred Stock at the discretion of the Company.

 

(b) Dividend Calculations. Subject to Section 3(a), dividends on the Preferred Stock shall be calculated on the basis of a 360-day year, consisting of twelve (12) thirty (30) calendar day periods, and shall accrue and compound daily commencing on the Original Issue Date, and shall be deemed to accrue from such date whether or not earned or declared and whether or not there are profits, surplus or other funds of the Corporation legally available for the payment of dividends. Dividends shall cease to accrue with respect to any Preferred Stock redeemed or converted, provided that the Corporation actually delivers the Conversion Shares within the time period required by Section 6(c)(i) herein.

 

 
 

 

(c) Late Fees. Any dividends that are not paid a Dividend Payment Date shall continue to accrue and shall entail a late fee (“Late Fees”), which must be paid in cash, at the rate of 14% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the Dividend Payment Date through and including the date of actual payment in full.

 

(d) Other Securities. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall redeem, purchase or otherwise acquire directly or indirectly any Junior Securities or pari passu securities other than any Preferred Stock purchased to the terms of this Certificate of Designation. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall directly or indirectly pay or declare any dividend or make any distribution upon (other than a dividend or distribution described in Section 2 or dividends due and paid in the ordinary course on preferred stock of the Corporation at such times when the Corporation is in compliance with its payment and other obligations hereunder), nor shall any distribution be made in respect of, any Junior Securities or pari passu securities as long as any dividends due on the Preferred Stock remain unpaid, nor shall any monies be set aside for or applied to the purchase or redemption (through a sinking fund or otherwise) of any Junior Securities or pari passu securities.

 

Section 3. Voting Rights. The Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise pari passu with, the Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise pari passu with, the Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing.

 

Section 4. Liquidation. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation. The Corporation shall mail written notice of any such Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder.

 

Section 5. Conversion.

 

a) Conversions at Option of Holder. Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations set forth in Section 5(d)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as Annex A (a “Notice of Conversion”). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.

 

 
 

 

b) Conversion Price. The conversion price (the “Conversion Price”) for the Preferred Stock shall be the amount equal to the lower of (1) a fixed price equaling the closing bid price of the Common Stock on the trading day immediately preceding the date of the Purchase Agreement and (2) the lowest traded price of the Common Stock during the ten (10) calendar days immediately preceding, but not including, the Conversion Date. All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such measuring period. Nothing herein shall limit a Holder’s right to pursue actual damages including, but not limited to, as a result of a Triggering Event pursuant to Section 10 hereof and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. Following an “Event of Default,” as defined in the Purchase Agreement, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price per share equaling eighty five percent (85%) of the lowest traded price for the Company’s common stock during the fifteen (15) Trading Days immediately preceding, but not including, the Conversion Date.

 

c) Mechanics of Conversion

 

i. Delivery of Conversion Shares Upon Conversion. Not later than two (2) Trading Days after each Conversion Date (the “Share Delivery Date”), the Corporation shall deliver, or cause to be delivered, to the converting Holder (A) the number of Conversion Shares being acquired upon the conversion of the Preferred Stock, which Conversion Shares shall be free of restrictive legends and trading restrictions, and (B) a bank check in the amount of accrued and unpaid dividends (if the Corporation has elected or is required to pay accrued dividends in cash). The Corporation shall deliver the Conversion Shares electronically through the Depository Trust Company or another established clearing corporation performing similar functions.

 

ii. Failure to Deliver Conversion Shares. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Conversion Notice.

 

iii. Obligation Absolute; Partial Liquidated Damages. The Corporation’s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder. In the event a Holder shall elect to convert any or all of the Stated Value of its Preferred Stock, the Corporation may not refuse conversion based on any claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the Preferred Stock of such Holder shall have been sought and obtained, and the Corporation posts a surety bond for the benefit of such Holder in the amount of 150% of the Stated Value of Preferred Stock which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to such Holder to the extent it obtains judgment. In the absence of such injunction, the Corporation shall issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant to Section 5 on the second Trading Day after the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $5,000 of Stated Value of Preferred Stock being converted, $100 per Trading Day (increasing to $150 per Trading Day on the third Trading Day and increasing to $200 per Trading Day on the sixth Trading Day after such damages begin to accrue) for each Trading Day after such second Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. All liquidated damages shall be paid to the Holder not later than the fifth (5th) Trading Day after notice is provided to the Company by the Holder stating that any such liquidated damages are due pursuant to this Section 5. Nothing herein shall limit a Holder’s right to pursue actual damages or declare a Triggering Event pursuant to Section 10 hereof for the Corporation’s failure to deliver Conversion Shares within the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

 

 
 

 

iv. Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion. In addition to any other rights available to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date pursuant to Section 5, and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a “Buy-In”), then the Corporation shall (A) pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder’s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under Section 5. For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The payment of all amounts due by the Company to the Holder shall be paid in cash no later than the fifth (5th) Business Day after notice is provided by a Holder to the Company requesting the payment of any such liquidated damages. The Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation’s failure to timely deliver the Conversion Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof.

 

v. Reservation of Shares Issuable Upon Conversion. The Company covenants that it will reserve and keep available out of its authorized and unissued shares of Common Stock a number of shares of Common Stock at least equal to 300% of the Required Minimum for the sole purpose of issuance upon conversion of the Preferred Stock and payment of dividends on the Preferred Stock, all as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Purchasers, not less than such aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable (taking into account the adjustments and restrictions of Section 7, but ignoring any Beneficial Ownership Limitations or other restrictions and/or limitations on conversions set forth herein or elsewhere) upon the conversion of the then outstanding shares of the Preferred Stock and payment of dividends hereunder. The Company covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable, and, at such times as a registration statement covering such shares is then effective under the Securities Act, will be registered for public resale in accordance with such registration statement. For purposes of this Certification of Designation, the term “Required Minimum” shall be defined as the product of (i) 300%, multiplied by (ii) the quotient of (A)(x) all outstanding Stated Value of all issued and outstanding shares of the Preferred Stock, (y) all unpaid dividends thereon (whether accrued or not), and (z) all fees and/or any costs and expenses relating to the Transaction Documents including, but not limited to Late Fees and liquidation damages, divided by (B) the Conversion Price on the date of Closing. The Required Minimum shall be increased from time to time to ensure appropriate coverage for Securities issued or issuable to Purchaser.

 

 
 

 

vi. Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the next whole share.

 

vii. Transfer Taxes and Expenses. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid. In the event that the Holder requests same-day processing for a Notice of Conversion, such Holder shall pay all Transfer Agent fees required for such same-day processing and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.

 

d) Beneficial Ownership Limitation. The Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder’s Affiliates, and any Persons acting as a group together with such Holder or any of such Holder’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred Stock or the Warrants) beneficially owned by such Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 6(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned by such Holder together with any Affiliates) and of how many shares of Preferred Stock are convertible shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder’s determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates) and how many shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, the Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Corporation shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Corporation’s most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Corporation shall within two (2) Trading Days confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock held by the applicable Holder.

 

 
 

 

Section 6. Intentionally Omitted.

 

Section 7. Certain Adjustments.

 

a) Stock Dividends and Stock Splits. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions that is payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, the Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b) Most Favored Nation Provision. From the date hereof until the date when the Holder no longer holds any Preferred Stock, upon any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration, Indebtedness or a combination of units thereof (a “Subsequent Financing”), the Holder may elect, in its sole discretion, to exchange (in lieu of conversion), if applicable, all or some of the shares of Preferred Stock then held for any securities or units issued in a Subsequent Financing on a $1.00 for $1.00 basis. The Company shall provide the Holder with notice of any such Subsequent Financing in the manner set forth below Additionally, if in such Subsequent Financing there are any contractual provisions or side letters that provide terms more favorable to the investors than the terms provided for hereunder, then the Company shall specifically notify the Holder of such additional or more favorable terms and such terms, at Holder’s option, shall become a part of the transaction documents with the Holder. The types of terms contained in another security that may be more favorable to the holder of such security include, but are not limited to, terms addressing stock sale price, private placement price per share, and warrant coverage.

 

c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder of will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder’s Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

 
 

 

d) Pro Rata Distributions. During such time as this Preferred Stock is outstanding, if the Corporation shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

e) Fundamental Transaction.

 

1) General. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (as defined below) assumes in writing all of the obligations of the Company under this Certificate of Designation in accordance with the provisions of this Section 7.e) pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, including agreements to deliver to the Holder in exchange for shares of Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Preferred Stock, including, without limitation, which is convertible into a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to the number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred Stock immediately prior to the consummation of such Fundamental Transaction) and (ii) if the Fundamental Transaction occurs within six (6) months of the Closing Date, the Successor Entity (including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. Upon the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of the applicable Fundamental Transaction, the provisions of this Certificate of Designation referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Certificate of Designation with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon conversion of the Preferred Stock at any time after the consummation of the applicable Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property) issuable upon the conversion of the Preferred Stock prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its equivalent) of the Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction had the Preferred Stock been converted immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the conversion of the Preferred Stock), as adjusted in accordance with the provisions of this Certificate of Designation. Notwithstanding the foregoing, and without limiting Section 5 hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section 7.e) to permit the Fundamental Transaction without the assumption of the Preferred Stock. In addition to and not in substitution for any other rights hereunder, prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to insure that the Holder will thereafter have the right to receive upon a conversion of the Preferred Stock at any time after the consummation of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other securities, cash, assets or other property) issuable upon the conversion of the Preferred Stock prior to such Fundamental Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction had the Preferred Shares been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the conversion of the Preferred Stock). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory to the Holder.

 

 
 

 

2) Black Scholes Value. Notwithstanding the foregoing and the provisions of Section 5 above, at the request of the Holder delivered at any time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the consummation of any Fundamental Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the date that is ninety (90) days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase the Preferred Stock from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes Value.

 

3) Fundamental Transaction. If, at any time while any Preferred Stock is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of the Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 6 on the conversion of the Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock into which each share of Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6 on the conversion of the Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this preferred stock following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction, purchase the shares of Preferred Stock from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value of the remaining unconverted shares of Preferred Stock on the date of the consummation of such Fundamental Transaction. “Black Scholes Value” means the value of the unconverted shares of Preferred Stock remaining on the date of the Holder’s request pursuant to Section 7(e)(2) which value is calculated using the Black Scholes Option Pricing Model for a “call” or “put” option, as elected by the Holder, as obtained from the “OV” function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common Stock during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant to Section 7(e)(2) and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any) plus the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price equal to the Conversion Price in effect on the date of the Holder’s request pursuant to Section 7(e)(2), (iii) a risk-free interest rate corresponding to the U.S. Treasury rate as of the date of the Holder’s request pursuant to Section 7(e)(2) if such request is prior to the date of the consummation of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility equal to the greater of 100% and the 30 day volatility obtained from the “HVT” function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental Transaction, (B) the consummation of the applicable Fundamental Transaction and (C) the date on which the Holder first became aware of the applicable Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Certificate of Designation and the other Transaction Documents in accordance with the provisions of this Section 7(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for the Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Preferred Stock which is convertible into a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the Conversion Price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Preferred Stock and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Preferred Stock and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

 
 

 

f) Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.

 

g) Notice to the Holders.

 

i. Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Conversion by Holder. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation (F) the Corporation shall take any action to effectuate an Corporation Redemption, or (G) a Triggering Event shall have occurred, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified (unless a greater or lesser time period is expressly required elsewhere in this Certificate of Designation), a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth in this Certificate of Designation.

 

 
 

 

(h) Participation in Subsequent Financing.

 

(i) Upon a Subsequent Financing, a Holder of at least one hundred (100) shares of Preferred Stock (each such Holder, a “Significant Purchaser”) shall have the right to participate in up to an amount of the Subsequent Financing equal to 100% of the Subsequent Financing (the “Participation Maximum”) on the same terms, conditions and price provided for in the Subsequent Financing.

 

(ii) At least five (5) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to each Significant Purchaser a written notice of its intention to effect a Subsequent Financing (“Pre-Notice”), which Pre-Notice shall ask such Significant Purchaser if it wants to review the details of such financing (such additional notice, a “Subsequent Financing Notice”). Upon the request of a Significant Purchaser, and only upon a request by such Significant Purchaser, for a Subsequent Financing Notice, the Company shall promptly, but no later than one (1) Trading Day after such request, deliver a Subsequent Financing Notice to such Significant Purchaser. The Subsequent Financing Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet or similar document relating thereto as an attachment.

 

(iii) Any Significant Purchaser desiring to participate in such Subsequent Financing must provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Significant Purchasers have received the Pre-Notice that such Significant Purchaser is willing to participate in the Subsequent Financing, the amount of such Purchaser’s participation, and representing and warranting that such Significant Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing Notice. If the Company receives no such notice from a Significant Purchaser as of such fifth (5th) Trading Day, such Significant Purchaser shall be deemed to have notified the Company that it does not elect to participate.

 

(iv) If by 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Significant Purchasers have received the Pre-Notice, notifications by the Significant Purchasers of their willingness to participate in the Subsequent Financing (or to cause their designees to participate) is, in the aggregate, less than the total amount of the Subsequent Financing, then the Company may effect the remaining portion of such Subsequent Financing on the terms and with the Persons set forth in the Subsequent Financing Notice.

 

(v) If by 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Purchasers have received the Pre-Notice, the Company receives responses to a Subsequent Financing Notice from Significant Purchasers seeking to purchase more than the aggregate amount of the Participation Maximum, each such Significant Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of the Participation Maximum. “Pro Rata Portion” means the ratio of (x) the Subscription Amount of Securities purchased on the Closing Date by a Significant Purchaser participating under this Section 7(h) and (y) the sum of the aggregate Subscription Amounts of Securities purchased on the Closing Date by all Significant Purchasers participating under this Section 7(h).

 

 
 

 

(vi) The Company must provide the Significant Purchasers with a second Subsequent Financing Notice, and the Significant Purchasers will again have the right of participation set forth above in this Section 7(h), if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated for any reason on the terms set forth in such Subsequent Financing Notice within ten (10) Trading Days after the date of the initial Subsequent Financing Notice.

 

(vii) The Company and each Significant Purchaser agree that if any Significant Purchaser elects to participate in the Subsequent Financing, the transaction documents related to the Subsequent Financing shall not include any term or provision whereby such Significant Purchaser shall be required to agree to any restrictions on trading as to any of the Securities purchased hereunder or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written consent of such Significant Purchaser. In addition, the Company and each Significant Purchaser agree that, in connection with a Subsequent Financing, the transaction documents related to the Subsequent Financing shall include a requirement for the Company to issue a widely disseminated press release by 9:30 am (New York City time) on the Trading Day of execution of the transaction documents in such Subsequent Financing (or, if the date of execution is not a Trading Day, on the immediately following Trading Day) that discloses the material terms of the transactions contemplated by the transaction documents in such Subsequent Financing.

 

(viii) Notwithstanding anything to the contrary in this Section 7(h) and unless otherwise agreed to by such Significant Purchaser, the Company shall either confirm in writing to such Significant Purchaser that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its intention to issue the securities in the Subsequent Financing, in either case in such a manner such that such Significant Purchaser will not be in possession of any material, non-public information, by the tenth (10th) Business Day following delivery of the Subsequent Financing Notice. If by such tenth (10th) Business Day, no public disclosure regarding a transaction with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such transaction has been received by such Significant Purchaser, such transaction shall be deemed to have been abandoned and such Significant Purchaser shall not be deemed to be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries.

 

(ix) Notwithstanding the foregoing, this Section 7(h) shall not apply in respect of an Exempt Issuance.

 

Section 8. Mandatory Corporation Redemption.

 

(a) On the thirtieth (30th) calendar day following the date Preferred Stock is issued (the “Corporation Redemption Payment Date”), the Corporation shall have the obligation to redeem one-third of the Preferred Stock outstanding for a redemption price equal to the Stated Value of each such Share of Preferred Stock, plus any accrued but unpaid dividends, plus all other amounts due to the Holder pursuant to this Certificate of Designation and/or any Transaction Document including, but not limited to Late Fees, liquidated damages and the legal fees and expenses of the Holder’s counsel relating to this Certification of Designation, any other Transaction Document and/or the transactions contemplated thereunder and/or hereunder (the “Corporation Redemption Price”). On the sixtieth (60th) calendar day following the date Preferred Stock is issued, the Corporation shall have the obligation to redeem one-half of the Preferred Stock then outstanding for the Corporate Redemption Price. On the ninetieth (90th) calendar day following the date Preferred Stock is issued, the Corporation shall have the obligation to redeem all of the Preferred Stock then outstanding for the Corporate Redemption Price.

 

(b) The Corporation Redemption Price required to be paid by the Corporation to each Holder shall be paid in the cash to each Holder of shares of Preferred Stock no later than two (2) calendar days from the date of mailing of the Corporation Redemption Notice (the “Corporation Redemption Payment Date”).

 

(c) Notwithstanding the delivery of a Corporation Redemption Notice, a Holder may convert some or all of its shares of Preferred Stock until the date it receives in full Corporation Redemption Price, provided, however, that notwithstanding anything to the contrary provided herein or elsewhere (i) in the event a Holder would be precluded from converting any shares of Preferred Stock, due to the limitation contained in Section 5, any such Holder may elect to extend the Corporation Redemption Payment Date as to any or all of such Holder’s Preferred Stock for up to one hundred twenty (120) days following the Corporation Redemption Payment Date to allow such Holder to convert its remaining Preferred Stock into Conversion Shares.

 

 
 

 

Section 9. Negative Covenants. From the date hereof until the date no shares of Preferred Stock are issued and outstanding, unless Holders of at least 75% in Stated Value of the then outstanding shares of Preferred Stock shall have otherwise given prior written consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly:

 

(a) other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;

 

(b) other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;

 

(c) amend its charter documents, including, without limitation, its articles of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder;

 

(d) repay, repurchase or offer to repay, repurchase or otherwise acquire of any shares of its Common Stock, Common Stock Equivalents or Junior Securities, other than as to the Conversion Shares as permitted or required under the Transaction Documents,

 

(e) pay cash dividends or distributions on Junior Securities of the Corporation;

 

(f) enter into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the Commission, unless such transaction is made on an arm’s-length basis and expressly approved by a majority of the disinterested directors of the Corporation (even if less than a quorum otherwise required for board approval); or

 

(g) enter into any agreement with respect to any of the foregoing.

 

Section 10. Redemption Upon Triggering Events.

 

(a) “Triggering Event” means, wherever used herein any of the following events (whatever the reason for such event and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):

 

i. the Corporation shall fail to deliver Conversion Shares issuable upon a conversion hereunder that comply with the provisions hereof prior to the fifth Trading Day after such shares are required to be delivered hereunder, or the Corporation shall provide written notice to any Holder, including by way of public announcement, at any time, of its intention not to comply with requests for conversion of any shares of Preferred Stock in accordance with the terms hereof;

 

ii. the Corporation shall fail for any reason to pay in full the amount of cash due pursuant to a Buy-In within five (5) Trading Days after notice therefor is delivered hereunder.

 

iii. the Corporation shall fail to have available a sufficient number of authorized and unreserved shares of Common Stock to issue to such Holder upon a conversion hereunder;

 

iv. unless specifically addressed elsewhere in this Certificate of Designation as a Triggering Event, the Corporation shall fail to observe or perform any other covenant, agreement or warranty contained in, or otherwise commit any breach of the Transaction Documents, and such failure or breach shall not, if subject to the possibility of a cure by the Corporation, have been cured within 5 calendar days after the date on which written notice of such failure or breach shall have been delivered;

 

v. the Corporation shall redeem Junior Securities or pari passu securities;

 

 
 

 

vi. the Corporation shall be party to a Change of Control Transaction;

 

vii. there shall have occurred a Bankruptcy Event;

 

viii. any monetary judgment, writ or similar final process shall be entered or filed against the Corporation, any subsidiary or any of their respective property or other assets for more than $50,000 (provided that amounts covered by the Corporation’s insurance policies are not counted toward this $50,000 threshold), and such judgment, writ or similar final process shall remain unvacated, unbonded or unstayed for a period of thirty (30) Trading Days;

 

ix. the electronic transfer by the Corporation of shares of Common Stock through the Depository Trust Company or another established clearing corporation once established subsequent to the date of this Certificate of Designation is no longer available or is subject to a ‘freeze” and/or “chill”;

 

x. the Corporation shall no longer be DWAC eligible; or

 

xi. any “Event of Default,” as defined in the Purchase Agreement.

 

b) Upon the occurrence of a Triggering Event, each Holder shall (in addition to all other rights it may have hereunder or under applicable law) have the right, exercisable at the sole option of such Holder, to require the Corporation to (A) redeem all of the Preferred Stock then held by such Holder for a redemption price, in cash, equal to the Triggering Redemption Amount, or (B) at the option of each Holder either (i) redeem all of the Preferred Stock then held by such Holder though the issuance to such Holder of such number of shares of Common Stock equal to the quotient of (x) the Triggering Redemption Amount, divided by (y) the lowest of (1) the Conversion Price, and (2) 80% of the lowest traded price of the Common Stock during the fifteen (15) Trading Days immediately prior to the date of election hereunder, and (ii) increase the dividend rate on all of the outstanding Preferred Stock held by such Holder retroactively to the initial Closing Date to 12% per annum thereafter. The Triggering Redemption Amount, whether payable in cash or in shares, shall be due and payable or issuable, as the case may be, within five (5) Trading Days of the date on which the notice for the payment therefor is provided by a Holder (the “Triggering Redemption Payment Date”). If the Corporation fails to pay in full the Triggering Redemption Amount hereunder on the date such amount is due in accordance with this Section (whether in cash or shares of Common Stock), the Corporation will pay interest thereon at a rate equal to the lesser of 18% per annum or the maximum rate permitted by applicable law, accruing and compounding daily from such date until the Triggering Redemption Amount, plus all such interest thereon, is paid in full.

 

Section 11. Registration Rights.

 

a) If at any time on or after the issuance date of the Preferred Stock, there is no effective registration statement registering, or no current prospectus available for, the resale of the Conversion Shares by the Holder, and the Company proposes to file any Registration Statement with respect to any offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Company for its own account or for shareholders of the Company for their account (or by the Company and by shareholders of the Company), other than a Registration Statement in connection with a merger or acquisition, then the Company shall (x) give written notice of such proposed filing to the Holders as soon as practicable but in no event less than ten (10) days before the anticipated filing date of the Registration Statement, which notice shall describe the amount and type of securities to be included in such Registration Statement, the intended method(s) of distribution, and the name of the proposed managing underwriter or underwriters, if any, of the offering, and (y) offer to the Holders the opportunity to register the sale of such number of Preferred Stock as such Holders may request in writing within five (5) days following receipt of such notice (a “Piggy-Back Registration”). The Company shall cause such Preferred Stock to be included in such registration and shall cause the managing underwriter or underwriters of a proposed underwritten offering to permit the Preferred Stock requested to be included in a Piggy-Back Registration on the same terms and conditions as any similar securities of the Company and to permit the sale or other disposition of such Preferred Stock in accordance with the intended method(s) of distribution thereof. All Holders proposing to distribute their Preferred Stock through a Piggy-Back Registration that involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggy-Back Registration.

 

 
 

 

b) Any Holder may elect to withdraw such Holder’s request for inclusion of Preferred Stock in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the Registration Statement. The Company (whether on its own determination or as the result of a withdrawal by persons making a demand pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of such Registration Statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the Holders in connection with such Piggy-Back Registration (including but not limited to any legal fees).

 

c) The Company shall notify the Holders at any time when a prospectus relating to such Holder’s Securities is required to be delivered under the Securities Act, upon discovery that, or upon the happening of any event as a result of which, the prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. At the request of such Holder, the Company shall also prepare, file and furnish to such Holder a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of the Preferred Stock, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. The Holders shall not offer or sell any Preferred Stock covered by the Registration Statement after receipt of such notification until the receipt of such supplement or amendment.

 

d) the Company may request a Holder to furnish the Company such information with respect to such Holder and such Holder’s proposed distribution of the Preferred Stock pursuant to the Registration Statement as the Company may from time to time reasonably request in writing or as shall be required by law or by the Commission in connection therewith, and such Holders shall furnish the Company with such information.

 

e) All fees and expenses incident to the performance of or compliance with this Section 11 by the Company shall be borne by the Company whether or not any Preferred Stock are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company’s counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock are then listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions) and (D) with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Preferred Stock with FINRA, (ii) printing expenses, (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other persons or entities retained by the Company in connection with the consummation of the transactions contemplated by this Section 11.

 

f) The Company and its successors and assigns shall indemnify and hold harmless each purchaser, each Holder, the officers, directors, members, partners, agents and employees (and any other individuals or entities with a functionally equivalent role of a person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each individual or entity who controls each purchaser or any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other individuals or entities with a functionally equivalent role of a person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling individual or entity (each, an “Indemnified Party”), to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any related prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any such prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Section 11, except to the extent, but only to the extent, that such untrue statements or omissions are based upon information regarding a purchaser or such Holder furnished to the Company by such party for use therein. The Company shall notify each purchaser and each Holder promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions contemplated by this Section 11 of which the Company is aware. If the indemnification hereunder is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then the Company shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Company and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of the Company and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for herein was available to such party in accordance with its terms. It is agreed that it would not be just and equitable if contribution pursuant to this Section 11(f) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding sentence. Notwithstanding the provisions of this Section 11(f), neither the purchaser nor any Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such party from the sale of all of their Registrable Securities pursuant to such Registration Statement or related prospectus exceeds the amount of any damages that such party has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

 
 

 

Section 12. Miscellaneous.

 

a) Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally or sent by a nationally recognized overnight courier service and by facsimile or e-mail, addressed to the Corporation, at 10800 Galaxie Avenue, Ferndale, Michigan 48220; Attention: Chief Executive Officer, e-mail [ ], or such other e-mail or address as the Corporation may specify for such purposes by prior written notice to the Holders delivered in accordance with this Section 12. Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of the Corporation, at the principal place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

b) Absolute Obligation. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.

 

c) Lost or Mutilated Preferred Stock Certificate. If a Holder’s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation.

 

d) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, stockholders, employees or agents) shall be commenced in the state and federal courts sitting in the Borough of Manhattan, New York, New York, (the “New York Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designation or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this Certificate of Designation, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

 
 

 

e) Waiver. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion. Any waiver by the Corporation or a Holder must be in writing.

 

f) Severability. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.

 

g) Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

h) Headings. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit or affect any of the provisions hereof.

 

i) Status of Converted or Redeemed Preferred Stock. Shares of Preferred Stock may only be issued pursuant to a Purchase Agreement. If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Preferred Stock.

 

 
 

 

RESOLVED, FURTHER, that the Chairman, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be and they hereby are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and Limitations in accordance with the foregoing resolution and the provisions of Nevada law.

 

IN WITNESS WHEREOF, the undersigned have executed this Certificate this [  ] day of April, 2024.

 

 

Name:  
Title:  

 

 
 

 

ANNEX A

 

NOTICE OF CONVERSION

 

(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES OF PREFERRED STOCK)

 

The undersigned hereby elects to convert the number of shares of Series B Convertible Preferred Stock indicated below into shares of common stock, par value $0.00001 per share (the “Common Stock”), of ARTIFICAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC., a Nevada corporation (the “ Corporation “), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as may be required by the Corporation in accordance with the Purchase Agreement. No fee will be charged to the Holders for any conversion, except for any such transfer taxes.

 

Conversion calculations:

 

Date to Effect Conversion:    
     
Number of shares of Preferred Stock owned prior to Conversion:    
     
Number of shares of Preferred Stock to be Converted:    
     
Stated Value of shares of Preferred Stock to be Converted:    
     
Dollar amount of Interest to be Converted:    
     
Other amounts owed to the Undersigned by the Corporation under the Certificate of Designation and/or any other Transaction Document to be Converted:    
     

Number of shares of Common Stock to be Issued:

   
     
Applicable Conversion Price:    
     
Number of shares of Preferred Stock subsequent to Conversion:    

 

Address for Delivery: ____________________________

 

Or

 

DWAC Instructions:

 

Broker no: ______

Account no: ______

 

Name of Entity Holder _________________ (Please Print)

 

By:    
Name:    
Title:    

 

Name of Individual Holder ________________ (Please Print)

 

_______________________(Signature of Individual Holder)

 

 

 

 

Exhibit 3.4

 

ARTIFICAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS

OF

SERIES C CONVERTIBLE PREFERRED STOCK

 

The undersigned, Steven Reinharz, does hereby certify that:

 

1. He is the Chief Executive Officer of ARTIFICAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC., a Nevada corporation (the “Corporation” or the “Company”).

 

2. The Corporation is authorized to issue up to 20,000,000 shares of preferred stock, of which 4,465,000 shares have been authorized , as follows: (a) 500 Series B Convertible Redeemable Preferred Stock (b) 4,350,000 Series E Preferred Stock; (c) 10,000 Series F Convertible Preferred Stock; and (d) 100,000 Series G Redeemable Preferred Stock . At January 29, 2025 the Company has issued the following preferred stock: (a) 3,350,000 Series E Preferred Stock and; (b) 2,513 Series F Convertible Preferred Stock.

 

3. The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”):

 

WHEREAS, the Articles of Incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 20,000,000 shares issuable from time to time in one or more series;

 

WHEREAS, the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series and the designation thereof, of any of them; and

 

WHEREAS, it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and other matters relating to Series C Preferred Stock, a series of the preferred stock, which shall consist of, except as otherwise set forth in the Purchase Agreement, up to 1000 shares of the preferred stock which the Corporation has the authority to issue, as follows:

 

NOW, THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of Series C Preferred Stock, a series of preferred stock for cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters relating to such series of preferred stock as follows:

 

TERMS OF PREFERRED STOCK

 

Section 1. Definitions. For the purposes hereof, the following terms shall have the following meanings:

 

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.

 

“Alternate Consideration” shall have the meaning set forth in Section 7(e).

 

 

 

 

“Bankruptcy Event” means any of the following events: (a) the Corporation or any Significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Corporation or any Significant Subsidiary thereof, (b) there is commenced against the Corporation or any Significant Subsidiary thereof any such case or proceeding that is not dismissed within sixty (60) days after commencement, (c) the Corporation or any Significant Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered, (d) the Corporation or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within sixty (60) calendar days after such appointment, (e) the Corporation or any Significant Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Corporation or any Significant Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts, or (g) the Corporation or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

“Beneficial Ownership Limitation” shall have the meaning set forth in Section 6(d).

 

“Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

“Buy-In” shall have the meaning set forth in Section 5(c)(iv).

 

“Change of Control Transaction” means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of 49% of the voting securities of the Corporation (other than by means of conversion or exercise of Preferred Stock and the Securities issued together with the Preferred Stock), (b) the Corporation merges into or consolidates with any other Person, or any Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately prior to such transaction own less than 33% of the aggregate voting power of the Corporation or the successor entity of such transaction, (c) the Corporation sells or transfers all or substantially all of its assets to another Person and the stockholders of the Corporation immediately prior to such transaction own less than 33% of the aggregate voting power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a one year period of more than one-half of the members of the Board of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the Original Issue Date), or (e) the execution by the Corporation of an agreement to which the Corporation is a party or by which it is bound, providing for any of the events set forth in clauses (a) through (d) above.

 

“Closing” means the closing of the purchase and sale of the Securities pursuant to Section 2.1 of the respective Purchase Agreements.

 

“Closing Date” means the applicable Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto and all conditions precedent to (i) each Holder’s obligations to pay the Subscription Amount for a Closing and (ii) the Corporation’s obligations to deliver the Securities have been satisfied or waived.

 

“Commission” or the “SEC” means the United States Securities and Exchange Commission.

 

“Common Stock” means the Corporation’s common stock, par value $0.00001 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed.

 

“Common Stock Equivalents” means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

“Conversion Amount” means the sum of the Stated Value at issue.

 

“Conversion Date” shall have the meaning set forth in Section 5(a).

 

“Conversion Price” shall have the meaning set forth in Section 5(b).

 

2

 

 

“Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms hereof.

 

“Corporation Redemption” has the meaning set forth in Section 8.

 

“Corporation Redemption Price” has the meaning set forth in Section 8.

 

“Corporation Redemption Payment Date” has the meaning set forth in Section 8.

 

“Corporation Redemption Notice” has the meaning set forth in Section 8.

 

“Designation, Amount and Par Value” The series of preferred stock shall be designated as Series C Convertible Preferred Stock and the number of shares so designated shall be up to 1000 (which shall not be subject to increase without the written consent of all of the Holders of the Preferred Stock. Each share of Preferred Stock shall have a par value of $0.01 per share and a stated value of $1,200, subject to increase set forth in Section 3 and/or elsewhere in this Certificate of Designation below.

 

“DTC” means the Depository Trust Company.

 

“DTC/FAST Program” means the DTC’s Fast Automated Securities Transfer Program. “Dividend” shall have the meaning set forth in Section 2.

 

“DWAC Eligible” means that (a) the Common Stock is eligible at DTC for full services pursuant to DTC’s Operational Arrangements, including without limitation transfer through DTC’s DWAC system, (b) the Corporation has been approved (without revocation) by the DTC’s underwriting department, (c) the Transfer Agent is approved as an agent in the DTC/FAST Program, (d) the Conversion Shares are otherwise eligible for delivery via DWAC, and (e) the Transfer Agent does not have a policy prohibiting or limiting delivery of the Conversion Shares via DWAC.

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“New York Courts” shall have the meaning set forth in Section 12(d). “Fundamental Transaction” shall have the meaning set forth in Section 7(e). “GAAP” means United States generally accepted accounting principles. “Holders” means Holders of the Preferred Stock.

 

“Indemnified Party” shall have the meaning set forth in Section 11(f).

 

“Indebtedness” means (a) any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Corporation’s balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business, and (c) the present value of any lease payments in excess of $10,000 due under leases required to be capitalized in accordance with GAAP.

 

“Junior Securities” means the Common Stock and all other Common Stock Equivalents of the Corporation other than those securities which are explicitly senior or pari passu to the Preferred Stock in dividend rights or liquidation preference.

 

“Late Fees” shall have the meaning set forth in Section 2(d).

 

“Liens” means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

“Liquidation” shall have the meaning set forth in Section 4. “Losses” shall have the meaning set forth in Section 11(f).

 

“Notice of Conversion” shall have the meaning set forth in Section 5.

 

3

 

 

“Original Issue Date” means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock.

 

“Permitted Governmental Indebtedness” means Indebtedness for the purpose of supporting product sales by the Borrower.

 

“Permitted Indebtedness” means (i)) Indebtedness of the Corporation set forth in Corporation’s most recent SEC report filed with the SEC by the Corporation on Form 10-Q or Form 10-K (the “SEC Reports”) provided none of such Indebtedness, has been increased, extended and/or otherwise changed), (ii) Indebtedness secured by Permitted Liens described in clauses “(iii)” of the definition of Permitted Liens, and (iv) Permitted Governmental Indebtedness.

 

“Permitted Liens” means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as materialmen’s liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (a) upon or in any equipment acquired or held by the Borrower or any of its Subsidiaries to secure the purchase price of such equipment or indebtedness incurred solely for the purpose of financing the acquisition or lease of such equipment, and (b) existing on such equipment at the time of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds of such equipment and (v) any Liens for Permitted Indebtedness set forth in (i) and (ii) of the definition of Permitted Indebtedness provided as to “(ii)” of Permitted Indebtedness such Liens were in existence and not amended, supplemented and/or modified since the original issuance date any such Indebtedness was incurred.

 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Piggy-Back Registration” shall have the meaning set forth in Section 11(a).

 

“Preferred Stock” shall mean Series C Convertible Preferred Stock of the Company.

 

“Premium Rate” shall have the meaning set forth in Section 8(a).

 

“Purchase Agreement” means that certain Securities Purchase Agreement, dated on or about the Original Issue Date, among the Corporation and the original Holders, as amended, modified or supplemented from time to time in accordance with its terms.

 

“Qualified Offering” means an underwritten offering by the Corporation resulting in net proceeds of at least

 

$5,000,000, occurring prior to the one year anniversary of the Original Issue Date. “Registration Statement” shall have the meaning set forth in Section 11(a).

 

“Securities” means the Preferred Stock and the Underlying Shares.

 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Share Delivery Date” shall have the meaning set forth in Section 5(c)(i).

 

“Stated Value” shall mean $1,200, subject to increase set forth in Section 3 and/or elsewhere in this Certificate of Designation.

 

“Subscription Amount” shall mean, as to each Holder, the aggregate amount to be paid for the Preferred Stock purchased pursuant to the Purchase Agreement as specified below such Holder’s name on the signature page of the Purchase Agreement and next to the heading “Subscription Amount,” in United States dollars and in immediately available funds.

 

4

 

 

“Subsidiary” means any subsidiary of the Corporation as set forth on Schedule 3.1(a) of the Purchase Agreement and shall, where applicable, also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Purchase Agreement.

 

“Successor Entity” shall have the meaning set forth in Section 3.

 

“Trading Day or Date” means a day on which the principal Trading Market is open for business.

 

“Trading Market” means any of the following markets or exchanges on which the Common Stock (or any other common stock of any other Person that references the Trading Market for its common stock) is listed or quoted for trading on the date in question: The NASDAQ Global Market, The NASDAQ Global Select Market, The NASDAQ Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE MKT, or the OTCQX Marketplace, the OTCQB Marketplace, the OTC Pink Marketplace or any other tier operated by OTC Markets Group Inc. (or any successor to any of the foregoing).

 

“Transaction Documents” means this Certificate of Designation, the Purchase Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated pursuant to the Purchase Agreement.

 

“Transfer Agent” means Transhare, with a mailing address of Bayside Center 1, 17755 North US Highway 19, Suite 140, Clearwater, Florida 33764 and any successor transfer agent of the Company.

 

“Triggering Event” shall have the meaning set forth in Section 10(a).

 

“Triggering Redemption Amount” means, for each share of Preferred Stock, the sum of (a) 135% of the Stated Value and (b) all accrued but unpaid dividends thereon and (c) all liquidated damages, Late Fees and other costs, expenses or amounts due in respect of the Preferred Stock including, but not limited to legal fees and expenses of legal counsel to the Holder in connection with, related to and/or arising out of a Triggering Event.

 

“Triggering Redemption Payment Date” shall have the meaning set forth in Section 10(b).

 

“Underlying Shares” means the shares of Common Stock issued and issuable upon conversion of the Preferred Stock.

 

“VWAP” means, for or as of any date for the Common Stock, the dollar volume-weighted average price for the Common Stock on the Trading Market during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (set to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of the Common Stock in the over-the-counter market on the electronic bulletin board for the Common Stock during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for the Common Stock by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for the Common Stock as reported in the “pink sheets” by OTC Markets Group Inc. (formerly Pink Sheets LLC). If the VWAP cannot be calculated for the Common Stock on such date on any of the foregoing bases, the VWAP of the Common Stock on such date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.

 

Section 2. Dividends.

 

(a) Dividends in Cash or in Kind. Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of twelve percent (12%) per annum, payable quarterly, beginning on the Original Issue Date and ending on the date that such share of Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Preferred Stock at the discretion of the Company.

 

5

 

 

(b) Dividend Calculations. Subject to Section 3(a), dividends on the Preferred Stock shall be calculated on the basis of a 360-day year, consisting of twelve (12) thirty (30) calendar day periods, and shall accrue and compound daily commencing on the Original Issue Date, and shall be deemed to accrue from such date whether or not earned or declared and whether or not there are profits, surplus or other funds of the Corporation legally available for the payment of dividends. Dividends shall cease to accrue with respect to any Preferred Stock redeemed or converted, provided that the Corporation actually delivers the Conversion Shares within the time period required by Section 6(c)(i) herein.

 

(c) Late Fees. Any dividends that are not paid a Dividend Payment Date shall continue to accrue and shall entail a late fee (“Late Fees”), which must be paid in cash, at the rate of 14% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the Dividend Payment Date through and including the date of actual payment in full.

 

(d) Other Securities. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall redeem, purchase or otherwise acquire directly or indirectly any Junior Securities or pari passu securities other than any Preferred Stock purchased to the terms of this Certificate of Designation. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall directly or indirectly pay or declare any dividend or make any distribution upon (other than a dividend or distribution described in Section 2 or dividends due and paid in the ordinary course on preferred stock of the Corporation at such times when the Corporation is in compliance with its payment and other obligations hereunder), nor shall any distribution be made in respect of, any Junior Securities or pari passu securities as long as any dividends due on the Preferred Stock remain unpaid, nor shall any monies be set aside for or applied to the purchase or redemption (through a sinking fund or otherwise) of any Junior Securities or pari passu securities.

 

Section 3. Voting Rights. The Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise pari passu with, the Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise pari passu with, the Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing.

 

Section 4. Liquidation. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation. The Corporation shall mail written notice of any such Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder.

 

6

 

 

Section 5.Conversion.

 

a) Conversions at Option of Holder. Each share of Preferred Stock shall be convertible, at any time and from time to time from and after 180 days from the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations set forth in Section 5(d)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as Annex A (a “Notice of Conversion”). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.

 

b)(i) Conversion Price. The conversion price (the “Conversion Price”) for the Preferred Stock shall be the amount equal to a fixed price equaling 90% of the lowest traded price of the Common Stock during the ten (10) trading days immediately preceding, but not including, the Original Issue Date for Preferred Stock All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such measuring period. Nothing herein shall limit a Holder’s right to pursue actual damages including, but not limited to, as a result of a Triggering Event pursuant to Section 10 hereof and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. Following an “Event of Default,” as defined in the Purchase Agreement, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price per share equaling eighty percent (80%) of the lowest traded price for the Company’s common stock during the fifteen (15) Trading Days immediately preceding, but not including, the Conversion Date.

 

(ii) Reset Adjustment. In addition to the adjustments set forth in Section 7, on each of the ninetieth (90th) and one hundred and eightieth (180th) calendar days immediately following the Original Issue Date (each, a “Reset Date”), if the Reset Price is less than the Conversion Price then in effect, the Conversion Price shall be adjusted to the Reset Price. For purposes hereof, the “Reset Price” means, with respect to each Reset Date, the lowest closing price of the Common Stock on any trading day during the five (5) trading day period immediately prior to such Reset Date.

 

c) Mechanics of Conversion

 

i. Delivery of Conversion Shares Upon Conversion. Not later than two (2) Trading Days after each Conversion Date (the “Share Delivery Date”), the Corporation shall deliver, or cause to be delivered, to the converting Holder (A) the number of Conversion Shares being acquired upon the conversion of the Preferred Stock, which Conversion Shares shall be free of restrictive legends and trading restrictions, and (B) a bank check in the amount of accrued and unpaid dividends (if the Corporation has elected or is required to pay accrued dividends in cash). The Corporation shall deliver the Conversion Shares electronically through the Depository Trust Company or another established clearing corporation performing similar functions.

 

ii. Failure to Deliver Conversion Shares. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Conversion Notice.

 

7

 

 

iii. Obligation Absolute; Partial Liquidated Damages. The Corporation’s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder. In the event a Holder shall elect to convert any or all of the Stated Value of its Preferred Stock, the Corporation may not refuse conversion based on any claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the Preferred Stock of such Holder shall have been sought and obtained, and the Corporation posts a surety bond for the benefit of such Holder in the amount of 150% of the Stated Value of Preferred Stock which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to such Holder to the extent it obtains judgment. In the absence of such injunction, the Corporation shall issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant to Section 5 on the second Trading Day after the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $5,000 of Stated Value of Preferred Stock being converted, $100 per Trading Day (increasing to $150 per Trading Day on the third Trading Day and increasing to $200 per Trading Day on the sixth Trading Day after such damages begin to accrue) for each Trading Day after such second Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. All liquidated damages shall be paid to the Holder not later than the fifth (5th) Trading Day after notice is provided to the Company by the Holder stating that any such liquidated damages are due pursuant to this Section 5. Nothing herein shall limit a Holder’s right to pursue actual damages or declare a Triggering Event pursuant to Section 10 hereof for the Corporation’s failure to deliver Conversion Shares within the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

 

iv. Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion. In addition to any other rights available to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date pursuant to Section 5, and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a “Buy-In”), then the Corporation shall (A) pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder’s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under Section 5. For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The payment of all amounts due by the Company to the Holder shall be paid in cash no later than the fifth (5th) Business Day after notice is provided by a Holder to the Company requesting the payment of any such liquidated damages. The Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation’s failure to timely deliver the Conversion Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof.

 

8

 

 

v. Reservation of Shares Issuable Upon Conversion. The Company covenants that it will reserve and keep available out of its authorized and unissued shares of Common Stock, 500,000,000 shares of Common Stock (appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock) for the sole purpose of issuance upon conversion of the Preferred Stock and payment of dividends on the Preferred Stock, all as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Purchasers, not less than such aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable (taking into account the adjustments and restrictions of Section 7, but ignoring any Beneficial Ownership Limitations or other restrictions and/or limitations on conversions set forth herein or elsewhere) upon the conversion of the then outstanding shares of the Preferred Stock and payment of dividends hereunder. The Company covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable, and, at such times as a registration statement covering such shares is then effective under the Securities Act, will be registered for public resale in accordance with such registration statement. For purposes of this Certification of Designation, the term “Required Minimum” shall be defined as the product of (i) 300%, multiplied by (ii) the quotient of (A)(x) all outstanding Stated Value of all issued and outstanding shares of the Preferred Stock, (y) all unpaid dividends thereon (whether accrued or not), and (z) all fees and/or any costs and expenses relating to the Transaction Documents including, but not limited to Late Fees and liquidation damages, divided by (B) the Conversion Price on the date of Closing. The Required Minimum shall be increased from time to time to ensure appropriate coverage for Securities issued or issuable to Purchaser.

 

vi. Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the next whole share.

 

vii. Transfer Taxes and Expenses. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid. In the event that the Holder requests same-day processing for a Notice of Conversion, such Holder shall pay all Transfer Agent fees required for such same-day processing and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.

 

d) Beneficial Ownership Limitation. The Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder’s Affiliates, and any Persons acting as a group together with such Holder or any of such Holder’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred Stock or the Warrants) beneficially owned by such Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this Section 6(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned by such Holder together with any Affiliates) and of how many shares of Preferred Stock are convertible shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder’s determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates) and how many shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, the Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Corporation shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Corporation’s most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Corporation shall within two (2) Trading Days confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock held by the applicable Holder.

 

9

 

 

e) Qualified Offering. Upon the consummation of a Qualified Offering, the Holder shall have the option to convert their Preferred Stock, along with any other preferred stock of the Company then held by them, into the securities issued in the Qualified Offering, at a 30% discount to the public offering price at which the securities in the Qualified Offering were issued.

 

Section 6. Intentionally Omitted.

 

Section 7. Certain Adjustments.

 

a) Stock Dividends and Stock Splits. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions that is payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, the Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b) Most Favored Nation Provision. From the date hereof until the date when the Holder no longer holds any Preferred Stock, upon any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration, Indebtedness or a combination of units thereof (a “Subsequent Financing”), the Holder may elect, in its sole discretion, to exchange (in lieu of conversion), if applicable, all or some of the shares of Preferred Stock then held for any securities or units issued in a Subsequent Financing on a $1.00 for $1.00 basis. The Company shall provide the Holder with notice of any such Subsequent Financing in the manner set forth below Additionally, if in such Subsequent Financing there are any contractual provisions or side letters that provide terms more favorable to the investors than the terms provided for hereunder, then the Company shall specifically notify the Holder of such additional or more favorable terms and such terms, at Holder’s option, shall become a part of the transaction documents with the Holder. The types of terms contained in another security that may be more favorable to the holder of such security include, but are not limited to, terms addressing stock sale price, private placement price per share, and warrant coverage.

 

c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “ Purchase Rights”), then the Holder of will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder’s Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

d) Pro Rata Distributions. During such time as this Preferred Stock is outstanding, if the Corporation shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

10

 

 

e) Fundamental Transaction.

 

1) General. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (as defined below) assumes in writing all of the obligations of the Company under this Certificate of Designation in accordance with the provisions of this Section 7.e) pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, including agreements to deliver to the Holder in exchange for shares of Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Preferred Stock, including, without limitation, which is convertible into a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to the number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred Stock immediately prior to the consummation of such Fundamental Transaction) and (ii) if the Fundamental Transaction occurs within six (6) months of the Closing Date, the Successor Entity (including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. Upon the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of the applicable Fundamental Transaction, the provisions of this Certificate of Designation referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Certificate of Designation with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon conversion of the Preferred Stock at any time after the consummation of the applicable Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property) issuable upon the conversion of the Preferred Stock prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its equivalent) of the Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction had the Preferred Stock been converted immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the conversion of the Preferred Stock), as adjusted in accordance with the provisions of this Certificate of Designation. Notwithstanding the foregoing, and without limiting Section 5 hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section 7.e) to permit the Fundamental Transaction without the assumption of the Preferred Stock. In addition to and not in substitution for any other rights hereunder, prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to insure that the Holder will thereafter have the right to receive upon a conversion of the Preferred Stock at any time after the consummation of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other securities, cash, assets or other property) issuable upon the conversion of the Preferred Stock prior to such Fundamental Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction had the Preferred Shares been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the conversion of the Preferred Stock). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory to the Holder.

 

2) Black Scholes Value. Notwithstanding the foregoing and the provisions of Section 5 above, at the request of the Holder delivered at any time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the consummation of any Fundamental Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the date that is ninety (90) days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase the Preferred Stock from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes Value.

 

11

 

 

3) Fundamental Transaction. If, at any time while any Preferred Stock is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of the Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 6 on the conversion of the Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock into which each share of Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6 on the conversion of the Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this preferred stock following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction, purchase the shares of Preferred Stock from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value of the remaining unconverted shares of Preferred Stock on the date of the consummation of such Fundamental Transaction. “Black Scholes Value” means the value of the unconverted shares of Preferred Stock remaining on the date of the Holder’s request pursuant to Section 7(e)(2) which value is calculated using the Black Scholes Option Pricing Model for a “call” or “put” option, as elected by the Holder, as obtained from the “OV” function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common Stock during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant to Section 7(e)(2) and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any) plus the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price equal to the Conversion Price in effect on the date of the Holder’s request pursuant to Section 7(e)(2), (iii) a risk-free interest rate corresponding to the U.S. Treasury rate as of the date of the Holder’s request pursuant to Section 7(e)(2) if such request is prior to the date of the consummation of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility equal to the greater of 100% and the 30 day volatility obtained from the “HVT” function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental Transaction, (B) the consummation of the applicable Fundamental Transaction and (C) the date on which the Holder first became aware of the applicable Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Certificate of Designation and the other Transaction Documents in accordance with the provisions of this Section 7(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for the Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Preferred Stock which is convertible into a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the Conversion Price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Preferred Stock and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Preferred Stock and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

f) Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.

 

12

 

 

g) Notice to the Holders.

 

i. Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow Conversion by Holder. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation (F) the Corporation shall take any action to effectuate an Corporation Redemption, or (G) a Triggering Event shall have occurred, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified (unless a greater or lesser time period is expressly required elsewhere in this Certificate of Designation), a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth in this Certificate of Designation.

 

(h) Participation in Subsequent Financing.

 

(i) Upon a Subsequent Financing, a Holder of at least one hundred (100) shares of Preferred Stock (each such Holder, a “Significant Purchaser”) shall have the right to participate in up to an amount of the Subsequent Financing equal to 100% of the Subsequent Financing (the “Participation Maximum”) on the same terms, conditions and price provided for in the Subsequent Financing.

 

(ii) At least five (5) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to each Significant Purchaser a written notice of its intention to effect a Subsequent Financing (“Pre-Notice”), which Pre-Notice shall ask such Significant Purchaser if it wants to review the details of such financing (such additional notice, a “Subsequent Financing Notice”). Upon the request of a Significant Purchaser, and only upon a request by such Significant Purchaser, for a Subsequent Financing Notice, the Company shall promptly, but no later than one (1) Trading Day after such request, deliver a Subsequent Financing Notice to such Significant Purchaser. The Subsequent Financing Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet or similar document relating thereto as an attachment.

 

13

 

 

(iii) Any Significant Purchaser desiring to participate in such Subsequent Financing must provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Significant Purchasers have received the Pre-Notice that such Significant Purchaser is willing to participate in the Subsequent Financing, the amount of such Purchaser’s participation, and representing and warranting that such Significant Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing Notice. If the Company receives no such notice from a Significant Purchaser as of such fifth (5th) Trading Day, such Significant Purchaser shall be deemed to have notified the Company that it does not elect to participate.

 

(iv) If by 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Significant Purchasers have received the Pre-Notice, notifications by the Significant Purchasers of their willingness to participate in the Subsequent Financing (or to cause their designees to participate) is, in the aggregate, less than the total amount of the Subsequent Financing, then the Company may effect the remaining portion of such Subsequent Financing on the terms and with the Persons set forth in the Subsequent Financing Notice.

 

(v) If by 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Purchasers have received the Pre-Notice, the Company receives responses to a Subsequent Financing Notice from Significant Purchasers seeking to purchase more than the aggregate amount of the Participation Maximum, each such Significant Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of the Participation Maximum. “Pro Rata Portion” means the ratio of (x) the Subscription Amount of Securities purchased on the Closing Date by a Significant Purchaser participating under this Section 7(h) and (y) the sum of the aggregate Subscription Amounts of Securities purchased on the Closing Date by all Significant Purchasers participating under this Section 7(h).

 

(vi) The Company must provide the Significant Purchasers with a second Subsequent Financing Notice, and the Significant Purchasers will again have the right of participation set forth above in this Section 7(h), if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated for any reason on the terms set forth in such Subsequent Financing Notice within ten (10) Trading Days after the date of the initial Subsequent Financing Notice.

 

(vii) The Company and each Significant Purchaser agree that if any Significant Purchaser elects to participate in the Subsequent Financing, the transaction documents related to the Subsequent Financing shall not include any term or provision whereby such Significant Purchaser shall be required to agree to any restrictions on trading as to any of the Securities purchased hereunder or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written consent of such Significant Purchaser. In addition, the Company and each Significant Purchaser agree that, in connection with a Subsequent Financing, the transaction documents related to the Subsequent Financing shall include a requirement for the Company to issue a widely disseminated press release by 9:30 am (New York City time) on the Trading Day of execution of the transaction documents in such Subsequent Financing (or, if the date of execution is not a Trading Day, on the immediately following Trading Day) that discloses the material terms of the transactions contemplated by the transaction documents in such Subsequent Financing.

 

(viii) Notwithstanding anything to the contrary in this Section 7(h) and unless otherwise agreed to by such Significant Purchaser, the Company shall either confirm in writing to such Significant Purchaser that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its intention to issue the securities in the Subsequent Financing, in either case in such a manner such that such Significant Purchaser will not be in possession of any material, non-public information, by the tenth (10th) Business Day following delivery of the Subsequent Financing Notice. If by such tenth (10th) Business Day, no public disclosure regarding a transaction with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such transaction has been received by such Significant Purchaser, such transaction shall be deemed to have been abandoned and such Significant Purchaser shall not be deemed to be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries.

 

(ix) Notwithstanding the foregoing, this Section 7(h) shall not apply in respect of an Exempt Issuance.

 

14

 

 

Section 8. Corporation Redemption.

 

(a) On the first Trading Day that is 180 calendar days from the issuance of the Preferred Shares, the Company shall have the obligation to redeem all outstanding Preferred Shares for one hundred nine and one half percent (109.5%) of the stated value, plus any accrued but unpaid dividends, plus all other amounts due to the Holder pursuant to the Certificate of Designation and/or any Transaction Documents (“Redemption Date”). Prior to the Redemption Date, the Company at its discretion and on three (3) Trading Days’ written notice, may to redeem all outstanding Preferred Shares for one hundred nine and one half percent (109.5%) of the stated value, plus any accrued but unpaid dividends, plus all other amounts due to the Holder pursuant to the Certificate of Designation and/or any Transaction Documents.

 

(b) A Holder may convert some or all of its shares of Preferred Stock until the date it receives in full the Corporation Redemption Price after 180 days from issuance , provided, however, that notwithstanding anything to the contrary provided herein or elsewhere (i) in the event a Holder would be precluded from converting any shares of Preferred Stock, due to the limitation contained in Section 5, any such Holder may elect to extend the Redemption Payment Date as to any or all of such Holder’s Preferred Stock for up to one hundred twenty (120) days following the Redemption Payment Date to allow such Holder to convert its remaining Preferred Stock into Conversion Shares.

 

Section 9. Negative Covenants. From the date hereof until the date no shares of Preferred Stock are issued and outstanding, unless Holders of at least 75% in Stated Value of the then outstanding shares of Preferred Stock shall have otherwise given prior written consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly:

 

(a) other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;

 

(b) other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;

 

(c) amend its charter documents, including, without limitation, its articles of incorporation and bylaws, in any manner that materially and adversely affects any rights of the Holder;

 

(d) repay, repurchase or offer to repay, repurchase or otherwise acquire of any shares of its Common Stock, Common Stock Equivalents or Junior Securities, other than as to the Conversion Shares as permitted or required under the Transaction Documents,

 

(e) pay cash dividends or distributions on Junior Securities of the Corporation;

 

(f) enter into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the Commission, unless such transaction is made on an arm’s-length basis and expressly approved by a majority of the disinterested directors of the Corporation (even if less than a quorum otherwise required for board approval); or

 

(g) enter into any agreement with respect to any of the foregoing.

 

Section 10. Redemption Upon Triggering Events.

 

(a) “Triggering Event” means, wherever used herein any of the following events (whatever the reason for such event and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):

 

i. the Corporation shall fail to deliver Conversion Shares issuable upon a conversion hereunder that comply with the provisions hereof prior to the fifth Trading Day after such shares are required to be delivered hereunder, or the Corporation shall provide written notice to any Holder, including by way of public announcement, at any time, of its intention not to comply with requests for conversion of any shares of Preferred Stock in accordance with the terms hereof;

 

15

 

 

ii. the Corporation shall fail for any reason to pay in full the amount of cash due pursuant to a Buy-In within five (5) Trading Days after notice therefor is delivered hereunder.

 

iii. the Corporation shall fail to have available a sufficient number of authorized and unreserved shares of Common Stock to issue to such Holder upon a conversion hereunder;

 

iv. unless specifically addressed elsewhere in this Certificate of Designation as a Triggering Event, the Corporation shall fail to observe or perform any other covenant, agreement or warranty contained in, or otherwise commit any breach of the Transaction Documents, and such failure or breach shall not, if subject to the possibility of a cure by the Corporation, have been cured within 5 calendar days after the date on which written notice of such failure or breach shall have been delivered;

 

v. the Corporation shall redeem Junior Securities or pari passu securities;

 

vi. the Corporation shall be party to a Change of Control Transaction;

 

vii. there shall have occurred a Bankruptcy Event;

 

viii. any monetary judgment, writ or similar final process shall be entered or filed against the Corporation, any subsidiary or any of their respective property or other assets for more than $50,000 (provided that amounts covered by the Corporation’s insurance policies are not counted toward this $50,000 threshold), and such judgment, writ or similar final process shall remain unvacated, unbonded or unstayed for a period of thirty (30) Trading Days;

 

ix. the electronic transfer by the Corporation of shares of Common Stock through the Depository Trust Company or another established clearing corporation once established subsequent to the date of this Certificate of Designation is no longer available or is subject to a ‘freeze” and/or “chill”;

 

x. the Corporation shall no longer be DWAC eligible ; or

 

xi. any “Event of Default,” as defined in the Purchase Agreement.

 

b) Upon the occurrence of a Triggering Event, each Holder shall (in addition to all other rights it may have hereunder or under applicable law) have the right, exercisable at the sole option of such Holder, to require the Corporation to (A) redeem all of the Preferred Stock then held by such Holder for a redemption price, in cash, equal to the Triggering Redemption Amount, or (B) at the option of each Holder either (i) redeem all of the Preferred Stock then held by such Holder though the issuance to such Holder of such number of shares of Common Stock equal to the quotient of (x) the Triggering Redemption Amount, divided by (y) the lowest of (1) the Conversion Price, and (2) 80% of the lowest traded price of the Common Stock during the fifteen (15) Trading Days immediately prior to the date of election hereunder, and (ii) increase the dividend rate on all of the outstanding Preferred Stock held by such Holder retroactively to the initial Closing Date to 12% per annum thereafter. The Triggering Redemption Amount, whether payable in cash or in shares, shall be due and payable or issuable, as the case may be, within five (5) Trading Days of the date on which the notice for the payment therefor is provided by a Holder (the “Triggering Redemption Payment Date”). If the Corporation fails to pay in full the Triggering Redemption Amount hereunder on the date such amount is due in accordance with this Section (whether in cash or shares of Common Stock), the Corporation will pay interest thereon at a rate equal to the lesser of 18% per annum or the maximum rate permitted by applicable law, accruing and compounding daily from such date until the Triggering Redemption Amount, plus all such interest thereon, is paid in full.

 

16

 

 

Section 11. Registration Rights.

 

a) If at any time on or after the issuance date of the Preferred Stock, there is no effective registration statement registering, or no current prospectus available for, the resale of the Conversion Shares by the Holder, and the Company proposes to file any Registration Statement with respect to any offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Company for its own account or for shareholders of the Company for their account (or by the Company and by shareholders of the Company), other than a Registration Statement in connection with a merger or acquisition, then the Company shall (x) give written notice of such proposed filing to the Holders as soon as practicable but in no event less than ten (10) days before the anticipated filing date of the Registration Statement, which notice shall describe the amount and type of securities to be included in such Registration Statement, the intended method(s) of distribution, and the name of the proposed managing underwriter or underwriters, if any, of the offering, and (y) offer to the Holders the opportunity to register the sale of such number of Preferred Stock as such Holders may request in writing within five (5) days following receipt of such notice (a “Piggy-Back Registration”). The Company shall cause such Preferred Stock to be included in such registration and shall cause the managing underwriter or underwriters of a proposed underwritten offering to permit the Preferred Stock requested to be included in a Piggy-Back Registration on the same terms and conditions as any similar securities of the Company and to permit the sale or other disposition of such Preferred Stock in accordance with the intended method(s) of distribution thereof. All Holders proposing to distribute their Preferred Stock through a Piggy-Back Registration that involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggy-Back Registration.

 

b) Any Holder may elect to withdraw such Holder’s request for inclusion of Preferred Stock in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the Registration Statement. The Company (whether on its own determination or as the result of a withdrawal by persons making a demand pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of such Registration Statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the Holders in connection with such Piggy-Back Registration (including but not limited to any legal fees).

 

c) The Company shall notify the Holders at any time when a prospectus relating to such Holder’s Securities is required to be delivered under the Securities Act, upon discovery that, or upon the happening of any event as a result of which, the prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. At the request of such Holder, the Company shall also prepare, file and furnish to such Holder a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of the Preferred Stock, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. The Holders shall not offer or sell any Preferred Stock covered by the Registration Statement after receipt of such notification until the receipt of such supplement or amendment.

 

d) the Company may request a Holder to furnish the Company such information with respect to such Holder and such Holder’s proposed distribution of the Preferred Stock pursuant to the Registration Statement as the Company may from time to time reasonably request in writing or as shall be required by law or by the Commission in connection therewith, and such Holders shall furnish the Company with such information.

 

e) All fees and expenses incident to the performance of or compliance with this Section 11 by the Company shall be borne by the Company whether or not any Preferred Stock are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company’s counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock are then listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions) and (D) with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Preferred Stock with FINRA, (ii) printing expenses, (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other persons or entities retained by the Company in connection with the consummation of the transactions contemplated by this Section 11.

 

17

 

 

f) The Company and its successors and assigns shall indemnify and hold harmless each purchaser, each Holder, the officers, directors, members, partners, agents and employees (and any other individuals or entities with a functionally equivalent role of a person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each individual or entity who controls each purchaser or any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other individuals or entities with a functionally equivalent role of a person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling individual or entity (each, an “Indemnified Party”), to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any related prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any such prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Section 11, except to the extent, but only to the extent, that such untrue statements or omissions are based upon information regarding a purchaser or such Holder furnished to the Company by such party for use therein. The Company shall notify each purchaser and each Holder promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions contemplated by this Section 11 of which the Company is aware. If the indemnification hereunder is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then the Company shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Company and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of the Company and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for herein was available to such party in accordance with its terms. It is agreed that it would not be just and equitable if contribution pursuant to this Section 11(f) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding sentence. Notwithstanding the provisions of this Section 11(f), neither the purchaser nor any Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such party from the sale of all of their Registrable Securities pursuant to such Registration Statement or related prospectus exceeds the amount of any damages that such party has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

Section 12. Miscellaneous.

 

a) Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally or sent by a nationally recognized overnight courier service and by facsimile or e-mail, addressed to the Corporation, at 10800 Galaxie Avenue, Ferndale, Michigan 48220; Attention: Chief Executive Officer, e-mail [ ], or such other e-mail or address as the Corporation may specify for such purposes by prior written notice to the Holders delivered in accordance with this Section 12. Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of the Corporation, at the principal place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

18

 

 

b) Absolute Obligation. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.

 

c) Lost or Mutilated Preferred Stock Certificate. If a Holder’s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation.

 

d) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, stockholders, employees or agents) shall be commenced in the state and federal courts sitting in the Borough of Manhattan, New York, New York, (the “New York Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designation or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this Certificate of Designation, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

e) Waiver. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion. Any waiver by the Corporation or a Holder must be in writing.

 

f) Severability. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.

 

g) Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

h) Headings. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit or affect any of the provisions hereof.

 

i) Status of Converted or Redeemed Preferred Stock. Shares of Preferred Stock may only be issued pursuant to a Purchase Agreement. If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Preferred Stock.

 

19

 

 

RESOLVED, FURTHER, that the Chairman, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be and they hereby are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and Limitations in accordance with the foregoing resolution and the provisions of Nevada law.

 

IN WITNESS WHEREOF, the undersigned have executed this Certificate this 10th day of February 2025.

 

/s/ Steve Reinharz  
Name: Steve Reinharz  
Title: CEO  

 

20

 

 

ANNEX A

 

NOTICE OF CONVERSION

 

(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES OF PREFERRED STOCK)

 

The undersigned hereby elects to convert the number of shares of Series C Convertible Preferred Stock indicated below into shares of common stock, par value $0.00001 per share (the “Common Stock”), of ARTIFICAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC., a Nevada corporation (the “ Corporation “), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as may be required by the Corporation in accordance with the Purchase Agreement. No fee will be charged to the Holders for any conversion, except for any such transfer taxes.

 

Conversion calculations:

 

Date to Effect Conversion:    
     
Number of shares of Preferred Stock owned prior to Conversion:    
     
Number of shares of Preferred Stock to be Converted:    
     
Stated Value of shares of Preferred Stock to be Converted:    
     
Dollar amount of Interest to be Converted:    
     
Other amounts owed to the Undersigned by the Corporation under the Certificate of Designation and/or any other Transaction Document to be Converted:    
     
Number of shares of Common Stock to be Issued:    
     
Applicable Conversion Price:    
     
Number of shares of Preferred Stock subsequent to Conversion:    

 

Address for Delivery: ________________________________

 

Or

 

DWAC Instructions:

 

Broker no: ________________

 

Account no: _______________

 

Name of Entity Holder________________________(Please Print)  
   
By:    
Name:    
Title:                                 
     
Name of Individual Holder_____________________(Please Print)  
   
__________________________(Signature of Individual Holder)  

 

21

 

 

Exhibit 4.1

 

 

 

 

 

Exhibit 5.1

 

Frederick M. Lehrer, P. A.

2108 Emil Jahna Road

Clermont, Florida 34711

(561) 706-7646

flehrer@securitiesattorney1.com

 

July 16, 2026

 

Artificial Intelligence Technology Solutions, Inc.

Attn: Board of Directors

 

Re: Artificial Intelligence Technology Solutions, Inc.
  Registration Statement on Form S-1

 

Board of Directors:

 

You have requested my opinion, as counsel, with respect to certain matters in connection with the filing by Artificial Intelligence Technology Solutions, Inc., a Nevada corporation (the “Registrant”), of a Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Act”), including a related prospectus filed with the Registration Statement (the “Prospectus”), covering the resale by Selling Stockholder Trillium Partners LP (“Trillium”) of one billion one hundred and sixty million (1,160,000,000) Common Stock Shares, par value $0.00001 (the “Shares”) to be sold by the Selling Stockholder, Trillium

 

For the purpose of rendering my opinion herein, I have reviewed: (i) the revised statutes of the State of Nevada to the extent I deem relevant to the matters opined upon herein; (ii) copies of the Company’s Articles of Incorporation and amendments thereto; (iii) the Company’s Bylaws, as currently in effect as of the date hereof; (iv) selected proceedings of the Company’s Board of Directors and certificates of the Company’s officers; and (v) such other documents as I have deemed necessary and relevant to the matter opined upon herein.

 

I have assumed the genuineness of all signatures, the conformity to authentic original documents of the copies of all such documents submitted to me as certified, conformed, and photocopied, including the quoted, extracted, excerpted, and reprocessed text of such documents. I have not been engaged to examine, nor have I examined, the Registration Statement for the purpose of determining the accuracy or completeness of the information included therein or the compliance and conformity thereof with the rules and regulations of the SEC or the requirements of Form S-1, and I express no opinion with respect thereto.

 

My opinion is limited to matters of the Nevada Revised Statutes and I do not express an opinion on the federal law of the United States of America or the law of any state or jurisdiction therein other than the State of Nevada, as specified herein.

 

On the basis of the foregoing, and in reliance thereon, I am of the opinion that the Shares being offered pursuant to the Registration Statement will be, when issued and in the manner described in the Registration Statement, validly issued, fully paid and non-assessable Shares.

 

I consent to the use of my opinion as an exhibit to the registration statement and to the reference thereto under the heading “Interests of Named Experts and Counsel” in the prospectus contained in the registration statement.

 

In giving the foregoing consents, I do not thereby admit that my firm comes within the category of persons or entities whose consent is required under Section 7 of the Act or the rules and regulations of the SEC promulgated thereunder.

 

Sincerely,

 

Frederick M. Lehrer, P. A.

 

By: /s/ Frederick M. Lehrer, Esq.  
  Frederick M. Lehrer, Esq.  

 

 

 

 

Exhibit 10.1

 

EQUITY PURCHASE AGREEMENT

 

This EQUITY PURCHASE AGREEMENT entered into as of the 23rd day of June, 2026 (this “Purchase Agreement”), by and between TRILLIUM PARTNERS LP, a Delaware limited partnership (the “Investor”), and Artificial Intelligence Technology Solutions Inc., a Nevada corporation (the “Company”). Investor and Company shall be referred to individually as “Party,” or “Parties” collectively.

 

WHEREAS, the Parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to Investor, from time to time as provided herein, and Investor shall purchase up to Ten Million and 00/100 Dollars ($10,000,000.00) of the Company’s Common Stock (as defined below); and

 

WHEREAS, as partial consideration for the Investor’s commitment hereunder, the Company shall issue to Investor an aggregate Five Million (5,000,000) common shares of the Company’s Common Stock (the “Commitment Shares”), issued in two equal tranches:

 

(i) first tranche of Two Million and Five Hundred Thousand (2,500,000) common shares upon S-1 effectiveness; and the remaining (ii) second tranche of Two Million and Five Hundred Thousand (2,500,000) common shares, issued ninety days later, which Commitment Shares shall be deemed fully earned upon execution of this Agreement.

 

NOW, THEREFORE, the parties hereto agree as follows:

 

Article 1. Certain Definitions

 

Section 1.1 Defined Terms. As used in this Purchase Agreement, the following terms shall have the following meanings specified or indicated (such meanings to be equally applicable to both the singular and plural forms of the terms defined).

 

“Accelerated Put” shall mean a Put elected by the Company pursuant to Section 2.1(b), subject to a forward Valuation Period and the floor price and knock-out mechanics set forth herein.

 

“Accelerated Purchase Price” shall mean, with respect to any Accelerated Put, eighty-five percent (85%) of the average of the three (3) lowest Closing Bid Prices of the Common Stock during the applicable Valuation Period, subject to the Floor Price.

 

“Average Daily Trading Volume” means the average daily trading volume of the Common Stock on the Principal Market for the ten (10) Trading Days immediately preceding the applicable Put Date, as reported by Bloomberg, Quotestream or another mutually agreed reporting service.

 

“Claim” shall mean any claim, demand, action, cause of action, suit, proceeding, investigation, arbitration, or other assertion of liability, whether civil, criminal, administrative, or otherwise, brought by any Person against an Indemnified Party for which indemnification may be sought under this Purchase Agreement.

 

“Closing” shall mean one of the closings of a purchase and sale of shares of Common Stock pursuant to Section 2.3.

 

“Closing Bid Price” means, for any given Trading Day, the last bid price per share of the Common Stock on such Trading Day as reported by the Principal Market, or if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or trading market where the Common Stock is listed or traded, or if no closing bid price is reported, the last closing trade price of the Common Stock on such Trading Day, or if no closing trade price is reported, the last reported bid price of the Common Stock on such Trading Day; provided, however, that if the Common Stock is not listed or traded on any exchange or trading market, the Closing Bid Price shall be determined in good faith by the Board of Directors of the Company.

 

“Closing Certificate” shall mean the closing certificate of the Company in the form of Exhibit B hereto.

 

“Closing Price” shall mean the closing bid price for the Company’s common stock on the Principal Market on a Trading Day as reported by Quotestream.

 

 

 

 

“Commitment Period” shall mean the period commencing on the Effective Date, and ending on the earlier of (i) the date on which Investor shall have purchased Put Shares pursuant to this Purchase Agreement for an aggregate Purchase Price of the Maximum Commitment Amount, or (ii) the date occurring thirty-six (36) months from the date of commencement of the Commitment Period.

 

“Commitment Stock” shall mean the Five Million (5,000,000) restricted shares of Common Stock to be issued by the Company to Investor as consideration for Investor’s purchase commitment hereunder, issuable in two equal tranches:

 

(i) Two Million Five Hundred Thousand (2,500,000) shares upon the date the Registration Statement is declared effective by the SEC (the “First Commitment Tranche”), and (ii) Two Million Five Hundred Thousand (2,500,000) shares on the date that is ninety (90) days following the effectiveness of the Registration Statement (the “Second Commitment Tranche”), each tranche to be registered in the Registration Statement.

 

“Common Stock” shall mean the Company’s common stock, $0.0001 par value per share, as authorized pursuant to the Company’s Articles of Incorporation and Bylaws, as each may be amended, restated, or otherwise modified from time to time in accordance with the laws of the State of Nevada, and any shares of any other class of common stock whether now or hereafter authorized by the Company’s Board of Directors or stockholders, having the right to participate in the distribution of dividends (as and when declared by the Board of Directors in its sole discretion and subject to any preferences, limitations, or restrictions set forth in the Articles of Incorporation, as amended), assets (upon liquidation, dissolution, or winding up of the Company, and subject to the prior rights of any preferred stockholders or other senior classes of stock), and any other monetary or economic rights associated with the Common Stock as set forth in, or as may be modified by, the Company’s Articles of Incorporation or Bylaws from time to time; provided, however, that any material amendment to the Articles of Incorporation or Bylaws that adversely affects the rights of the Investor with respect to the Common Stock held or to be acquired hereunder shall require prior written notice to the Investor in accordance with the notice provisions of this Purchase Agreement on

 

Article 6.

 

“Damages” shall mean any loss, claim, damage, liability, cost and expense (including, without limitation, reasonable attorneys’ fees and disbursements and costs and expenses of expert witnesses and investigation).

 

“Effective Date” shall mean the date that the Registration Statement is declared effective by the SEC.

 

“Estimated Shares” shall mean, solely in connection with an Accelerated Put, the number of shares of Common Stock to be delivered by the Company to Investor’s brokerage account equal to one hundred twenty-five percent (125%) of the applicable Investment Amount divided by the Closing Bid Price for the Trading Day immediately prior to the Put Notice Date. No Estimated Shares shall be required in connection with a Regular Put.

 

“Exchange Act” shall mean the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder.

 

“FINRA” shall mean the Financial Industry Regulatory Authority, Inc.

 

“Investment Amount” shall mean, with respect to any Put, the dollar amount specified by the Company in the applicable Put Notice that the Company elects to receive from Investor in exchange for the issuance of Put Shares, determined in accordance with Section 2.2. Notwithstanding, such amount shall not be (i) less than the Minimum Purchase Amount, (ii) more than the Maximum Purchase Amount, or (iii) result in the Investor’s Beneficial Ownership Cap of the Common Stock exceeding the ownership limitation set forth herein

 

“Material Adverse Effect” shall mean any effect on the business, operations, properties, or financial condition of the Company that is material and adverse to the Company and/or any condition, circumstance, or situation that would prohibit or otherwise materially interfere with the ability of the Company to enter into and perform its obligations under any of this Purchase Agreement.

 

“Maximum Commitment Amount” shall mean Ten Million Dollars ($10,000,000).

 

“Person” shall mean an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.

 

 

 

 

“Principal Market” shall mean any of the national exchanges (i.e. NYSE, NYSE AMEX, Nasdaq), OTCQX, OTCQB, the OTC Bulletin Board, or other principal exchange which is at the time the principal trading exchange or market for the Common Stock.

 

“Put” shall mean the right of the Company to require the Investor to purchase shares of Common Stock pursuant to either a Regular Put or an Accelerated Put, subject to the terms and conditions of this Purchase Agreement. The Company shall specify the elected Put type in each Put Notice; if no election is specified, the Put shall be deemed a Regular Put.

 

“Put Date” shall mean any Trading Day during the Commitment Period that a Put Notice is deemed delivered pursuant to Section 2.2(b).

 

“Put Notice” shall mean a written notice, substantially in the form of Exhibit A hereto, to Investor setting forth the Investment Amount with respect to which the Company intends to require Investor to purchase shares of Common Stock pursuant to the terms of this Purchase Agreement.

 

“Put Notice Date” shall mean the Trading Day on which a Put Notice is deemed delivered to Investor in accordance with Section 2.2(b).

 

“Put Shares” shall mean all shares of Common Stock issued or issuable pursuant to a Put that has been exercised or may be exercised in accordance with the terms and conditions of this Purchase Agreement.

 

“Registrable Securities” shall mean (a) the Put Shares, (b) the Commitment Shares, and (c) any securities issued or issuable with respect to any of the foregoing by way of exchange, stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise. As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when:

 

(i) a Registration Statement covering such Registrable Securities has been declared effective by the SEC and such Registrable Securities have been disposed of pursuant to such Registration Statement;

 

(ii) such Registrable Securities have been sold pursuant to Rule 144 under the Securities Act;

 

(iii) such Registrable Securities have been otherwise transferred and the Company has delivered new certificates or other evidence of ownership for such securities not bearing a restrictive legend and not subject to any transfer restrictions under the Securities Act; or (iv) such Registrable Securities are eligible for resale without restriction pursuant to Rule 144 (including without volume, manner-of-sale or current public information requirements).

 

“Registration Statement” shall mean the Company’s effective registration statement on file with the SEC, and any follow up registration statement or amendment thereto.

 

“Regular Purchase Price” shall mean, with respect to any Regular Put, eighty-five percent (85%) of the average of the three (3) lowest Closing Bid Prices of the Common Stock during the ten (10) consecutive Trading Days immediately preceding (but not including) the applicable Put Date.

 

“Regular Put” shall mean a Put elected by the Company pursuant to Section 2.1(a), subject to lookback pricing based on the ten (10) Trading Days immediately preceding the Put Date.

 

“Regulation D” shall mean Regulation D promulgated under the Securities Act.

 

“SEC” shall mean the Securities and Exchange Commission.

 

“Securities Act” shall mean the Securities Act of 1933 and the rules and regulations promulgated thereunder.

 

“SEC Documents” shall mean, as of a particular date, all reports and other documents filed by the Company pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the Company’s then most recently completed and reported fiscal year as of the time in question (provided that if the date in question is within ninety days of the beginning of the Company’s fiscal year, the term shall include all documents filed since the beginning of the preceding fiscal year).

 

 

 

 

“Short Sales” shall have the meaning as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).

 

“Signing Date” shall mean the date on which this Purchase Agreement is executed and delivered by both the Company and the Investor, as first set forth on the signature page hereof.

 

“Trading Day” shall mean a day on which the Principal Market shall be open for business.

 

“Transaction Documents” shall mean this Purchase Agreement and the RRA Purchase Agreement.

 

“Transfer Agent” shall mean the transfer agent for the Common Stock (and to any substitute or replacement transfer agent for the Common Stock upon the Company’s appointment of any such substitute or replacement transfer agent).

 

“Valuation Period” shall mean, solely with respect to an Accelerated Put, the period of ten (10) consecutive Trading Days commencing on the first Trading Day following the applicable Put Date. At the end of the Valuation Period, (i) if the number of Estimated Shares delivered to Investor exceeds the actual number of Put Shares issuable pursuant to the applicable Put Notice, Investor shall promptly return to the Company shares equal to such excess via DWAC; and (ii) if the number of Estimated Shares is less than the actual number of Put Shares issuable, the Company shall promptly issue to Investor additional shares equal to such shortfall.

 

Article 2. Purchase and Sale of Common Stock

 

Section 2.1 Puts. Upon the terms and conditions set forth herein (including, without limitation, the provisions of Article 5), on any Put Date the Company may exercise a Put by the delivery of a Put Notice, substantially in the form attached hereto as Exhibit A. The Company shall elect in each Put Notice whether such Put is a Regular Put or an Accelerated Put. If no election is specified, the Put shall be deemed a Regular Put. The number of Put Shares that Investor shall purchase pursuant to such Put shall be determined by dividing the Investment Amount specified in the Put Notice by the applicable Purchase Price (a) Regular Put. The Company may deliver a Regular Put Notice at any time during the Commitment Period, subject to the conditions set forth in Section 5.2, provided that at least five (5) Trading Days have elapsed since the delivery of the immediately preceding Put Notice of any type. The Regular Purchase Price and the number of Regular Put Shares shall be determined as of the Put Date. No Estimated Shares shall be required in connection with a Regular Put, and no post-Closing adjustment shall apply.

 

(b) Accelerated Put. The Company may deliver an Accelerated Put Notice at any time during the Commitment Period, subject to the conditions set forth in Section 5.2, provided that (i) at least five (5) Trading Days have elapsed since the delivery of the immediately preceding Put Notice of any type, and (ii) no Valuation Period from a prior Accelerated Put is then active. Concurrently with the delivery of each Accelerated Put Notice, the Company shall deliver the applicable Estimated Shares to Investor’s brokerage account. The Accelerated Purchase Price and the number of Accelerated Put Shares shall be determined at the end of the applicable Valuation Period.

 

Section 2.2 Mechanics.

 

(a) Put Notice. At any time and from time to time during the Commitment Period, the Company may deliver a Put Notice to Investor, subject to the conditions set forth in Section 5.2; provided, however, that (i) the Investment Amount identified in the applicable Put Notice, when taken together with all prior Put Notices, shall not exceed the Maximum Commitment Amount;

 

(ii) the Investment Amount for any single Put Notice shall not exceed two hundred fifty percent (250%) of the Average Daily Trading Volume of the Common Stock for the ten (10) Trading Days immediately preceding the Put Notice Date, multiplied by the Purchase Price;

 

(iii) the Company shall not deliver a Put Notice during an active Valuation Period for any previous Put Notice;

 

 

 

 

(iv) the Company shall not deliver a Put Notice unless at least five (5) Trading Days have elapsed since the delivery of the immediately preceding Put Notice; and (v) the Company shall not deliver an Accelerated Put Notice if, after giving effect to the issuance of the Estimated Shares to be delivered in connection therewith, the Investor together with its affiliates would beneficially own in excess of 4.99% of the then issued and outstanding shares of Common Stock, as calculated pursuant to Section 13(d) of the Exchange act and Rule 13d-3 promulgated thereunder (the “Beneficial Ownership Cap”). For the avoidance of doubt, the Beneficial Ownership limitation applicable to Regular Puts shall be calculated based on the Put Shares issuable at the applicable Regular Purchase Price rather than Estimated shares. For purposes of this subsection (v), the number of shares of Common Stock beneficially owned by the Investor shall include the Estimated Shares to be delivered pursuant to such Put Notice but shall exclude any shares of the Common Stock issuable upon exercise or conversion of any unexercised or unconverted portion of any securities of the Company held by the Investor that are subject to a limitation on conversion or exercise analogous to this provision. Concurrently with the delivery of each Accelerated Put Notice, the Company shall deliver the applicable Estimated Shares to Investor’s brokerage account. No Estimated Shares shall be required in connection with a Regular Put Notice.

 

(b) Date Of Delivery Of Put Notice. A Put Notice shall be deemed delivered on (i) the Trading Day it is received by Investor, whether electronically or physically (by mail or in person), if such notice is received on or prior to 12:00 noon Nevada time, or (ii) the immediately succeeding Trading Day if it is received whether electronically or physically (by mail or in person), after 12:00 noon Nevada time on a Trading Day or at any time on a day which is not a Trading Day.

 

Section 2.3 Closings.

 

(a) Determination of Purchase Price.

 

(i) Regular Put Purchase Price. With respect to each Regular Put, the purchase price shall equal the Regular Purchase Price, determined as of the Put Date. The Regular Put is not subject to a Valuation Period, a Floor Price, or any post-Closing adjustment.

 

(ii) Accelerated Put Purchase Price; Floor Price; Knock-Out Mechanic. With respect to each Accelerated Put, the purchase price shall equal the Accelerated Purchase Price, determined at the end of the Valuation Period. Each Accelerated Put is subject to a minimum floor price (the “Floor Price”) equal to the greater of: (A) seventy-five percent (75%) of the Closing Bid Price of the Common Stock on the applicable Put Date; or (B) any higher minimum price per share specified by the Company in the applicable Accelerated Put Notice. In the event that during a Valuation Period the Closing Bid Price on any Trading Day is less than the Floor Price (each such Trading Day, a “Low Price Day”), then for each such Low Price Day the parties shall have no right to sell and shall be under no obligation to purchase one-tenth (1/10th) of the Investment Amount specified in the applicable Put Notice, and the Investment Amount shall be deemed reduced accordingly. In the event that three (3) Low Price Days occur during any Valuation Period, the balance of each party’s right and obligation to sell and purchase the remaining Investment Amount under such Put Notice shall terminate on such third Low Price Day (the “Termination Day”), and the Investment Amount shall be adjusted to include only one- tenth (1/10th) of the initial Investment Amount for each Trading Day during the Valuation Period prior to the Termination Day on which the Closing Bid Price equaled or exceeded the Floor Price.

 

(b) Calculation of Put Shares. The number of Put Shares to be purchased by Investor with respect to a Put shall be determined by dividing the Investment Amount set forth in the applicable Put Notice by the Purchase Price.

 

(c) Regular Put Closing. The closing of each Regular Put shall occur no later than one (1) Trading Day following the applicable Put Date. At each Regular Put Closing, simultaneously:

 

(i) the Company shall deliver the applicable Put Shares to Investor’s brokerage account via DWAC through the Depository Trust Company (DTC) system; and (ii) Investor shall deliver to the Company the Investment Amount by wire transfer of immediately available funds to an account designated by the Company. The Company shall not be required to deliver Put Shares prior to the receipt of the Investment Amount. The Purchase Price and number of Put Shares for a Regular Put are determined as of the Put Date and are not subject to post-Closing adjustment.

 

(d) Closing. The closing of each Put (each, a “Closing”) shall occur on a Trading Day mutually agreed upon by the parties, but in no event later than five (5) Trading Days following the applicable Put Date (the “Closing Date”). At each Closing:

 

(i) The Company shall deliver the Put Shares to Investor’s brokerage account via DWAC through the Depository Trust Company system; and (ii) Investor shall deliver to the Company the Investment Amount by wire transfer or immediately available funds to an account designated by the Company.

 

 

 

 

(e) Delivery Mechanics. Delivery of Put Shares via DWAC to Investor’s brokerage account shall occur prior to or contemporaneously with Investor’s obligation to deliver the Investment Amount.

 

(f) Valuation Period; True-Up. The Purchase Price shall be determined at the end of the Valuation Period in accordance with the definition thereof. The Investor shall wire the applicable Investment Amount to the Company no later than one (1) Trading Date following the end of the Valuation Period. Failure by Investor to timely fund any Investment Amount shall constitute a material default entitling the Company to the remedies set forth in this Purchase Agreement, including, without limitation, termination.

 

(g) Settlement Default.

 

(i) Investor Default. If Investor fails to deliver the Investment Amount for any Put Shares in accordance with this

 

Section 2.3 on the applicable Closing Date following receipt of such Put Shares, such failure shall constitute a material breach of this Purchase Agreement and an Event of Default under Section 8.1(a), entitling the Company to exercise all rights and remedies set forth in

 

Section 8.2 hereof.

 

(ii) Company Default. If the Company fails to deliver the Put Shares in accordance with this

 

Section 2.3 on the applicable Closing Date, such failure shall constitute a material breach of this Purchase Agreement and an Event of Default under Section 8.1(a), entitling the Investor to exercise all rights and remedies set forth in

 

Section 8.2 hereof, including without limitation the right to seek specific performance and recovery of direct damages.

 

Article 3. Representations and Warranties

 

Section 3.1 Representations and Warranties by the Investor. Investor represents and warrants to the Company that:

 

(a) Investment Intent and Resale. Investor is acquiring the Registrable Securities for its own account in the ordinary course of its business. Investor acknowledges that the Put Shares and Commitment Shares are being acquired in transactions not involving a public offering and that such securities are restricted securities under applicable federal securities laws. Investor understands and acknowledges that it may resell the Registrable Securities only pursuant to an effective Registration Statement under the Securities Act, in compliance with the exemption provided by Rule 144 thereunder, or pursuant to another available exemption from the registration requirements of the Securities Act. Investor has no present arrangement to sell the Registrable Securities to or through any specific person or entity in a transaction that would constitute a distribution within the meaning of the Securities Act; provided, however, that Investor reserves the right to dispose of the Registrable Securities at any time and in any manner in compliance with applicable federal and state securities laws, the rules and regulations of FINRA, and the rules of the Principal Market, including without limitation pursuant to the Registration Statement to be filed in accordance with the Registration Rights Agreement.

 

(b) No Legal Advice from the Company. The Investor acknowledges that it has had the opportunity to review this Purchase Agreement and the transactions contemplated by this Purchase Agreement with its own legal counsel and investment and tax advisors. The Investor is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of its representatives or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated by this Purchase Agreement or the securities laws of any jurisdiction.

 

(c) Accredited Investor. Investor is a sophisticated investor (as described in Rule 506(b)(2)(ii) of Regulation D) and an accredited investor (as defined in Rule 501 of Regulation D), and Investor has such experience in business and financial matters that it is capable of evaluating the merits and risks of an investment in the Registrable Securities. Investor acknowledges that an investment in the Registrable Securities is speculative and involves a high degree of risk.

 

 

 

 

(d) Authority.

 

(i) Investor has the requisite power and authority to enter into and perform its obligations under this Purchase Agreement and the transactions contemplated hereby in accordance with its terms;

 

(ii) the execution and delivery of this Purchase Agreement and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action and no further consent or authorization of Investor or its partners is required; and (iii) this Purchase Agreement has been duly authorized and validly executed and delivered by Investor and constitutes a valid and binding obligation of Investor enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

 

(e) Not an Affiliate. Investor is not an officer, director or “affiliate” (as that term is defined in Rule 405 of the Securities Act) of the Company.

 

(f) Organization and Standing. Investor is a limited partnership duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Investor is duly qualified and in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, other than those in which the failure so to qualify would not have a material adverse effect on Investor.

 

(g) Absence of Conflicts. The execution and delivery of this Purchase Agreement and any other document or instrument contemplated hereby, and the consummation of the transactions contemplated hereby and thereby, and compliance with the requirements hereof and thereof, will not (a) violate any law, rule, regulation, order, writ, judgment, injunction, decree or award binding on Investor, (b) violate any provision of any indenture, instrument or Purchase Agreement to which Investor is a party or is subject, or by which Investor or any of its assets is bound, or conflict with or constitute a material default thereunder, (c) result in the creation or imposition of any lien pursuant to the terms of any such indenture, instrument or Purchase Agreement, or constitute a breach of any fiduciary duty owed by Investor to any third party, or (d) require the approval of any third-party (that has not been obtained) pursuant to any material contract, instrument, Purchase Agreement, relationship or legal obligation to which Investor is subject or to which any of its assets, operations or management may be subject.

 

(h) Disclosure; Access to Information. Investor had an opportunity to review copies of the SEC Documents filed on behalf of the Company and has had access to all publicly available information with respect to the Company.

 

(i) Manner of Sale. At no time was Investor presented with or solicited by or through any leaflet, public promotional meeting, television advertisement or any other form of general solicitation or advertising.

 

(j) Financial Ability. On the date hereof, Investor has and will have sufficient cash or cash equivalents available, directly or through one or more affiliates, to pay the Purchase Price for up to the Maximum Commitment Amount in connection with any Put by the Company during the term of this Purchase Agreement.

 

Section 3.2 Representations and Warranties by the Company. Company represents and warrants to the Investor that:

 

(a) Organization of the Company. The Company is a corporation duly organized and validly existing and in good standing under the laws of the State of Nevada and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted. The Company is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, other than those in which the failure so to qualify would not have a Material Adverse Effect.

 

(b) Authority.

 

(i) the Company has the requisite corporate power and authority to enter into and perform its obligations under this Purchase Agreement and to issue the Put Shares;

 

 

 

 

(ii) the execution and delivery of this Purchase Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action and no further consent or authorization of the Company or its Board of Directors or stockholders is required; and (iii) each of this Purchase Agreement and has been duly executed and delivered by the Company and constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

 

(c) Capitalization. As of June 15, 2026, the authorized capital stock of the Company consists of 27,500,000,000 shares of Common Stock, $0.0001 par value per share, of which 387,232,589 shares were issued and outstanding. Except as otherwise disclosed in the SEC Documents or on Schedule 4.3, there are no outstanding securities which are convertible into shares of Common Stock, whether such conversion is currently exercisable or exercisable only upon some future date or the occurrence of some event in the future. All of the outstanding shares of Common Stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable.

 

(d) Common Stock. The Company is in full compliance with all reporting requirements of the Exchange Act. The Company’s Common Stock is currently listed on the Principal Market.

 

(e) SEC Documents. The Company may make available to Investor true and complete copies of the SEC Documents (including, without limitation, proxy information and solicitation materials). To the Company’s knowledge, the Company has not provided to Investor any information that, according to applicable law, rule or regulation, should have been disclosed publicly prior to the date hereof by the Company, but which has not been so disclosed. As of their respective dates, the SEC Documents complied in all material respects with the requirements of the Exchange Act, and other federal laws, rules and regulations applicable to such SEC Documents, and none of the SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Documents comply as to form and substance in all material respects with applicable accounting requirements and the published rules and regulations of the SEC or other applicable rules and regulations with respect thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the periods involved (except (a) as may be otherwise indicated in such financial statements or the notes thereto or (b) in the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

 

(f) Valid Issuances. When issued and paid for as herein provided, the Put Shares shall be duly and validly issued, fully paid, and non-assessable. The sales of the Put Shares pursuant to this Purchase Agreement, and the Company’s performance of its obligations hereunder, shall not (a) result in the creation or imposition of any liens, charges, claims or other encumbrances upon the Put Shares, or any of the assets of the Company, or (b) entitle the holders of outstanding shares of Common Stock to preemptive or other rights to subscribe to or acquire the Common Stock or other securities of the Company. The Put Shares shall not subject Investor to personal liability, in excess of the subscription price by reason of the ownership thereof.

 

(g) No Conflicts. The execution, delivery and performance of this Purchase Agreement by the Company and the consummation by the Company of the transactions contemplated hereby, including without limitation the issuance of the Put Shares, do not and will not (a) result in a violation of the Company’s Articles of Incorporation or Bylaws or (b) conflict with, or constitute a material default (or an event that with notice or lapse of time or both would become a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material Purchase Agreement, indenture, instrument or any “lock-up” or similar provision of any underwriting or similar Purchase Agreement to which the Company is a party, or (c) result in a violation of any federal, state or local law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable to the Company or by which any property or asset of the Company is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect) nor is the Company otherwise in violation of, conflict with or in default under any of the foregoing. The business of the Company is not being conducted in violation of any law, ordinance or regulation of any governmental entity, except for possible violations that either singly or in the aggregate do not and will not have a Material Adverse Effect. The Company is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Purchase Agreement or issue and sell the Common Stock in accordance with the terms hereof (other than any SEC, FINRA or state securities filings that may be required to be made by the Company subsequent to any Closing, any registration statement that may be filed pursuant hereto); provided that, for purposes of the representation made in this sentence, the Company is assuming and relying upon the accuracy of the relevant representations and Purchase Agreements of Investor herein.

 

 

 

 

(h) No Material Adverse Change. As of the date of this Purchase Agreement no event has occurred that would have a Material Adverse Effect on the Company.

 

(i) Litigation and Other Proceedings. Except as disclosed in the Company’s SEC filings, there are no lawsuits or proceedings pending or to the knowledge of the Company threatened, against the Company, nor has the Company received any written or oral notice of any such action, suit, proceeding or investigation, which would have a Material Adverse Effect. No judgment, order, writ, injunction or decree or award has been issued by or, so far as is known by the Company, requested of any court, arbitrator or governmental agency which would have a Material Adverse Effect.

 

(j) Dilution. The number of shares of Common Stock issuable as Put Shares may increase substantially in certain circumstances, including, but not necessarily limited to, the circumstance wherein the trading price of the Common Stock declines during the period between the Effective Date and the end of the Commitment Period. The Company’s executive officers and directors have studied and fully understand the nature of the transactions contemplated by this Purchase Agreement and recognize that they have a potential dilutive effect. The board of directors of the Company has concluded in its good faith business judgment that such issuance is in the best interests of the Company. The Company specifically acknowledges that, subject to this Purchase Agreement, its obligation to issue the Put Shares is binding upon the Company and enforceable regardless of the dilution such issuance may have on the ownership interests of other shareholders of the Company.

 

(k) Transfer Agent. The Company represents and warrants that (a) its account with its transfer agent is current and in good standing, (b) all fees and balances owed to its transfer agent have been paid in full and are not past due as of the date of this Purchase Agreement, and (c) there are no outstanding disputes with its transfer agent that would reasonably be expected to impair or delay the delivery of Put Shares or Estimated Shares pursuant to this Purchase Agreement. The Company shall maintain its transfer agent account in good standing throughout the Commitment Period and shall promptly notify Investor in writing in the event that any such account becomes delinquent or any dispute arises with the transfer agent that could reasonably be expected to affect the delivery of shares hereunder.

 

(l) Commitment Stock. As additional consideration for Investor’s purchase commitment hereunder, the Company shall issue to Investor the Commitment Stock as follows:

 

(i) the First Commitment Tranche of Two Million Five Hundred Thousand (2,500,000) restricted shares of Common Stock shall be issued upon the date the Registration Statement is declared effective by the SEC; and (ii) the Second Commitment Tranche of Two Million Five Hundred Thousand (2,500,000) restricted shares of Common Stock shall be issued on the date that is ninety (90) days following the effectiveness of the Registration Statement. Upon issuance, each tranche of Commitment Shares shall be duly and validly issued, fully paid, and non-assessable, free and clear of all liens, claims, charges, encumbrances, and restrictions of any kind, except for applicable restrictions under federal and state securities laws and the restrictive legend to be placed thereon pending registration for resale. Both tranches of Commitment Shares shall be registered for resale by Investor in the Registration Statement pursuant to the Registration Rights Agreement. The failure of the Company to timely issue either tranche of Commitment Shares shall constitute an Event of Default under

 

Section 8.1 hereof.

 

(m) DTC and DWAC Eligibility.

 

(i) The Company’s Common Stock is eligible for electronic delivery through the Depository Trust Company (“DTC”) and the Company’s transfer agent is a DTC participant in good standing, authorized and able to process DWAC (Deposit and Withdrawal at Custodian) transfers with respect to the Common Stock as of the date of this Purchase Agreement;

 

 

 

 

(ii) the Company has no knowledge of any pending or threatened action, inquiry, or proceeding by DTC, its transfer agent, or any governmental or regulatory authority that would reasonably be expected to result in the suspension, termination, or impairment of the Company’s DTC eligibility or DWAC transfer capability;

 

(iii) the Company’s transfer agent has received, or will receive prior to the initial Closing, all necessary authorizations and instructions required to process DWAC transfers of Put Shares and Commitment Shares to Investor’s brokerage account in accordance with this Purchase Agreement; and (iv) the Company shall use its commercially reasonable efforts to maintain its DTC eligibility and DWAC transfer capability throughout the entire Commitment Period, and shall promptly notify Investor in writing within two (2) Trading Days in the event that the Company’s DTC eligibility or DWAC transfer capability is suspended, terminated, or otherwise impaired for any reason.

 

Article 4. Covenants

 

Section 4.1 Covenants of the Investor. Investor covenants to the Company:

 

(a) Compliance with Law; Trading in Securities. Investor’s trading activities with respect to shares of the Common Stock will be in compliance with all applicable state and federal securities laws, rules and regulations and the rules and regulations of FINRA and the Principal Market on which the Common Stock is listed or quoted.

 

(b) Short Sales and Confidentiality. Neither Investor nor any affiliate of the Investor acting on its behalf or pursuant to any understanding with it will execute any Short Sales of the Common Stock during the period from the date hereof to the end of the Commitment Period; provided, however, that the following shall not constitute Short Sales for purposes of this Section 4.1(b):

 

(i) the sale of shares of Common Stock by Investor after the delivery of a Put Notice, in a number not to exceed the number of Put Shares reasonably expected to be issued pursuant to such Put Notice, calculated based on the Closing Bid Price on the Trading Day immediately preceding the Put Notice Date;

 

(ii) the sale of shares of Common Stock by Investor that are held in Investor’s brokerage account at the time of such sale, including without limitation any Estimated Shares previously delivered to Investor pursuant to Section 2.2(a) or any Put Shares or Commitment Shares registered for resale pursuant to the Registration Statement; and (iii) any hedging or similar transaction by Investor or its affiliates that does not involve the direct sale or transfer of shares of Common Stock of the Company, provided that such transaction does not violate applicable securities laws or the rules of the Principal Market.

 

(c) For the avoidance of doubt, and in accordance with Regulation SHO under the Exchange Act, any sale by Investor of shares of Common Stock that Investor owns or has an unconditional right to receive at the time of such sale shall not constitute a Short Sale for purposes of this Purchase Agreement, regardless of the timing of actual settlement or delivery of such shares.

 

(d) Investor agrees to maintain the confidentiality of all non-public disclosures made to it in connection with this transaction, including the existence and terms of this transaction, other than disclosures to its legal counsel, investment advisors, and affiliates on a need-to-know basis, or as required by applicable law or regulation.

 

Section 4.2 Covenants of the Company. Company covenants to the Investor:

 

(a) Reservation of Common Stock. The Company will, from time to time as needed in advance of a Closing Date, reserve and keep available until the consummation of such Closing, free of preemptive rights sufficient shares of Common Stock for the purpose of enabling the Company to satisfy its obligation to issue the Put Shares and the Commitment Stock to be issued in connection therewith. The number of shares so reserved from time to time, as theretofore increased or reduced as hereinafter provided, may be reduced by the number of shares actually delivered hereunder.

 

(b) Listing of Common Stock. If the Company applies to have the Common Stock traded on any other Principal Market, it shall include in such application the Put Shares, and shall take such other action as is necessary or desirable in the reasonable opinion of Investor to cause the Common Stock to be listed on such other Principal Market as promptly as possible. Subject to Section 3.2, the Company shall use its commercially reasonable efforts to continue the listing and trading of the Common Stock on the Principal Market (including, without limitation, maintaining sufficient net tangible assets) and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the FINRA and the Principal Market.

 

 

 

 

(c) Certain Purchase Agreements. So long as this Purchase Agreement remains in effect, the Company covenants and agrees that it will not, without the prior written consent of the Investor, enter into any other equity line of credit Purchase Agreement with a third party during the first one hundred eighty (180) days of the Commitment Period having terms and conditions substantially comparable to this Purchase Agreement. After such 180-day period, the Company is free to enter into other such agreements as it desires without the Investor’s consent. For the avoidance of doubt, nothing contained in the Transaction Documents shall restrict, or require the Investor’s consent for, any Purchase Agreement providing for the issuance or distribution of any equity securities pursuant to any Purchase Agreement or arrangement that is not commonly understood to be an “equity line of credit.”

 

Article 5. Conditions Precedent to Delivery of Put Notices and Conditions to Closing

 

Section 5.1 Conditions Precedent to the Obligation of the Company to Issue and Sell Common Stock. The obligation hereunder of the Company to issue and sell the Put Shares to Investor is subject to the satisfaction of each of the conditions set forth below.

 

(a) Accuracy of Investor’s Representations and Warranties. The representations and warranties of Investor shall be true and correct in all material respects as of the date of this Purchase Agreement and as of the date of each such Closing as though made at each such time.

 

(b) Performance by Investor. Investor shall have performed, satisfied and complied in all respects with all covenants, Purchase Agreements and conditions required by this Purchase Agreement to be performed, satisfied or complied with by Investor at or prior to such Closing.

 

(c) Principal Market Regulation. The Company shall not issue any Put Shares, and the Investor shall not have the right to receive any Put Shares, if the issuance of such shares would exceed the aggregate number of shares of Common Stock which the Company may issue without breaching the Company’s obligations under the rules or regulations of the Principal Market (the “Exchange Cap”).

 

Section 5.2 Conditions Precedent to the Right of the Company to Deliver a Put Notice and the Obligation of Investor to Purchase Put Shares. The right of the Company to deliver a Put Notice and the obligation of Investor hereunder to acquire and pay for the Put Shares is subject to the satisfaction of each of the following conditions:

 

(a) Effective Registration Statement. The Registration Statement, and any amendment or supplement thereto, shall remain effective for the sale by Investor of the Registrable Securities subject to such Put Notice, and (i) neither the Company nor Investor shall have received notice that the SEC has issued or intends to issue a stop order with respect to such Registration Statement or that the SEC otherwise has suspended or withdrawn the effectiveness of such Registration Statement, either temporarily or permanently, or intends or has threatened to do so and (ii) no other suspension of the use or withdrawal of the effectiveness of such Registration Statement or related prospectus shall exist.

 

(b) Accuracy of the Company’s Representations and Warranties. The representations and warranties of the Company shall be true and correct in all material respects (except for representations and warranties specifically made as of a particular date), except for any conditions which have temporarily caused any representations or warranties herein to be incorrect and which have been corrected with no continuing impairment to the Company or Investor.

 

(c) Performance by the Company. The Company shall have performed, satisfied and complied in all material respects with all covenants, Purchase Agreements and conditions required by this Purchase Agreement to be performed, satisfied or complied with by the Company.

 

(d) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or adopted by any court or governmental authority of competent jurisdiction that prohibits or directly and materially adversely affects any of the transactions contemplated by this Purchase Agreement, and no proceeding shall have been commenced that may have the effect of prohibiting or materially adversely affecting any of the transactions contemplated by this Purchase Agreement.

 

 

 

 

(e) Adverse Changes. Since the date of filing of the Company’s most recent SEC Document, no event that had or is reasonably likely to have a Material Adverse Effect has occurred.

 

(f) No Suspension of Trading in or Delisting of Common Stock. The trading of the Common Stock shall not have been suspended by the SEC, the Principal Market or the FINRA and the Common Stock shall have been approved for listing or quotation on and shall not have been delisted from the Principal Market; provided, however, if the Common Stock is delisted from its current Principal Market but subsequently listed or quoted on a different Principal Market, the right of the Company to issue and sell the Put Shares to Investor shall be revived and this condition precedent shall be considered satisfied.

 

(g) Commitment Stock. The First Commitment Tranche of the Commitment Stock shall have been duly issued to Investor upon effectiveness of the Registration Statement in accordance with this Purchase Agreement. The Second Commitment Tranche shall be issued no later than ninety (90) days following such effectiveness.

 

(h) Five Percent Limitation. On each Closing Date, the number of Put Shares then to be purchased by Investor shall not exceed the number of such shares that, when aggregated with all other shares of Common Stock then owned by Investor beneficially or deemed beneficially owned by Investor, would result in Investor owning more than the Beneficial Ownership Cap. For purposes of this Section, in the event that the amount of Common Stock outstanding as determined in accordance with Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder is greater on a Closing Date than on the date upon which the Put Notice associated with such Closing Date is given, the amount of Common Stock outstanding on such Closing Date shall govern for purposes of determining whether Investor, when aggregating all purchases of Common Stock made pursuant to this Purchase Agreement, would own more than 4.99% of the Common Stock following such Closing Date.

 

(i) Principal Market Regulation and Regulatory Limitations. The Company shall not issue any Put Shares, and the Investor shall not have the right to receive any Put Shares (i), if the issuance of such shares would exceed the Exchange Cap or (ii) violate any applicable governmental regulatory restrictions.

 

(j) No Knowledge. The Company shall have no knowledge of any event more likely than not to have the effect of causing such Registration Statement to be suspended or otherwise ineffective (which event is more likely than not to occur within the five (5) Trading Days following the Trading Day on which such Put Notice is deemed delivered).

 

(k) No Violation of Shareholder Approval Requirement. The issuance of shares of Common Stock with respect to the applicable Closing, if any, shall not violate the shareholder approval requirements of the Principal Market.

 

(l) DTC and DWAC Eligibility. As of each Put Notice Date and each Closing Date, the Company’s Common Stock shall remain eligible for electronic delivery through DTC and the Company’s transfer agent shall remain authorized and able to process DWAC transfers with respect to the Put Shares to be delivered pursuant to the applicable Put Notice. In the event the Company loses DTC eligibility or DWAC transfer capability, the Company shall promptly notify Investor and the right of the Company to deliver Put Notices shall be suspended until such eligibility and capability is restored and confirmed in writing to Investor.

 

(m) Other. On the date of delivery of each Put Notice, Investor shall have received a certificate in substantially the form and substance of Exhibit B hereto, executed by an executive officer of the Company and to the effect that all the conditions to such Closing shall have been satisfied as at the date of each such certificate.

 

Article 6. Notice

 

Section 6.1 Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and delivered by one of the following methods:

 

(a) personal delivery;

 

(b) registered or certified United States mail, return receipt requested, postage prepaid;

 

 

 

 

(c) reputable overnight courier service, charges prepaid; or (d) electronic mail in PDF or other legible format, provided that the sending party receives written or electronic confirmation of receipt. Notices shall be deemed effective:

 

(i) upon personal delivery;

 

(ii) upon confirmed electronic mail delivery, if sent before 5:00 p.m. Eastern Time on a Business Day, otherwise on the next succeeding Business Day;

 

(iii) one (1) Business Day after deposit with an overnight courier; or (iv) five (5) Business Days after deposit in the United States mail. Either party may update its notice information by providing at least ten (10) days prior written notice to the other party in accordance with this Section 6.1. The addresses for such communications shall be: If to the Company: Artificial Intelligence Technology Solutions Inc. Attention: Steve Reinharz, CEO 10800 Galaxie Avenue Ferndale, MI 48220 Email: steve.r@radsecurity.com Copy to (which shall not constitute notice): __________________________ __________________________ __________________________ __________________________ If to Investor: Trillium Partners LP Attention: Stephen Hicks 17210 Germano Court Naples, FL 34110 Email: shicks@southridge.com Tel: 203-431-8300 Fax: 203-431-8301 Copy to (which shall not constitute notice): Bianchi and Brandt Attention: Wendy Culbertson, Esq. 6730 N. Scottsdale Rd., Suite 100 Scottsdale, AZ 85253 Email: wendy@culbertson.esq Tel: 480-787-5419 Either party hereto may from time to time change its address or facsimile number for notices under this

 

Section 6.1 by giving at least ten (10) days’ prior written notice of such changed address or facsimile number to the other party hereto.

 

Article 7. Indemnification

 

Section 7.1 Indemnification. Each party (an “Indemnifying Party”) agrees to indemnify and hold harmless the other party along with its officers, directors, employees, and authorized agents, and each Person or entity, if any, who controls such party within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (an “Indemnified Party”) from and against any Damages, joint or several, and any action in respect thereof to which the Indemnified Party becomes subject to, resulting from, arising out of or relating to (i) any misrepresentation, breach of warranty or nonfulfillment of or failure to perform any covenant or Purchase Agreement on the part of Indemnifying Party contained in this Purchase Agreement, (ii) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any post-effective amendment thereof or supplement thereto, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, (iii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in the light of the circumstances under which the statements therein were made, not misleading, or (iv) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rule or regulation under the Securities Act, the Exchange Act or any state securities law, as such Damages are incurred, except to the extent such Damages result primarily from Indemnified Party’s failure to perform any covenant or Purchase Agreement contained in this Purchase Agreement or Indemnified Party’s negligence, recklessness or bad faith in performing its obligations under this Purchase Agreement; provided, however, that the foregoing indemnity Purchase Agreement shall not apply to any Damages of an Indemnified Party to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made by an Indemnifying Party in reliance upon and in conformity with written information furnished to the Indemnifying Party by the Indemnified Party expressly for use in the Registration Statement, any post-effective amendment thereof or supplement thereto, or any preliminary prospectus or final prospectus (as amended or supplemented).

 

Section 7.2 Method of Asserting Indemnification Claims. All claims for indemnification by any Indemnified Party (as defined below) under

 

Section 7.1 shall be asserted and resolved as follows:

 

(a) In the event any Claim in respect of which an Indemnified Party might seek indemnity under

 

 

 

 

Section 7.1 is asserted against or sought to be collected from such Indemnified Party by a person other than a party hereto or an affiliate thereof (a “Third Party Claim”), the Indemnified Party shall deliver a Notice pursuant to Article 6, enclosing a copy of all papers served, if any, and specifying the nature of and basis for such Third Party Claim and for the Indemnified Party’s Claim for indemnification that is being asserted under any provision of

 

Section 7.1 against an Indemnifying Party, together with the amount or, if not then reasonably ascertainable, the estimated amount, determined in good faith, of such Third Party Claim (a “Claim Notice”) with reasonable promptness to the Indemnifying Party. If the Indemnified Party fails to provide the Claim Notice with reasonable promptness after the Indemnified Party receives notice of such Third Party Claim, the Indemnifying Party shall not be obligated to indemnify the Indemnified Party with respect to such Third Party Claim to the extent that the Indemnifying Party’s ability to defend has been prejudiced by such failure of the Indemnified Party. The Indemnifying Party shall notify the Indemnified Party as soon as practicable within the period ending thirty (30) calendar days following receipt by the Indemnifying Party of either a Claim Notice or an Indemnity Notice (as defined in Section 7.2(b)) (the “Dispute Period”) whether the Indemnifying Party disputes its liability or the amount of its liability to the Indemnified Party under

 

Section 7.1 and whether the Indemnifying Party desires, at its sole cost and expense, to defend the Indemnified Party against such Third Party Claim.

 

(i) If the Indemnifying Party notifies the Indemnified Party within the Dispute Period that the Indemnifying Party desires to defend the Indemnified Party with respect to the Third Party Claim pursuant to this Section 7. 2(a), then the Indemnifying Party shall have the right to defend, with counsel reasonably satisfactory to the Indemnified Party, at the sole cost and expense of the Indemnifying Party, such Third Party Claim by all appropriate proceedings, which proceedings shall be vigorously and diligently prosecuted by the Indemnifying Party to a final conclusion or will be settled at the discretion of the Indemnifying Party (but only with the consent of the Indemnified Party in the case of any settlement that provides for any relief other than the payment of monetary damages or that provides for the payment of monetary damages as to which the Indemnified Party shall not be indemnified in full pursuant to Section 7.2). The Indemnifying Party shall have full control of such defense and proceedings, including any compromise or settlement thereof; provided, however, that the Indemnified Party may, at the sole cost and expense of the Indemnified Party, at any time prior to the Indemnifying Party’s delivery of the notice referred to in the first sentence of this clause (i), file any motion, answer or other pleadings or take any other action that the Indemnified Party reasonably believes to be necessary or appropriate to protect its interests; and provided further, that if requested by the Indemnifying Party, the Indemnified Party will, at the sole cost and expense of the Indemnifying Party, provide reasonable cooperation to the Indemnifying Party in contesting any Third Party Claim that the Indemnifying Party elects to contest. The Indemnified Party may participate in, but not control, any defense or settlement of any Third Party Claim controlled by the Indemnifying Party pursuant to this clause (i), and except as provided in the preceding sentence, the Indemnified Party shall bear its own costs and expenses with respect to such participation. Notwithstanding the foregoing, the Indemnified Party may take over the control of the defense or settlement of a Third Party Claim at any time if it irrevocably waives its right to indemnity under

 

Section 7.2 with respect to such Third Party Claim.

 

(ii) If the Indemnifying Party fails to notify the Indemnified Party within the Dispute Period that the Indemnifying Party desires to defend the Third Party Claim pursuant to Section 7. 2(a), or if the Indemnifying Party gives such notice but fails to prosecute vigorously and diligently or settle the Third Party Claim, or if the Indemnifying Party fails to give any notice whatsoever within the Dispute Period, then the Indemnified Party shall have the right to defend, at the sole cost and expense of the Indemnifying Party, the Third Party Claim by all appropriate proceedings, which proceedings shall be prosecuted by the Indemnified Party in a reasonable manner and in good faith or will be settled at the discretion of the Indemnified Party(with the consent of the Indemnifying Party, which consent will not be unreasonably withheld). The Indemnified Party will have full control of such defense and proceedings, including any compromise or settlement thereof; provided, however, that if requested by the Indemnified Party, the Indemnifying Party will, at the sole cost and expense of the Indemnifying Party, provide reasonable cooperation to the Indemnified Party and its counsel in contesting any Third Party Claim which the Indemnified Party is contesting. Notwithstanding the foregoing provisions of this clause (ii), if the Indemnifying Party has notified the Indemnified Party within the Dispute Period that the Indemnifying Party disputes its liability or the amount of its liability hereunder to the Indemnified Party with respect to such Third Party Claim and if such dispute is resolved in favor of the Indemnifying Party in the manner provided in clause (iii) below, the Indemnifying Party will not be required to bear the costs and expenses of the Indemnified Party’s defense pursuant to this clause (ii) or of the Indemnifying Party’s participation therein at the Indemnified Party’s request, and the Indemnified Party shall reimburse the Indemnifying Party in full for all reasonable costs and expenses incurred by the Indemnifying Party in connection with such litigation. The Indemnifying Party may participate in, but not control, any defense or settlement controlled by the Indemnified Party pursuant to this clause (ii), and the Indemnifying Party shall bear its own costs and expenses with respect to such participation.

 

 

 

 

(iii) If the Indemnifying Party notifies the Indemnified Party that it does not dispute its liability or the amount of its liability to the Indemnified Party with respect to the Third Party Claim under

 

Section 7.2 or fails to notify the Indemnified Party within the Dispute Period whether the Indemnifying Party disputes its liability or the amount of its liability to the Indemnified Party with respect to such Third Party Claim, the amount of Damages specified in the Claim Notice shall be conclusively deemed a liability of the Indemnifying Party under

 

Section 9.2 and the Indemnifying Party shall pay the amount of such Damages to the Indemnified Party on demand. If the Indemnifying Party has timely disputed its liability or the amount of its liability with respect to such claim, the Indemnifying Party and the Indemnified Party shall proceed in good faith to negotiate a resolution of such dispute; provided, however, that if the dispute is not resolved within thirty (30) days after the Claim Notice, the Indemnifying Party shall be entitled to institute such legal action as it deems appropriate.

 

(b) In the event any Indemnified Party should have a Claim against the Indemnifying Party that does not involve a Third Party Claim, the Indemnified Party shall deliver a written notification of a claim for indemnity under

 

Section 7.2 specifying the nature of and basis for such claim, together with the amount or, if not then reasonably ascertainable, the estimated amount, determined in good faith, of such claim (an “Indemnity Notice”) with reasonable promptness to the Indemnifying Party. The failure by any Indemnified Party to give the Indemnity Notice shall not impair such party’s rights hereunder except to the extent that the Indemnifying Party demonstrates that it has been irreparably prejudiced thereby. If the Indemnifying Party notifies the Indemnified Party that it does not dispute the claim or the amount of the claim described in such Indemnity Notice or fails to notify the Indemnified Party within the Dispute Period whether the Indemnifying Party disputes the claim or the amount of the claim described in such Indemnity Notice, the amount of Damages specified in the Indemnity Notice will be conclusively deemed a liability of the Indemnifying Party under

 

Section 7.2 and the Indemnifying Party shall pay the amount of such Damages to the Indemnified Party on demand. If the Indemnifying Party has timely disputed its liability or the amount of its liability with respect to such claim, the Indemnifying Party and the Indemnified Party shall proceed in good faith to negotiate a resolution of such dispute; provided, however, that if the dispute is not resolved within thirty (30) days after the Claim Notice, the Indemnifying Party shall be entitled to institute such legal action as it deems appropriate.

 

(c) The Indemnifying Party agrees to pay the Indemnified Party, promptly as such expenses are incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.

 

(d) The indemnity provisions contained herein shall be in addition to (i) any cause of action or similar rights of the Indemnified Party against the Indemnifying Party or others, and (ii) any liabilities the Indemnifying Party may be subject to.

 

Article 8. Default; Remedies

 

Section 8.1 Events of Default. Each of the following shall constitute an “Event of Default”:

 

(a) a material breach by either party of its obligations under this Purchase Agreement, including, without limitation, a failure by Investor to timely fund any Investment Amount in accordance with

 

Section 2.3 or a failure by the Company to timely deliver Put Shares in accordance with Section 2.3;

 

(b) any material breach of any representation, warranty or covenant by either party that remains uncured for a period of five (5) Trading Days after written notice thereof from the non-breaching party; and (c) with respect to either party, the commencement of a voluntary or involuntary bankruptcy, insolvency or similar proceeding, or the appointment of a receiver, custodian or similar official over such party or its material assets.

 

 

 

 

Section 8.2 Remedies. Upon the occurrence of an Event of Default:

 

(a) the non-breaching party may terminate this Purchase Agreement upon written notice to the breaching party;

 

(b) the non-breaching party shall be entitled to pursue any and all remedies available at law or in equity, excluding specific performance against Investor with respect to funding obligations, including, without limitation, damages and specific performance, subject to applicable law; and (c) in the case of a settlement failure under Section 2.3, other than delays caused by transfer agent, DTC or other third-party settlement systems outside such party’s reasonable control, the non-breaching party shall be entitled to recover any direct damages incurred as a result of such failure.

 

Section 8.3 No Waiver. The exercise by either Party of any remedy shall constitute a waiver of any of the rights or remedies available to such party.

 

Article 9. Miscellaneous

 

Section 9.1 Governing Law; Jurisdiction. This Purchase Agreement shall be governed by and interpreted in accordance with the laws of the State of Nevada without regard to the principles of conflicts of law. Each of the Company and Investor hereby submit to the exclusive jurisdiction of the United States Federal and state courts located in the State of Nevada with respect to any dispute arising under this Purchase Agreement, the Purchase Agreements entered into in connection herewith or the transactions contemplated hereby or thereby.

 

Section 9.2 JURY TRIAL WAIVER. The Company and the Investor hereby waive a trial by jury in any action, proceeding or counterclaim brought by either of the parties hereto against the other in respect of any matter arising out of or in connection with the Transaction Documents.

 

Section 9.3 Assignment. This Purchase Agreement shall be binding upon and inure to the benefit of the Company and Investor and their respective successors. Neither this Purchase Agreement nor any rights of Investor or the Company hereunder may be assigned by either party to any other person.

 

Section 9.4 Third Party Beneficiaries. This Purchase Agreement is intended for the benefit of the Company and Investor and their respective successors, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

Section 9.5 Termination. The Company may terminate this Purchase Agreement at any time by written notice to the Investor. Additionally, this Purchase Agreement shall terminate at the end of Commitment Period or as otherwise provided herein; provided, however, that the provisions of Article IX, and Sections 10.1 and 10.2 shall survive the termination of this Purchase Agreement for a period of twenty four (24) months. Notwithstanding anything to the contrary herein, this Purchase Agreement shall automatically terminate, without any further action or notice by any party, upon the occurrence of any of the following events with respect to the Company:

 

(i) the commencement by the Company of a voluntary case under any applicable bankruptcy, insolvency or similar law;

 

(ii) the commencement of an involuntary case against the Company that is not dismissed within sixty (60) days;

 

(iii) the appointment of a receiver, trustee, custodian or similar official for the Company or for all or substantially all of its assets; or (iv) the making by the Company of a general assignment for the benefit of creditors.

 

Section 9.6 Entire Purchase Agreement, Amendment; No Waiver. This Purchase Agreement and the instruments referenced herein contain the entire understanding of the Company and Investor with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor Investor makes any representation, warranty, covenant or undertaking with respect to such matters. This Purchase Agreement may not be amended.

 

 

 

 

Section 9.7 Fees and Expenses. The Company agrees to pay its own expenses in connection with the preparation of this Purchase Agreement and performance of its obligations hereunder. In addition, the Company shall reimburse Investor for the reasonable and documented legal fees and disbursements of Investor’s counsel in connection with the preparation, negotiation and execution of this Purchase Agreement and the transactions contemplated hereby, in an amount of Fifteen Thousand Dollars ($15,000), which amount shall be payable upon the occurrence of the initial Closing. The Company shall pay all stamp or other similar taxes and duties levied in connection with issuance of the Put Shares pursuant hereto.

 

Section 9.8 Counterparts. This Purchase Agreement may be executed in multiple counterparts, each of which may be executed by less than all of the parties and shall be deemed to be an original instrument which shall be enforceable against the parties actually executing such counterparts and all of which together shall constitute one and the same instrument. This Purchase Agreement may be delivered to the other parties hereto by facsimile transmission or email of a copy of this Purchase Agreement bearing the signature of the parties so delivering this Purchase Agreement.

 

Section 9.9 Severability. In the event that any provision of this Purchase Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Purchase Agreement shall continue in full force and effect without said provision; provided that such severability shall be ineffective if it materially changes the economic benefit of this Purchase Agreement to any party.

 

Section 9.10 Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other Purchase Agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Purchase Agreement and the consummation of the transactions contemplated hereby.

 

Section 9.11 No Strict Construction. The language used in this Purchase Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

 

Section 9.12 Equitable Relief. The Company recognizes that in the event that it fails to perform, observe, or discharge any or all of its obligations under this Purchase Agreement, any remedy at law may prove to be inadequate relief to Investor. The Company therefore agrees that Investor shall be entitled to temporary and permanent injunctive relief in any such case without the necessity of proving actual damages.

 

Section 9.13 Title and Subtitles. The titles and subtitles used in this Purchase Agreement are used for the convenience of reference and are not to be considered in construing or interpreting this Purchase Agreement.

 

Section 9.14 Reporting Entity for the Common Stock. The reporting entity relied upon for the determination of the Closing Price for the Common Stock on any given Trading Day for the purposes of this Purchase Agreement shall be the OTC Markets Group Inc. (otcmarkets.com) or any successor thereto. In the event that the Common Stock is uplisted to a national securities exchange, including without limitation NYSE, NYSE American, or NASDAQ, the reporting entity shall automatically transition to Bloomberg Finance L.P. or such other reporting service as is customarily relied upon for such exchange. The written mutual consent of Investor and the Company shall be required to employ any other reporting entity not contemplated by this Section.

 

Section 9.15 Publicity. The Company and Investor shall consult with each other in issuing any press releases or otherwise making public statements with respect to the transactions contemplated hereby and no party shall issue any such press release or otherwise make any such public statement without the prior written consent of the other parties, which consent shall not be unreasonably withheld or delayed, except that no prior consent shall be required if such disclosure is required by law, in which such case the disclosing party shall provide the other parties with prior notice of such public statement. Notwithstanding the foregoing, the Company shall not publicly disclose the name of Investor without the prior written consent of such Investor, except to the extent required by law. Investor acknowledges that this Purchase Agreement and all or part of the Transaction Documents may be deemed to be “material contracts” as that term is defined by Item 601(b)(10) of Regulation S-K, and that the Company may therefore be required to file such documents as exhibits to reports or registration statements filed under the Securities Act or the Exchange Act. Investor further agrees that the status of such documents and materials as material contracts shall be determined solely by the Company, in consultation with its counsel.

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Equity Purchase Agreement to be executed by the undersigned, thereunto duly authorized, as of the date first set forth above.

 

TRILLIUM PARTNERS LP  
     
By: /s/ Stephen Hicks  
Name: Stephen Hicks  
Title: Manager of GP  

 

Counter signature on next page

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
     
By: /s/ Steve Reinharz  
Name: Steve Reinharz  
Title: Chief Executive Officer  

 

 

 

 

SCHEDULE 4.3

 

Outstanding Securities

 

 

 

 

EXHIBIT A

 

FORM OF PUT NOTICE

 

TO: TRILLIUM PARTNERS LP

 

We refer to the Equity Purchase Agreement dated , 2026 (the “Purchase Agreement”) entered into by Artificial Intelligence Technology Solutions Inc. (the “Company”) and you. Capitalized terms defined in the Purchase Agreement shall, unless otherwise defined, have the same meaning when used herein.

 

We hereby:

 

1. Give you notice that we require you to purchase $ (the “ Investment Amount”) in Put Shares;

 

2. Put Type Election (select one):

 

☐ Regular Put – Lookback pricing; settlement next Trading Day following Put Date.

☐ Accelerated Put – Forward Valuation Period pricing; Floor Price and knock-out mechanics apply; settlement within one (1) Trading Day following end of Valuation Period.

 

*If no election is made, this Put Notice shall be deemed a Regular Put.

 

3. Notify you that, pursuant to Section 2.2 of the Purchase Agreement, the Estimated Shares to be delivered concurrently herewith to your brokerage account via DWAC are as follows:

 

● Investment Amount: $_____

● Closing Bid Price (prior Trading Day): $_____

● Estimated Shares (125% x Investment Amount ÷ Closing Bid Price): _____ shares; and

 

4. Certify that, as of the date hereof, to the best of our knowledge, the conditions set forth in Section 5.2 of the Purchase Agreement are satisfied.

 

Date: , __________________

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

By: ___________________

 

Name: Steve Reinharz

 

Title: Chief Executive Officer

 

 

 

 

EXHIBIT B

 

FORM OF

CERTIFICATE OF THE CHIEF EXECUTIVE

OFFICER OF

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

 

Pursuant to Section 5.2 of that certain Equity Purchase Agreement dated June 23, 2026 (the “Purchase

 

Agreement”) by and between the Company and Trillium Partners LP (the “Investor”), the undersigned, in his capacity as the Chief Executive Officer of Artificial Intelligence Technology Solutions Inc. (the “Company”), and not in his individual capacity, hereby certifies, as of the date hereof (such date, the “Condition Satisfaction Date”), the following:

 

1. The representations and warranties of the Company are true and correct in all material respects as of the Condition Satisfaction Date as though made on the Condition Satisfaction Date (except for representations and warranties specifically made as of a particular date) with respect to all periods, and as to all events and circumstances occurring or existing to and including the Condition Satisfaction Date, except for any conditions which have temporarily caused any representations or warranties of the Company set forth in the Purchase Agreement to be incorrect and which have been corrected with no continuing impairment to the Company or Investor; and

 

2. All of the Company’s conditions to Closing set forth in Section 5.2 of the Purchase Agreement have been satisfied as of the Condition Satisfaction Date.

 

Capitalized terms used herein shall have the meanings set forth in the Purchase Agreement unless otherwise defined herein.

 

IN WITNESS WHEREOF, the undersigned has hereunto affixed his hand as of the day of , 20__.

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
     
By:    
Name: Steve Reinharz  
Title: Chief Executive Officer  

 

 

 

 

Exhibit 10.2

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION RIGHTS AGREEMENT entered into as of the 23rd day of June, 2026 (this “RRA”), by and between TRILLIUM PARTNERS LP, a Delaware limited partnership (the “Investor”), and Artificial Intelligence Technology Solutions Inc., a Nevada corporation (the “Company”) is made pursuant to the Equity Purchase Agreement (the “Purchase Agreement”), referenced and incorporated herein. Investor and Company shall be referred to individually as “Party,” or “Parties” collectively. IN CONSIDERATION of the promises, the mutual provisions of this Agreement, and other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, Parties hereto agree as follows:

 

Article 1. Definitions.

 

Section 1.1 Defined Terms. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this RRA, the following terms shall have the following meanings:

 

“Allowed Delay” shall mean any period during which the Company has suspended the use of the Registration Statement and the related Prospectus pursuant to

 

Section 6.2 of this RRA, not to exceed twenty (20) consecutive Trading Days or forty-five (45) Trading Days in any twelve (12) month period, due to:

 

(i) the existence of material non-public information regarding the Company that the Board of Directors has determined in good faith would require disclosure in the Registration Statement or Prospectus and that it is not in the best interests of the Company to disclose at such time;

 

(ii) the occurrence of any event that requires the preparation of a supplement or amendment to the Prospectus so that such Prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein; or (iii) any pending corporate development, transaction, or negotiation that the Board of Directors has determined in good faith would be required to be disclosed in the Registration Statement or Prospectus and that premature disclosure of which would materially and adversely affect the Company; provided, however, that an Allowed Delay shall not include any suspension or blackout period that constitutes an Event as defined hereunder.

 

“Business Day” means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of Nevada of are authorized or required by law or other governmental action to close. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

“Effectiveness Deadline” means, with respect to the Initial Registration Statement required to be filed hereunder, the 60th calendar day following the Filing Deadline and with respect to any additional Registration Statements which may be required pursuant to Article 2, the 60th calendar day following the date on which an additional Registration Statement is required to be filed hereunder; provided, however, that in the event the Company is notified by the SEC that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Deadline as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Deadline falls on a day that is not a Trading Day, then the Effectiveness Deadline shall be the next succeeding Trading Day. Notwithstanding the foregoing, the Effectiveness Deadline shall be automatically extended on a day-for-day basis for any delay attributable solely to SEC review timing, staff comment letters, or other SEC action or inaction outside the Company’s reasonable control, provided that the Company is diligently pursuing effectiveness and responding to SEC comments in good faith and in a timely manner.

 

“Event” shall mean any of the following:

 

(i) the Registration Statement is not filed on or before the Filing Deadline;

 

 

 

 

(ii) the Registration Statement is not declared effective by the SEC on or before the Effectiveness Deadline provided, however, that no Event shall be deemed to occur under this clause (ii) to the extent that the failure to achieve effectiveness by the Effectiveness Deadline results solely from SEC review timing, staff comment letters, or other SEC action or inaction outside the Company’s reasonable control, so long as the Company is diligently pursuing effectiveness and responding to SEC comments in good faith;

 

(iii) after the Registration Statement has been declared effective, the Company fails to maintain the effectiveness thereof (or the Prospectus contained therein is not available for use) for more than the permitted blackout period set forth in Section 6.2; or (iv) after the Registration Statement has been declared effective, trading in the Common Stock is suspended or the Common Stock is delisted from the Principal Market for more than three (3) consecutive Trading Days..

 

“Event Date” shall mean the date on which an Event first occurs.

 

“Excluded Registration” means any registration of equity securities of the Company solely for a Company sponsored employee benefit plan.

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

“Filing Deadline” means:

 

(i) with respect to the Initial Registration Statement, the date that is as soon as practicable following the Signing Date (as defined in the Purchase Agreement), and (ii) with respect to any additional Registration Statements which may be required pursuant to Section 2.3, the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities. “Holder” or

 

“Holders” means Trillium Partners LP and any permitted transferee or assignee of Registrable Securities to whom rights under this RRA have been duly assigned in accordance with

 

Section 6.5 hereof; provided that any such transferee or assignee shall be deemed a “Holder” hereunder only upon delivery to the Company of written notice of such transfer or assignment and such transferee’s or assignee’s written RRA to be bound by the terms and conditions of this RRA.

 

“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the SEC pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

“Rule 144” means Rule 144 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any other similar or successor rule or regulation of the SEC that may at any time permit the Holders to sell securities of the Company to the public without registration.

 

“Rule 415” means Rule 415 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the SEC providing for offering securities on a continuous or delayed basis.

 

“Rule 424” means Rule 424 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

“SEC Guidance” means:

 

(i) any publicly available written or oral guidance of the SEC staff, or any comments, requirements or requests of the SEC staff; and (ii) the Securities Act.

 

“Underlying Securities” means the shares of Common Stock or other securities issuable upon exercise of the Warrant.

 

 

 

 

Article 2. Required Registration.

 

Section 2.1 Filing. The Company shall prepare, as soon as practicable following the Signing Date, and file with the SEC a Registration Statement covering the resale of all Registrable Securities issued and issuable under the Purchase Agreement. The Registration Statement filed hereunder shall be on Form S-1 (or Form S-3, if available).

 

Section 2.2 Effectiveness. The Company shall use its reasonable best efforts to cause such Registration Statement to be filed under this RRA to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Deadline, and shall keep such Registration Statements continuously effective under the Securities Act until the earlier of:

 

(i) the date that all Registrable Securities covered by such Registration Statement no longer constitute Registrable Securities, or (ii) the date all Registrable Securities have been sold (the “Effectiveness Period”).

 

Section 2.3 Rule 415 Cutback. Notwithstanding the registration obligations set forth in Section 2.1, if the SEC informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to (i) first exclude securities not constituting Registrable Securities;

 

(ii) second, include Registrable Securities on a pro rata basis among Holders. The Company shall use reasonable best efforts to file additional Registration Statements to cover any omitted Registrable Securities.

 

Section 2.4 Liquidated Damages. If an Event occurs, the Company shall pay to the Investor an amount in cash equal to one and one-half percent (1.5%) of the aggregate Investment Amount paid by the Investor under the Purchase Agreement as of the Event Date, and an additional one and one-half percent (1.5%) for each subsequent thirty (30) day period (or pro rata portion thereof) during which such Event continues (the “Liquidated Damages”). Liquidated damages shall be paid within five (5) Business Days of each thirty (30) day period. Notwithstanding the foregoing:

 

(i) the maximum aggregate Liquidated Damages payable to the Investor shall not exceed four percent (4%) of the aggregate Investment Amount;

 

(ii) no Liquidated Damages shall accrue during any period in which the Company is unable to maintain effectiveness solely due to the Investor’s failure to provide required information under Section 4(a); and (iii) the parties acknowledge that the Liquidated Damages set forth herein represent a reasonable and genuine pre-estimate of the damages that would be suffered by the Investor as a result of an Event, that such amount is fair and reasonable under the circumstances existing as of the date of this RRA, that the Liquidated Damages do not constitute a penalty, and that the Investor would not have entered into this Registration Rights Agreement absent this liquidated damages provision.

 

Article 3. Obligations

 

Section 3.1 Obligations of the Company. In connection with the Company’s registration obligations hereunder, the Company shall:

 

(a) Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than three (3) Trading Days prior to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated therein by reference), the Company shall:

 

(i) furnish to each Holder copies of all such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review and reasonable comment of such Holders and their counsel, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act; provided, however, that:

 

(i) the Company shall not be obligated to provide Holders advance copies of any universal shelf registration statement registering securities in addition to those required hereunder, or any Prospectus prepared thereto;

 

(ii) the pre-filing review obligations set forth in this

 

Section 3.1 shall be suspended during any blackout or suspension period implemented by the Company pursuant to

 

 

 

 

Section 6.2 of this RRA, and the applicable review period shall recommence upon the termination of such blackout or suspension period, with the filing deadline extended by the number of Trading Days during which the blackout or suspension was in effect; and (iii) notwithstanding the foregoing, in no event shall the Company circulate any draft Registration Statement, Prospectus, or amendment or supplement thereto to any Holder during a blackout or suspension period if such document contains, incorporates by reference, or omits any material non-public information that is the basis for such blackout or suspension, unless and until such information has been publicly disclosed by the Company in accordance with applicable securities laws.

 

(b) (i) Prepare and file with the SEC such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the SEC such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this RRA), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the SEC with respect to a Registration Statement or any amendment thereto, and (iv) comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this RRA) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.

 

(c) If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case, prior to the applicable Filing Deadline, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities.

 

(d) The Company shall ensure that the Registration Statement covers all Put Shares issued and issuable from time to time under the Purchase Agreement.

 

(e) Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible:

 

(i) (A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement has been filed; (B) when the SEC notifies the Company whether there will be a “review” of such Registration Statement; and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the SEC or any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, in each case, after the such Registration Statement has been declared effective, (iii) of the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus, provided, however, in no event shall any such notice contain any information which would constitute material, non- public information regarding the Company or any of its Subsidiaries.

 

(f) Use its reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.

 

 

 

 

(g) Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the SEC; provided, that any such item which is available on the EDGAR system (or successor thereto) need not be furnished. Subject to the terms of this RRA, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the Company has given notice pursuant to Section 6.7.

 

(h) The Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder.

 

(i) Prior to any resale of Registrable Securities by a Holder, use its reasonable best efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that, the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.

 

(j) If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may request.

 

(k) Upon the occurrence of any event contemplated by clause (v) or (vi) of Section 4(d), as promptly as reasonably possible under the circumstances taking into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 4(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its reasonable best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.

 

(l) Comply with all applicable securities rules and regulations.

 

Section 3.2 Obligation of the Holder(s).

 

(a) Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this RRA as Appendix A (a “Selling Stockholder Questionnaire”) on a date that is not less than ten (10) days prior to the Filing Deadline or by the end of the fourth (4th) Trading Day following the date on which such Holder receives draft materials in accordance with Section 2(a). Each Holder shall furnish in writing to the Company such additional information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it, and shall execute such documents in connection with such registration, as shall be reasonably required to effect the registration of such Registrable Securities. A Holder shall provide such information to the Company at least two (2) Business Days prior to the first anticipated filing date of such Registration Statement if such Holder elects to have any of the Registrable Securities included in the Registration Statement. The Company shall not be required to include the Registrable Securities of a Holder in a Registration Statement, and no Event shall be deemed to occur and or continue solely as a result of the failure to include the Registrable Securities of such Holder in the Registration Statement, if such Holder fails to furnish to the Company a fully completed Selling Stockholder Questionnaire at least two (2) Business Days prior to the Filing Deadline.

 

 

 

 

(b) Each Holder agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of a Registration Statement hereunder, unless such Holder has notified the Company in writing of its election to exclude all of its Registrable Securities from such Registration Statement.

 

(c) Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

(d) Each Holder agrees that, upon receipt of any notice from the Company of either:

 

(i) the commencement of an Allowed Delay, or (ii) the happening of an Event pursuant to Section 3.1(d) hereof, such Holder will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities, until such Holder has received written notice from the Company (the “Advice”) that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company shall:

 

(i) deliver the Advice to each Holder as promptly as practicable following the cessation of the circumstances giving rise to the Allowed Delay or applicable event, and in any event no later than the Trading Day immediately following such cessation;

 

(ii) use its reasonable best efforts to ensure that the use of the Prospectus may be resumed as promptly as practicable and in any event within the time limitations set forth in the definition of Allowed Delay and

 

Section 6.2 hereof;

 

(iii) not commence an Allowed Delay unless the Company has provided each Holder with prior written notice of such Allowed Delay to the extent permitted by applicable law and the Company’s obligations with respect to material non-public information; and (iv) ensure that the aggregate duration of all Allowed Delays during any twelve (12) month period does not exceed the limitations set forth in

 

Section 6.2 hereof, it being understood that any suspension exceeding such limitations shall constitute an Event under

 

Section 1.1 and trigger the Liquidated Damages obligations set forth therein.

 

(e) The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such Holder and, if required by the SEC, the natural persons thereof that have voting and dispositive control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities solely because any Holder fails to furnish such information within three (3) Trading Days of the Company’s request, any liquidated damages that are accruing at such time shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended until such information is delivered to the Company.

 

 

 

 

Article 4. Registration Expenses.

 

Section 4.1 Registration Expenses. All fees and expenses incident to the performance of or compliance with this RRA by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (a) all registration and filing fees (including, without limitation, fees and expenses of the Company’s counsel and independent registered public accountants) (i) with respect to filings made with the SEC, (ii) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (iii) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (b) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (c) messenger, telephone and delivery expenses of the Company, (d) fees and disbursements of counsel for the Company, (e) Securities Act liability insurance, if the Company so desires such insurance, and (f) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this RRA. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this RRA (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar SECs of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.

 

Article 5. Indemnification.

 

Section 5.1 Indemnification. The indemnification, contribution, and claims procedures with respect to the transactions contemplated by this RRA, including without limitation any claims arising from the Registration Statement, any Prospectus, or any amendment or supplement thereto, shall be governed exclusively by Article 7 of the Purchase Agreement, which is incorporated herein by reference in its entirety. The parties acknowledge that the indemnification provisions of Article 7 of the Purchase Agreement are intended to cover all claims arising under both the Purchase Agreement and this RRA, and that no separate or additional indemnification rights or obligations shall arise under this RRA.

 

Article 6. Miscellaneous.

 

Section 6.1 Continuous Issuance Coverage. The Company shall, from time to time, file such amendments or additional Registration Statements as may be necessary to ensure that all Put Shares issued or issuable pursuant to the Purchase Agreement are covered by an effective Registration Statement.

 

Section 6.2 Blackout and Suspension Limit. The Company may suspend the use of the Registration Statement for no more than twenty (20) consecutive Trading Days, and no more than forty-five (45) Trading Days in any 12-month period.

 

Section 6.3 Purchase Agreement Integration. This RRA is entered into in connection with, and is subject to the terms of, the Purchase Agreement, provided, however, that in the event of any conflict between this RRA and the Purchase Agreement, the terms of this RRA shall control with respect to the subject matter hereof.

 

Section 6.4 Remedies. In the event of a breach by the Company or by a Holder of any of their respective obligations under this RRA, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this RRA, including recovery of damages, shall be entitled to specific performance of its rights under this RRA. Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this RRA and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.

 

Section 6.5 Prohibition on Filing Other Registration Statements. The Company shall not, other than as provided in the Purchase Agreement, file any other registration statements (specifically excluding a registration statement on Form S-8) until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the SEC, provided that this Section 7(b) shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this RRA and shall not prohibit the Company from filing a registration statement for a primary offering by the Company, provided that the Company makes no offering of securities pursuant to such registration statement prior to the effective date of the Registration Statement required hereunder that includes all of the Registrable Securities.

 

 

 

 

Section 6.6 Amendments and Waivers. The provisions of this Registration Rights Agreement may not be amended, modified, or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by both the Company and the Investor. Any waiver or consent granted hereunder shall be effective only in the specific instance and for the specific purpose for which it was given and shall not constitute a continuing waiver or consent with respect to any other provision or circumstance. No failure or delay by either party in exercising any right, power, or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power, or remedy preclude any other or further exercise thereof or the exercise of any other right, power, or remedy. No consideration shall be offered or paid to either party to amend or consent to a waiver or modification of any provision of this Registration Rights Agreement unless such amendment or waiver is documented in writing and executed by both parties in accordance with this Section 6.6.

 

Section 6.7 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement. Any such notice or communication so given or made shall be deemed to have been given or made and to have been received on the day of delivery if delivered, or on the day of e-mailing or sending by other means of recorded communication, provided that such day in either event is a Business Day and the communication is so delivered, e-mailed or sent before 5:00 p.m. Eastern on such day.

 

Section 6.8 Successors and Assigns. This RRA shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under the Purchase Agreement.

 

Section 6.9 Entire RRA. This RRA, the Purchase Agreement and the other Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior RRAs and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

Section 6.10 Execution and Counterparts. This RRA may be executed in two or more counterparts, all of which when taken together shall be considered one and the same RRA and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered physically or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such physical delivery or “.pdf” signature page were an original thereof.

 

Section 6.11 Governing Law; Jurisdiction, WAIVER OF JURY TRIAL. All questions concerning the construction, validity, enforcement and interpretation of this RRA shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this RRA (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the United States Federal and state courts located in the State of Nevada (the “Nevada Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Nevada Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Nevada Courts, or such Nevada Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this RRA and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this RRA or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this RRA, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

Section 6.12 Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

 

 

 

 

Section 6.13 Severability. If any term, provision, covenant or restriction of this RRA is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable best efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

Section 6.14 Headings. The headings in this RRA are for convenience only, do not constitute a part of the RRA and shall not be deemed to limit or affect any of the provisions hereof.

 

Section 6.15 Independent Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing contained herein or in any other RRA or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this RRA or any other matters, and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this RRA, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of a single RRA with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that each provision contained in this RRA is between the Company and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as of the date first written above.

 

TRILLIUM PARTNERS LP  
     
By: /s/ Stephen Hicks  
Name: Stephen Hicks  
Title: Manager of GP  

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
     
By: /s/ Steve Reinharz  
Name: Steve Reinharz  
Title: Chief Executive Officer  

 

 

 

 

APPENDIX A

 

SELLING STOCKHOLDER QUESTIONNAIRE

 

This Selling Stockholder Questionnaire (this “Questionnaire”) is being furnished to you in connection with the Registration Rights Agreement (the “RRA”) entered into between Artificial Intelligence Technology Solutions Inc., a Nevada corporation (the “Company”), and Trillium Partners LP (the “Investor”), dated as of __________________, 2026, in connection with the Equity Purchase Agreement of the same date (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the RRA or the Purchase Agreement, as applicable.

 

The information requested in this Questionnaire is required to prepare the Registration Statement to be filed with the Securities and Exchange Commission (the “SEC”) covering the resale of the Registrable Securities, including the Put Shares and the Commitment Shares, by the Investor as a selling stockholder. The Company is required to include accurate and complete selling stockholder information in the Registration Statement and the related Prospectus.

 

Please complete ALL sections of this Questionnaire in full. Incomplete responses may delay the filing of the Registration Statement and may result in the tolling of Liquidated Damages as provided in the RRA. Please return the completed Questionnaire to the Company no later than ten (10) days prior to the Filing Deadline, or within four (4) Trading Days of receipt of draft Registration Statement materials, whichever is earlier.

 

If any information provided herein changes prior to the effective date of the Registration Statement or during the Effectiveness Period, you are obligated to promptly notify the Company in writing of such change so that the Registration Statement and Prospectus may be updated accordingly.

 

PART I — HOLDER IDENTIFICATION

 

1.1 Full Legal Name of Selling Stockholder

 

Legal Name:

 

1.2 Form of Entity

 

Please check the applicable box:

 

☐ Individual / Natural Person

☐ Corporation

☐ Limited Partnership

☐ Limited Liability Company

☐ Trust

☐ Other (please specify): ___________________________________

 

1.3 State / Jurisdiction of Organization

 

Jurisdiction:

 

1.4 Principal Business Address

 

Street Address:

City: State / Province:

Zip / Postal Code: Country:

 

1.5 Contact Information

 

Contact Name:

Title:

Telephone:

Email Address:

 

1.6 Tax Identification / EIN

 

EIN / Tax ID:

Note: Social Security Numbers should NOT be provided in this Questionnaire. Please provide your Employer Identification Number (EIN) or equivalent tax identification number only.

 

 

 

 

PART II — NATURAL PERSONS WITH VOTING AND DISPOSITIVE CONTROL

 

If the Selling Stockholder is an entity (corporation, partnership, LLC, trust, or other), please identify all natural persons who have voting and/or dispositive control over the Registrable Securities held by the Selling Stockholder. This information may be required by the SEC for inclusion in the Registration Statement.

 

2 2.1 Controlling Natural Person(s)

 

Please list ALL natural persons with voting and/or dispositive control:

 

Full Legal Name Title / Relationship Voting / Dispositive Control

 

PART III — SECURITIES INFORMATION

 

3.1 Commitment Shares

 

Number of Commitment Shares: 5,000,000 (2,500,000 upon S-1 effectiveness; 2,500,000 ninety (90) days thereafter)

 

3.2 Put Shares As of the date of this Questionnaire, please provide the following information with respect to Put

 

Shares:

 

Maximum number of Put Shares issuable:

 

Note: The actual number of Put Shares to be included in the Registration Statement will be determined based on the Maximum Commitment Amount divided by the applicable Purchase Price floor, and will be updated in subsequent amendments to the Registration Statement as necessary.

 

3.3 Total Registrable Securities

 

Total shares to be registered:

 

3.4 Other Holdings

 

Do you beneficially own any other shares of Common Stock of the Company not being registered pursuant to the Registration Statement?

 

☐ No

☐ Yes — if yes, please describe:

Description:

 

3.5 Broker / DTC Participant Information

 

Please provide the brokerage account information to which DWAC transfers of Registrable Securities will be delivered:

 

Broker-Dealer Name:

DTC Participant Number:

Account Name:

Account Number:

 

 

 

 

PART IV — BENEFICIAL OWNERSHIP AND AFFILIATIONS

 

4.1 Beneficial Ownership Cap Confirmation

 

Please confirm that, as of the date of this Questionnaire, after giving effect to the issuance of all Registrable Securities to be registered hereunder, the Selling Stockholder together with its affiliates does not and will not beneficially own in excess of 4.99% of the then issued and outstanding shares of Common Stock of the Company, calculated in accordance with Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder.

 

☐ Confirmed — the Selling Stockholder does not and will not exceed the 4.99% Beneficial Ownership Cap.

☐ Cannot confirm — please explain: ___________________________________

 

4.2 Affiliate Status

 

Is the Selling Stockholder an “affiliate” of the Company as that term is defined in Rule 405 of the Securities Act of 1933 (i.e., a person that directly or indirectly controls, or is controlled by, or is under common control with, the Company)?

 

☐ No

☐ Yes — if yes, please describe the nature of the affiliation:

Description:

 

4.3 Officer or Director Status

 

Is the Selling Stockholder, or any natural person with voting or dispositive control over the Selling Stockholder, an officer or director of the Company?

 

☐ No

☐ Yes — if yes, please identify:

Name / Title:

 

4.4 Broker-Dealer Status

 

Is the Selling Stockholder a registered broker-dealer, or an affiliate of a registered broker-dealer?

 

☐ No

☐ Yes, the Selling Stockholder is a registered broker-dealer.

☐ Yes, the Selling Stockholder is an affiliate of a registered broker-dealer.

 

If yes, please confirm that the Registrable Securities were acquired in the ordinary course of business and that at the time of acquisition, the Selling Stockholder had no agreements or understandings, directly or indirectly, with any person to distribute the securities.

 

4.5 Short Sales

 

Has the Selling Stockholder, or any affiliate of the Selling Stockholder acting on its behalf, executed any Short Sales (as defined in the Purchase Agreement) of the Company’s Common Stock during the period from the date of the Purchase Agreement to the date of this Questionnaire?

 

☐ No

☐ Yes — if yes, please describe:

Description:

 

 

 

 

PART V — PLAN OF DISTRIBUTION

 

Please describe the manner in which the Selling Stockholder intends to sell or otherwise dispose of the Registrable Securities. This information will be included in the Plan of Distribution section of the Prospectus. The Selling Stockholder may sell the Registrable Securities in one or more of the following manners (check all that apply):

 

☐ On the OTC Markets or any national securities exchange on which the Common Stock may be listed, at prevailing market prices at the time of sale.

☐ In privately negotiated transactions at prices agreed upon by the parties.

☐ Through broker-dealers who may act as agents or principals.

☐ Through one or more underwriters on a firm commitment or best-efforts basis.

☐ In block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal.

☐ Through the writing of options on the shares, whether such options are listed on an options exchange or otherwise.

☐ A combination of any such methods of sale.

☐ Other (please describe): ___________________________________

 

PART VII — REPRESENTATIONS AND CERTIFICATIONS

 

By executing this Questionnaire below, the undersigned Selling Stockholder hereby represents, warrants, and certifies to the Company that:

 

(a) All information provided in this Questionnaire is true, correct, and complete in all material respects as of the date hereof.

 

(b) The Selling Stockholder will promptly notify the Company in writing of any change in the information provided herein that occurs prior to or during the Effectiveness Period of the Registration Statement.

 

(c) The Selling Stockholder understands that this information will be included in the Registration Statement and the related Prospectus filed with the SEC and that such documents will be publicly available.

 

(d) The Selling Stockholder acknowledges that the Company and its counsel will rely on the information provided herein in preparing the Registration Statement and the Prospectus, and the Selling Stockholder agrees to indemnify and hold harmless the Company with respect to any material misstatement or omission in the Registration Statement arising from inaccurate information provided by the Selling Stockholder in this Questionnaire, in accordance with the indemnification provisions of Article 7 of the Purchase Agreement.

 

(e) The Selling Stockholder has reviewed the Purchase Agreement and the Registration Rights Agreement and agrees to be bound by all terms and conditions applicable to Holders thereunder.

 

Signature page follows

 

SIGNATURE

 

Signature Date

Printed Name Title (if entity)

Name of Selling Stockholder (Entity):

Please return this completed Questionnaire to:

Artificial Intelligence Technology Solutions Inc.

Attention: Steve Reinharz, Chief Executive Officer

10800 Galaxie Avenue Ferndale, MI 48220

Email: steve.r@radsecurity.com

With a copy to counsel as designated in the Purchase Agreement

 

 

 

 

Exhibit 10.3

 

LEASE AGREEMENT

 

(10800 Galaxie Avenue, Ferndale, MI)

 

THIS LEASE is made effective as of March 10, 2021, by and between 10800 Galaxie Ave, LLC (“Landlord”) and Robotic Assistance Devices, Inc., with an address of 31103 Rancho Viejo Rd., Suite D2114, San Juan Capistrano, CA 92675 (“Tenant”).

 

1. PREMISES. Landlord, in consideration of the rents to be paid and the covenants and agreements to be performed by Tenant, does hereby lease unto Tenant the real property containing an approximately 29,316 square foot building (the “Building”) commonly known as 10800 Galaxie Avenue, Ferndale, Michigan 48220, as more particularly depicted on Exhibit A attached hereto (the “Premises”).

 

2. TERM; OPTION TO EXTEND. The term of the Lease (“Term”) shall be for a period of 10 years commencing May 1, 2021 (the “Commencement Date”) and ending April 30, 2031. Tenant shall have an option to extend the lease for 10 years thereafter with written notice to the Landlord provided 90 days or more prior to the expiration of the initial 10 year Lease Term.

 

3. POSSESSION. Landlord shall deliver possession of the Premises as of the Commencement Date. Landlord shall paint the exterior walls and the interior warehouse walls and warehouse ceiling before the Commencement Date. Otherwise, Tenant acknowledges that it is accepting the Premises in its “AS IS” condition.

 

4. BASE RENT; ADDITIONAL RENT. As basic rent (“Base Rent”) for the Premises, Tenant hereby agrees to pay to Landlord, without deduction, set-off, prior notice or demand, the following basic rent:

 

(a) For years 1 through 3, Fifteen Thousand Eight Hundred Seventy Nine and 50/100 Dollars ($15,879.50) per month, which is based upon a rental rate of $6.50 per square foot (triple net). The first month’s rent is due 7 days prior to the Commencement Date.

 

(b) Beginning in year 4, on May 1, 2015, rent will increase 3% (three percent) per annum, compounded annually.

 

(c) As additional rent (“Additional Rent”), during the Term, Tenant shall pay to Landlord all of the operating expenses related to the ownership and operation of the Premises, including without limitation, real estate taxes, insurance, maintenance expenses, repairs and utilities, subject to the terms below.

 

(d) All rental payments (including Additional Rent) shall be made in advance, on or before the first day of each calendar month, continuing through the balance of the Lease Term and any extensions thereof.

 

1

 

 

(e) All rent (including Additional Rent) hereunder shall be paid to Landlord at 13210 Cloverdale, Oak Park, Michigan 48237 or to such other persons or at such other places as Landlord may from time to time designate by written notice.

 

(f) Should any rent, including Basic Rent or Additional Rent required to be made by Tenant hereunder remain unpaid within ten (10) days after that the sum is due, Tenant shall pay as a late fee an additional 2% of the Base and Additional Rent totals for that month.

 

(g) If Tenant exercises the option to extend this Lease Term for an additional 10 years, Base Rent is the first year of the extension (year 11) shall be increased 3% over the Base Rent in year 10, and Base Rent shall increase annually by 3% every year of the extension thereafter, compounded annually.

 

5. SECURITY DEPOSIT. Tenant shall deposit with Landlord upon execution hereof the sum of Fifteen Thousand Eight Hundred Seventy Nine and 50/100 Dollars ($15,879.50) as security deposit for Tenant’s faithful performance of Tenant’s obligations hereunder. If Tenant fails to pay rent or other charges due hereunder, or otherwise defaults with respect to any provision of this Lease, Landlord may use, apply or retain all or any portion of the deposit for the payment of any rent or other charge in default or for the payment of any other sum to which Landlord may become obligated by reason of Tenant’s default, or to compensate Landlord for any loss or damage which Landlord may suffer thereby. Landlord shall be required to keep the deposit separate from its general accounts. If Tenant performs all of Tenant’s obligations hereunder, the deposit, or so much thereof as has not theretofore been applied by Landlord, shall be returned, without payment of interest or other increment for its use, to Tenant (or, at Landlord’s option, to the assignee, if any, of Tenant’s interest hereunder) at the expiration of the term hereof, and after Tenant has vacated the Premises.

 

6. USE AND OCCUPANCY.

 

(a) The Premises are hereby leased to Tenant upon the express condition that Tenant shall use the Premises for business of assembling electronic devices of various types and for general office use. Specifically these devices are autonomous robots in various form factors. Some outdoor space will be converted into a unmanned autonomous vehicle obstacle and testing course. Some other outdoor space may be converted into an enclosed drone test space, pending relevant ordinances. Indoor space will be used to test similar types of devices. No other use of the Premises is allowed without the express, written approval of the Landlord, secured in advance of any new use.

 

(b) Tenant shall not make or permit objectionable odors or noise at the Premises and shall not interfere with the rights of other tenants. Tenant shall not permit the use or storage of material amounts of hazardous substances or permit any waste or illegal act. Tenant will be using batteries and will properly store batteries.

 

2

 

 

7. CONDITION OF PREMISES. Taking possession of the Premises by the Tenant shall be conclusive evidence against the Tenant that the Premises were in good and satisfactory condition when possession of the same was so taken; and the Tenant will, at the expiration or earlier termination of this Lease, by lapse of time or otherwise, return the Premises to the Landlord in the same condition as it existed on the Commencement Date, with ordinary wear and tear excepted.

 

8. ALTERATIONS; IMPROVEMENTS. Tenant shall not make any modifications, alterations or additions to the Premises without Landlord’s written approval. If any modifications or alterations are made, a reputable licensed and insured contractor must be utilized and all proper permits must be obtained and fulfilled. Prior to Lease termination, Tenant must restore the Premises to its condition as of the Commencement Date. Tenant agrees to construct all modifications, alterations and additions in accordance with all codes and provide Landlord electronic as-built drawings.

 

9. REPAIRS AND MAINTENANCE.

 

(a) Tenant shall maintain the Premises in good condition as it existed as of the Commencement Date and promptly make all repairs and replacements for which Tenant is responsible with quality materials and workmanship in compliance with all regulations. The obligation to maintain shall include, without limitation, windows, office entries, walls, floors, electrical and lighting systems, replacing light bulbs and ballasts, signage, fire monitoring equipment (and NFPA inspections/certifications), dock levelers, shelters and doors, plumbing, and tube heaters serving the Premises. Except as provided in sub paragraph (b), below, maintenance of the Premises shall be the responsibility of the Tenant, at the Tenant’s expense. Tenant shall promptly repair Property damage caused by its agents, employees or visitors or Landlord may make such repair and bill Tenant. Tenant shall not permit any action that may void roof, HVAC or other warranties or overload any building component or mezzanine. All trash removal, landscaping and snow removal services, including without limitation, application of ice melters on the entire Premises and removal of snow from parking lots, walkways, pathways, doorways and loading docks of the Premises shall be the responsibility of the Tenant, and shall be performed at Tenant’s expense.

 

(b) Landlord shall be responsible, at its cost, to maintain and repair, the roof, foundation and four outer walls of the Building. Landlord shall be responsible for any necessary maintenance, repair or replacement of the HVAC.

 

10. UTILITIES. Tenant shall be solely liable for usage of all utility service to the Leased Premises. All utility bills shall be paid by Tenant. Tenant is to register all utilities servicing the Lease Premises in Tenant’s name. These should be registered by Tenant on or before taking possession of the Lease Premises.

 

3

 

 

11. ENVIRONMENTAL MATTERS. Tenant represents and warrants that it shall not engage in or conduct any activity or operation at the Premises in violation of any applicable environmental laws.

 

12. PERSONAL PROPERTY TAXES. Tenant shall pay all personal property taxes assessed against any leasehold improvements or personal property kept on the Premises during the Lease Term and any extension thereof.

 

13. REAL PROPERTY TAXES. Tenant hereby agrees to reimburse and pay to Landlord, any and all real estate or ad valorem taxes levied or assessed against the Leased Premises or current installments of special assessments, if any, against the real property or Building which are attributable to Tenant’s occupancy of the Premises within the Term. Tenant shall promptly, upon receipt of an invoice from Landlord, but in no event more than ten (10) days after receipt of the invoice, make payment to the Landlord for the full amount of the invoice. The invoice shall include a copy of the applicable tax bill, any and all real estate or ad valorem taxes levied or assessed against the Premises. If applicable, the parties may agree that such taxes have been paid in advance by or on behalf of, Landlord prior to the Commencement Date and that the portion to be paid by Tenant shall be determined by a pro rata adjustment of such taxes on a due date basis for the number of days of the term hereof.

 

14. CASUALTY. In the event of total or partial destruction of the Premises by fire or other casualty through no fault of Tenant, Landlord agrees to promptly restore and repair the Premises at Landlord’s expense to the original condition as when Tenant first took possession of the Premises as of the Commencement Date; provided, however, that Landlord shall not have any obligation hereunder to reconstruct any of the Tenant’s improvements. Any insurance proceeds not used by Landlord in restoring or repairing the Premises shall be the sole property of Landlord. Rent shall proportionately abate during the time that the Premises or part thereof are unusable because of any such damage thereto. Notwithstanding the foregoing, if the Premises are (i) so destroyed that they cannot be repaired or rebuilt within two hundred seventy (270) days from the date on which the insurance claim is adjusted; or (ii) destroyed by a casualty which is not covered by the insurance required hereunder or, if covered, such insurance proceeds are not released by any mortgagee entitled thereto; then either Landlord or Tenant may, upon thirty (30) days’ written notice to the other party, terminate and cancel this Lease as of the date of such casualty and all further obligations hereunder shall thereupon cease and terminate, including without limitation Landlord’s obligation to rebuild the Premises. Notwithstanding anything to the contrary, there shall be no abatement of rental or right to terminate this Lease if such fire or other cause damaging or destroying the Premises shall result from the negligence or willful act of the Tenant, its agents, invitees or employees. If the Tenant shall use any part of the Premises for storage during the period of repair a reasonable charge shall be made therefor against the Tenant. Landlord shall not repair/replace property of Tenant or others.

 

4

 

 

15. SIGNS. Tenant may not place any signs on the exterior of the building without Landlord’s prior written consent, which shall not be unreasonably withheld, conditioned or delayed. Any approved signs must conform to any applicable governmental regulations. Landlord consents to the current signage at the Premises as of the Commencement Date.

 

16. LIABILITY, INDEMNIFICATION AND INSURANCE.

 

(a) During the term of this Lease, Landlord shall maintain commercially reasonable fire and extended coverage insurance at full replacement cost on the Building, with all risk coverage, but shall not protect Tenant’s property or Tenant’s leasehold improvements on the Premises. Tenant agrees to timely reimburse Landlord, upon being billed, for all premiums for such insurance which the Landlord shall carry on the leased premises and which are attributable to Tenant’s possession of the Leased Premises during the Term. Tenant shall reimburse Landlord for all such premiums within 10 days of Landlord’s service of the insurance invoices upon the Tenant. The insurance purchased shall be at the replacement cost of the premises hereinabove described and shall be an all-risk policy.

 

(b) The Tenant agrees to indemnify and hold harmless the Landlord from any liability for damages to any person or property in, on or upon said Premises from any cause whatsoever (except to the extent caused by the negligence or willful misconduct of Landlord, its other tenants or any of its respective agents, employees, visitors or contractors), and Tenant will procure and keep in effect during the term hereof general liability and property damage insurance for the benefit of the Landlord in the sum of Two Million and 00/100 Dollars ($2,000,000.00) for damages resulting to one (1) person and Two Million and 00/100 Dollars ($2,000,000.00) for damages resulting from one (1) casualty, and Two Million and 00/100 Dollars ($2,000,000.00) of property damage insurance resulting from any one (1) occurrence. Tenant shall deliver certificates of insurance for all policies required pursuant to this Section 16 to the Landlord, and upon Tenant’s failure so to do, the Landlord may at its option obtain such insurance and the cost thereof shall be paid as additional rent due and payable upon the next ensuing rent day. Any policies issued pursuant to this Section 16(b) shall name Landlord as an additional insured and loss payee.

 

(c) Landlord agrees to indemnify and hold harmless the Tenant from any liability for damages to any person or property in, on or upon the Premises which arise as a result of Landlord’s gross negligence or intentional misconduct.

 

(d) Tenant acknowledges that it shall be responsible for obtaining insurance for its own personal property.

 

(d) Any policies obtained by the parties pursuant to this Section 16 must also provide for at least thirty (30) days prior written notice to Landlord and Tenant before expiration or cancellation.

 

5

 

 

17. TENANT’S DEFAULT. Tenant’s failure to pay Base Rent, Additional Rent, or to perform its other obligations under this Lease (and any extension or renewal of this Lease), may result in eviction, termination of this Lease, the filing of an action at law or in equity, and such other actions as the Landlord may determine within its sole discretion. Landlord shall not be limited in its choice of remedies. Tenant shall not be excused of its obligation to pay Base Rent, Additional Rent, or other required payments and reimbursements under this Lease without the express written consent of the Landlord or an order from a court of competent jurisdiction otherwise.

 

18. EMINENT DOMAIN. If the whole or any material part of the Premises shall be taken by any public authority under the power of eminent domain, then the term of this Lease shall cease on the part so taken from the day the possession of that part shall be required for any public purpose and the rent shall be paid up to that day. If more than twenty-five percent (25%) of the useable floor space of the Premises is so taken or a portion of the Premises that is material in Tenant’s business operations is so taken, then from that day, either the Landlord or Tenant shall have the right either to cancel this Lease and declare the same null and void. In the event neither party elects to terminate the Lease pursuant to this Section 18, then Tenant shall continue in the possession of the remainder of the term under the terms herein provided, except that the rent shall be reduced in proportion to the amount of the Premises taken. Promptly after any such taking, Landlord, at its sole cost and expense, will make all necessary repairs or alterations to the Building as originally installed by Landlord, so that the remaining Premises shall constitute a complete architectural structure and be able to be used in Tenant’s business. All damages awarded for such taking shall belong to and be the property of the Landlord except Tenant may claim dislocation damages provided such amount does not reduce Landlord’s award.

 

19. TENANT ASSIGNMENT AND SUBLETTING. The Tenant covenants not to assign or transfer this Lease or hypothecate or mortgage the same or sublet said Premises or any part thereof without the written consent of the Landlord.

 

20. ATTORNMENT. In the event the Premises are sold, whether by a foreclosure or otherwise, this Lease shall continue in full force and effect, and Tenant agrees, upon request, to attorn to and acknowledge the successor/owner at such sale as Landlord hereunder; provided such successor/owner will recognize this Lease, unless and until it is in default beyond any applicable cure period. Landlord will provide Tenant with an acceptable subordination, non-disturbance and attornment agreement from any lender holding a mortgage on the Premises immediately upon lease execution and from time to time in the event that a new mortgage is recorded encumbering the Building.

 

6

 

 

21. QUIET ENJOYMENT. The Landlord covenants that the said Tenant, so long as Tenant is not in default hereunder beyond any applicable cure period, shall and may peacefully and quietly have, hold and enjoy the said Premises for the Term aforesaid.

 

22. RIGHT TO RE-ENTER AND TERMINATE. If the Tenant at any time during the Term of this Lease shall:

 

(a) Default in the timely payment of any installment of Base Rent or Additional Rent to be paid by Tenant hereunder within ten (10) days after that such sum was due; or

 

(b) Default in the timely payment of any installment of any sum specifically to be paid by Tenant hereunder (other than Base Rent or Additional Rent) within ten (10) days after written notice from Landlord that such sum was due; or

 

(c) Default in the observance or performance of any of Tenant’s other covenants hereunder (other than the covenant to pay Base Rent or Additional Rent or any other sum herein specified to be paid by Tenant) and such default shall not have been cured within thirty (30) days after Landlord shall have given to Tenant written notice specifying such default; provided, however, that if the default complained of shall be of such a nature that the same cannot be completely remedied or cured within such thirty-day period, then such cure period shall be deemed extended for the purposes of this Section 22 if Tenant shall have commenced curing such default within such thirty-day period and shall proceed with reasonable diligence and in good faith to remedy the default complained of; or

 

(d) Be adjudicated bankrupt or insolvent, or have a receiver or trustee appointed for all or substantially all of its business or assets on the ground of Tenant’s insolvency, or suffer an order to be entered approved a petition filed against Tenant seeking reorganization of Tenant under the Federal Bankruptcy Laws or any other applicable law or statute of the United States or any State thereof; or

 

(e) Make an assignment for the benefit of its creditors, or file a voluntary petition in bankruptcy or a petition or answer seeking reorganization or arrangement under the Federal Bankruptcy Laws or any other applicable law or statute of the United States or any State thereof, or shall file a petition to take advantage of any insolvency act or shall consent to the appointment of a receiver or trustee of all or a substantial part of its business and property; then, upon the happening of any one or more of such events of default and the expiration of any applicable period of time for curing such default, Landlord may, without further demand for rent due or for the observance or performance of any of said terms, conditions or agreements, elect to do one or more of the following: (i) upon reasonable prior written notice to Tenant identifying the act to be done, perform, on behalf and at the expense of Tenant, any obligation of Tenant under this Lease which Tenant has failed to perform, the actual and reasonable cost of which performance by Landlord shall be deemed additional rent and shall be payable by Tenant to Landlord upon demand; (ii) upon not less than fifteen (15) days prior written notice to Tenant, terminate this Lease and re-enter said Premises and remove all persons and property therefrom, in accordance with Michigan law; or (iii) exercise any other right or remedy available to Landlord at law or in equity. If this Lease is terminated pursuant to this Section 22, Tenant shall remain liable for damages and Rent due hereunder.

 

7

 

 

23. ENTRY AND INSPECTIONS. Landlord shall be entitled to enter the Premises upon reasonable advance notice of at least forty-eight (48) hours (except in the event of emergencies) during its normal business hours. Landlord shall be permitted subject to the limitations specified above, to show the Premises to a prospective tenant within the last ninety (90) days of the Term or at any time upon exercise by Tenant of its early termination option under this Lease. Tenant further agrees that during the ninety (90) days prior to the expiration of the Term Landlord may place thereon any usual or ordinary “For Sale” or “To Lease” signs. Landlord and his agent shall at all times have and retain a key with which to unlock all of the doors, in, upon and about the Premises, excluding Tenant’s vaults and safes, to open said doors in an emergency in order to obtain entry to the Premises, and entry to the Premises by Landlord by any means and such entry shall not, be construed or deemed to be a forcible or unlawful entry into or a detainer of the Premises or an eviction of Tenant from the Premises or any portion thereof.

 

24. HOLDING OVER AND RE-RENTING. If Tenant shall retain possession of the Premises or part thereof after expiration or termination hereof, in the absence of a new lease or amendment, then Tenant shall pay Landlord for each month of such retention in the amount of 110% of the monthly Base Rent for the last period prior to the date of such expiration or termination as well as the Additional Rent as required hereunder. Acceptance by Landlord of such payments after such expiration or termination shall not constitute a renewal of this Lease. This provision shall not operate as a waiver of Landlord’s right to re-entry or any other right of Landlord. Tenant shall be a month to month tenant during the period of any such holding over without the consent of Landlord.

 

25. ACCORD AND SATISFACTION. No payment by Tenant or receipt by Landlord of a lesser amount than the monthly rental herein stipulated shall be deemed to be other than on account of the earliest stipulated rent, nor shall any endorsement or statement on any check or any letter accompanying any check or payment as rent be deemed an accord and satisfaction, and Landlord shall accept such check or payment without prejudice to Landlord’s right to recover the balance of such rent or pursue any other remedy.

 

26. WAIVER OF JURY TRIAL. LANDLORD AND TENANT HEREBY WAIVE TRIAL BY JURY IN CONNECTION WITH ANY ACTION FOR SUMMARY PROCEEDINGS TO RECOVER POSSESSION OF REALTY. FURTHER, LANDLORD AND TENANT WAIVE TRIAL BY JURY IN CONNECTION WITH ANY ACTION ARISING OUT OF OR RELATING TO THE COVENANTS, TERMS, CONDITIONS OR PROVISIONS OF THIS LEASE.

 

8

 

 

27. RECEIPT OF MONEY AFTER TERMINATION OF LEASE. No receipt of money by the Landlord from the Tenant after the termination of this Lease shall reinstate, continue or extend the term, nor affect or waive any notice given by the Landlord to the Tenant prior to such receipt of money.

 

28. SUBORDINATION. This Lease shall be subordinate to any mortgage or ground lease. Tenant shall, upon Landlord’s request, execute any instrument or instruments reasonably acceptable to Tenant which shall permit a mortgage against Landlord’s fee interest in the Premises to be superior to the lien of this Lease, provided, however, that any such instrument shall include an agreement with Tenant which will provide that, so long as Tenant pays the rents due under this Lease and is not otherwise in default hereunder beyond any applicable cure period, the holder of such mortgage will not disturb possession of Tenant, notwithstanding any default under such mortgage.

 

29. NOTICES. Any notice or other communication required or permitted to be given under this Lease will be sufficient if it is in writing, sent to the applicable address set forth below (or as otherwise specified by any party by notice to the other parties in accordance with this Section 29) and delivered personally, mailed by certified or registered first-class mail or sent by recognized overnight courier, postage prepaid, and will be deemed given (i) when so delivered personally, sent by facsimile or email (ii) if mailed by certified or registered first-class mail, three business days after the date of mailing, or (iii) if sent by recognized overnight courier, one day after the date of sending.

 

If to Landlord:   If to Tenant:
     
10800 Galaxie Ave., LLC   Robotic Assistance Devices, Inc.
13210 Cloverdale   31103 Rancho Viejo Rd., Suite D2114
Oak Park, MI 48237   San Juan Capistrano, CA 92675
Attn: Yehuda Cohen    
E-Mail: Yehuda@TCFcompanies.com    
     
with a copy to (which shall not constitute notice to Landlord):    
     
Hickey, Cianciolo, Finn & Atkins, PC    
901 Wilshire Dr., Suite 550    
Troy, Michigan 48084    
Attn: Steven M. Hickey    
E-Mail: smh@hclawyers.com    

 

9

 

 

30. CUMULATIVE REMEDIES, NON-WAIVER. The receipt by Landlord of any rent or payment with or without knowledge of the breach of any covenant hereof shall not be deemed a waiver of any such breach and no waiver by Landlord of any sum due hereunder or any provision hereof shall be deemed to have been made unless expressed in writing and signed by Landlord. No delay or omission in the exercise of any right or remedy accruing to Landlord upon any breach by Tenant under this Lease shall impair such right to remedy or be construed as a waiver of any such breach heretofore or condition herein contained and shall not be deemed to be a waiver of any subsequent breach of the same or any other term, covenant or condition herein contained. All rights, powers, options or remedies afforded to Landlord either hereunder or by law shall be cumulative and no alternative and the exercise of one right, power, option or remedy shall not bar other rights, powers, options or remedies allowed herein or by law.

 

31. TIME IS OF THE ESSENCE. Time is of the essence of this Lease, and each provision herein contained. If the Tenant consists of more than one person, all covenants and obligations of the Tenant are joint and several. All terms, conditions and covenants herein agreed to be performed by the Tenant shall be performed at its sole cost and expense.

 

32. SUCCESSORS. The covenants, conditions and agreements made and entered into by the parties hereto are declared binding on their respective heirs, successors, representatives and assigns.

 

33. APPLICABLE LAW, JURISDICTION AND VENUE. This Lease shall be governed by, and construed in accordance with, the laws of the State of Michigan. Disputes will be litigated in the State Courts for the County of Oakland, State of Michigan. Tenant submits to this venue as proper, and submits to the personal jurisdiction of these State Courts, waiving any right of removal to the Federal courts.

 

34. CAPTIONS. The section headings of this Lease are inserted only as a matter of convenience and for reference and in no way define, limit or describe the scope of intent of this Agreement or any provision hereof, or in any way affect this Agreement.

 

35. WAIVER OF SUBROGATION. Landlord shall cause each insurance policy carried by Landlord insuring the Premises against loss by fire and causes covered by standard extended coverage, and Tenant shall cause each insurance policy carried by Tenant and insuring the Premises and its fixtures and contents against loss by fire and causes covered by standard extended coverage, to be written in a manner so as to provide that the insurance company waives all right of recovery by way of subrogation against Landlord or Tenant in connection with any loss or damage covered by any such policies. Neither party shall be liable to the other for any loss or damage caused by fire or any of the risks enumerated in standard extended coverage insurance, provided such insurance was obtainable at the time of such loss or damage. If the release of either Landlord or Tenant, as set forth in the second sentence of this Section 35, shall contravene any law with respect to exculpatory agreements, the liability of the party in question shall be deemed not released but shall be deemed secondary to the latter’s insurance.

 

10

 

 

36. ENTIRE AGREEMENT. All understandings and agreements heretofore made between the parties hereto are merged in this Lease, which alone fully and completely expresses the agreement between Landlord and Tenant, and any executory agreement hereafter made shall be ineffective to change, modify, discharge or effect an abandonment of it, in whole or in part, or a surrender of this Lease or of the Premises or any part thereof or of any interest of Tenant therein unless such executory agreement is in writing and signed by Landlord and Tenant.

 

37. ESTOPPEL CERTIFICATE. Within ten (10) days of request, Tenant shall deliver to Landlord, or any prospective landlord or mortgagee, a statement certifying: a) the Expiration Date; b) that this Lease is unmodified except as specified; c) the date to which Rent has been paid; d) that there are no defaults of Landlord’s obligations except as specified; and e) and other information as reasonably requested, provided the form is mortgagee’s or Landlord’s standard form.

 

38. COUNTERPARTS; AMENDMENTS. This Lease may be executed by the parties hereto in separate counterparts, each of which when executed and delivered shall be an original but all such counterparts shall constitute but one and the same instrument. The parties agree that signatures exchanged by facsimile or PDF format will be deemed original signatures. This Lease may not be terminated, amended, supplemented, waived or modified except by an instrument in writing signed by each of the parties hereto.

 

39. RECORDING. Neither party shall record this Lease or a copy thereof without the written consent of the other.

 

40. BROKERS. Each party represents and warrants unto the other that it has not been represented by a broker, agent or other party in this transaction, and that there are no claims for brokerage commissions or finder’s fees in connection with this Lease, and each party agrees to indemnify the other and hold it harmless from all liabilities arising from any such claim arising from an alleged agreement or act by the indemnifying party (including, without limitation, the cost of counsel fees in connection therewith); such agreement to survive the termination of this Lease.

 

41. LIENS. Tenant shall keep the Property free from liens. Any lien not released or bonded over within ten (10) days of filing may be released by any means Landlord deems reasonable, including payment of the claim. Such sums advanced shall be considered Additional Rent and shall due immediately, but in no instance later than 3 days from demand.

 

42. RULES. Tenant shall comply with all property rules reasonably set forth by Landlord. Tenant may not install signs, lettering or advertising without Landlord’s written consent and must comply with governmental regulations and Property standards. Tenant must use a compactor or covered dumpster for all trash. No outside storage shall be permitted.

 

11

 

 

43. SALE OF PROPERTY. If the Property is sold, Landlord shall be released from future liability and Tenant shall look to Landlord’s successor (if any Security Deposit has been transferred). Except for this Article, this Lease shall not be affected by an ownership change.

 

44. FORCE MAJEURE. Except for timely Rent payment, Landlord or Tenant shall not be in default hereunder when performance of any term or condition is prevented by a cause beyond its control.

 

45. PARKING. Tenant and its guests may use the currently paved areas for passenger vehicle parking. No parking of inoperative vehicles or trailers on the Property is allowed. Tenant shall not sublet any portion of the parking area without the express written consent of the Landlord in advance.

 

IN WITNESS WHEREOF, the parties have hereunto set their hands as of the day and year above set forth.

 

LANDLORD:   TENANT:
         
10800 GALAXIE, LLC   ROBOTIC ASSISTANCE DEVICES, INC.
         
By:     By:  
Name: Yehuda Cohen   Name: Steve Reinharz
Its: Manager   Its: President

 

12

 

 

EXHIBIT A

 

[ATTACH SITE PLAN]

 

13

 

 

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Registration Statement on this Form S-1 of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated June 8, 2026, with respect to our audit of the consolidated financial statements of Artificial Intelligence Technology Solutions, Inc. and Subsidiaries as of February 28, 2026 and February 28, 2025 and for each of the years then ended, which appears in the Registration Statement of Artificial Intelligence Technology Solutions, Inc. in this Form S-1. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

 

/s/ L J Soldinger Associates, LLC  
   
Deer Park, Illinois  
United States of America  
   
July 16, 2026